26Th European Congress of Pathology Pathology – Understanding Disease

26th European Congress of Pathology Pathology – Understanding disease

30 August – 3 September 2014 ExCeL, London, United Kingdom

Final www.esp-congress.org Programme

jointly organised by a European Society of Pathology a Pathology London 2014 Ltd (a trading subsidiary of The Pathological Society of Great Britain and Ireland)

ECP 2014 · London Table of Contents

page page Welcome Address 4 Scientific Programme 27 Saturday, 30 August 2014 28 Organisers 5 Sunday, 31 August 2014 28 Monday, 1 September 2014 40 Committees 6 Tuesday, 2 September 2014 51 Wednesday, 3 September 2014 60 Working Groups of the ESP 7 Poster Sessions 67 Keynote Speakers 8 Sunday, 31 August 2014 68 Monday, 1 September 2014 91 Speaker Public Lecture 12 Tuesday, 2 September 2014 114 Wednesday, 3 September 2014 137 Bursaries 13 Congress Information 161 CME / CPD Accreditation 14 Industry Symposia 167 Venue Overview 15 Acknowledgements 172 Programme Overview 17 Colour Legend 17 Exhibition Floor Plan 174 Saturday, 30 August 2014 17 Sunday, 31 August 2014 18 List of Exhibitors 175 Monday, 1 September 2014 20 Tuesday, 2 September 2014 22 Social Events 180 Wednesday, 3 September 2014 24 Tours 181

Index of Authors 187

e Host Organisations e Congress and Exhibition Office European Society of Pathology Rue Bara 6 1070 Brussels, Belgium CPO HANSER SERVICE GmbH and Paulsborner Str. 44 Pathology London 2014 Ltd 14193 Berlin, Germany (a trading subsidiary of The Pathological Phone: +49 – 30 – 300 669-0 Society of Great Britain and Ireland) Fax: +49 – 30 – 305 73 91 Company Registered in England and Wales, Email: [email protected] Co No: 8425474 e Congress Venue e Scientific Contact ExCeL London Prof. Ian Ellis One Western Gateway Nottingham University Hospitals Royal Victoria Dock Dept Histopathology, City Hospital Campus, London E16 1XL, UK Nottingham City Hospital www.excel-london.co.uk Hucknall Road Nottingham NG5 1PB, UK www.esp-congress.org

Phone: +44 – 115 – 9691169 Extension 56875 E-mail: [email protected] 3 Welcome Address ECP 2014 · London

Dear Colleague,

The 26th European Congress of Pathology (ECP 2014) will for the first time be organised as a joint venture between the European Society of Pathology and Pathology London 2014 Ltd (a trading subsidiary of The Pathological Society of Great Britain and Ireland).

It will be held, from 30 August to 3 September 2014 in the ExCeL Centre in London, United Kingdom.

On behalf of the European Society of Pathology and the Pathological Society of Great Britain and Ireland we would like to invite you to join us in London for a meeting that will be both exciting and involving, reflecting the rapid changes in our profession, both in unravelling disease mechanisms and in our clinical diagnostic working practice.

The motto of the Congress – Understanding Disease – is the well-known mission statement of Pathological Society of Great Britain and Ireland. And it is timely, now that we have greater understanding of many diseases arising from the ongoing revolution in genetics and other translational research methods.

Pathology is more than ever at the centre of clinical decision making, resulting in new challenges and opportunities. It is the philosophy of both the European Society of Pathology and the Pathological Society of Great Britain and Ireland that through better understanding of diseases we can improve the quality of diagnosis and treatment of patients.

The London 2014 scientific programme aims to bring science, translational research and clinical application together to provide delegates with a comprehensive forum for dissemination of research findings, exploration of modern technologies and up to date education.

In addition to providing a rewarding scientific and educational programme the London 2014 meeting will bring together pathologists and scientists from all over the world in a convivial environment providing a memorable social experience. We are looking forward to welcoming you and spending a great time in London.

Prof. Han van Krieken President of the European Society of Pathology

Prof. Ian Ellis President of the Pathological Society of Great Britain and Ireland

4 ECP 2014 · London Organisers e Brief Description of the ESP e Brief Description of The European Society of Pathology (ESP) The Pathological Society was established in 1963 in Brussels and is The Pathological Society of Great Britain and a leading force in European pathology and, Ireland, founded in 1906, is the professional as such, is pivotal to the future of the spe- organisation supporting academic pathol- cialty in Europe and beyond. As a scientific ogy in the UK and is dedicated to enhanc- society, the ESP has, as its primary aim, the ing high quality research and education in promotion of high quality diagnostic prac- pathology in its broadest sense. The stated tice, applied and translational research and focus and mission of the Pathological Society under- and postgraduate education in the is to promote the understanding of disease field of human pathology. This is achieved and the Society actively engages with other through its congresses, its journal Virchows organisations and in partnership to develop Archiv and various other activities. The ESP programmes to achieve this goal. We are de- interacts with national pathology societies in lighted that Understanding Disease has been Europe and has developed links with other adopted as the motto of London 2014 our EU bodies in close collaboration with UEMS joint meeting with the European Society of (Union Européenne des Médecins Spécial- Pathology. Membership of the Society, often istes) and EAPCP (European Association of referred to as Path Soc, is open to all indi- Pathology Chairs and Programme Directors). viduals involved in pathological research and education and includes the option of a sub- The European School of Pathology under the scription to our Society Journal. The Journal auspices of the ESP and with the support of of Pathology is one of the foremost and high- 19 Working Groups representing different est impact journals in the field. fields of pathology is involved in the organisation of courses to meet the needs of young Path Soc currently hosts a major conference pathologists. The ESP also provides an in- twice a year with outstanding speakers on a frastructure for quality assurance projects in range of topics from basic molecular pathol- diagnostic molecular pathology, such as the ogy to diagnostic practice and provides a ESP QA KRAS project for testing of colorectal forum for investigators across the world to cancer. present their research. The Society also has a generous range of grants that it awards to Office of the ESP its members including PhD studentships, Rue Bara 6, 1070 Brussels, Belgium scholarships and travel support. It aims to Phone: +32 – 485899129 facilitate future high quality research, by de- Fax: +32 – 25208036 veloping programmes for undergraduate and E-mail: [email protected] postgraduate teaching, and by engaging with www.esp-pathology.org the general public.

Pathological Society of Great Britain and Ireland 2 Carlton House Terrace, London, SW1Y 5AF, UK Phone: +44 – 20 7976 1260 Fax: +44 – 20 7930 2981 E-mail: [email protected] www.pathsoc.org www.pathsoc.org / conversations

5 Committees ECP 2014 · London e Executive Council of the ESP President: Han van Krieken, The Netherlands President-elect: Pierre Bedossa, France Secretary: Ilmo Leivo, Finland Treasurer: Marco Santucci, Italy Members: Aurelio Ariza, Spain Arzu Ensari, Turkey Jean-François Fléjou, France Janina Kulka, Hungary Holger Moch, Switzerland Aleš Ryška, Czech Republic Dina Tiniakos, Greece Gordan M. Vujanic, UK Past President: Fátima Carneiro, Portugal President of the Advisory Council: Fred Bosman, Switzerland e Pathological Society Finance and General Purposes Sub-committee and Co-opted Committee Members for the Dutch and Irish representatives

President: Ian Ellis General Secretary: Richard Byers Treasurer: Nicholas Rooney Meetings Secretary: Adrienne Flanagan Chair, Education & Training Sub-committee: Elizabeth Soilleux Chair, Research Sub-committee: Mohammad Ilyas Dutch Path Soc Representative: Roel Goldschmeding Irish Republic Representative: Cecily Quinn a Organising Committee Ian Ellis, UK Richard Byers, UK Adrienne Flanagan, UK Nicholas Rooney, UK Han van Krieken, The Netherlands Fred T. Bosman, Switzerland Fátima Carneiro, Portugal Michael Wells, UK

6 ECP 2014 · London Working Groups of the ESP

Chair of the ESP Working Groups: Fátima Carneiro, Portugal

1. Breast Pathology 11. IT in Pathology, computational Chair: A. Sapino, Italy Chair: K. Kayser, Germany Secretary: G. Cserni, Hungary 12. Molecular Pathology 2. Cytopathology Chair: G. Stanta, Italy Chair: P. Zeppa, Italy Secretary: G. Hoefler, Austria 3. Dermatopathology 13. Nephropathology Chair: T. Brenn, UK Chair: I. S. D. Roberts, UK 4. Digestive Diseases Pathology Secretary: H. Hopfer, Switzerland Chair: C. Langner, Austria 14. Paediatric and Perinatal Pathology Secretary: V. Paradis, France Chair: M. Cohen, UK 5. Electron Microscopy Secretary: P. Borralho Nunes, Portugal Chair: J. Lloreta-Trull, Spain 15. Pathologists / Cytologists and Techni- Secretary: A. Franchi, Italy cians in Favour of Developing Countries 6. Endocrine Pathology Chair: D. Soldini, Switzerland Chair: A. Couvelard, France 16. Pulmonary Pathology Secretary: Y. Kapran, Turkey Chair: L. Carvalho, Portugal 7. Gynaecological Pathology 17. Soft Tissue and Bone Pathology Chair: M. R. Raspollini, Italy Chair: P. C. W. Hogendoorn, Secretary: S. Stolnicu, Romania The Netherlands 8. Head and Neck Pathology Secretary: A. Neuville, France Chair: I. Fonseca, Portugal 18. Thymic and Mediastinal Pathology Secretary: S. Di Palma, UK Chair: A. Marx, Germany 9. History of Pathology 19. Uropathology Chair: J. van den Tweel, The Netherlands Chair: A. Lopez-Beltran, Spain 10. Infectious Diseases Pathology Chair: G. Cathomas, Switzerland

Associated Societies a Association for European Cardiovascular Pathology (AECVP) a European Association for Haematopathology (EAHP) a Paediatric Pathology Society (PPS)

7 Keynote Speakers ECP 2014 · London e Harald Stein (Germany)

Harald Stein is Emeritus Professor of the Charité University Medicine Berlin. Currently he is chairman of the Berlin Re- ference Center for Lymphoma- and Haematopathology and director of the Institute for Pathodiagnostik Berlin.

His scientific findings include the discovery of histiocytic lymphomas being derived from B cells, the proliferation marker molecule Ki-67, the Hodgkin lymphoma most characteristic cytokine receptor CD30, the description of three new lymphoma diseases anaplastic large cell lymphoma, plasmablastic lymphoma and nodular B-cell rich classical Hodgkin lymphoma. He contributed to the finding that the dysplastic cells of Hodgkin lymphoma are monoclonal expansions of B cells.

Together with Peter Isaacson he founded in 1991 the International Lymphoma Study Group (ILSG) by bringing 19 internationally known experts in haematopathology together which resulted in a close cooperation between the old and new world and finally in a worldwide used lymphoma classification published by the WHO in 2001 and updated in 2008.

8 ECP 2014 · London Keynote Speakers e Ian Tomlinson (UK) BM, BCh, MA, PhD, FRCPath, FMedSci a Professor of Molecular and Population Genetics, University of Oxford a Fellow of The Queen’s College, Oxford a Honorary Consultant in Clinical Genetics, Oxford University Hospitals and Regional Genetics Service a Visiting Professor, University College, London

Publications Over 400 publications in peer-reviewed journals and book chapters, mostly in the field of cancer genetics

Prizes and awards a EV50 European Achiever of the Year, 2005 a EU Descartes Prize Finalist, 2005 a Fellow of the Academy of Medical Sciences, 2009 a The United European Gastroenterology Research Prize, 2013

Invited keynote lectures a Goudie Lecture, Pathological Society of Great Britain and Ireland, 2014 a Keynote Lecture, Golden Helix Symposium, Torino, 2012 a Eldon Gardner Lecture International Society for Hereditary Gastrointestinal Tumours, San Antonio, 2011 a Keynote Lecture, Polymorphisms and Colorectal Cancer Risk, Dutch Society for Tumour Cell Biology, 2008 a Special Lecturer, Common genes and cancer, European School of Genetic Medicine, Bolo- gna, 2007 a Invited speaker, Princess Takamatsu Symposium on Colorectal Cancer, Tokyo, 2007

9 Keynote Speakers ECP 2014 · London e Jan Hoeijmakers (The Netherlands)

Our DNA is constantly damaged by influences from inside and outside our body. Damage in our DNA can cause diseases, like cancer, and it can make our body age. Prof. Jan Hoeijma- kers researches our DNA repair mechanisms. By modulating DNA repair, he recently succeeded in largely controlling the process of ageing in mammals like mice.

Background Jan Hoeijmakers Prof. Jan Hoeijmakers is an expert in the field of DNA repair and ageing. He studied biology and joined the genetics department of Erasmus MC after taking his doctoral degree in 1981. Since 1993 he is professor in Molecular Genetics at Erasmus University Rotterdam. Under his leadership, a brand new molecular biological research started in the field of ageing and cancer.

Hoeijmakers has received various prices and grants for his scientific work.

10 ECP 2014 · London Keynote Speakers e Susanne Burdak-Rothkamm (UK)

Professional education & employment 1993 – 1999 Medical School, Justus-Liebig-University, Giessen, Germany 1999 – 2003 Foundation Year Equivalent (AiP) & Research Fellow, Saarland University Hospital, Germany 2003 – 2007 Research Fellow, Gray Cancer Institute, Northwood / Oxford University, UK 2007 – 2008 Research Fellow, CCRCB, Queen’s University Belfast, UK 2008 – 2011 Specialty Registrar in Histopathology, Buckinghamshire Hospitals, UK 2011 – 2014 Specialty Registrar in Histopathology, Oxford University Hospitals, UK since 08 / 2014 Molecular Diagnostics Fellow, Oxford University, UK

Selected publications a Burdak-Rothkamm S, Rothkamm K, Prise KM. Contribution of the BRCA / FA Pathway to the Radiation-induced DNA Damage Response in Non-targeted Cells. Journal of Pathology 224 (2011), S12-S12 a Rothkamm K, Burdak-Rothkamm S. Ionizing Radiation-Induced DNA Strand Breaks and gamma-H2AX Foci in Cells exposed to Nitric Oxide. Methods Mol Biol 704:17-25 (2011) a Burdak-Rothkamm S, Rothkamm K, Prise K. Inter-Cellular Activation of DNA Damage Signal- ling Following Radiation Treatment. Journal of Pathology 222 (2010), S11-S11 a Bauerschmidt C, Arrichiello C, Burdak-Rothkamm S, Woodcock M, Stevens DL, Hill MA, and Rothkamm K. Cohesin promotes the repair of ionising radiation-induced DNA double-strand breaks in replicated chromatin. Nucleic Acids Res 38:477-87 (2010) a Burdak-Rothkamm S, and Prise KM. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. European Journal of Pharmacology, 625:151-155 (2009) a Burdak-Rothkamm S, Rothkamm K, and Prise KM. ATM acts downstream of ATR in the DNA damage response signalling of bystander cells. Cancer Res, 68:7059-7065 (2008) a Tartier L, Gilchrist S, Burdak-Rothkamm S, Folkard M, and Prise KM. Cytoplasmic irradiation induces mitochondrial dependent 53BP1 protein relocalization in irradiated and bystander cells. Cancer Res, 67:5872–5879 (2007) a Burdak-Rothkamm S, Short SC, Folkard M, Rothkamm K, and Prise KM. ATR-dependent radiation-induced gamma-H2AX foci in bystander primary human astrocytes and glioma cells. Oncogene, 26:993-1002 (2007) a Burdak-Rothkamm S, Rübe CE, Nguyen TP, Ludwig D, Feldmann K, Wiegel T, and Rübe C. Radiosensitivity of tumour cell lines after pre-treatment with the EGFR-tyrosine kinase inhibitor ZD1839 (Iressa). Strahlenther Onkol, 181(3):197-204 (2005)

11 Speaker Public Lecture ECP 2014 · London e Christopher Fletcher (USA)

CHRISTOPHER D.M. FLETCHER, M.D., FRCPath, graduated from St. Thomas’s Hospital Medical School in London and ob- tained postgraduate qualifications from the Royal College of Pathologists (MRCPath – 1988) and the University of London (M.D. – 1991) in the United Kingdom. He received his training in pathology at St. Thomas’s Hospital / United Medical & Den- tal Schools in London, U.K.

Dr. Fletcher’s main areas of interest include the clinicopathologic and molecular genetic analyses of soft tissue tumours. Dr. Fletcher has published extensively on the pathology of soft tissue tumours and is probably best known for his work challenging the diagnostic entities of malignant fibrous histiocytoma and hemangiopericytoma. He has also described for the first time a variety of lesions, including, among others, deep benign fibrous histiocytoma, angiomyofibroblastoma, retiform hemangioendothelioma, spindle cell liposarcoma, myoepithelial lesions of soft tissue, cellular angiofibroma and soft tissue angiofibroma. He has worked extensively on cytogenetic / morphologic correlations in soft tissue tumours. He is Chairman of the WHO Working Group on the classification of soft tissue tumours, having been senior editor of both the 2002 and most recent 2013 classifications. He has nearly 600 publications, including almost 400 original pa- pers on soft tissue neoplasms, and several books, among which are the two-volume Diagnostic Histopathology of Tumours, the 4th edition of which was published in Spring of 2013, and the 3rd series AFIP Fascicle on Soft Tissue Tumours.

He has been the recipient of numerous honors and awards (including most recently the Harvey Goldman Distinguished Teacher & Mentor award of the USCAP), is on the editorial board of 17 international journals and was President of the Association of Directors of Anatomic and Surgical Pathology for two terms from 2003-2006. More recently he has been President of the International Society of Bone & Soft Tissue and Bone Pathology and the President of the Arthur Purdy Stout Society. Before moving to the United States in 1995, Dr. Fletcher was the Director of the Soft Tissue Tumour Unit at St. Thomas’s Hospital in London and Professor of Surgi- cal Pathology in the University of London; he is currently Professor of Pathology at Harvard Medical School, Vice Chair, Anatomic Pathology at Brigham and Women’s Hospital, Boston, Massachusetts and Chief of Onco-Pathology at the Dana-Farber Cancer Institute in Boston.

12 ECP 2014 · London Bursaries e Bursaries The ESP and the Pathological Society have awarded bursaries to support the attendance of residents and trainees in pathology at the congress in London. Bursaries include a free registration to the congress as well as a monetary grant of EUR 150.

The recipients are: Pavla Latalova, Czech Republic Maham Akhlaq, UK Pedro Luis, Portugal Iban Aldecoa, Spain Ana Luís, Portugal Makbule Çisel Aydin, Turkey Javier Martin Lopez, Spain Svitlana Bachurska-Yovcheva, Bulgaria Tamara Martinovic, Serbia Iulia Barsan, Romania Denisa Georgiana Moncea, Romania Alberto Berjón García, Spain Filipa Moreno, Portugal Hemalatha Bhuvanai-Sitaraaman, UK Nazarena Nannini, Italy Adelina Birceanu-Corobea, Romania Adela-Corina Nechifor-Boila, Romania Marie Bjødstrup Jensen, Denmark Daniela Necula, Israel Martina Bosic, Serbia Tzahi Neuman, Israel John Brain, UK Eranga Nissanka-Jayasuriya, UK Meral Bugdayci, Turkey Caetano Oliveira, Portugal María Cámara, Spain Helder Oliveira Coelho, Portugal Lucian Ceacaru, Romania Alexandra Oniga, Romania Raluca Chirculescu, Romania Santiago Ortiz, Portugal André Coelho, Portugal Ozgur, Ozkayar, Turkey Andreea, Contolenco, Romania Joana Pardal, Portugal Jennifer Costa, Portugal Diana Pasov, Romania Francisca Costa, Portugal Luis Pérez-Casanova, Spain Krasimir Dangalov, Bulgaria Jorge Pinheiro, Portugal Renata Dias, Portugal Anamaria Pop, Romania Lyubomira Dimitrova, Bulgaria Christos Poulios, Greece Tihana Dzombeta, Croatia Valentina Ranucci, Italy Diana Felizardo, Portugal Marc Rassy, Lebanon Sarra Fouli, Tunisia Cioly, Rivero Colmenarez, Spain Ana Galaghar, Portugal Alejandra Rosell Alayza, Spain Tsvetomir Garev, Bulgaria Rita Sampaio, Portugal María Belén Goiburú Chenú, Spain Liliana Santos, Portugal Diogo, Gonçalves, Portugal Denitsa Serteva, Bulgaria Ayse Gül Gülay, Turkey Sabina Shrestha, Nepal Banita Gurung, Nepal Roberto Silva, Portugal Laura Herrero, Spain Shikha Singhal, UK Agota Ilyes, Romania Chella van der Post, The Netherlands Ahmed Ismail, Egypt Jelena Vjestica, Serbia Koni Ivanova, Bulgaria Monica-Gheorghina Weber, Romania Ivana, Jelicic, Serbia Xiaogang Wen, Portugal Nikolay Karnaukhov, Russia Jessie M. Wu, UK Orsolya Kiss, Hungary Zarifa Yusifli, Turkey Viktor H. Koelzer, Switzerland Tatjana Zablocka, Latvia Bence Kõvári, Hungary Maja Zivotic, Serbia Levente Kuthi, Hungary Johanne Lade Keller, Denmark

13 CME / CPD Accreditation ECP 2014 · London e CME Accreditation e Continual Professional Develop- The ESP 26th European Congress of Patholo- ment (CPD) Accreditation gy (ECP 2014) is accredited by the European Royal College of Pathologists – AccreditationCouncil for Continuing Medical CPD Accreditation Education (EACCME) to provide the following CME activity for medical specialists. The Delegates must sign in every day they are at- EACCME is an institution of the European tending at the Pathological Society Booth in Union of Medical Specialists (UEMS), www. order to be issued with certificates. uems.net. The '26th European Congress of Credits can only be issued for each full day of Pathology (ECP 2014)' is designated for a attendance as shown below. Those attending maximum of 24 hours of European external for less than a full day need to claim credits CME credits. Each medical specialist should by submitting reflective notes in their CPD claim only those hours of credit that he/she portfolio. actually spent in the educational activity. 31 Aug 2014 7 credits Through an agreement between the European Union of Medical Specialists and the American 1 Sept 2014 7 credits Medical Association, physicians may convert 2 Sept 2014 7 credits EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information 3 Sept 2014 7 credits on the process to convert EACCME credit to AMA credit can be found at www.ama-assn. Whole congress 29 credits org/go/internationalcme. Live educational activities, occurring outside of Canada, recognized by the UEMS- IBMS (Institution of Biomedical Sciences) EACCME for ECMEC credits are deemed CPD Accreditation to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of CPD Code: MC008N14 Certification Program of The Royal College of Physicians and Surgeons of Canada. Credits = 5 for full day attendance

The following credits are given for each con- Attendees are encouraged to participate in gress day reflective practice. IBMS Members should see www.ibms.org for further information on Half Full reflection as part of their continuing professi- CME credits congress day congress day onal development.

31 Aug 2014 3 credits 6 credits

1 Sept 2014 3 credits 6 credits

2 Sept 2014 3 credits 6 credits

3 Sept 2014 3 credits 6 credits

Please note: Please note: Participants can get their CME certifica- Delegates must sign in every day they are at- tes at the CME terminals located in the tending at the Pathological Society Booth Registration Area. in order to be issued with CPD certificates.

14 ECP 2014 · London Venue Overview e Level 0 ICC Auditorium ICC Auditorium

Registration ESP/Path Soc Counter Booth Main Entrance Catering Poster Exhibition Poster Technical Exhibition Technical ICC Capital Hall

15 Venue Overview ECP 2014 · London

e Level 3

Entrance to Capital Suite 16 / Room 17 Room 14 Room 1 5 12 11 10 Room 7 / Room 8 / Room 9 / Speakers‘ Preview Room Speakers‘ Preview ICC Capital Suite Room 1

16 ECP 2014 · London Colour Legend e Colours and Abbreviation Codes of Sessions

BREAST Breast pathology KEYNOTE Keynote lectures

CARD Cardiovascular pathology MOPA Molecular pathology

CYTO Cytopathology NEPH Nephropathology

Pathologists in favour of DEVEL NEURO Neuropathology developing countries

DERM Dermatopathology OPHTH Ophthalmic pathology

DIGE Digestive diseases pathology OTHER Other topics

EM Electron microscopy PAED Paediatric and perinatal pathology

ENDO Endocrine pathology PULM Pulmonary pathology

GYNAE Gynaecological pathology SO-TI Soft tissue and bone pathology

HAEMA Haematopathology SPEC-ESP Special session ESP

Special session H & N Head and neck pathology SPEC-PSOC Pathological Society

HIST History of pathology THYM Thymic and mediastinal pathology

INFE Infectious diseases pathology URO Uropathology

IT IT in pathology

BM a Business Meeting SS a Slide Seminar OFP a Oral Free Paper Session SY a Symposium PSOC a Pathological Society Session TR a Trainee Session SC a Short Course UG a Undergraduate Session SPEC a Special Session VM a Videomicroscopy

Programme Overview per Day e Saturday, 30 August 2014

16:00 – 19:00 Registration

19:00 – 22:00 OPENING CEREMONY (ICC Auditorium) and WELCOME RECEPTION (ICC Capital Hall)

20:00 – 22:00 Technical Exhibition (ICC Capital Hall)

17 Programme Overview per Day ECP 2014 · London e Sunday, 31 August 2014

ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Auditorium Suite 7 / 12 Suite 8 / 11 Suite 9 / 10 Suite 14 Suite 15 / 16 Suite 17 Suite 1

07:15 ICC Capital Suite 1 a Industry-sponsored Session ICC Capital Suite 1 a Industry-sponsored Session 07:15 – – 08:15 (see page 168) (see page 168) 08:15

SY BREAST SC PULM SS H&N SY Joint ENDO SY Joint GYNAE SPEC ESP / EQA SY HISTORY OFP DIGE I & CYTO & URO

Integrating Pleura & Diagnostic Thyroid surgical Similarities and ESP Quality Great Men of Digestive morphology and Mesothelioma difficulties pathology and dissimilarities Assurance Guy’s Hospital diseases molecular pathol- in head and neck cytopathology: between male Programme and their diseases pathology I ogy: A need and female (EQA) 08:30 pathology Same target dif- 08:30 for a new breast uro-genital tract – ferent problems? – cancer prognostic pathology 12:00 12:00 index 09:30 – 10:30 09:30 – 10:30 inc Path Soc / Japanese Soc of Pathology Lecture Coffee Break & Poster Viewing & Poster 9 Coffee Break Coffee Break & Poster Viewing & Poster 9 Coffee Break (Presenters to be on-site for discussion) (Presenters to be on-site for discussion)

12:15 12:15 ICC Auditorium e Path Soc Doniach Lecture Harald Stein (Germany) ICC Auditorium e Path Soc Doniach Lecture Harald Stein (Germany) – – Road to a modern lymphoma classification Road to a modern lymphoma classification 13:00 13:00

13:00 ICC Capital Suite 7 / 12, 8 / 11 and 9 / 10 a Industry-sponsored Sessions ICC Capital Suite 7 / 12, 8 / 11 and 9 / 10 a Industry-sponsored Sessions 13:00 – – 14:30 (see pages 168 / 169) (see pages 168 / 169) 14:30 4 Lunch 4 Lunch SS BREAST SY PULM SC H&N SY+ BM ENDO SY MEDIA SY ICCR OFP URO OFP CARD 07:00 – 19:00 Registration 09:00 – 17:00 Technical Exhibition 09:00 – 17:00 Technical Invasive or Small Airways Recent Unifying Pathology, The ICCR Uropathology Cardiovascular non-invasive? Disease advances in concepts in patients and the approach to pathology 14:30 14:30 the pathogenesis carcinoids / well- public cancer reporting – – and diagnosis differentiated in the era of 16:30 16:30 of head and NETs, from head biomarkers and neck tumours to toes targeted therapies: We’re here to help!

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee BM BREAST BM PULM SY H&N SS ENDO OFP MOPA VM PSOC OFP DERM OFP SO-TI

Business Meeting Microenviron- Update Difficult Molecular pathol- Gastrointestinal Dermatopathol- Soft tissue and ment in lung in molecular issues in ogy Stromal Tumours ogy bone pathology 17:00 17:00 cancer pathology of endocrine – – head and neck tumours 19:00 19:00 tumours

18 ECP 2014 · London Programme Overview per Day

e Sunday, 31 August 2014

ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Auditorium Suite 7 / 12 Suite 8 / 11 Suite 9 / 10 Suite 14 Suite 15 / 16 Suite 17 Suite 1

07:15 ICC Capital Suite 1 a Industry-sponsored Session ICC Capital Suite 1 a Industry-sponsored Session 07:15 – – 08:15 (see page 168) (see page 168) 08:15

SY BREAST SC PULM SS H&N SY Joint ENDO SY Joint GYNAE SPEC ESP / EQA SY HISTORY OFP DIGE I & CYTO & URO

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee BM BREAST BM PULM SY H&N SS ENDO OFP MOPA VM PSOC OFP DERM OFP SO-TI

19 Programme Overview per Day ECP 2014 · London e Monday, 1 September 2014

ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Auditorium Suite 7 / 12 Suite 8 / 11 Suite 9 / 10 Suite 14 Suite 15 / 16 Suite 17 Suite 1 SC URO SY PSOC SS DERM SY OPHTH SC HAEM SY CARD SY IT OFP BREAST

Advances in Next generation Important diag- Applied molecu- Myeloprolifera- Consensus docu- Digital pathology Breast pathology uropathology: sequencing and noses in dermato- lar diagnostics tive Syndromes ment on surgical in routine diag- The art and pathology pathology in ocular (MDS) and My- pathology of the nosis: Applica- science of uropa- (organised by pathology eloproliferative aorta from the tion, barriers, 08:30 08:30 thology Trainees) Neoplasms Association consultation, – – (MPN): Mimics, for European and standardiza- 12:00 12:00 progressions and Cardiovascular tion

09:30 – 10:30 transformation Pathology and the 09:30 – 10:30 Society for Cardiovascular Pathology Coffee Break & Poster Viewing & Poster 9 Coffee Break Viewing & Poster 9 Coffee Break (Presenters to be on-site for discussion) (Presenters to be on-site for discussion)

12:15 12:15 ICC Auditorium e Path Soc Goudie Lecture Ian Tomlinson (UK) ICC Auditorium e Path Soc Goudie Lecture Ian Tomlinson (UK) – – The genetics of colorectal cancer The genetics of colorectal cancer 13:00 13:00

13:00 ICC Capital Suite 7 / 12, 8 / 11 and 9 / 10 a Industry-sponsored Sessions ICC Capital Suite 7 / 12, 8 / 11 and 9 / 10 a Industry-sponsored Sessions 13:00 – – 14:30 (see page 170) (see page 170) 14:30 4 Lunch 4 Lunch SY Joint ISUP / SY PSOC / SY DERM SPEC Joint ESP / SY Joint HAEM SC CARD OFP DIGE II OFP ENDO ESP / URO JPATH EORTC & H&N 09:00 – 17:00 Technical Exhibition 09:00 – 17:00 Technical 08:00 – 19:00 Registration Recent develop- The pathology of Developments SPECTA Lymphoprolif- Lymphatic Digestive Endocrine and ments in urologic drug discovery in melanoma platforms eration in the system: The diseases molecular breast 14:30 14:30 cancer and development head and neck: forgotten second pathology II pathology – – Lymphoma and circulation 16:30 16:30 lymphoma- in health and mimics disease

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee SS + BM URO SY PSOC SY Joint DERM SPEC ESP OFP HAEM VM GYN OFP PAED OFP H&N & MOPA

Tumour-like Trainees – Meet Molecular ESP Postgraduate Haematopathol- Difficult cases in Paediatric and Head and neck conditions in the experts pathology of skin Symposium: ogy gynaecological perinatal pathology 17:00 17:00 uropathology (organised by malignancies Histopathology pathology pathology – – Trainees) training and 19:00 19:00 competency testing across Europe

20:30 20:30 – Congress Concert Congress Concert – 22:30 Central Hall Westminster Central Hall Westminster 22:30

20 ECP 2014 · London Programme Overview per Day

e Monday, 1 September 2014

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee SS + BM URO SY PSOC SY Joint DERM SPEC ESP OFP HAEM VM GYN OFP PAED OFP H&N & MOPA

20:30 20:30 – Congress Concert Congress Concert – 22:30 Central Hall Westminster Central Hall Westminster 22:30

21 Programme Overview per Day ECP 2014 · London e Tuesday, 2 September 2014

ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Auditorium Suite 7 / 12 Suite 8 / 11 Suite 9 / 10 Suite 14 Suite 15 / 16 Suite 17 Suite 1 SY DIGE SY PSOC SY NEPH SC Joint PAED SY CYTO SY INFE OFP Joint IT SC NEURO & GYNAE & OTHER

Basics of invasion Undergraduate Complement Trophoblastic Advances in head Infectious dis- IT in pathology What is new for and metastasis Forum in renal disease diseases and neck cytopa- eases pathology / and other topics general patholo- in cancers of the and differential thology European Bone gists digestive system diagnosis Marrow Working 08:30 08:30 Group: Infectious – – diseases involve 12:00 12:00 the Bone Marrow 09:30 – 10:30 09:30 – 10:30 Coffee Break & Poster Viewing & Poster 9 Coffee Break Viewing & Poster 9 Coffee Break (Presenters to be on-site for discussion) (Presenters to be on-site for discussion)

12:15 ICC Auditorium e ESP Symeonidis Lecture Jan Hoeijmakers (The Netherlands) ICC Auditorium e ESP Symeonidis Lecture Jan Hoeijmakers (The Netherlands) 12:15 – The impact of DNA damage on ageing; getting ageing largely under The impact of DNA damage on ageing; getting ageing largely under – 13:00 control in mice control in mice 13:00

13:00 ICC Capital Suite 7 / 12 and 8 / 11 a Industry-sponsored Sessions ICC Capital Suite 7 / 12 and 8 / 11 a Industry-sponsored Sessions 13:00 – – 14:30 (see page 171) (see page 171) 14:30 4 Lunch 4 Lunch SC DIGE SY Joint PSOC SY NEPH BM PAED SC CYTO SY + BM INFE BM + SS GYNAE SY Joint NEURO / JPATH / HIST PATH SOC / ESP 09:00 – 17:00 Technical Exhibition 09:00 – 17:00 Technical 08:00 – 19:00 Registration Obesity and Concerning the Renal transplant Hot topics in Exfoliative cyto- Infections you The future of OB- Brain tumours – digestive disease origin of malig- pathology paediatric pathology what might regret GYN pathology From new basic 14:30 14:30 pathology nant tumours: pathology is the future? missing concepts to an – – Boveri at 100 improved practi- 16:30 16:30 cal approach

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee BM DIGE SY + BM SO-TI SS NEPH SS PAED SS CYTO VM HAEM OFP GYN OFP Joint NEURO & OPHTH

What´s hot in Genetics and Challenging Foetal and pae- Lung and MYC or not MYC? Gynaecological Neuropathology / digestive disease therapeutic glomerular diatric thoracic mediastinal All you need to pathology Ophthalmic 17:00 17:00 pathology? targets in diagnoses pathology cytopathology know about MYC- pathology – – sarcoma driven aggressive 19:00 19:00 B-cell lymphomas

22 ECP 2014 · London Programme Overview per Day

e Tuesday, 2 September 2014

16:30 16:30 – –

17:00 Break Break 17:00 9 Coffee 9 Coffee BM DIGE SY + BM SO-TI SS NEPH SS PAED SS CYTO VM HAEM OFP GYN OFP Joint NEURO & OPHTH

23 Programme Overview per Day ECP 2014 · London e Wednesday, 3 September 2014

ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Capital ICC Auditorium Suite 7 / 12 Suite 8 / 11 Suite 9 / 10 Suite 14 Suite 15 / 16 Suite 17 Suite 1 SY DIGE SY SO-TI SY GYNAE UG ESP / IAP SY EM BM MOPA SY + BM DEVEL OFP PULM

Joint UEG and Practical Breaking news in Pathology in Multidisciplinary Technological Carrying out Pulmonary ESP symposium: challenges in gynaecological medical under- approach to the improvement research projects pathology Grading and scor- soft tissue pathology (WHO graduate educa- diagnosis of oriented to better in African coun- ing in digestive classification tion mesothelioma diagnostics in tries: A challenge 08:30 08:30 disease pathology and beyond) and non-small FFPE tissues that becomes – – cell lung car- reality 12:00 12:00 cinoma in the

09:30 – 10:30 era of targeted 09:30 – 10:30 therapy Coffee Break & Poster Viewing & Poster 9 Coffee Break Viewing & Poster 9 Coffee Break (Presenters to be on-site for discussion) (Presenters to be on-site for discussion)

12:00 12:00 – ICC Auditorium e ESP General Assembly ICC Auditorium e ESP General Assembly – 13:00 13:00

13:00 13:00 – ICC Capital Suite 1 e Path Soc Annual General Meeting ICC Capital Suite 1 e Path Soc Annual General Meeting – 14:00 14:00 4 Lunch 4 Lunch SS Joint DIGE SS SO-TI SY JPATH / SY ESP / ESMO SS EM SS PSOC OFP CYTO OFP NEPH & INFE VIRCHOWS

Infectious Practical chal- A guide to peer Molecular EM in the diagno- General Cytopathology Nephropathology diseases of the lenges in soft review for au- classification of sis of non-neo- pathology quiz 14:00 14:00 08:00 – 19:00 Registration digestive system tissue: Immuno- thors, reviewers tumours: Disease plastic diseases: (organised by – – histochemistry and readers entity or target A resident's slide Trainees) 16:00 16:00 vs. molecular recognition? seminar profiling

16:00 16:00 – – Coffee Coffee 16:30 Break Break 16:30 9 9 16:30 ICC Auditorium e Path Soc Oakley Lecture Susanne Burdak-Rothkamm (UK) ICC Auditorium e Path Soc Oakley Lecture Susanne Burdak-Rothkamm (UK) 16:30 – Cancers breeding cancer? – An intercellular DNA damage signalling network Cancers breeding cancer? – An intercellular DNA damage signalling network – 17:00 propagates tumour-induced DNA damage in distant proliferating tissue propagates tumour-induced DNA damage in distant proliferating tissue 17:00

17:00 17:00 – ICC Auditorium e Plenary Oral Free Paper Session ICC Auditorium e Plenary Oral Free Paper Session – 18:15 18:15

18:15 18:15 ICC Auditorium e Public Lecture Chris Fletcher (USA) ICC Auditorium e Public Lecture Chris Fletcher (USA) – – Accurate diagnosis – the pathologist's role Accurate diagnosis – the pathologist's role 19:00 19:00 19:00 19:00 – ICC Auditorium e Closing Ceremony ICC Auditorium e Closing Ceremony – 19:15 19:15

20:30 20:30 – Congress Party Congress Party – 24:00 Museum of London Docklands Museum of London Docklands 24:00

24 ECP 2014 · London Programme Overview per Day

e Wednesday, 3 September 2014

12:00 12:00 – ICC Auditorium e ESP General Assembly ICC Auditorium e ESP General Assembly – 13:00 13:00

17:00 17:00 – ICC Auditorium e Plenary Oral Free Paper Session ICC Auditorium e Plenary Oral Free Paper Session – 18:15 18:15

20:30 20:30 – Congress Party Congress Party – 24:00 Museum of London Docklands Museum of London Docklands 24:00

25 ECP 2014 · London

Save the date

27th ECP Belgrade 2015 Pathology – breaking barriers in medicine 5 – 9 September 2015 Sava Centar, Belgrade, Serbia

ESP President Han van Krieken, The Netherlands

Scientific Committee Local Organising Committee Han van Krieken, The Netherlands Jovan Lole Vasiljević, Chair Fatima Carneiro, Portugal Jelena Sopta Fredric T. Bosman, Switzerland Dejan Oprić Gordan Vujanić, UK and Serbia Milana Panjković Jasmina Marković-Lipkovski, Miloš Milovanović Serbia Sanja Milenković, Serbia

26 ECP 2014 · London

e Scientific Programme

a Keynote Lectures

a Symposia

a Slide Seminars

a Short Courses

a Business Meetings

a Videomicroscopy

a Special Sessions

a Pathological Society Sessions

a Oral Free Paper Sessions

11 12 / /

Short Course Short Slide Seminar London · 2014 ECP Japanese Society of Society Japanese / ICC Capital Suite 8 ICC Capital Suite 7 ICC Capital , Switzerland , Ireland , United Kingdom Ann Sandison , France Galateau-Sallé Francoise Simpson, Canada Roderick , United Kingdom Attanoos Richard 08:30 – 08:50 08:50 – 09:10 09:10 – 09:30 10:30 – 10:45 08:30 – 09:00 09:00 – 09:30 10:30 – 11:00 11:00 – 11:30 11:30 – 12:00 11:15 – 11:55 11:15 SS-01 08:30 – 12:00 SC-01 08:30 – 12:00 Head and Neck Pathology Diagnostic difficulties in head and neck pathology Chairs: Pulmonary Pathology & Mesothelioma Pleura Chairs: 001 Badoual, France Cécile 002 , Italy Eugenio Maiorano 003 Mary Toner 004 Republic , Czech Laco Jan 001 of to small biopsy interpretation Approach and its pitfalls pleura , France Galateau-Sallé Francoise 002 in mesothelioma Role of molecular biology diagnosis and differentials Lucien Chirieac, USA 003 Asbestos and mesothelioma: Amphiboles V chrysotile , United Kingdom Attanoos Richard 004 Non asbestos mesothelioma Handen Zeren, Turkey 005 diseases Infancy pleural Elisabeth Bruder 008 Society Pathological of AR relevance Clinical Lecture: Pathology negative in triple expression and ER beta cancers breast , Japan Sasano Hironobu -

Special Session Special Session ICC Auditorium ICC Auditorium ICC Capital Hall ICC Capital Ian Ellis, United Kingdom , Sweden Tot Tibor 09:15 – 09:30 09:00 – 09:15 08:45 – 09:00 08:30 – 08:45 11:05 – 11:15 10:50 – 11:05 10:30 – 10:50

Sunday, 31 August 2014 31 August Sunday, Saturday, 30 August 2014 30 August Saturday, Chairs: prognostic index prognostic Symposium SY-01 08:30 – 12:00 cancer new breast pathology: A need for a Integrating morphology and molecular morphology Integrating Welcome Reception Welcome Pathology Breast 20:00 – 22:00 WR-01 OP-01 19:00 – 20:30 Opening Ceremony

004 , Sweden Tot Tibor Subgross morphology prognostic markers morphology prognostic Subgross 003 Gábor Cserni, Hungary involvement The prognostic influence of lymph node influence of lymph node The prognostic 002 Ian Ellis, United Kingdom Index The 20+ years of the Nottingham Prognostic The 20+ years of the Nottingham Prognostic 001 factors and indicies in breast cancer factors and indicies in breast Panel Discussion: The future of prognostic of prognostic Discussion: The future Panel 007 28 , Italy Anna Sapino morphology and molecular pathology Breast cancer prognostic index integrating index integrating prognostic cancer Breast 006 Paul van Diest, The Netherlands Paul Clinically useful molecular prognostic param Clinically useful molecular prognostic eters 005 Panel Discussion: Traditional prognostic factors prognostic Discussion: Traditional Panel e

e Scientific Programme a Programme Scientific / Sunday Saturday Saturday, 30 Aug Sunday, 31 Aug Roderick Simpson,Canada 009 Ann Sandison, UnitedKingdom 008 Spomenka Manojlovic,Croatia 007 Uta Flucke, TheNetherlands 006 Mauro Papotti , Italy thology Challenges inhistopathologyandcytopa Poorly differentiated thyroid carcinomas: 005 Manuel SobrinhoSimões,Portugal techniques helpthehistopathologist? Follicular patternedtumours:Doancillary 004 Guido Fadda, Italy help thecytopathologist? The “grey zone”:Doancillarytechniques 003 Virginia A.Livolsi,USA tumours: Challengesinhistopathology The “grey zone”infollicularpatterned 002 Philippe Vielh, France lenges incytopathology Keith Hunter 005 ECP 2014 ·London The “grey zone”infollicularlesions:Chal 001 Chairs: thology: Sametarget different problems? Thyroid surgical pathologyandcytopa Pathology /Cytopathology Endocrine 08:30 –12:00 SY-02 Symposium 11:45 –12:00 11:30 –11:45 11:15 –11:30 11:00 –11:15 11:30 –12:00 11:00 –11:30 10:30 –11:00 09:00 –09:30 10:45 –11:00 08:30 –09:00 Philippe Vielh, France Virginia A.Livolsi,USA , UnitedKingdom ICC CapitalSuite9

/ 10 - - -

Scientific Programme aSunday Antonio Lopez-Beltran, Spain tract Neuroendocrine tumoursoftheurogenital 006 Marisa Rose Nucci,USA Ectopic prostatic tissueintheuterinecervix 005 Adeboye Osunkoya, USA Mullerianosis ofthebladder 004 Hemamali Samaratunga, Australia Pathology ofthemaleurethra 003 Esther Oliva,USA Pathology ofthefemaleurethra 002 Wolter Oosterhuis,TheNetherlands Germ celltumours:Theovaryandthetestis 001 Karl Kashofer EQA forNGStesting 004 Sandi Deans,UnitedKingdom EQA formoleculartestingintheUK 003 Els deQueker Most commonproblems encountered inEQA 002 Han vanKrieken,TheNetherlands testing inEurope Overview ofQualityAssurance formolecular 001 Chairs: ESP QualityAssurance Programme (EQA) Spec-SY-01 Chairs: male andfemaleuro-genital tract pathology Similarities anddissimilaritiesbetween Pathology /Uropathology Gynaecological 08:30 –12:00 SY-03 Symposium 08:30 –12:00 11:30 –12:00 11:10 –11:30 10:50 –11:10 10:30 –10:50 09:05 –09:30 08:30 –09:05 11:00 –11:30 10:30 –11:00 09:00 –09:30 08:30 –09:00 Han vanKrieken,TheNetherlands Maria Rosaria Raspollini, Italy Antonio Lopez-Beltran, Spain Els deQueker , Austria , Belgium ICC CapitalSuite15 , Belgium ICC CapitalSuite14 Special SessionESP

/ 16 29

Sunday, 31 Aug - - - -

London · 2014 ECP

, G. Bas ICC Capital Suite 1 Suite ICC Capital Oral Free Paper Session Paper Free Oral , M. Seymour Quirke , P. , Turkey Anne Hoorens, Belgium Anne Hoorens, , Turkey Arzu Ensari , United Kingdom Novelli Marco 08:30 – 08:40 09:00 – 09:10 09:10 – 09:20 09:20 – 09:30 08:50 – 09:00 08:40 – 08:50 08:30 – 12:00 08:30 I Pathology Digestive Diseases Chairs: OFP-01 Pathological diagnostic criterion of blood diagnostic criterion of Pathological in colorectal and lymphatic vessel invasion ob an for developing framework cancer: A 001 jective pathological diagnostic system using jective pathological diagnostic Delphi method , Japan Kojima Motohiro , J. Akiba, H. Shimazaki, K. Iwaya, M. Kage geal cancer J. Blayney, United Kingdom Alex L. C. Hewitt, A. I. Wright, A. Aziz, H. I. Grabsch Immediate ex vivo intra-arterial methylene Immediate ex vivo intra-arterial the detection of blue injection may improve cancer lymph node metastases in colorectal Gozde Kir O. Alimoglu, B. C. Sarbay 004 in gastric profiles Identification of microRNA with neoadjuvant patients treated carcinoma alone or surgery chemotherapy Baldoni, Brazil Barcelos Michelle Camillo, C. Malheiros Coutinho Begnami M. D. Ferreira 005 retrieval after influence lymph node Factors cancer for rectal resection Somaia Elsheikh, United Kingdom A. Zaitoun 006 does Neoadjuvant cytotoxic chemotherapy in oesopha not affect vascular remodelling ulin (AREG) expression levels as a biomark a levels as expression (AREG) ulin and panitumumab benefit in er of prognosis cancer (aCRC) RAS-wt advanced colorectal Jenny Seligmann, United Kingdom , G. Hemmings, Elliott, B. Jacobs , F. S. Richman J. Barrett, S. Tejpar 003 , , K. Shomori Ohkura, S. Horiguchi Y. Ajioka, A. Ochiai , Y. R. Kushima 002 (EREG) and amphireg Combined epiregulin

- Portugal 1860) and adrenal 1860) and adrenal 1866) and his many 1858) and Bright’s 1858) and Bright’s –

– ICC Capital Suite 17 ICC Capital – 1935) and his mistak

1964) and her famous – – , USA Rosa Henriques de Gouveia, Rosa Jan G. van den Tweel, The Jan Netherlands 09:15 – 09:40 08:30 – 09:15 11:30 – 12:00 10:55 – 11:30 10:30 – 10:55 11:30 – 12:00 11:30

Chairs: 08:30 – 12:00 diseases Symposium SY-04 and their Hospital Guy’s of Men Great History of Pathology Carl Sternberg (1872 Carl Sternberg Thomas Hodgkin (1798 002 001 Geller Stephen contributions 30 , United Kingdom J. StewartCameron Richard Bright (1789 Richard disease 005 Matthew Clarke, United Kingdom Thomas Addison (1793 insufficiency 004 , United Kingdom Andre Coetzee 003 Reed (1874 Dorothy paper Roland Sedivy, Austria Roland en conclusions Ian Cree, United Kingdom molecular testing for cancer patients for cancer testing molecular Requirements for laboratories that perform that perform laboratories for Requirements 005 Scientific Programme a Sunday Programme Scientific Sunday, 31 Aug J. Gimeno,S.Serrano , L.Espinosa E. LopezArribillaga , O.MirallesY. Bing, Mar Iglesias,Spain correlates withWntactivation Accumulation ofpanethcellsinadenomas 013 H. I.Grabsch J. D.Hayden,T. Arai,T. Yoshikawa, S.Savola J. Coffa, V. Menon,L.C.HewittT. Aoyama, R. Langley L. C.Hewitt,W. Allum,D.Cunningham Gayatri Raghuram, UnitedKingdom sults from theOE02trialcohort mour regression inoesophagealcancer:Re dictor ofmetastaticinfiltration andnodaltu Lymph nodediameterisanunreliable pre 010 A. Lugli,U. Stein P. Herrmann,E.Karamitopoulou, I.Zlobec Viktor H.Koelzer in colorectal cancer ed inColonCancer1(MACC-1) expression Geographic analysisofMetastasisAssociat 009 E. Karamitopoulou, I.ZlobecA.Lugli V. Mele,I.Giandomenica , L.Terracciano, Viktor H.Koelzer gression CD168) andpromote colorectal cancerpro nan acid mediator motility (RHAMM, EMT-like cancercellsover-express hyaluro 008 E. Karamitopoulou, H.DawsonA.Lugli M. Helbling,V.-H. Koelzer Inti Zlobec,Switzerland budding phenotypeincolorectal cancer possible suppressors oftheEMT-like tumour CpG methylationofTWIST1 andTWIST2 as 007 ECP 2014 ·London Arnaldo N.S.Silva,UnitedKingdom cancers and downstream targets inJapanesegastric Co-amplification of receptor tyrosine kinases 012 B. Wijnhoven A. vanNistelrooij,L.Koppert, K.Biermann Winand Dinjens,TheNetherlands markers inesophagealadenocarcinoma Genomic alterations aspotentialclonality 011 11:30 –11:40 11:00 –11:10 10:50 –11:00 10:40 –10:50 10:30 –10:40 11:20 –11:30 11:10 –11:20 , S.P. Stenning, H.I.Grabsch , Switzerland , Switzerland , J.A.Galván

------Scientific Programme aSunday M. HasbySaad Eiman AdelHasby,Egypt immunized IBDexperimentalanimalmodel mansoni eggantigenimmunizedandnon- Foxp3+ Tregulatory cellsinschistosoma 015 M. Carneiro J. MarçalGomes,M.d´Aguiar T. Rodrigues-Sousa, A.R.Xavier Lina Carvalho, Portugal dysplasia duction, where AS Wt mice keep high gland with impaired reactive oxygenspeciespro lonic carcinogenesis inNcf1-deficient mice, Glands above muscularis mucosae house co 014 Cecily Quinn,Ireland 006 Giuseppe Floris,Belgium 005 Maria P. Foschini, Italy 004 Janina Kulka, Hungary 003 Aleš Ryška,Czech Republic 002 Malcolm Hayes,Canada 001 Chairs: Invasive ornon-invasive? Breast Pathology 14:30 –16:30 SS-02 Harald Stein,Germany (Pathological SocietyDoniachLecture) Road toamodernlymphomaclassification Chairs: 12:15 –13:00 KL-01 11:50 –12:00 11:40 –11:50 16:10 –16:30 15:50 –16:10 15:30 –15:50 15:10 –15:30 14:50 –15:10 14:30 –14:50 Richard Byers,UnitedKingdom Cecily Quinn,Ireland Gábor Cserni,Hungary Han vanKrieken,TheNetherlands

Keynote Lecture ICC Auditorium ICC Auditorium Slide Seminar

, T. Ferreira, ,

- - Sunday, 31 Aug

- -

10 / well- /

London · 2014 ECP ICC Capital Suite 14 ICC Capital Suite 9 ICC Capital , United Kingdom Suzy Lishman, United Kingdom Han van Krieken, The Netherlands Günter Klöppel, Germany Guido Rindi, Italy 14:30 – 15:00 15:00 – 15:45 14:30 – 14:55 14:55 – 15:20 16:06 – 16:30 16:06 15:20 – 15:45 15:45 – 16:10 15:45 – 16:05 Symposium SY-07 14:30 – 16:30 Pathology, patients and the public Pathology, Chairs: Symposium SY-06 14:30 – 16:30 toes head to NETs, from differentiated (+ Business Meeting) Chairs: Endocrine Pathology in carcinoids Unifying concepts 001 story Week The National Pathology Suzy Lishman, United Kingdom 002 How to develop an effective event for the session which will give public: An interactive delegates some top tips and a chance to de 001 but different with similar features Tumours names? Günter Klöppel, Germany 002 What is com Classification and terminology: 005 An update melanoma: Mucosal , USA Prasad Manju mon? Why is it different? Guido Rindi, Italy 003 Do tumourigenic and signalling pathway go the same route? , Switzerland Perren Aurel 004 be used therapies Should the same targeted for any site? Eric Baudin, France 16:10 – 16:25 Business affairs Public engagement: The patient’s perspective Oliver Kathy velop their public engagement skills United Kingdom Davies, Karen 003

- 11 12 / /

Short Course Short ICC Capital Suite 8 ICC Capital Suite 7 Suite ICC Capital , Slovenia Nina Gale, Slovenia Czech Republic Alena Skalova, Czech , Austria Helmut Popper 14:30 – 14:54 16:00 – 16:30 15:30 – 16:00 15:00 – 15:30 14:30 – 15:00 15:42 – 16:06 15:18 – 15:42 14:54 – 15:18

SC-02 14:30 – 16:30 Chairs: diagnosis of head and neck tumours Recent advances in the pathogenesis and Head and Neck Pathology Chairs: Andrew United Kingdom , Nicholson Small Airways Disease Small Airways Symposium SY-05 – 16:30 14:30 Pathology Pulmonary Pathogenesis and diagnosis of sinonasal sinonasal of and diagnosis Pathogenesis 001 lung allograft dysfunction (CLAD): Oblitera dysfunction (CLAD): lung allograft 004 of chronic New concepts in development , United Kingdom William Wallace Pathology of ‘near normal’ lung biopsies of ‘near normal’ Pathology 003 , Italy Calabrese Fiorella disease Neuroendocrine proliferations in airway in airway proliferations Neuroendocrine 002 , United Kingdom Andrew Nicholson and classification of small airways disease and classification of small The role of the pathologist in the diagnosis pathologist in the diagnosis of the The role 001 James Lewis, USA James carcinomas knowledge about HPV-related oropharyngeal oropharyngeal knowledge about HPV-related Less and less crypt-ic: Advances in our 32 Nina Zidar 004 head and neck carcinogenesis Epithelial mesenchymal transition in the Epithelial mesenchymal transition 003 ting pathology with molecular information , United Kingdom Silvana Di Palma 002 ex-pleomorphic adenoma: Confron- Carcinoma , Italy Franchi Alessandro adenocarcinomas , Italy Calabrese Fiorella tive and restrictive phenotypes tive and restrictive Scientific Programme a Sunday Programme Scientific Sunday, 31 Aug David Ellis,Australia cancer reporting: Siriwhere are you? Electronic implementationofstructured 005 John Srigley,Canada ment inoncologypractice Laying thefoundationforqualityimprove Population-level structured cancerpathology: 004 WashingtonMary , USA ers”: Challenges forthereporting pathologist Suzy Lishman,UnitedKingdom to getinvolved International Pathology Day–yourchance 005 Han vanKrieken,TheNetherlands Pathology andthepublic:Thenextsteps 004 ECP 2014 ·London From “ancillary studies”to“cancerbiomark 003 Glenn McCluggage,UnitedKingdom Evidence, debateandconsensus The ICCRdatasetdevelopmentprocess: 002 David Ellis,Australia ICCR –from clinicalnecessitytoglobalgoals Introduction tocancerreporting andthe 001 Chairs: pies: We’re here tohelp! the era ofbiomarkers andtargeted thera The ICCR approach to cancer reporting in 14:30 –16:30 SY-08 Symposium 16:10 –16:25 15:45 –16:10 16:25 –16:30 16:05 –16:25 15:20 –15:45 14:55 –15:20 14:30 –14:55 Fred Bosman,Switzerland Michael Wells, UnitedKingdom ICC CapitalSuite15

/ 16 - - - Scientific Programme aSunday A. Protheroe,J.JohnsonM.Chitnis Vishnu Parameshwaran , UnitedKingdom pathology review in testicularseminomafollowingspecialist Prognostic valueoflymphovascularinvasion 004 C. Kwak Ko K.-T. Ja-Hee Suh,Republic ofKorea tive prostate cancer nosis ofpatientswithlymphnode(LN)posi Effect oflymphnodeGleasonscore onprog 003 M. Srougi,A.AntunesK.LeiteS.Reis V. Guimarães,A.Nesrallah , C.Passerotti, N. Viana,E.SaldanhaR.Oyama Daniela Sanchez, Brazil sive prostate cancer MSMB genevariantincreases riskofaggres 002 H. Moch K. Tostovršnik Jera Jeruc , Slovenia translocations inSlovenianpatients Renal cellcarcinoma associatedwith Xp11 006 S. Bhattarai Kingdom Hemalatha Bhuvanai-Sitaraaman, United bladder cancer prostate inradical cystoprostatectomies for A studyonwholemountassessmentofthe 005 I. Roberts, C.Verrill L. Browning,D.Cole, P., G.Turner Gill M. Storz, A.vonTeichmann, J.Bonventre H.-U. Schildhaus, E.Compérat, P. Schraml, Karl-Friedrich Deml,Switzerland renal carcinoma new distinctentityorsubtypeofclearcell Clear cellpapillaryrenal cellcarcinoma: A 001 Chairs: Uropathology 14:30 –16:30 OFP-02 15:00 –15:10 14:50 –15:00 14:40 –14:50 15:20 –15:30 15:10 –15:20 14:30 –14:40 , Y.-S. Park, K.-C. Moon , C.-S. Kim, Dan Berney,UnitedKingdom Carmen LuzMenendez,Spain Pedro Oliveira, Portugal Oral Free Paper Session ICC CapitalSuite17

- - - Sunday, 31 Aug - - -

London · 2014 ECP Akt pathway? , The Netherlands , The Netherlands / , P. Mangin Doenz, J. Grimm, P. , F. , R. Hetzer Krabatsch , T. , B. Gorodetski, Krabatsch , T. , K. Wassilew 14:40 – 14:50 14:40 15:50 – 16:00 15:40 – 15:50 15:10 – 15:20 15:20 – 15:30 15:30 – 15:40 14:50 – 15:00 15:00 – 15:10 002 rates adult autopsy of Dutch 35 years Blokker Britt M. , M. G. M. Hunink, A. C. Weustink Audit of compliance with the Royal College post mortem best practice of Pathologists scenarios Sorkin, United Kingdom Tracy L. Wahab 009 of autopsies in St. Vincent’s Uni A review versity Hospital, Dublin, Ireland , Ireland McCarthy Aoife Crotty T. Intramyocardial distribution of the lymphatic Intramyocardial network in ischemic and dilated cardiomy opathy Zeh, Germany Michael E. Potapov K. Wassilew 008 Reasoning behind autopsy consents for in- behind autopsy consents Reasoning adults hospital deceased Britt M. Blokker , , M. G. M. Hunink A. C. Weustink CT-angiographical and Pathomorphological atherosclerotic of coronary characteristics death cardiac plaques in cases of sudden , Switzerland Michaud Katarzyna S. Grabherr 005 4 prevent 1 and PMCA deletion of Does by influ remodelling pathological cardiac encing the PI3K , United Kingdom Cook Sam , E. Cartwright N. Stafford 006 Aortic valve pathology in patients supported by a continuous-flow left ventricular assist device , Germany Saito Tomohiro E. Potapov R. Hetzer 007 J. W. Oosterhuis J. W. 003 Oosterhuis J. W. 004 - -

ICC Capital Suite 1 Oral Free Paper Session Paper Free Oral , , S. Varnous , P. Rouvier , P. Katarzyna Michaud, Switzerland Michaud, Katarzyna United Kingdom Helen Doran, United Kingdom Mary Sheppard, PTEN immunostatus and biochemical and biochemical immunostatus PTEN 14:30 – 14:40 16:10 – 16:20 16:00 – 16:10 15:50 – 16:00 15:40 – 15:50 15:30 – 15:40 15:30 /

OFP-03 14:30 – 16:30 Chairs: Cardiovascular Pathology Cardiovascular A. Loupy , France Marion Tible heart transplantation miRNAs as biomarkers of the rejection in miRNAs as biomarkers of the rejection 001 34 , J.-P. Duong Van Huyen Duong Van Bruneval, J.-P. X. Jouven, P. , T. Beuscart, C. Suberbielle, R. Guillemain, T. S. Høyer Percutaneous renal biopsies are highly ac biopsies are renal Percutaneous , Møldrup, A. Hørlyck Nielsen, U. Kjærgaard T. 011 Marie Bjødstrup Jensen, Denmark , G. Trevisian Khetrapal Sharp, P. V. T. hospital setting Kate Smith, United Kingdom Kate study in a Danish university retrospective Renal Cell Carcinoma (ccRCC) Renal Cell Carcinoma tumours: A when assessing renal curate mechanism for disease aetiology in clear cell clear in aetiology mechanism for disease LIMD1 deregulation as a novel molecular LIMD1 deregulation J. Markovic-Lipkovski 010 Maja Zivotic, Serbia , D. Dundjerovic, J. Vjestica, S. Cirovic, M. Bosic Different patterns of FGFR1 and NCAM ex patterns of FGFR1 and NCAM Different cell tumours of renal , M. Zivotic, S. Cirovic, D. Dundjerovic might affect biological behaviour pressions Jelena Vjestica, Serbia 009 renal cell tumours renal D. Djordjevic, J. Markovic-Lipkovski 008 4 in human epididymis protein of Expression , T. van der Kwast , T. , J. Sykes D. Trudel Michelle Downes, Canada Michelle with cribriform architecture carcinoma architecture with cribriform ERG cohort a prostatectomy in rate free relapse 007 Scientific Programme a Sunday Programme Scientific Sunday, 31 Aug Susan Mallett,UnitedKingdom and theugly Diagnostic studydesign:Thegood,thebad 006 Clive Wells, UnitedKingdom The issueofoverdiagnosis inbreast pathology P. Bruneval V. ThomasdeMontpreville,F. Paraf Laure Gibault,France treated withtheantidiabeticagentbenfluorex Aortic andmitral valvulopathyinpatients 010 ECP 2014 ·London Erik Thunnissen,TheNetherlands Role offree radicals incarcinogenesis 001 005 Nikita Makretsov,Canada biomarker testing? Why weneedevidence-basedbreast cancer 004 Maria Merino,USA and insitumucinousbreast carcinoma diseases. Themolecularprofiling ofinvasive Mucinous carcinoma ofthebreast, oneortwo 003 Clive Wells , UnitedKingdom 2013 –14 news EWGBCSP 002 Anna Sapino, Italy Working group news2013 001 Chairs: Microenvironment inlungcancer Pulmonary Pathology 17:00 –19:00 BM-02 Chairs: Breast Pathology 17:00 –19:00 BM-01 18:35 –19:00 16:00 –16:10 17:00 –17:30 18:10 –18:35 17:45 –18:10 17:20 –17:45 17:10 –17:20 17:00 –17:10 Fiorella Calabrese, Italy Lina Carvalho, Portugal Clive Wells , UnitedKingdom Anna Sapino, Italy ICC CapitalSuite7 Business Meeting Business Meeting

– ICC Auditorium 14

/ 12 Scientific Programme aSunday Alena Skalova,Czech Republic cinoma dermoid carcinoma andadenoid-cystic car Molecular pathologyofadenoidcysticcarci 003 Tim Helliwell,UnitedKingdom for patients? section: Whichprovides thebestoutcome Wim Timens, TheNetherlands Desmoplastic stroma reaction –foeorfriend? 004 Lina Carvalho, Portugal genesis Inflammation intheprocess ofearlycarcino 003 Helmut Popper perimental modeloflungadenocarcinoma salivary glandtumoursotherthan mucoepi Significance ofmoleculargeneticanalysisin 005 Ilmo Leivo,Finland carcinoma Molecular pathologyofmucoepidermoid 004 Göran Stenman,Sweden noma Sentinel node,selectiveorradical neckdis 002 Alfons Nadal, Spain head andnecksites Pathogenesis ofsquamouscellcarcinoma of 001 cancer progression andinvasioninanex The role ofhypoxiaandinflammationin 002 Chairs: and necktumours Update inmolecularpathologyofhead Head andNeckPathology 17:00 –19:00 SY-09 Symposium 17:48 –18:12 18:30 –19:00 18:00 –18:30 18:36 –19:00 18:12 –18:36 17:24 –17:48 17:00 –17:24 17:30 –18:00 Ilmo Leivo,Finland Isabel Fonseca, Portugal , Austria ICC CapitalSuite8

/ 11 35 ------Sunday, 31 Aug - - - - -

, E. Sabo,

London · 2014 ECP , , N. De Nève, O. Blanchard , R. J. A. Fijneman 17:20 – 17:30 17:20 17:50 – 18:00 18:00 – 18:10 18:10 – 18:20 17:30 – 17:40 17:40 – 17:50 003 in circulat testing and KRAS mutation EGFR , M. A. van de Wiel, I. Nagtegaal C. J. A. Punt, B. Carvalho, B. Ylstra, G. A. Meijer Adenoma and carcinoma components in co Adenoma and carcinoma next genera Clinical validation of targeted and lung cancers tion sequencing for colon , Belgium Nicky D’Haene M. Le Mercier Demetter H. El-Housni, B. Dessars, P. Heimann, I. Salmon , P. M. Remmelink 006 clonality determinations using tar Tumour sequencing geted next generation Winand Dinjens, The Netherlands , Atmodimedjo I. Geurts-Giele, P. E. J. Dubbink 007 cancer of Cten in colorectal The regulation Hannah Thorpe, United Kingdom S. Al-Ghamdi, M. Ilyas 008 DNA copy number aberration-associated novel candidate detection reveals breakpoint cancer driver genes for colorectal , The Netherlands Evert van den Broek O. Krijgsman, D. Sie, J. C. Haan, ing plasma DNA of lung cancer patients us patients of lung cancer DNA ing plasma system (Sequenom’s ing a high-throughput a targeted and technology) MassARRAY it useful Melt Analysis: Is High Resolution detection? for routine France Marius Ilie, , , M. Poudenx N. Guibert, N. Ebran , C. H. Marquette, I. Nanni-Métellus Hofman Barlesi, G. Milano, P. Métellus, F. P. 004 for KRAS lonic tumours show discordance mutation , Israel Dov Hershkovitz , E. Prinz, S. Noy Bick E. Simon, T. O. Ben-Izhak, M. Vieth 005 - - -

10 /

Slide Seminar Slide

ICC Capital Suite 14 ICC Capital Suite 9 Suite ICC Capital Oral Free Paper Session Paper Free Oral Giorgio Stanta, Italy Giorgio Manuel Sobrinho Simões, Portugal Manuel Sobrinho , Switzerland Komminoth Paul Austria Hoefler, Gerald Mohammad Ilyas, United Kingdom 18:45 – 19:00 18:30 – 18:45 18:15 – 18:30 18:00 – 18:15 17:45 – 18:00 17:30 – 17:45 17:15 – 17:30 17:00 – 17:15 17:00 – 17:10 17:10 – 17:20

Chairs: Molecular Pathology 17:00 – 19:00 OFP-04 Chairs: Difficult issues in endocrine tumours Difficult issues SS-03 – 19:00 17:00 Endocrine Pathology , Italy Volante Marco 008 Virginia A. Livolsi, USA Virginia 007 , Spain Teijeiro José Cameselle 006 , France Cazes Aurelie 005 Switzerland , Komminoth Paul 004 , Switzerland Perren Aurel 003 , Italy Rosa La Stefano 002 , Ireland Fabre Aurelie 001 Targeted next generation sequencing vali sequencing next generation Targeted 001 36 , , C. H. Marquette L. Bouhlel, S. Lalvée , C. Butori, Hofman, E. Long-Mira, C. Bence V. Hofman P. Potential false negative immunohistochemi Potential Marius Ilie, France 002 by FISH rearrangement chromosomal , G. Cross, K. Manger H. Karim cal evaluation of ALK status in lung adeno associated with “borderline” carcinoma Mohammad Ilyas, United Kingdom predictive testing in colorectal cancer using testing in colorectal predictive dates the utility of diagnostic biopsies for diagnostic of utility the dates Scientific Programme a Sunday Programme Scientific Sunday, 31 Aug A. R.Bamber W. Heywood,K.MillsN.J.Sebire Renan DeMenezes,UnitedKingdom tion: Proof ofprincipleusingananimalmodel as atoolfortheinvestigationofdecomposi Mass spectroscopic analysisoffree peptides 011 P. Morrill,K.Schmitt V. Spivey Jonathan Frampton, UnitedKingdom mised forcirculating tumourDNAdetection sensitivity andspecificityofassaysopti Using reference standards toanalysethe 010 Lupo, F. Thivolet,A.McLeer-Florin M. Devouassoux-Shisheboran,A.Mansuet- F. Galateau-Sallé, J.-P. Merlio,S.Garcia J.-M. Vignaud,M.AntoineF. Penault-Llorca , H. Bégueret, M.IlieV. Grégoire, I. Rouquette, H.BlonsN.LeStang, Sylvie Lantuejoul, France tools inlungadenocarcinomas centres ofALKrearrangement diagnostic A French multicentricvalidationfrom 15 009 ECP 2014 ·London Cord Langner Gieri Cathomas, Switzerland Marco Novelli, UnitedKingdom Neil Shepherd, UnitedKingdom Chair: (Videomicroscopy Session) Gastrointestinal Stromal Tumours 17:00 –19:00 Spec-SY-02 18:40 –18:50 18:30 –18:40 18:20 –18:30 Neil Shepherd, UnitedKingdom , L.RyanA.MulliganC.Thorne , Austria Special SessionPath Soc ICC CapitalSuite15

/ 16

- -

Scientific Programme aSunday E. Selva,S.Lalvée, G.Poissonnet, M. Ilie,V. Hofman , C.Bence, C.Butori Elodie Long-Mira, France microemboli inpatientswithmelanoma istry characteristics ofcirculating tumour Clinical significanceandimmunocytochem 003 J. Shah,S.PulimoodR.George Meera Peter care centre ma: A5yearretrospective studyfrom atertiary Subcutaneous panniculitislikeTcelllympho 002 G. Narli,D.DemirelA.Haholu M. Gamsizkan,U. Berber Ismail Yilmaz, Turkey nomas tation analysisincutaneousmalignantmela M. Ilie,S.LassalleV. Hofman,C.Bence, Elodie Long-Mira, France Why itisusefulinadailyroutine practice? astatic melanomabyimmunohistochemistry: Detection oftheBRAFV600Emutationinmet 004 J.-P. Lacour H. Schmidt, S.J.Hamilton-Dutoit, T. Steiniche R. Riber-Hansen,C.Dahl , P. Guldberg, Johanne Lade Keller marker incutaneous melanoma? Is absentc-KITexpression aprognostic 007 V. Jenei,G.Thomas Karwan Moutasim,UnitedKingdom expression andfunctionincancer Hedgehog inhibitionup-regulates integrin 006 A. Akyol,Ö.Gököz Özlem Tanas, Turkey dysregulation incutaneousadnexaltumours The wnt 005 P. Bahadoran,P. Hofman C. Butori,S.Lalvée, J.-P. Lacour BRAF, C-KIT, NRAS,GNAQ andGNA11mu 001 Chairs: Dermatopathology 17:00 –19:00 OFP-05 17:20 –17:30 17:10 –17:20 17:30 –17:40 18:00 –18:10 17:50 –18:00 17:40 –17:50 17:00 –17:10 Pedram Gerami, USA Eduardo Calonje, UnitedKingdom / beta-catenin signalingpathway , P. Bahadoran,P. Hofman , Oman Oral Free Paper Session , Denmark ICC CapitalSuite17 , Z.Kucukodaci, ,

37 - - - - - Sunday, 31 Aug

/ ------, ,

, B. Gloor London · 2014 ECP , C. Bouvier , USA CD44+) and triple positive (CD24+ CD44+) and triple positive EpCAM+) subpopulations as indica EpCAM+) , A. Lugli, E. Karamitopoulou / / 17:20 – 17:30 17:20 17:30 – 17:40 18:10 – 18:20 17:40 – 17:50 17:50 – 18:00 18:00 – 18:10 003 CXCL14 and ratio, splice variant CXCR4 by sarcoma in Ewing survival predict CXCR7 activation inhibiting CXCR4 , The Netherlands Sand Laurens Hogendoorn C. W. , P. K. Szuhai, D. Berghuis 004 peri in the of FOXP3+ T-cells Accumulation Immunohistochemical diagnosis of Solitary less) in bone tumours Lee, Singapore Victor , D. Virshup Jia K. Chua, Y. 008 Fibrous / Haemangiopericytomas Tumours of A. Lugli, E. Karamitopoulou 005 stem cell mark of putative Overexpression (budding) cells in pan ers within EMT-type double aggressive cancer identifies creatic (CD24+ CD44+ tors of poor outcome , Switzerland Martin Wartenberg , , I. Zlobec, J. A. Galván, A. Perren Schmid P. B. Gloor 006 of the USP6 locus in cellular Rearrangements of tendon sheath: Under-recognized fibroma examples of nodular fasciitis? Jodi Carter , J. Westendorf , X. Wang M. Erickson-Johnson M. Chou, A. Oliveira 007 Wnt of YJ5 (Wnt Carrier Protein Expression tumoural compartment is associated with an is associated compartment tumoural strong is a and budding phenotype EMT-like factor in non- and independent prognostic Ductal Adenocarcino metastatic Pancreatic ma (PDAC) , Switzerland Martin Wartenberg H. Koelzer , V. I. Zlobec, A. Perren the meninges Nicolas Macagno, France , A. Loundou, K. Mokhtari, André M. d. P. , Métellus , P. M. Catherine, A. Vasiljevic D. Figarella-Branger - - -

well- / France

ICC Capital Suite 1 Oral Free Paper Session Paper Free Oral , Belaud-Rotureau , M.-A. , , E. Schemitsch , S. Ketcheson , M. Le Calve, Burtin, S. Henno , F. Chris Hemmings, Australia Belgium Forsyth, Ramses 17:00 – 17:10 17:10 – 17:20 18:40 – 18:50 18:30 – 18:40 18:20 – 18:30 18:10 – 18:20 18:10

17:00 – 19:00 Chairs: OFP-06 and Bone Pathology Soft Tissue Diagnostic utility of p16 immunohistochem 001 38 V. Iakovlev V. Tony Lin, Canada Tony A. Nauth thelial progenitor cells thelial progenitor Augmenting rotator cuff repair using endo cuff repair Augmenting rotator , F. Dugay Cabillic, F. F. 002 differentiated liposarcoma and dedifferenti liposarcoma differentiated , Solene-Florence Kammerer-Jacquet S. Thierry N. Stock in situ hybridation ated liposarcoma confirmed by fluorescence confirmed by fluorescence ated liposarcoma istry in atypical lipomatous tumour , B. Lekic, S. Cirovic, J. Stojkovic-FIlipovic Martina, Serbia Bosic , R. Hsieh, C. Camillo-Coutinho (SCC) of the skin N. Boricic, D. Brasanac Marcello Menta S. Nico, Brazil Marcello Cell Carcinoma 7 in Squamous 5 and protein pathogenesis? maintenance of minichromosome Expression and BRAF mutations determinant in its and BRAF mutations 011 Primary oral mucosal melanoma: Are NRAS mucosal melanoma: Are Primary oral Lourenco , S. V. J. Dumet Fernandes 010 G. Saldanha, J. H. Pringle 009 cutaneous melanoma Joshi, United Kingdom Kushal Ö. Gököz primary markers in of prognostic Development , Turkey Aydin Makbule Çisel cases Lymphocytic Vasculitis: Classification of 127 of 127 Classification Vasculitis: Lymphocytic 008 Scientific Programme a Sunday Programme Scientific Sunday, 31 Aug L. Holzer Andrej Coer in Dupuytren’s Disease junction proteins connexions26,30and43 Immunohistochemical evaluationofgap 010 A. Leithner Beate Rinner Heterogeneity ofChordoma cells 009 ECP 2014 ·London J. Feichtinger A. El-Heliebi,T. Kroneis,K.Wagner near the Registration Counter in theLevel0Boulevard Please visittheESP 18:30 –18:40 18:20 –18:30 i , G.Holzer , S.Scheipl, B.Liegl-Atzwanger , Slovenia , G.Thallinger , Austria , F. Quehenberger , D.Kolb, , / Scientific Programme aSunday Path SocBooth 39

Sunday, 31 Aug - 10 11

/ /

Slide Seminar London · 2014 ECP ICC Capital Suite 9 ICC Capital Suite 8 08:30 – 09:00 09:00 – 09:30 10:30 – 11:00 11:00 – 11:30 11:30 – 12:00 , Denmark Steffen Heegaard , Germany Ilske Oschlies , USA Gerami Pedram , United Kingdom Coupland Sarah 10:30 – 11:00 10:30 08:30 – 08:32 08:32 – 08:52 11:30 – 12:00 11:00 – 11:30 Symposium SY-10 08:30 – 12:00 Important diagnoses in dermatopathology Important Chairs: SS-04 08:30 – 12:00 Ophthalmic Pathology Applied molecular diagnostics in ocular pathology Chairs: Dermatopathology Integration of next-generation sequencing sequencing of next-generation Integration tech From pathology: into lymphoreticular 003 , Germany Ilske Oschlies 003 / 004 , USA Gerami Pedram 005 / 006 Thomas Brenn, United Kingdom 007 / 008 , United Kingdom Calonje Eduardo 009 / 010 , USA Hornick Jason 001 Introduction , United Kingdom Coupland Sarah 002 Update in the molecular genetics of eyelid tumours , Denmark Steffen Heegaard 001 / 002 Sequencing bone and soft tissue tumours – bone and soft tissue tumours Sequencing research in translational new horizons , United Kingdom Adrienne Flanagan 005 nology basis to targeted therapy to targeted nology basis , United Kingdom Campbell Peter 004 outcome in bowel cancer – targeted Improving genes sequencing of cancer-related Phil Quirke, United Kingdom - 12 /

Short Course Short

ICC Auditorium ICC Capital Suite 7 Special Session Path Soc Special Session Path Karwan Moutasim, United Kingdom Karwan , United Kingdom Gemma Petts Ferran Algaba, Spain Ferran Italy , Raspollini Maria Rosaria 09:00 – 09:30 08:30 – 09:00 10:30 – 10:50 09:10 – 09:30 08:50 – 09:10 08:30 – 08:50 10:50 – 11:10 11:10 – 11:30

Monday, 1 September 2014 1 September Monday,

Spec-SY-03 08:30 – 12:00 Chairs: (organised by Trainees) (organised Next generation sequencing and pathology Next generation

Chairs: science of uropathology SC-03 08:30 – 12:00 and art The uropathology: Advances in Uropathology John Le Quesne, United Kingdom future – new molecular technologies shaping the new molecular technologies shaping the – Changing philosophy of cancer diagnostics 002 Peter Furness, United Kingdom Peter is fast approaching Cellular pathology – the post-genomic future Cellular pathology – the post-genomic future 001 004 Ferran Algaba, Spain Ferran and science Translocation renal cell carcinoma. The art cell carcinoma. renal Translocation 003 Dan Berney, United Kingdom The science Molecular aspects of carcinoma of the penis. Molecular aspects of carcinoma 002 , Italy Maurizio Colecchia penis. The art Pathologics subtypes of carcinoma of the of the carcinoma subtypes of Pathologics 001 40 Only science? Arndt Hartmann, Germany 006 uropathology. in syndromes cancer Hereditary Prognostic biomarkers in NMIBC. The science Prognostic , Italy Raspollini Maria Rosaria 005 sis of metastatic RCC Republic Ondrej Hes, Czech Immunohistochemistry in differential diagno Immunohistochemistry in differential

e Scientific Programme a Monday Programme Scientific Monday, 1 Sept Hans Kvasnicka, Germany ing systemforstromal changes ative neoplasms. Introducing thenewgrad The post-therapeutic marrow inPh-prolifer 004 Falko Fend, Germany eloproliferative neoplasms Progression andtransformation ofPh-my 003 Hans Kreipe,Germany for classification eloproliferative neoplasms.Therelevance Round tablediscussion 11:40 –12:00 Fiona Roberts, UnitedKingdom Update innon-lymphomatousorbitaltumours 007 Ming-Qing Du,UnitedKingdom adnexal lymphomas Update in the molecular pathology ofocular 006 Sarah Coupland, UnitedKingdom melanoma Update in the molecular genetics of uveal 005 Geeta Vemuganti , India blastoma Update inthemolecularpathologyofretino 004 Hardeep Mudhar tival tumours Update inthemoleculargeneticsofconjunc 003 ECP 2014 ·London Advances inmolecularpathologyofPh-my 002 Jon vanderWalt, UnitedKingdom neoplasms Mimics andquestionsinmyeloproliferative 001 Chairs: Mimics, progressions andtransformation Myeloproliferative Neoplasms(MPN): Myeloproliferative Syndromes (MDS)and Haematopathology 08:30 –12:00 SC-04 10:52 –11:14 10:30 –10:52 11:20 –11:40 11:00 –11:20 10:30 –11:00 09:12 –09:30 08:52 –09:12 09:00 –09:30 08:30 –09:00 Christine Beham-Schmid, Austria Annette Schmitt-Graeff , UnitedKingdom ICC CapitalSuite14 Short Course , Germany

------Scientific Programme aMonday 006 Marc Halushka,USA diseases-molecular pathology Familial patternsindegenerative aortic 005 Ornella Leone,Italy definition anddiagnosticcriteria Medial degeneration oftheaorta:Terms, 004 Allard vanderWal, TheNetherlands rysms Atherosclerosis andinflammatoryaorticaneu 003 SheppardMary , UnitedKingdom logica classificationanddiagnosticcriteria Daniel Arber – MyelodysplasiaRelatedChanges(MRC) interface withAcuteMyeloidLeukaemia(AML) Progression andtransformation ofMDSandits Giulia D’Amati, Italy or degenerative? Daily practice borderline cases,inflammatory 006 Marcus Kremer Non-neoplastic mimicsofmyelodysplasia 005 Infectious andnoninfectiousaortitis:Histo 002 Patrick Bruneval,France Presentation oftheproject 001 Consensus documentonsurgical pathol Cardiovascular Pathology Chairs: the SocietyforCardiovascular Pathology European Cardiovascular Pathology and ogy oftheaorta from theAssociationfor 08:30 –12:00 SY-11 Symposium 11:30 –12:00 11:00 –11:30 10:30 –11:00 09:05 –09:30 11:36 –11:58 11:14 –11:36 08:40 –09:05 08:30 –08:40 Marc Halushka,USA Patrick Bruneval,France , USA , Germany ICC CapitalSuite15

/ 16 41 - - - Monday, 1 Sept - - -

London · 2014 ECP

ICC Capital Suite 1 Suite ICC Capital Oral Free Paper Session Paper Free Oral Anna Sapino, Italy Anna Sapino, Switzerland Varga, Zsuzsanna Going, United Kingdom James 08:30 – 08:40 10:30 – 10:40 09:10 – 09:20 08:50 – 09:00 09:00 – 09:10 08:40 – 08:50 08:30 – 12:00 08:30 Pathology Breast Chairs: OFP-07 Links between pathology and transcrip pathology and Links between 001 Human epidermal growth factor receptor 2 factor receptor Human epidermal growth Does biopsies of the breast: testing in core Tertiary a experience of The matter? size Hospital Care , Portugal André Coelho , J. Ramón Vizcaíno Moreno F. 007 ex differentially markers are DNA repair I. Ellis, E. Rakha M. Craze, E. Provenzano, C. Caldas, I. Ellis, A. Mukherjee 006 cancers breast in BRCA-mutated pressed Andrew Green, United Kingdom D. Caracappa, C. Nolan, D. Macmillan, Biological and clinical significance of PARP1 of Biological and clinical significance cancer in breast expression protein Andrew Green, United Kingdom , , A. Alshareeda D. Caracappa, A. Benhasouna C. Nolan, D. Macmillan, S. Madhusudan, I. Ellis, E. Rakha 003 in Audit of consistency of DCIS grading biopsies and excision specimens core breast Mark Ong, United Kingdom S. Pinder 004 significance of ma Assessing the prognostic 14 & 15 in primary trix metalloproteinases cancer breast , United Kingdom Thomas Chadwick Chin, B. Liu, R. Russell, O. Rueda, S.-F. tomes in breast cancer: Exploring the tomes in breast cohort METABRIC Abhik Mukherjee, United Kingdom , R. Russell, Chin E. Provenzano, S.-F. , O. Rueda, B. Liu, G. Turashvili , S. Aparicio, B. Mahler-Araujo, I. Ellis C. Caldas 002 - -

ICC Capital Suite 17 Suite ICC Capital , Germany , Germany , Austria , Germany Klaus Kayser David Ameisen, France , Spain Rojo Garcia Marcial Gian Kayser

10:30 – 10:45 08:45 – 09:00 08:30 – 08:45 11:35 – 12:00 11:20 – 11:35 11:10 – 11:20 10:55 – 11:10 10:45 – 10:55 09:00 – 09:30

Chairs: Part 2 Part Part 1 Part standardization Chairs: Application, barriers, consultation, and consultation, barriers, Application, Digital pathology in routine diagnosis: diagnosis: in routine Digital pathology Symposium SY-12 – 12:00 08:30 IT in Pathology Entropy: A useful tool for diagnosis assis Entropy: 004 002 , Germany Borkenfeld Stephan Virtual slides, measurements, consultation Virtual slides, measurements, 001 pathology institute: The virtual international Predictive diagnosis and automated mea diagnosis and Predictive 009 Arvydas, Lithuania Laurinavicius novel information on biomarker expression 008 Digital immunohistochemistry to retrieve Helmut Popper Gian Kayser 42 TMA software in virtual slides surements using virtual microscopy and Definiens Definiens and microscopy using virtual Automatic analysis of tissue microarrays analysis of tissue microarrays Automatic 007 , Spain Rojo Garcia Marcial Standards on digital pathology imaging Standards 006 005 biopsy diagnosis in routine Virtual microscopy , The Netherlands Marius Nap , Brazil Metze Konradin tance in virtual microscopy? Manfred Dietel, Germany daily workflow How to better integrate virtual slides into the How to better integrate 003 East , Egypt Essam Ayad The progress of digital pathology in the Middle The progress Scientific Programme a Monday Programme Scientific Monday, 1 Sept V. Gaspar M. Grunkin,S.NielsenV. Jensen,P. Heikkiä, Anja Brügmann,Denmark ing quality tein expression usedinassessmentofstain Image analysisofbreast cancerHER2pro 013 T. Wozniak, M.Holicki, W. Grzesiak W. Ploszynska,M.SalamagaI.Mirwa-Tomczak, M. Stepaniuk, L.Teresinski, E.Bocher Andrzej Kram, Poland digital analysisandeye-ballingestimation core biopsies: Comparison of automated Proliferation indexKi67inbreast cancer 012 M. Velikonja, D.Glavac , Slovenia Joze Pizem neurofibromatosis type1 stromal giant cells is not characteristic for stromal hyperplasiaandmultinucleated Gynecomastia withpseudoangiomatous 011 A. Coelho, R.Vizcaíno Filipa Moreno,Portugal cancer biopsiesonclinicalsetting receptor 2statusevaluationininvasivebreast Validation ofhumanepidermalgrowth factor 010 Y. Mir Susan MacPherson,UnitedKingdom clearance OSNA andresults offollow-upaxillarynode Rate ofsentinelnodepositivityfollowing 009 M. Ibrahim,D.Steele , K.Miller Suzanne Parry, UnitedKingdom ICC &ISHScheme tors ERandPR:FindingsoftheUKNEQAS Staining issueswithbreast hormonerecep 008 ECP 2014 ·London 11:30 –11:40 11:20 –11:30 11:10 –11:20 11:00 –11:10 10:50 –11:00 10:40 –10:50 , M.Vyberg ,

- - - Scientific Programme aMonday M. Martín N. Martín,M.CasasR.CaballeroE.Carrasco, J. delaHaba,A.BarnadasT. García-Caballero , L. Calvo,BernetA.Lluch , O.Burgués Federico Rojo, Spain study GEICAM /2011-06 in ASCO bridization forHER2testinginbreast cancer histochemical andDNARNAinsituhy Cristina Magi-Galluzzi,USA biopsies indailypractice ofpathology Contemporary reporting ofneedleprostate 005 Lars Egevad,Sweden tectomy specimens.What’snew? Contemporary evaluation of radical prosta 004 Fleming,UnitedKingdom Stewart ing ofrenal cellcarcinoma Analytical performanceofdifferent immuno 014 The ICCRinitiativeforhandlingandreport 003 Brett Delahunt,NewZealand ISUP grading systemforrenal cellcarcinoma 002 , Italy Guido Martignoni neoplasia ISUP Vancouver classificationof renal 001 Ian Tomlinson, UnitedKingdom ( The geneticsofcolorectal cancer Chairs: Recent developments in urologic cancer ISUP /ESPUropathology 14:30 –16:30 SY-13 Symposium Carneiro, Fátima Chairs: 12:15 –13:00 KL-02 Pathological Society 16:06 –16:30 15:42 –16:06 11:40 –11:50 15:18 –15:42 14:54 –15:18 14:30 –14:54 Mohammad Ilyas,UnitedKingdom Lars Egevad,Sweden Antonio Lopez-Beltran, Spain / CAP 2007and2013guidelines: GoudieLecture) Portugal Keynote Lecture ICC Auditorium ICC Auditorium

43 - - - - Monday, 1 Sept - - - 10 /

London · 2014 ECP Special Session ESP Special ICC Capital Suite 14 , Germany ICC Capital Suite 9 Suite ICC Capital Head and Neck Pathology /

, Germany Kingdom , Switzerland Arnaud Roth Fred Bosman, Switzerland Fred Stephan Ihrler Stephan 14:30 – 15:00 15:00 – 15:30 15:30 – 16:00 14:30 – 15:00 15:30 – 16:00 15:00 – 15:30 16:00 – 16:30 16:00 – 16:30 Symposium SY-15 14:30 – 16:30 Haematopathology head and in the Lymphoproliferation and lymphoma-mimics neck: Lymphoma Chairs: Andrew , United Wotherspoon 14:30 – 16:30 14:30 Spec-SY-05 ESP / EORTC platforms SPECTA Chairs: 001 so more need pathologists, even Oncologists in the 21st century Switzerland Arnaud Roth, 002 pathology center How does a reference function in SPECTA? , Germany Daniela Aust 003 col sequencing of routinely Next generation 001 lymphomas and lymphopro EBV-associated Lymphomas in the Waldeyer region in the Waldeyer Lymphomas , United Kingdom Andrew Wotherspoon 003 Lymphopro Sjoegren-Mikulicz-Lymphoma: IgG4 disease: Manifestations in the head and neck Abbas Agaimy, Germany liferations in the head and neck liferations Dojcinov, United Kingdom Stefan 002 in the salivary glands liferation Ihrler Stephan 004 lected FFPE tissues: Dream or nightmare? lected FFPE tissues: Dream Ultan McDermott, United Kingdom 004 context: in a European Tissue transfer What’s the legal framework? , Belgium Anastassia Negrouk

- 11 12 / /

ICC Capital Suite 8 ICC Capital Suite 7 Suite ICC Capital Special Session Path Soc Session Path Special Martin, United Kingdom Cook Daniela Massi, Italy Peter Hall, United Kingdom Peter 16:00 – 16:30 15:30 – 16:00 15:00 – 15:30 14:30 – 15:00 15:00 – 15:30 14:30 – 15:00 16:00 – 16:30 15:30 – 16:00

Chairs: Developments in melanoma Dermatopathology 14:30 – 16:30 Symposium SY-14 Chair: development The pathology of drug discovery and and of drug discovery pathology The Spec-SY-04 – 16:30 14:30 Journal of Pathology Rikke Riber-HansenDenmark , sentinel lymph nodes for melanoma Progress in pathological assessment of in pathological assessment of Progress 004 Willeke Blokx, The Netherlands molecular aspects Studies of spitzoid tumours including their 003 , Belgium Joost van den Oord infiltrates in melanoma infiltrates 002 Significance of plasma cell and lymphocytic Daniela Massi, Italy Focus on PD-L1 in human melanoma Focus 001 The impact of intra-tumour genetic heteroge The impact of intra-tumour 002 , The Netherlands Iris Nagtegaal tool in oncology clinical trials tool in oncology clinical Pathology is a necessary and informative a necessary and informative is Pathology 001 44 David Huntsman, Canada there any hope? there and the promise of personalised medicine: Is and the promise The genetic complexity of common cancers 004 , USA Reis-Filho Jorge Epistatic interactions and drug discovery Epistatic interactions 003 Charles Swanton, United Kingdom therapy neity on response and resistance to targeted to targeted and resistance neity on response Scientific Programme a Monday Programme Scientific Monday, 1 Sept L. Selivanova, D.Shatsky Tatiana Birg, Russia matory boweldisease tional diagnostic criteria forileitisininflam Elevation ofneuroendocrine cellsas addi 002 G. Qiu,J.Fallowfield, W. Irving,N.Guha Lorine Meijer-Jorna, TheNetherlands rent classificationandnewentities Lymphatic tumoursandmalformations:Cur 005 Lukasz Adamczyk,UnitedKingdom Patrick J.Gallagher,UnitedKingdom nosis Venolymphatic invasion–patternsanddiag 004 Kristiana Gordon, UnitedKingdom edema ECP 2014 ·London G. Dolman,J.ShuC.Hawkes Abed Zaitoun,UnitedKingdom Chronic HepatitisC(CHC)infection clinical outcomesincirrhosiscausedby Quantification of elastin as a predictor of 001 Mechanisms ofdiseaseinpaediatriclymph 003 Ivana Kholová,Finland lymphatic endothelium-markersandpitfalls Immunohistochemical characterization ofthe 002 Niklas Telinius, Denmark structure andfunctionofthethoracic duct The lymphaticsystemwithemphasison 001 Chairs: Digestive DiseasesPathology II 14:30 –16:30 OFP-08 Chairs: circulation inhealthanddisease Lymphatic system: The forgotten second Cardiovascular Pathology 14:30 –16:30 SC-05 14:40 –14:50 16:06 –16:30 15:42 –16:06 14:30 –14:40 15:18 –15:42 14:54 –15:18 14:30 –14:54 Kingdom Manuel Rodriguez-Justo, United Phil Quirke,UnitedKingdom Anne Jouret-Mourin,Belgium Allard vanderWal, Ulrik Baandrup,Denmark Oral Free Paper Session ICC CapitalSuite15 ICC CapitalSuite17 , A.Tertychnyy TheNetherlands

Short Course

/ 16 - - - - - Scientific Programme aMonday van Oordt,A.Geldof J. A.M.Belien,C.W. Menke-vanderHouven A. C.Hiemstra,V. M.H.Coupe, B.Diosdado Jeroen A.C.M.Goos,TheNetherlands metastases isassociatedwithpoorprognosis (PTGS2) expression incolorectal cancerliver and Prostaglandin-endoperoxide Synthase2 Epidermal Growth Factor Receptor (EGFR) 006 J. Kirby John Brain, UnitedKingdom plantation? in immunemediatedinjurylivertrans agents: Unraveling therole oftheepithelium Pleiotropic effectsofimmunosuppressive 005 B. Gloor J. Galván,I.ZlobecM.Wartenberg, A.Lugli Eva Karamitopoulou-Diamantis, (PDAC) type inPancreatic DuctalAdenocarcinoma with anEMT-type tumourbuddingpheno fectors Snail1,ZEB1andZEB2isassociated Wnt-independent activationoftheEMT-ef 004 O. B.Schaffalitzky deMuckadell F. Caillol,L.Palazzo , B.MialheMorellon B. Napoleon,PujolM.Giovannini , Anne IsabelleLemaistre,France cated inthisnewimaginginterpretation cysts, andhowpathologistscould beimpli Confocal LaserEndomicroscopy inpancreatic A correlation betweenhistologyandreal time M. Farquhar Reynolds,UnitedKingdom Gary virus-associated Hepatocellularcarcinoma a keyrole inthepathogenesisofHepatitisC The autotaxin-lysophosphatidateaxisplays 007 O. S.Hoekstra,R.J.A.Fijneman 008 M. Wakelam, J.McKeating T. Baumert,P. Murray M. B.Mortensen,A.-S. Cribe,T. Pless , Sönke Detlefsen,Denmark a single-centre studyfrom Denmark the diagnosisofautoimmunepancreatitis in Core needlebiopsyplaysacentral role for 003 15:20 –15:30 15:10 –15:20 15:00 –15:10 15:30 –15:40 15:40 –15:50 14:50 –15:00 , A.Perren , S.RudgeG.WilsonL.Mailly , P. Balfe,S.Hübscher , G.A.Meijer Switzerland ,

45 , , - - - - Monday, 1 Sept - - - -

, London · 2014 ECP , A. Erdogan Cakir 15:00 – 15:10 15:00 15:30 – 15:40 15:40 – 15:50 15:50 – 16:00 16:00 – 16:10 15:10 – 15:20 15:20 – 15:30 004 High- achieves: pathological the Unlocking FFPE tissue study for proteomic throughput using RPPA Ola Negm, United Kingdom Tighe, , C. Nolan, P. A. Muftah, A. Green crine tumours Annika Blank, Switzerland , , I. Marinoni, L. Boos, A. Schmitt L. Wehweck A. Perren Immunohistochemical expression of soma expression Immunohistochemical Utility of emerin Immunohistochemistry epithelial lesions (IHC) in well differentiated of thyroid Turkey , Ipek Coban G. Bulbul Dogusoy , M. Alper Unal, E. Karakilic D. Kokenek T. 007 recep Clinical significance of cannabinoid in human ma tors CB1 and CB2 expression lesions lignant and benign thyroid , Greece Eleftheria Lakiotaki , , I. Delladetsima Alexandrou C. Giaginis, P. , S. Theocharis I. Giannopoulou, E. Patsouris 008 Clinical significance of EphB4 and EphB6 in human malignant and benign expression lesions thyroid Giaginis, Greece Constantinos , , I. Delladetsima, C. Troungos Alexandrou P. , S. Theocharis E. Patsouris 009 phosphatase 2A in the protein Variation in breast (PP2A) complex is a common event cancer patients , Malta Shawn Baldacchino , J. De Gaetano, , K. Sacco C. Saliba, S. Falzon , G. Caruana Dingli, J. Debono, A. G. Fenech , G. Grech C. Scerri 010 variability of MIB1 staining Interlaboratory neuroendo pancreatic in well differentiated I. Ellis, E. Rakha 005 subtypes 2 and 5 in Merkel tostatin receptor data Preliminary cell carcinoma: Delektorskaya, Russia Vera K. Orlova, L. Demidov 006 - -

, E. Cuppen,

ICC Capital Suite 1 , , L. van der Kolk , J. Wes Oral Free Paper Session Paper Free Oral , M. A. van de Wiel, A. S. , M. A. van de , B. Diosdado Italy Rosa, La Stefano Turkey Kapran, Yersu 14:40 – 14:50 14:30 – 14:40 14:50 – 15:00 16:10 – 16:20 16:00 – 16:10 15:50 – 16:00 15:50

Chairs: OFP-09 14:30 – 16:30 Pathology Endocrine and Molecular Breast , , C. Marchiò Wai A. Leonidou, P. Sarah Maguire, United Kingdom Sarah positive breast cancer positive breast alternative splicing in oestrogen receptor- alternative splicing in oestrogen SF3B1 K700E mutations are associated with SF3B1 K700E mutations are 002 S. Sapia, M. Sobrinho Simões Catarina Eloy, Portugal Catarina and Ewing family tumour of the thyroid The grey zone between small cell carcinoma carcinoma cell small between zone grey The 001 , P. Tighe, I. Ellis, E. Rakha S. Mirza, P. 46 , Band , V. , A. Green , A. Alshareeda D. Jerjees Ola Negm, United Kingdom Proteomics of breast cancer of breast Proteomics 003 , R. Natrajan Solomon, J. Reis-Filho , A. Sapino, A. Vincent- C. Ng, B. Weigelt F. Ahmed, N. Ramdan F. treatment for experimental liver fibrosis in rats in for experimental liver fibrosis treatment Iman Shaheed, Egypt 011 mesenchymal cells as a Bone marrow-derived , A. Mensenkamp, A. Cats, O. Balague Ponz , H. van Krieken N. Hoogerbrugge, M. Ligtenberg , The Netherlands Chella van der Post Manders, I. Vogelaar P. hereditary diffuse gastric cancer hereditary logical criteria to predict CDH1 mutations in CDH1 mutations criteria to predict logical , C. J. J. Mulder Bolijn, L. Bosch G. A. Meijer 010 of clinicopatho Evaluating the performance L. M. Timmer , E. Berezikov R. Q. J. Schaapveld , The Netherlands Beatriz Carvalho screening purposes screening miRNAs detection in stool accurately identi in stool accurately detection miRNAs for population patients cancer fies colorectal 009 Scientific Programme a Monday Programme Scientific Monday, 1 Sept Antonio Lopez-Beltran, Spain Business meeting 18:50 –19:00 George Netto,USA alised medicineinoncologicpathology T. Rachid, C.MandarimdeLacerda A. Penna deCarvalho,F. Graus-Nunes, Vanessa Souza-Mello,Brazil tissue tocounterobesityinC57BL erator-activated receptors agonistinadipose Telmisartan actsasapan-peroxisome prolif 012 M. Hamoir B. Weynand, J.Rahier Monika Lamba Saini, Belgium Thyroid Carcinoma (PTC) Expression ofMAPkinasesinPapillary 011 ECP 2014 ·London Genomic applicationsinpathology Presidential Lecture: 007 Joao Cassis, Portugal 006 Cioly Rivero Colmenarez, Spain 005 Dilek Baydar 004 Justine Varinot, France 003 Svitlana Bachurska-Yovcheva, Bulgaria 002 , Germany Simone Bertz 001 Chairs: (+ BusinessMeeting) including Presidential Lecture Tumour-like conditionsinuropathology Uropathology 17:00 –19:00 SS-05 16:20 –16:30 16:10 –16:20 18:30 –18:50 18:15 –18:30 18:00 –18:15 17:45 –18:00 17:30 –17:45 17:15 –17:30 17:00 –17:15 Dilek Baydar Isabel Trias, Spain , E.Marbaix , Turkey , Turkey , M.Mourad

ICC Auditorium Slide Seminar /

6 mice / person

- - Scientific Programme aMonday Jason Hornick, USA Cutaneous mesenchymaltumours 004 Alexander Lazar the skin Tumour predisposition syndromes involving 003 Pedram Gerami, USA cytic lesions Richard Byers,UnitedKingdom cases Haematopathology – an artto enjoy difficult 002 Robert Goldin,UnitedKingdom cal liverpathology Claude Cuvelier European histopathology training The historyofharmonisation attemptsfor 001 Value ofFISHinthediagnosismelano 002 Marco Santucci, Italy Update incutaneousT-cell lymphomas 001 A mysteriousandrewarding worldofmedi 001 Chairs: testing across Europe Histopathology training andcompetency Postgraduate Symposium Chairs: Molecular pathologyofskinmalignancies Pathology Dermatopathology /Molecular 17:00 –19:00 SY-16 Symposium Chairs: (organised byTrainees) Trainees –Meettheexperts 17:00 –19:00 Spec-SY-06 17:00 –19:00 Spec-SY-07 18:30 –19:00 18:00 –18:30 17:55 –18:50 17:00 –17:20 17:30 –18:00 17:00 –17:30 17:00 –17:55 Michael Wells, UnitedKingdom Pedram Gerami, USA Jason Hornick, USA Olena Dotsenko, UnitedKingdom Abhik Mukherjee,UnitedKingdom Fred Bosman,Switzerland , Belgium , USA Special SessionPath Soc ICC CapitalSuite8 ICC CapitalSuite7 ICC CapitalSuite9 Special SessionESP

/ / / 11 12 10 47

- - Monday, 1 Sept - - - 16 /

London · 2014 ECP ICC Capital Suite 15 , Austria , K. Naresh Simona Stolnicu, Romania Harry Hollema, The Netherlands 17:20 – 17:40 17:40 – 18:00 18:00 – 18:20 18:20 – 18:40 18:40 – 19:00 17:00 – 17:20 17:30 – 17:40 17:30 17:50 – 18:00 17:40 – 17:50 VI-01 Videomicroscopy 17:00 – 19:00 Difficult cases in gynaecological pathology Chairs: Gynaecological pathology Anais Malpica, USA 002 Harry Hollema, The Netherlands 003 Moinfar Farid 004 Simona Stolnicu, Romania 005 Ben Davidson, Norway 006 Czernobilsky, Israel Bernard 001 004 staining het intra-tumour of An assessment A snapshot of changing trends in EBV Asso in EBV of changing trends A snapshot 006 with patients in Comparison of blast counts myelodysplasia Jodie Chalmers, United Kingdom , J. Pawade Clench Johansson, T. U. erogeneity in diffuse large B-cell lymphoma lymphoma B-cell large in diffuse erogeneity sub-classification , United Kingdom Reade Samuel , K. Linton, J. Hall R. Byers, J. Radford 005 B-cell and Burkitt Lymphoma ciation among (intermediate be unclassifiable Lymphoma, and B-cell Lymphoma tween diffuse large of a UK A perspective Burkitt Lymphoma): Centre Academic Referral Tertiary Lee, United Kingdom Jasmin , I. Ortiz De Mendibil, H. Ibrahim, D. MacDonald M. Bower - - - - -

, Y. Zadik , Y. ICC Capital Suite 14 , J. Hall, J. Mansfield, Oral Free Paper Session Paper Free Oral , United Kingdom , K. Blal, R. Zelser Falko Fend, Germany Fend, Falko German Ott, Germany 17:00 – 17:10 17:20 – 17:30 17:10 – 17:20 18:00 – 18:20 18:20 – 18:40 17:40 – 18:00 17:20 – 17:40 17:20

OFP-10 17:00 – 19:00 Chairs: Haematopathology Oral cavity and jawbone lymphoma: Clinico Oral 001 48 A. Molven, L. Helgeland, O. K. Vintermyr , Norway Ellen Berget usage and mutation status in follicular lym phoma Post-Transplant Lymphoproliferative Disor Lymphoproliferative Post-Transplant Immunoglobulin heavy chain variable gene Tumour Infiltrating Lymphocytes (TILs) in Lymphocytes Infiltrating Tumour 003 002 significance of Investigating the prognostic Christian Slater , K. Oguejiofor C. Rose K. Linton, R. Byers der (PTLD): A novel approach F. Shokaier F. Tzahi Neuman, Israel pathological study of 53 cases , United Kingdom Wells Michael General discussion General 18:40 – 19:00 David Bailey, United Kingdom assessment European union law and international spe European pathology competency A pan-European 005 004 , United Kingdom Cunliffe Stephen Fred Bosman, Switzerland Fred and entitle requirements cialist registration ments European board examinations in pathology board European 003 , United Kingdom West Kevin exams and assessments exams Inter-nation differences in histopathology histopathology in differences Inter-nation 002 Scientific Programme a Monday Programme Scientific Monday, 1 Sept D. Konovalov Anna Mitrofanova, Russia Tumour ofliver Report of 5 cases of malignant Rhabdoid 004 N. Coleman J. M.Tunnacliffe, A.J.EnrightC.Nicholson, K. L.Raby Matthew J.Murray, UnitedKingdom serum microRNA profiles Solid tumoursofchildhooddisplayspecific 003 M. Candusso,P. Calvo,R.Boldrini , F. Callea I. Giovannoni,R.MarianiE.Bellacchio, Paola Francalanci, Italy mutations andrare formsoftransmission ic cholestasis: Detection and meaningof new E. AbdElzaher Dina Abdallah,Egypt WT1 expression sion inWilms’Tumour anditsrelevance to ECP 2014 ·London Genotyoing of progressive familial intrahepat 002 L. Pereira deAlmeida I. Onofre,T. Ferreira, A.AlarcãoLadeirinha Lina Carvalho, Portugal opment opportunity to understand embryonic devel Human inducedpluripotentstemcells asan 006 S. Koo, L.ThiaA.BushNicholson A. Velani, A.Rice, A.MonteroD.M.Hansell Slaveya Yancheva, UnitedKingdom childhood InterstitialLungDiseases(chILD) Hyperplasia ofInfancy(NEHI)andother Bombesin stainingin Neuroendocrine cell 005 D. Kachanov Endothelial Growth Factor (VEGF)expres The prognostic significance of Vascular 001 Chairs: Paediatric andPerinatal Pathology 17:00 –19:00 OFP-11 17:30 –17:40 17:20 –17:30 17:10 –17:20 17:50 –18:00 17:40 –17:50 17:00 –17:10 George Kokai, UnitedKingdom Kingdom Esin Kotiloglu Karaa, United Bo Ngan,Canada , H.K.SainiS.Bailey , M.Teleshova , V. Roschin, D.Rogozhin, , G.Khedr

Oral Free Paper Session ICC CapitalSuite17 , H.Elleithy

, S.V. Wool ,

- - - Scientific Programme aMonday M. Orchard, N.J.Sebire L. Kiho,H.CassI.Wolfe, S.Upton Andrew R.Bamber behavioral trends inLondon2005 early childhood:Demographic, social,and Sudden unexpecteddeathsininfancyand 012 A. R.Bamber Rebecca Piper autopsy cohortfrom aspecialistcenter dren andadolescents:Causesofdeathinan Sudden unexpecteddeathininfants,chil 011 P. Ramani,J.McNally Elise Gradhand, UnitedKingdom Disease through bowelspecimensinHirschsprung’s Evaluation oftissueshrinkageinpull- 010 J. Stahlschmidt, D.Treanor Mohamed Elmoursi,UnitedKingdom in intrauterine growth restriction tual slidestoquantifyplacentalvasculature Novel insightsfrom usingStereology invir 009 D. Treanor Mohamed Elmoursi,UnitedKingdom ture reconstruction ofplacentalmicro-architec A novelapproach towards three dimensional 008 C. Suberbielle,E.Jacquemin M. Dao,D.HabesC.MussiniE.Gonzales Catherine Guettier cipients ic rejection inpediatriclivertransplant re C4d immunostainingassociatedwithchron 007 18:50 –19:00 18:40 –18:50 18:30 –18:40 18:20 –18:30 18:10 –18:20 18:00 –18:10 , N.Simpson , J.Pryce, N.J.Sebire , UnitedKingdom , France , UnitedKingdom , N.Simpson –

2010 49 - - - - - Monday, 1 Sept - - - - , , S. Temam London · 2014 ECP , F. , M. Abbaci, F. , M. Ferchiou , F. Nunes , F. , N. Paiva , C. Rodini , I. Breuskin, N. Assouly 18:40 – 18:50 18:00 – 18:10 18:00 18:10 – 18:20 18:20 – 18:30 18:30 – 18:40 18:50 – 19:00 C. Laplace-Builhé 011 the prog Human papilloma virus reduces 007 sialadenitis sclerosing chronic related IgG4 it exist? – does , United Kingdom Gunasekara Tharanga , I. Bagwan L. Pitkin, S. Di Palma 008 next analysis by bisulfite DNA Methylation OSCC to early detect sequencing generation scrapings oral from , Italy Luca Morandi , , C. Marchetti Monti, S. Asioli, A. Tarsitano V. Foschini , M. P. D. Gissi, L. Montebugnoli 009 cancer stem cell of expression Differential and HPV-negative markers in HPV-positive of the head and squamous cell carcinoma neck Slovenia , Metka Volavšek N. Zidar 010 Confocal Laser Evaluation of probe-based during endoscopic resec Endomicroscopy nostic value of UICC’s TNM classification in (SCC) tonsillar Squamous Cell Carcinomas , The Netherlands Speel Ernst-Jan Hoebers, M. , F. , M. Stuut J. Straetmans , B. Kremer Lacko 012 of cancer stem cell markers Expression sur with overall CD44 and Nanog correlate Squamous in oral vival and aggressiveness Cell Carcinoma , Brazil Rodrigues Maria Fernanda C. Xavier F. tion of T1-T2 Squamous Cell Carcinoma Cell Carcinoma Squamous tion of T1-T2 (SCC) of head and neck: A histo-morpholog study ical correlative , France Odile Casiraghi A. Ben Lakhdar De Leeuw ------

ICC Capital Suite 1 Suite ICC Capital Oral Free Paper Session Paper Free Oral Tim Helliwell, United Kingdom Tim , United Kingdom Silvana Di Palma 17:00 – 17:10 17:50 – 18:00 17:40 – 17:50 17:30 – 17:40 17:20 – 17:30 17:10 – 17:20

Chairs: OFP-12 – 19:00 17:00 Pathology Head and Neck , I. Bello, C. Bitu, J. Hagström, R. Coletta Alhadi Almangush, Finland model for survival Early stage oral tongue cancer: A prognostic tongue cancer: A prognostic oral Early stage 001 , E. King, G. Thomas, K. Moutasim M. Ward 50 Megan Jenkins, United Kingdom neck cancer prognosis The role of alphav beta6 integrin in head and The role 006 , C. Giaginis, J. Klijanienko, I. Kotta-Loizou X. Sastre Garau , Greece Stamatios Theocharis , , E. Dana, E. Patsouris Alexandrou P. Concomitant elevated FAK and Src expres and Src Concomitant elevated FAK (SCC) Cell Carcinoma cal grade and favourable disease-free pa disease-free and favourable cal grade tients’ survival in mobile tongue Squamous 005 sion is associated with high histopathologi , P. Warnke , P. A. Ohlmann, J. Bräsen, H. René HMGA2 as new prognostic marker of squa HMGA2 as new prognostic , Denmark Siegfried Loeschke 004 cavity mous cancer of the oral N. Hirshorn, R. Bulvik, A. Meirovitz, M. Elkin Tzahi Neuman, Israel Induction of heparanase by HPV E6 onco E6 by HPV heparanase Induction of gene in head and neck squamous cell carci noma , L. Ebbers, van Kempen R. Noorlag, P. 003 , The Netherlands Koole Koos , van Diest, R. Koole , P. Peeters T. Grolman, R. J. J. van Es, S. M. Willems W. oropharyngeal cancer oropharyngeal Fibroblast growth factor receptor 2 overex receptor factor growth Fibroblast and in oral regulated is differently pression 002 I. Leivo , T. Salo, , R. Grénman, T. Koivunen Soini, P. Y. Scientific Programme a Monday Programme Scientific Monday, 1 Sept H. Wood, P. Quirke Kate Sutton , UnitedKingdom osis patients Iris Nagtegaal, TheNetherlands sis forcarcinomas ofthedigestivesystem Factors indicatingariskofdistantmetasta 005 Gustavo Ayala, USA tive system Perineural invasionincancersofthediges 004 David Horst,Germany metastasis incoloncancer RTK-Ras-signaling asdriverofinvasionand 003 Florian Greten,Germany ment anditsrole forcancerprogression The gastrointestinal tumourmicroenviron 002 Nick A.Wright,UnitedKingdom gators e ECP 2014 ·London of adenomasinfamilialadenomatous polyp Assessing thegeneticmechanism of growth 002 network Introduction &updateontheundergraduate 001 Stem cellsincancer:Instigatorsandpropa 001 Chairs: Undergraduate Forum Undergraduates / 08:30 –12:00 Spec-SY-08 Chairs: cers ofthedigestivesystem Basics of invasion and metastasis in can Digestive DiseasesPathology 08:30 –12:00 SY-17 Symposium Tuesday, 2September2014 11:30 –12:00 11:00 –11:30 10:30 –11:00 09:00 –09:30 08:45 –09:00 08:30 –08:45 08:30 –09:00 John McDermott,UnitedKingdom Richard Byers,UnitedKingdom Nick A.Wright,UnitedKingdom Thomas Kirchner Pathological Society Special SessionPath Soc ICC CapitalSuite7 , Germany ICC Auditorium

/ 12 ------Scientific Programme aTuesday 007 pathologic andmolecularstudyon28patients Leptomeningeal melanocytictumours:A C. Sauer Cornelia MariaPaul, Germany tor 2(IGF2)inthymictumours A structured debatecontestingthestate 11:15 –12:00 A. delaFouchardière, V. Costes, V. Rigau Gabrielle Goldman-Levy,France Loss ofimprintinginsulin-likegrowth fac 006 J. Spicer D. Gonzalez-de-Casro,A.Wallace, R.Butler I. Schrijver Joshua Kapp, UnitedKingdom tions inclinicalcancerdiagnostics from FFPEmaterialleadstomissedmuta Variation in pre-analytical DNA extraction 005 R. Dina,L.Foroni, M.Valganon Alyce Hayes,UnitedKingdom thyroid nodules pre-operative managementofpatientswith Molecular testingformutationsimproves 004 M. Booth,K.SuttonBack John McDermott,UnitedKingdom tional Pathology Network Morgan Back, UnitedKingdom Nigel Kirkham,UnitedKingdom For (againstpathologyincurriculum) John McDermott,UnitedKingdom Michael Wells, UnitedKingdom Against (forpathologyincurriculum) curriculum”: not beapriorityintoday’sundergraduate ment “Clinicalpathologyexperienceshould pathology through thedevelopmentofaNa Increasing undergraduate involvementin 003 11:00 –11:15 10:45 –11:00 10:30 –10:45 09:15 –09:30 09:00 –09:15 , J.BridgeR.Hamoudi , B.Schalke, A.MarxD.Belharazem , L.JenningsG.Tsongalis, M.Li 51 , - - - - Tuesday, 2 Sept - - 16 /

Short Course Short London · 2014 ECP ICC Capital Suite 14 Suite ICC Capital ICC Capital Suite 15 , United Kingdom Jon van der Walt , Portugal Schmitt Fernando , Switzerland Gieri Cathomas Pio, Italy Zeppa 08:30 – 08:50 08:30 – 09:00 09:00 – 09:30 10:30 – 11:00 11:00 – 11:30 11:30 – 12:00 09:10 – 09:30 08:50 – 09:10 10:30 – 10:53

Cytopathology head and neck cytopathology Advances in Chairs: SC-07 08:30 – 12:00 Infectious diseases involve the bone marrow Chairs: 08:30 – 12:00 08:30 Infectious Diseases / European Pathology Group Working Bone Marrow Symposium SY-19 001 inter The marrow. viruses and the Herpes 001 node Lymph , USA L. Katz Ruth 002 Salivary glands , France Jerzy Klijanienko 003 Thyroid Switzerland Massimo Bongiovanni, 004 Soft tissue Marinsek, Slovenia Ziva Pohar 005 How ancillary techniques can help in FNA of head and neck tumours , Portugal Schmitt Fernando Haemophagocytic syndrome Sebastian Lucas, United Kingdom 003 Mycobacterial infections in immunocompe marrow the in infections Granulomatous other than mycobacteria , Switzerland Tzankov Alexandar section of infection and neoplasia , United Kingdom Kikkeri Naresh 002 patients tent and immunosuppressed , United Kingdom Moonim Mufaddal 004 - - - - 10 11 / /

Gynae

/ Short Course Short , Switzerland ICC Capital Suite 9 ICC Capital Suite 8 Suite ICC Capital , France Marta, United Kingdom Cohen , Italy Raspollini Maria Rosaria , United Kingdom Cook Terry Helmut Hopfer 08:30 – 09:00 10:55 – 11:20 10:30 – 10:55 09:00 – 09:30 08:30 – 09:00 11:30 – 12:00 10:30 – 11:00 11:00 – 11:30 09:00 – 09:30

Chairs: Trophoblastic diseases and differential di diseases and differential Trophoblastic agnosis cological Pathology SC-06 08:30 – 12:00 Pathology and Perinatal Paediatric Chairs: Complement in renal disease in renal Complement Symposium SY-18 – 12:00 08:30 Nephropathology 11:20 – 12:15 with tropho Common diagnosis problems , United Kingdom Cook Terry 001 Complement in other glomerular diseases Complement in other glomerular 004 Ingeborg Bajema, The Netherlands Ingeborg C3 glomerulopathy 003 , Italy Marina Noris Haemolytic uraemic syndrome Haemolytic uraemic 002 Matthew Pickering, United Kingdom 001 biology Complement , USA Ona Faye-Petersen Placental Mesenchymal Dysplasia 52 005 , USA Kaplan Cynthia Recent advances in the pathological diagno 004 Hydrops Neil J. Sebire, United Kingdom 003 sis of hydatidiform moles , United Kingdom Wells Michael 002 of the non-villous trophoblast Tumours Sophie Patrier blastic disease

UK Renal Pathology EQA participants' meeting UK Renal Pathology , United Kingdom Ian Roberts Scientific Programme a Tuesday Programme Scientific Tuesday, 2 Sept R. Scully Christopher vonRuhland, UnitedKingdom centre study lar basementmembrane thickness:Amulti The effectsoftissueprocessing onglomeru 005 E. Arkoumani,M.Sarigul P. Gopinath,A.DowningS.Jader Salam Al-Sam, UnitedKingdom diagnosis? Is it safe to use digital pathology for biopsy 004 J. Simpson,K.Washington, M.Wells L. Hirschowitz, M.JudgeA.Kwiatkowski, F. Bosman,B.ChmaraJ.Srigley David Ellis,Australia core datasetsforpathologycancerreporting porting: Developmentofevidence-based The internationalcollaboration oncancerre 003 Peter Caie, UnitedKingdom cancer patientsthrough imageanalysis Stratifying highriskearlystagecolorectal 002 S. Guelcher Vladimir Iakovlev, Canada meshes: Afindingoverlookedfordecades In vivodegradation ofsurgical polypropylene Gieri Cathomas, Switzerland marrow biopsies:Stateoftheart Molecular diagnosisofinfectioninbone 006 Paul Hofman,France Infection orartifact? Blue blobsinthemarrow. Easilymissed!! 005 ECP 2014 ·London 001 Chairs: IT inPathology 08:30 –12:00 OFP-13 09:10 –09:20 09:00 –09:10 08:50 –09:00 08:40 –08:50 11:16 –11:39 10:53 –11:16 08:30 –08:40 Pierre Bedossa,FrancePierre Fred Bosman,Switzerland , J.MorganD.Griffiths , R.Bendavid / Other Topics Oral Free Paper Session ICC CapitalSuite17 , J.Dvorak ,

- - - Scientific Programme aTuesday Automatic imagequalityassessmentindigi 010 V. Souza,N.Schenka, J.Vassallo, F. Soares A. Renno, M.Alvesjr., R.Rocha, P. Souza, Andre Schenka, Brazil cancer cell markersinamurinemodelofbreast Simvastatin decreases expression ofstem 009 K. Linton,C.West , R.Byers K. Oguejiofor Christian Slater lymphoid TissueMicroarrays (TMAs) tiplexed immunohistochemistry(IHC)in Lymphocytes (TIL) using chromogenic mul phenotypically distinctTumour Infiltrating software canaccurately quantifyimmuno Multispectral imagingand image analysis 008 M. Ferreira, P. Oliveira,C.Sousa-Pinto Pedro Luis,Portugal experience inPortugal try ofadultautopsyreports: TheDGS Implementing anationwideelectronic regis 007 S. Mallett P. Teresa, J.GarattB.GilksE.Torlakovic, Nikita Makretsov,Canada Diagnostic accuracy study breast cancerusinghierarchical modelling: gram forsteroid hormonereceptors in D. N.Vieira G. Tralhão, S.RamosB.Silva , F. Corte Real, Rosa HenriquesdeGouveia , Portugal scientific bondthrough time... Winiwarter, LeoBuerger: Anhistorical- Thoukudídes, CarlFriedländer, Felix von 012 V. Sanchez, H.El-Daly Tzu-Hsi Song,UnitedKingdom row trephine biopsies delineation ofmegakaryocytesinbonemar A supervisedimageanalysisframework for 011 P. Bertheau, J.-B. Yunès M. Battistella,L.Legrès, A.Janin C. Deroulers,V. Perrier David Ameisen,France tal pathology:From ideatoimplementation Modelling Canadianqualitycontrol testpro 006 11:00 –11:10 10:50 –11:00 10:40 –10:50 10:30 –10:40 11:20 –11:30 11:10 –11:20 09:20 –09:30 , J.HallG.AshtonMansfield , UnitedKingdom , N.M.Rajpoot , F. Bouhidel,

/ SICO

------

Tuesday, 2 Sept - - - 12 /

Short Course Short London · 2014 ECP Special Session ICC Auditorium ICC Auditorium Keynote Lecture Keynote ICC Capital Suite 7 Peter Hall, United Kingdom Peter Manfred Dietel, Germany Pierre France Bedossa, , France Paradis Valerie Elizabeth M. Brunt, USA United Kingdom Elizabeth Soilleux, 14:30 – 14:45 14:45 – 15:20 15:20 – 15:55 14:30 – 15:00 15:00 – 15:30 15:30 – 16:00 16:00 – 16:30 Spec-SY-09 14:30 – 16:30 Boveri at 100 mours: Chairs: 12:15 – 13:00 12:15 Chairs: ageing; of DNA damage on impact The in under control largely Getting ageing Lecture) mice (ESP Symeonidis Hoeijmakers , The Netherlands Jan SC-09 14:30 – 16:30 Digestive Diseases Pathology disease pathology Obesity and digestive Chairs: Path Soc / Journal of / History Pathology of Pathology Concerning the origin of malignant tu KL-03 001 The life and times of Theodor Boveri Manfred Dietel, Germany 002 and cancer Boveri & chromosomes Sverre Heim, Norway 003 to cancer Boveri & genetic predisposition David Huntsman, Canada 001 disorder? liver disease: A genetic Fatty Quentin Anstee, United Kingdom 002 aspects liver disease: Pathological Fatty Elizabeth M. Brunt, USA 003 in diges inflammation and fibrosis Obesity, tive diseases Pierre Bedossa, France 004 The pathological effects of obesity and meta tract on the gastrointestinal bolic syndrome , United Kingdom Feakins Roger - - - -

Short Course Short , D. Oukrif around the CNS: around / ICC Capital Suite 1 , , M. Rodriguez-Justo James Lowe, United Kingdom James Ariza, Spain Aurelio 09:00 – 09:30 08:30 – 09:00 10:30 – 11:07 11:07 – 11:44 11:40 – 11:50 11:30 – 11:40 11:30

Chairs: 08:30 – 12:00 pathologists What is new for general SC-08 Neuropathology 002 nonneoplastic lesions present Tumefactive, , United Kingdom Ironside James The autopsy in dementia 001 54 Janice Holton, United Kingdom Janice thologists? 003 Soft tissue tumours in pa Muscle disease: What is new for general , United Kingdom Roncaroli Federico ing in the CNS 004 , The Netherlands Pieter Wesseling What’s so special? dyskinesia: A retrospective analysis dyskinesia: A retrospective , C. Brochhausen J. Ewen, C. J. Kirkpatrick ultrastructural diagnosis of primary ciliaryprimary of diagnosis ultrastructural Bethencourt , Germany V. Nora Are brush or scratch biopsies superior for the biopsies scratch or brush Are 014 , M. Gandy E. Bloom, I. Puccio S. Khan, R. J. Haidry , M. Novelli, L. Lovat R. Hamoudi Mohammed Adil Butt, United Kingdom Mohammed metaplasia-dysplasia-oesophageal adeno metaplasia-dysplasia-oesophageal sequence carcinoma Digital Image Analysis enhances quantita enhances Image Analysis Digital the squamous- in pathology tive molecular 013 Scientific Programme a Tuesday Programme Scientific Tuesday, 2 Sept Desley Neil,UnitedKingdom pants' meeting UK RenalTransplant Pathology EQApartici 16:30 –17:00 Candice Roufosse, UnitedKingdom ment oftransplant biopsies? Does EMhavearole intheroutine assess 004 Bob Colvin, USA totoxicity (ADCC)inAMR Olivia Shaw uation Nick A.Wright,UnitedKingdom sia tomalignancy Boveri &cancerevolution:From preneopla 004 ECP 2014 ·London nioymdae Clua Cy Cellular evaluation /Antibody-mediated Chronic vascularlesions:Pathogenesis and 003 Alexandre Loupy,France mediated rejection Recognition and categorisation of antibody- 002 Megan Dishop,USA diffuse lungdiseaseinchildren Interstitial lungdiseasesI:Genetic formsof 002 Coffin, USA Cheryl New classificationofsofttissues 001 Donor specificantibody:Detectionandeval 001 Chairs: Hot topicsinpaediatricpathology Paediatric andPerinatal Pathology 14:30 –16:30 BM-03 Chairs: Renal transplant pathology Nephropathology 14:30 –16:30 SY-20 Symposium 16:00 –16:30 15:55 –16:30 15:30 –16:00 15:00 –15:30 15:00 –15:30 14:30 –15:00 14:30 –15:00 Rita Alaggio,Italy Paula Borralho Nunes,Portugal Desley Neil,UnitedKingdom Chris Bellamy,UnitedKingdom , UnitedKingdom ICC CapitalSuite9 ICC CapitalSuite8 Business Meeting

/ / 10 11 - - - - - Scientific Programme aTuesday Monique Courtade-Saidi, France Urine 005 Ben Davidson,Norway Serous effusions 004 Beatrix Cochand Priollet,France view Business affairs 16:00 –16:30 Helmut Popper matory diseases Felix Offner Infections associated withimplants 003 Abbas Agaimy,Germany Infections mimickingmalignancies 002 Silvia Vanessa Lourenco,Brazil peutics Infectious sideeffectsofbiological thera 001 The papsmearsinthedifferent EU:Anover 003 Kari Syrjänen,Finland Molecular testingincervicalscreening 002 John Smith,UnitedKingdom Conventional andliquidbasedpapsmear 001 Interstitial lungdiseasesII:Acquired inflam 003 Infections youmightregret missing Infectious DiseasesPathology Chairs: Exfoliative cytopathologywhatisthefuture? Cytopathology 14:30 –16:30 SC-10 Chairs: (+ BusinessMeeting) 14:30 –16:30 SY-21 Symposium 16:06 –16:30 15:42 –16:06 15:16 –15:39 14:53 –15:16 14:30 –14:53 15:18 –15:42 14:54 –15:18 14:30 –14:54 15:30 –16:00 John Smith,UnitedKingdom Kari Syrjänen,Finland Vsevolod Zinserling,Russia Sebastian Lucas,UnitedKingdom Gieri Cathomas, Switzerland , Austria , Austria ICC CapitalSuite15 ICC CapitalSuite14 Short Course

/ 16

55 - - - Tuesday, 2 Sept -

London · 2014 ECP , United ICC Auditorium Business Meeting ICC Capital Suite 1 Suite ICC Capital , Austria , United Kingdom , Germany , Hungary Cord Langner Cord , France Paradis Valerie Ho-Keung Ng, Hong Kong Ho-Keung Sebastian Brandner Kingdom 17:00 – 17:25 17:25 – 17:50 17:50 – 18:15 18:15 – 18:40 15:00 – 15:30 15:30 – 16:00 14:30 – 15:00 16:00 – 16:30 Digestive Diseases Pathology What’s hot in digestive disease pathology? Chairs: BM-05 17:00 – 19:00 14:30 – 16:30 14:30 / Pathological Neuropathology Society / ESP new basic concepts From tumours: Brain approach practical to an improved Chairs: Symposium SY-22 001 Oesophagus and stomach , Italy Fiocca Roberto 002 bowel Small and large Thomas Kirchner 003 Liver and biliary tract Zsuzsa Schaff 004 Pancreas , United Kingdom Campbell Fiona 18:40 – 19:00 Business affairs The new molecular stars on the glioma stage The new molecular stars Ariza, Spain Aurelio 002 routine in the Reporting molecular findings to the 2016 WHO with reference practice, classification update Ng, Hong Kong Ho-Keung 003 mimics of glioblas Recognising variants and 001 toma Sebastian Brandner 004 with cells stem cancer of interaction The tumour microenvironment of China Republic Xiu-wu Bian, People’s

- - -

Business Meeting ICC Capital Suite 17 , K. Wassilew , N. Semenova, N. Blum , R. Hetzer , Italy Raspollini Maria Rosaria Simona Stolnicu, Romania 15:00 – 15:30 14:30 – 15:00 16:00 – 16:30 15:30 – 16:00 16:03 – 16:15 15:39 – 15:51 15:39 15:51 – 16:03

Chairs: The future of OB-GYN pathology of OB-GYN pathology future The (+ Slide Seminar) Gynaecological Pathology BM-04 14:30 – 16:30 002 of obstetrical pathology: Intro The future , Italy Raspollini Maria Rosaria Activities of the WG 001 56 Tumour heterogeneity as a source of of as a source heterogeneity Tumour 004 Stanta, Italy Giorgio , Spain Prat Jaime molecular analysis variability challenge The future of gynaecological pathology: A The future 003 of new imaging modalities (MRI etc) on peri of new imaging modalities (MRI Neil J. Sebire, United Kingdom and perinatal autopsy work and the impact natal autopsy duction of molecular methods to placental Business meeting 16:15 – 16:30 , D. Nunes Oliveira, D. Nunes Oliveira Ribeiro, S. Gomes Peixoto A. L. Rocha , Brazil Diane Isabelle Magno Cavalcante in Ceará, Brazil in Ceará, Fever: A retrospective autopsy-based study A retrospective Fever: 006 Dengue Hemorrhagic Autopsy findings in V. Swistunov V. D. Kemper , Russia Vsevolod Zinserling Michael Zeh, Germany Michael tissue slices Active toxoplasmosis after thoracic trans thoracic after toxoplasmosis Active condition? An underestimated plantation: 005 in of Mycobacteria revealing New aspects 004 Scientific Programme a Tuesday Programme Scientific Tuesday, 2 Sept ECP 2014 ·London Business meeting 18:50 –19:00 Chris Hemmings,Australia Secondary molecularalterations inGIST 005 Adrienne Flanagan,UnitedKingdom Genomic dataofosteosarcomas 004 A. B.Hassan,UnitedKingdom MTP Targets fortherapy underdebate:IGFRand 003 Paola DalCin,USA and softtissuetumours New tumourspecificgeneticeventsinbone 002 Roberto Tirabosco, UnitedKingdom bone andchondroblastoma Histone 3,3mutationsingiantcelltumourof 001 Sandrine Florquin, TheNetherlands 005 Ran Perera, UnitedKingdom 004 Agnieszka Perkowska-Ptasinska, Poland 003 Paul Bass , UnitedKingdom 002 Kerstin Amann,Germany 001 Chairs: Challenging glomerulardiagnoses Nephropathology 17:00 –19:00 SS-06 Chairs: coma (+BusinessMeeting) Genetics andtherapeutic targets insar Soft TissueandBonePathology 17:00 –19:00 SY-23 Symposium 18:28 –18:50 18:06 –18:28 17:44 –18:06 17:22 –17:44 17:00 –17:22 18:00 –18:15 17:45 –18:00 17:30 –17:45 17:15 –17:30 17:00 –17:15 Adrienne Flanagan, Sandrine Florquin, TheNetherlands Jasmina Markovic-Lipkovski, Netherlands Pancras C.W. Hogendoorn,The

ICC CapitalSuite8 ICC CapitalSuite7/12 UnitedKingdom Slide Seminar Serbia / 11 -

Scientific Programme aTuesday , UnitedKingdom Amanda Herbert 005 Ambrogio Fassina , Italy 004 Ruth L.Katz, USA 003 Lukas Bubendorf 002 TötschMartin , Austria 001 Rajeev Shukla,UnitedKingdom 007 David Ellis,Australia 006 Bruce Pawel, USA 005 Samantha Holden,UnitedKingdom 004 Aurore Coulomb, France 003 Glenn Taylor 002 Paul Dickman, USA 001 Ian Roberts, UnitedKingdom 008 Renate Kain, Austria 007 Helmut Hopfer 006 Chairs: Foetal andpaediatricthoracic pathology Paediatric andPerinatal Pathology 17:00 –19:00 SS-07 Chairs: Lung andmediastinalcytopathology Cytopathology 17:00 –19:00 SS-08 18:36 –19:00 18:12 –18:36 17:48 –18:12 17:24 –17:48 17:00 –17:24 18:42 –18:59 18:25 –18:42 18:08 –18:25 17:51 –18:08 17:34 –17:51 17:17 –17:34 17:00 –17:17 18:45 –19:00 18:30 –18:45 18:15 –18:30 Paul Dickman, USA Irene Scheimberg, UnitedKingdom Martin TötschMartin , Austria Ruth L.Katz , USA , Canada , Switzerland , Switzerland ICC CapitalSuite9 ICC CapitalSuite14

Slide Seminar Slide Seminar / 10 57

Tuesday, 2 Sept - - - -

ovarian ovarian /

London · 2014 ECP URI amplification in en / , R. Crawford, M. Jimenez-Linan 17:40 – 17:50 17:40 17:50 – 18:00 18:30 – 18:40 18:40 – 18:50 18:20 – 18:30 18:00 – 18:10 18:10 – 18:20 005 tubal in site assignment Primary high-grade serous carcinoma serous high-grade Canada , Blake Gilks , G. McCluggage N. Singh, N. Wilkinson 006 at occult appendiceal lesions of Prevalence tu of mucinous ovarian removal the time of Neoadjuvant chemotherapy in epithelial Neoadjuvant chemotherapy ovarian cancer: Clinicopathological and sur Immunophenotype and HPV status of vulvar (SCC) Squamous Cell Carcinoma sarcomatoid Ana Luís, Portugal Lopes, J. Ribeiro, R. Vieira, C. Bartosch P. M. G. Tibiletti, C. Riva 010 vival analysis of 31 cases Ana Luís, Portugal , C. Meireles, S. Carvalho, D. Pereira C. Bartosch 011 Chromogenic 19q12 in situ hybridization for Chromogenic detection of CCNE1 of hypercalce Ovarian small cell carcinoma complement mutations SMARCA4 type: mic other rhabdoid tumour features , Poland Jolanta Kupryjanczyk L. Szafron, J. Moes-Sosnowska, , A. Dansonka-Mieszkowska, I. Rzepecka , , A. Podgorska J. Plisiecka-Halasa , B. Konopka A. Budzilowska, A. Rembiszewska 009 Gynaecological cancer as sentinel cancer in and Clinico-pathological Syndrome: Lynch molecular features Cimetti, Italy Laura I. Carnevali, A. M. Chiaravalli, N. Sahnane, , Sessa , F. Rossi , L. Libera, T. D. Furlan mours Luiza Moore, United Kingdom K. Gajjar 007 dometrial cancer , Switzerland Matthias Drach , , M. Storz Wild, L. A. Henricksen A. Noske, P. , S. Singh, H. Moch A. Tubbs 008 - - - -

16 /

ICC Capital Suite 17 ICC Capital Suite 15 Suite ICC Capital Oral Free Paper Session Paper Free Oral , A. N. Ihvan Jaume Ordi, Spain Ordi, Jaume , Germany Leticia Quintanilla-Fend , Germany German Ott de Leval, Switzerland Laurence Glenn McCluggage, United Kingdom Portugal Ana Felix, 18:20 – 19:00 17:40 – 18:20 17:00 – 17:40 17:30 – 17:40 17:20 – 17:30 17:10 – 17:20 17:00 – 17:10

Chairs: Gynaecological Pathology OFP-14 17:00 – 19:00

Chairs: about MYC-driven aggressive B-cell lym B-cell aggressive about MYC-driven phomas MYC or not MYC? All you need to know All you need to MYC? or not MYC Videomicroscopy VI-02 – 19:00 17:00 Haematopathology Laurence de Leval, Switzerland de Laurence Presentation of three cases of three Presentation 003 German Ott, Germany 002 cases of three Presentation , Germany Leticia Quintanilla-Fend Presentation of three cases of three Presentation 001 , B. Gilks, N. Le, S. Boehm I. Said, A. Faruqi 58 py in high-grade serous ovarian cancer serous py in high-grade Singh, United Kingdom Naveena 004 of a system to quantify histopatho Validation chemothera to neoadjuvant logical response G. McCluggage (OCRS): Scoring Response Cancer Ovarian B. Khatri, B. Clarke, G. McCluggage, , United Kingdom Shauna Casey Sarah Aitken, United Kingdom Sarah Adenomyomas of the uterine cervix of endo cervical type: Report of 12 cases present in ovarian sex cord-stromal tumours in ovarian sex cord-stromal present 003 , G. Kir C. S. Topal 002 not are IDH2 and IDH1 in mutations Somatic A. Flanagan Meryem Dogan, Turkey in endometrial carcinomas elongated, and fragmented invasion pattern elongated, and fragmented Prognostic significance of the microcystic, microcystic, of the significance Prognostic

001 Scientific Programme a Tuesday Programme Scientific Tuesday, 2 Sept M. Shaaban,R.AbdAllah M. AbdEl-Wahed, M.Kandil, E.AbdElzaher Rehab Samaka, Egypt immunohistochemical study medulloblastoma inEgyptianpatients: An Identification ofmolecularsubgrouping of 005 P. vanDaele W. vandenBosch, H.SimonszI.Bleyen A. Breijer Robert Verdijk, TheNetherlands idiopathic orbitalinflammation Frequency ofIgG4-positiveplasmacellsin 004 F. Botelho E. Costa, C.OliveiraJ.MurtaR.Proença M. Laranjo,R.Treixo, A.M.Abrantes Gonçalo Brites,Portugal An orthotopicanimalmodelofretinoblastoma 003 S. Mondello,G.Tuccari G. Branca,R.T. Soundara , E.Vitarelli Valeria Barresi,Italy drogliomas to differentiate astrocytomas from oligoden in humangliomas:Potential useasamarker ment binding protein (p-CREB) expression Phosphorylated Cyclic-AMP responsive ele 002 I. Vajtai, S.BerezowskaE.Vassella Ekkehard Hewer tomas R. H.Young, E.Oliva Mª EstherGuerra Fernández, Spain gy: Astudyof30cases mours withfibroblastic The spectrumofendometrialstromal tu 012 ECP 2014 ·London ATRX andLOH 1p19q statusinoligoastrocy 001 Chairs: Pathology Neuropathology /Ophthalmic 17:00 –19:00 OFP-15 17:40 –17:50 17:30 –17:40 17:20 –17:30 17:10 –17:20 18:50 –19:00 17:00 –17:10 Steffen Heegaard, Denmark Federico Roncaroli, UnitedKingdom Joanne Martin, UnitedKingdom Joanne Martin, , A.vanTilburgD.Paridaens, , Switzerland Oral Free Paper Session ICC CapitalSuite1 / myxoid morpholo

- - - - - ,

Scientific Programme aTuesday EGFR andEGFRvIIIdetectioninGlioblasto 010 M. Williams,K.Kurian A. Shaw Claire Faulkner RT-PCR andFISH BRAF fusionsinpilocyticastrocytoma using A combinedstrategy forthedetectionof 009 D. Paridaens, A.deKlein S. Benulek,B.KristE.Post, E.Zwarthoff A. Koopmans, K.Ober Robert Verdijk, TheNetherlands nevi andextremely rare inuvealmelanoma junctival melanoma,absentinconjunctival Tert promoter mutations are frequent incon 008 N. Naus,E.KilicA.deKlein M. vandenBerg,J.Vaarwater A. Koopmans, R.Brouwer Robert Verdijk, TheNetherlands melanoma try fordetectionofBAP1mutationsinuveal Clinical significanceofimmunohistochemis 007 E. Gelpi,M.CuatrecasasW. Poewe, E.Tolosa R. Vannozzi, K.Zavaglia , A.G.Naccarato S. Franceschi, M.LaFerla, F. Lessi,P. Aretini , C. M.Mazzanti,F. G.Carbone , V. Ortenzi, Cristian Scatena, Italy free survival Molecular mechanismsrelated torecurrence Glioblastoma wholetranscriptome analysis: 012 M. Manchini, A.LastP. Sundar M. Gessi,A.zurMuehlenE.Doerner Torsten, Germany Pietsch of theCNS diagnostics andprognostification oftumours Molecular inversion profiling: A helpful tool in 011 K. Hopkins,Kurian, A.Shaw P. White,R.deSouzaM.Willimas A. Palmer Claire Faulkner vidualised therapies ma: Methodstoselectpatientsfornovelindi J. NavarroOtano,N.Stefanova, A.Sagasta Iban Aldecoa,Spain in theentericnervoussystem Alpha-synuclein immunoreactivity patterns 006 18:30 –18:40 18:20 –18:30 18:10 –18:20 18:00 –18:10 18:50 –19:00 18:40 –18:50 17:50 –18:00 , H.HaynesWilliamsS.Lowis , H.WilliamsC.WraggHaynes , UnitedKingdom , UnitedKingdom , H.Dubbink , T. vandenBosch , , D.Paridaens,

59 - - - - Tuesday, 2 Sept - - - -

10 11 / / London · 2014 ECP

Special Session ESP ICC Capital Suite 9 ICC Capital Suite 8 , Saudi Arabia , USA Han van Krieken, The Netherlands Amr Samir , Spain Prat Jaime Glenn McCluggage, United Kingdom 08:30 – 09:00 08:30 – 09:00 09:00 – 09:30 10:30 – 10:55 10:55 – 11:20 11:20 – 11:45 11:30 – 12:00 11:00 – 11:30 11:00 Spec-SY-10 08:30 – 12:00 cation Chairs: Symposium SY-26 08:30 – 12:00 and beyond) ogy (WHO classification Chairs: ESP / IAP edu undergraduate medical in Pathology Gynaecological Pathology pathol gynaecological in news Breaking 001 What pathology do junior doctors need to know? , United Kingdom Cohen Nicki 001 fallopian tube, The new staging of ovarian, and peritoneal cancer , Spain Prat Jaime 002 What’s new in adnexal pathology Glenn McCluggage, United Kingdom 003 What’s new in endometrial pathology Xavier Matias-Guiu, Spain 004 thologist and pitfalls Practical challenges in diagnosing sarcomas challenges Practical Chris Fletcher mesenchymal pathology in uterine What’s new , Austria Lax Sigurd 005 What’s new in cervical and vulval pathology Simon Herrington, United Kingdom 11:45 – 12:00 the pa from Round table: Considerations cation of STT cation , Italy Dei Tos Angelo Paolo 005 004 classifi vs. clinical classification Pathology - - - - - 12 /

ICC Auditorium , USA , Austria ICC Capital Suite 7 , United Kingdom 11:15 – 12:00 10:30 – 11:15 Chris Fletcher , Italy Dei Tos Angelo Paolo Cord Langner Cord Massimo Pinzani, United Kingdom 09:00 – 09:30 08:30 – 09:00 08:30 – 09:00 10:30 – 11:00 09:00 – 09:30

Wednesday, 3 September 2014 September 3 Wednesday,

Chairs: 08:30 – 12:00 challenges in soft tissue Practical Symposium SY-25 Soft Tissue and Bone Pathology

and scoring in digestive disease pathology and scoring Chairs: Joint UEG and ESP symposium: Grading Grading and ESP symposium: Joint UEG Symposium SY-24 08:30 – 12:00 Digestive Diseases Pathology Digestive Diseases Practical challenges in diagnosing bone tu Practical Cyril Fisher Cyril Pseudomalignant soft tissue tumours 002 001 Pathology of neoadjuvant treatment in gas treatment of neoadjuvant Pathology 001 60 , USA Hornick Jason genetics in soft tissue tumours 003 Challenges in immunohistochemistry and mours Hogendoorn, The Netherlands C. W. Pancras Massimo Pinzani, United Kingdom Grading and scoring the activity of liver dis Grading Pierre Bedossa, France 005 / 006 Talk: Tandem eases , United Kingdom Simon Travis , United Kingdom Neil Shepherd Grading and scoring the activity of gastroin Grading testinal diseases 003 / 004 Talk: Tandem , Germany Thomas Longerich 002 in hepa treatment of neoadjuvant Pathology tumours tobiliary and pancreatic , Canada Chetty Runjan trointestinal tumours trointestinal

e Scientific Programme a Wednesday Programme Scientific Wednesday, 3 Sept Paola Dal Cin,USA gets oflungandpleural tumours:An update Cytogenetic andmoleculartherapeutic tar 005 Josep Lloreta-Trull, Spain diagnosis ofmesothelioma Contribution ofelectron microscopy tothe 004 César Morán, USA ma: Cluesandpitfalls Discussion 11:30 –12:00 Lisa Browning, UnitedKingdom century good old-fashionedteachinginthe21st The valueofpathologymuseumcollections; 004 Ray McMahon,UnitedKingdom programme? How tomaintainpathologyinanintegrated 003 Jane Dahlstrom, Australia students Inspiring learninginpathologyformedical 002 ECP 2014 ·London Histopathological diagnosisofmesothelio 003 Lina Carvalho, Portugal From theseventiestillnowwithIHCupdating Insights inNSCLC electron microscopy – 002 César Morán, USA and pitfalls Histopathological diagnosisofNSCLC: Clues 001 Chairs: therapy lung carcinoma intheera oftargeted sis ofmesotheliomaandnon-smallcell Multidisciplinary approach tothediagno Electron Microscopy 08:30 –12:00 SY-27 Symposium 11:30 –12:00 11:00 –11:30 11:00 –11:30 10:30 –11:00 09:00 –09:30 10:30 –11:00 09:00 –09:30 08:30 –09:00 Paola DalCin,USA Josep Lloreta-Trull, Spain ICC CapitalSuite14

Scientific Programme aWednesday - - - Karl-Friedrich Becker embedded tissue Advances inprotein analysisfrom paraffin 008 Karl Kashofer Gerald Hoefler diagnostics Advantages andtroubleshooting inNGS 006 /007 Serena Bonin,Germany Giorgio Stanta,Italy extraction fordiagnostics Guidelines improvement forDNAandRNA 004 /005 Caterina Marchiò, Italy Manfred Dietel,Germany tions inmolecularpathologydiagnostics 002 /003 Giorgio Stanta,Italy diagnostics Activities oftheWGtoimprove thequalityof 001 Danny Milner in Africa Autopsy basedresearch oncerebral malaria 002 Paola Castillo , Spain minimally invasiveautopsystudy Causes ofdeathinsub-Saharan Africa: A 001 How toimprove tissuepre-analytical condi Chairs: better diagnosticsinFFPEtissues Technological improvement orientedto Molecular Pathology 08:30 –12:00 BM-06 Chairs: ity (+BusinessMeeting) countries: Achallengethatbecomesreal Carrying outresearch projects inAfrican Pathologists infavourofdevelopingcountries 08:30 –12:00 SY-28 Symposium 11:30 –12:00 08:30 –09:00 08:50 –09:10 08:30 –08:50 Gerald Hoefler Giorgio Stanta,Italy Giulia DeFalco, Italy Stefano Guzzetti,Italy Davide Soldini,Switzerland 11:00 –11:30 10:30 –11:00 09:00 –09:30 , USA , Austria , Austria ICC CapitalSuite15 , Germany , Austria ICC CapitalSuite17 Business Meeting

/ 16 61 - - Wednesday, 3 Sept - - - - -

, ,

, D. Cross, London · 2014 ECP , , M. Schiavon , K. Wassilew , F. Rea ,, G. Di Gregorio F. , Germany , United Kingdom , M. Falzon , N. Archard 09:00 – 09:10 09:00 10:30 – 10:40 10:40 – 10:50 10:50 – 11:00 09:10 – 09:20 11:00 – 11:10 004 in correlation Immunologic-histopathologic in lung trans rejection antibody-mediated , Thunnissen M. van Oosterhout, F. Handling of lung cancer endobronchial ul lung cancer endobronchial Handling of , A. G. Nicholson Wallace W. 007 variability for the WHO classi Interobserver carcinoids fication of pulmonary Speel, The Netherlands Ernst-Jan van Suylen, M. den Bakker D. Swarts, R.-J. Ramaekers , F. Dingemans , A.-M. M. Volante 008 of inducible nitric Apoptosis and expression oxide synthase in normothermic perfused do cold storage to standard lungs compared nor lungs , Italy Nannini Nazarena , S. Sadeghpour Lunardi F. , M. Loy A. Rebusso Calabrese F. 009 induces EMT Senescent microenvironment their epithelial cells promoting on broncial transformation , Portugal Lina Carvalho , I. Carreira, , L. Mendes, M. Chanson M. Val , A. Ladeirinha, A. Alarcão, C. Rodrigues plant patients Dagmar Kemper , , M. Zeh, N. Lachmann C. Schönemann , R. Hetzer M. Niemann 005 the in involved sites samples at trasound Medicine UK Stratified Cancer Research Programme Emily Shaw , H. Doran, Taniere Cane, P. D. Rassl, P. Morgan, K. Oien, G. Noel-Storr F. M. C. Alpoim 010 clinical experi The ALK testing in NSCLC: UK Tertiary ence and perspective of a large Centre Referral Gandy, United Kingdom Michael , A. Saetta, , J. Starczynski D. Allen, S. Mackie Ellery P. ------

ICC Capital Suite 1 Oral Free Paper Session Paper Free Oral Lina Carvalho, Portugal Lina Carvalho, Italy Calabrese, Fiorella Susan Davies, United Kingdom 08:30 – 08:40 08:50 – 09:00 08:40 – 08:50 10:50 – 11:10 10:30 – 10:50 09:10 – 09:30 09:10

08:30 – 12:00 Chairs: OFP-16 Pulmonary Pathology bronchial biopsy of bronchial asthma pa biopsy of bronchial bronchial but no difference in PAR-2 expression in expression in PAR-2 but no difference Higher TGF-ß with lower CD124 and TSLP, TSLP, and CD124 lower TGF-ß with Higher 001 S. Lassalle, C. Butori, J. Mouroux, 62 V. Hofman, M. Ilie, E. Long-Mira, L. Bouhlel, V. Hofman C. H. Marquette, P. Coraline Bence, France Coraline marker evaluation in NSCLC bronchial biopsies and lung surgical speci biopsies and lung surgical bronchial bio mens: A potential pitfall for theranostic Discrepancies of assessment of c-MET ex Discrepancies by immunohistochemistry between pression , , E. Long-Mira, C. Bence Hofman V. 003 Comparative assessment of c-MET expres Comparative Marius Ilie, France , E. Selva, C. Butori, S. Lalvée Hofman C. H. Marquette, P. tissue from patients with NSCLC tissue from 002 tumour cells and tumour sion on circulating , T. Olejar , T. , M. Sterclova , J. Kukal M. Vasakova Czech Republic Matej, Czech Radoslav tients in comparison to COPD patients Business meeting & election of chairman Business meeting & election 11:30 – 12:00 Final discussion 11:10 – 11:30 Roberto Monaco, Italy Roberto Africa A cytology based screening programme in programme A cytology based screening 005 Geographical distribution of viral cancero distribution of viral Geographical , United Kingdom A. van den Bosch Cornelia 004 genesis in Africa , Kenya Shahin Sayed in Africa Synergies between private and public health public health private and between Synergies 003 Scientific Programme a Wednesday Programme Scientific Wednesday, 3 Sept M. Brunelli M. Chilosi,E.BriaG.Tortora, A.Scarpa S. Pilotto,E.GilioliA.Nottegar Anna Caliò, Italy in non-smallcelllungcancer to polyploidyrather thanspecificALKgains cal fordetermininggenecopynumberdue Correction forcontrol chromosomes iscriti 014 J. Jassem W. Rzyman,R.DziadziuszkoF. R.Hirsch, A. Sejda,M.W. Wynes, W. Biernat, Szymon Wojtylak, Poland cell lungcarcinoma Evaluation ofFGFR1alterations innon-small 013 Z. Hutka L. Janakova,Z.Kviatkovska, K.Scheerova, A. Farkasova, T. Balharek,M.Barthova , Lukas Plank,Slovakia ing role ofimmunohistochemicaltests cancer doesnotsupportthepossiblescreen testing ofALKstatusinnon-small-celllung Parallel immunohistochemicalandFISH 012 F. Calabrese F. Lunardi,M.Loy Nazarena Nannini, Italy eling andpulmonaryhypertension native lungsisassociatedwithvesselremod sion oftransforming growth factorbetain Idiopathic pulmonaryfibrosis: Overexpres 011 ECP 2014 ·London Rosa Miquel,Spain 004 Felix Offner 003 Elizabeth M.Brunt,USA 002 Neil Shepherd, UnitedKingdom 001 Chairs: Infectious diseasesofthedigestivesystem Diseases Pathology Pathology /Infectious Diseases Digestive 14:00 –16:00 SS-09 11:40 –11:50 11:30 –11:40 11:20 –11:30 11:10 –11:20 14:45 –15:00 14:30 –14:45 14:15 –14:30 14:00 –14:15 Gieri Cathomas, Switzerland Dina Tiniakos, UnitedKingdom , Austria , F., E.Balestro Rea ICC Auditorium Slide Seminar , S.Knuutila

Scientific Programme aWednesday

- - - - Raf Sciot,Belgium Conclusion 008 Cleofe Romagosa Perez Portabella, Spain 007 David Creytens,Belgium 006 Arjen Cleven,TheNetherlands 005 Khin Thway,UnitedKingdom 004 Sophie LeGuellec,France 003 Philipp Ströbel, Germany 002 Jean-Michel Coindre, France Introduction 001 Simon Herrington , UnitedKingdom Peer review: Past, present andfuture 001 Stefan Hübscher 008 Gieri Cathomas, Switzerland 007 Uta Drebber 006 Runjan Chetty,Canada 005 Chairs: nohistochemistry vs.molecularprofiling Practical challengesinsofttissue:Immu Soft TissueandBonePathology 14:00 –16:00 SS-10 Chairs: viewers andreaders A guidetopeerreview forauthors, re Pathology /Virchows of Journal 14:00 –16:00 Spec-SY-11 15:54 –16:00 15:36 –15:54 15:18 –15:36 15:00 –15:18 14:42 –15:00 14:24 –14:42 14:06 –14:24 14:00 –14:06 14:00 –14:30 15:45 –16:00 15:30 –15:45 15:15 –15:30 15:00 –15:15 Raf Sciot,Belgium Jean-Michel Coindre, France Fred Bosman,Switzerland Peter Hall,UnitedKingdom , Germany , UnitedKingdom ICC CapitalSuite7 ICC CapitalSuite8 Special Session Slide Seminar

/ / 12 11 63 - -

Wednesday, 3 Sept 16 /

London · 2014 ECP , Germany ICC Capital Suite 15 Special Session Path Soc Special Session Path Czech Republic Aleš Ryška, Czech , United Kingdom Wells Michael 14:40 – 15:00 14:40 15:00 – 15:20 15:20 – 15:40 15:40 – 16:00 14:15 – 14:30 14:30 – 14:45 14:45 – 15:00 15:00 – 15:15 15:15 – 15:30 15:30 – 15:45 15:45 – 16:00 14:00 – 14:15

Spec-SY-13 14:00 – 16:00 General Pathology Quiz Pathology General by organised (Slide Seminar Discussion Trainees) Chairs: 003 Kingdom , United Adegbaju Oluwayomi 004 , Austria Muss Wolfgang 005 Ingrid Haußer-Siller 006 United Kingdom , Andrew Yarwood A recurrent brain tumour brain A recurrent , United Kingdom Olena Dotsenko 002 An unusual bone tumour Abhik Mukherjee, United Kingdom 003 Close buddies – drugs and the liver , United Kingdom Gemma Petts 004 A lump in the parotid Moutasim, United Kingdom Karwan 005 Multiple soft tissue nodules in the neck of a patient post-thyroidectomy Republic Sobande, Czech Folakemi 006 tumour in the lung A rare , Portugal Joana Pardal 007 Abnormal gastric biopsies , The Netherlands Chella van der Post 008 A dumbbell tumour of the spine Republic Jiri Soukup, Czech 001 - -

10 /

Slide Seminar Special Session ESP ICC Capital Suite 14 , United Kingdom ICC Capital Suite 9 Bart Wagner Han van Krieken, The Netherlands , Italy Franchi Alessandro Johann De Bono, United Kingdom 14:20 – 14:40 14:00 – 14:20 14:30 – 15:00 14:00 – 14:30 15:30 – 16:00 15:00 – 15:30 15:00 – 15:30 14:30 – 15:00 14:30

Chairs: diseases: A resident’s slide seminar diseases: A resident’s EM in the diagnosis of non-neoplastic EM in the diagnosis of non-neoplastic 14:00 – 16:00 Microscopy Electron SS-11 Chairs: Disease entity or target recognition? Disease entity or target Spec-SY-12 14:00 – 16:00 Molecular classification of tumours: of tumours: Molecular classification ESP / ESMO

Elizabeth Angus, United Kingdom 002 Patricia Goggin, United Kingdom Patricia 001 002 Mor therapy: cancer and targeted Breast Phil Quirke, United Kingdom therapy colorectal cancer: Implications for targeted cancer: Implications for targeted colorectal Molecular or histological classification of histological classification Molecular or 001 64 Prediction of response to neoadjuvant thera of response Prediction Sibylle Loibl, Germany 004 subclassification David Olmos, Spain of molecular cancer in the aera py of breast for prostate cancer for prostate 003 medicine Molecular pathology and precision , The Netherlands Jesse Wesseling phology versus molecular General discussion General 15:30 – 16:00 Peter Hall, United Kingdom Peter reviews and reviewers and reviews Peer review for authors: How to deal with authors: How to deal for review Peer 003 Fred Bosman, Switzerland Fred reviewer Peer review for reviewers: How to be a good be a good How to for reviewers: review Peer 002 Scientific Programme a Wednesday Programme Scientific Wednesday, 3 Sept J. R.Vizcaíno A. Coelho, F. CastroPoças, P. Bateira, Francisca Costa, Portugal tiary hospitalexperience aspiration ofpancreatic cysticlesions:A ter Endoscopic ultrasound-guided fineneedle 006 F. I.Camacho, A.Yeguas, R.Granados Hilda G.Tellez, Spain lymphadenopathy piration biopsyforthetriageofpatientswith Cytological criteriaappliedtofine-needleas 005 A. Chott Wolfgang Pokieser therapy tient selectionforradio-frequency-ablation Rapid on-siteevaluationmayoptimizepa 004 R. Luís,M.CardosoA.AlvesD.López-Presa Pedro Luis,Portugal risk HPVincidence An institutionalretrospective studyofhigh- 003 A. Pontecorvi, L.LaroccaG.Fadda T. Bizzarro,C.Ricci , C.Lombardi M. Martini,S.CapodimontiP. Straccia, Esther Rossi, Italy cyto-histological institutionalexperience BRAF expression inthyroid neoplasms:A Role of immunocytochemical and molecular 002 I. Kern, P. Hofman Marius Ilie,France D5F3 clone Accuracy of immunocytochemistry with the cal specimensofnon-smallcelllungcancer: ECP 2014 ·London Detection ofALKrearrangement incytologi 001 Chairs: Cytopathology 14:00 –16:00 OFP-17 14:50 –15:00 14:40 –14:50 14:30 –14:40 14:20 –14:30 14:10 –14:20 14:00 –14:10 UnitedKingdom Amanda Herbert, Lukas Bubendorf, Switzerland Ambrogio Fassina, Italy , Austria Oral Free Paper Session ICC CapitalSuite17

Scientific Programme aWednesday - - - - K. Budde,D.Schmidt, H.-H. Neumayer Kaiyin Wu, Germany outcomes rather thanthetypeofrejection closely associatedwiththekidneyallograft The severityofacutevascularrejection is 003 F. N.Özdemir B. HandanÖzdemir predicts poorrenal allograft survival Pre-transplant renal arterialvasculopathy 002 S. Bellur Ian Roberts, UnitedKingdom dence from theVALIGA studycohort E. Vigliar A. Bianco, U. Malapelle,C.DeLuca Claudio Bellevicine,Italy A validationstudyonmutatedcelllines bodies indifferent cytologicalpreparations: U. Panzer M. Noriega, G.Wolf Silke Brix,Germany tising glomerulonephritis predicts outcomeinANCA associatednecro Histopathological glomerulardamage score 005 M. Haberal F. N.Özdemir B. HandanÖzdemir Conference polyomavirus workinggroup in10thBanff recent grading schemathatwasproposed by portance of histopathological findings and Polyomavirus Nephropathy: Prognostic im 004 B. Rudolph Performance ofEGFRmutantspecificanti 007 the prognostic valueoftheschema:Evi of IgA nephropathy and impact of scoring on Reproducibility oftheOxford Classification 001 Chairs: Nephropathology 14:00 –16:00 OFP-18 14:20 –14:30 14:10 –14:20 14:40 –14:50 14:30 –14:40 15:00 –15:10 14:00 –14:10 Stewart Fleming,UnitedKingdom Stewart Ian Roberts, UnitedKingdom Dusan Ferluga, UnitedKingdom , S.Troyanov , P. Pisapia,P. Pallante , G.Troncone , R.Stahl, T. Wiech , G.Moray , E.BaskinA.Terzi , E.S.Ayva, Oral Free Paper Session , W. Jabs,F. Özcan, , Turkey , Turkey , T. Cook, R.Coppo , M.Haberal ICC CapitalSuite1

65 - - - - Wednesday, 3 Sept -

London · 2014 ECP Public Lecture Special Session

ICC Auditorium ICC Auditorium ICC Auditorium ICC Auditorium Plenary Session Plenary Keynote Lecture Keynote Finland Finland , USA Marco Santucci, Italy Santucci, Marco Han van Krieken, The Netherlands Ian Ellis, United Kingdom Ian Ellis, United Kingdom United Kingdom Adrienne Flanagan, Chairs: Closing Ceremony PU-01 18:15 – 19:00 diagnosis – the pathologist’s role Accurate Chris Fletcher CL-01 19:00 – 19:15 16:30 – 17:00 16:30 Chairs: Ilmo Leivo, cancer? – An intercel breeding Cancers network signalling damage DNA lular DNA damage tumour-induced propagates tissue in distant proliferating Society Oakley Lecture) (Pathological , United Susanne Burdak-Rothkamm Kingdom PL-01 17:00 – 18:15 Session Paper Free Oral Plenary Chairs: KL-04

/ - -

, P. Kadambi , P. Thomas , P. , USA 15:30 – 15:40 15:20 – 15:30 15:10 – 15:20 15:00 – 15:10 14:50 – 15:00 14:50

66 , H. Ruff M. Foshat , USAMarjan Afrouzian capillaries: What does it mean? MSB-positivity in renal allograft peritubular allograft MSB-positivity in renal 010 H. Gakiopoulou , , E. Patsouris Korkolopoulou A. Georgalis, P. , Greece Vlachopanos Georgios post-transplant recurrent IgA nephropathy IgA recurrent post-transplant in the intrarenal infiltrates of native and infiltrates in the intrarenal The expression of regulatory T-lymphocytes T-lymphocytes of regulatory The expression , Atsaves, M. Detsika, E. Poulaki V. 009 Greece Hariklia Gakiopoulou, E. A. Lianos Structural Heme Oxygenase-1 depletion: kidney in the rat functional consequences SMA expressions: Possible predictors of out of predictors Possible SMA expressions: 008 Glomerular nestin and interstitial alpha- nestin and interstitial Glomerular , M. Zivotic, S. Cirovic, J. Vjestica , A. Peco-Antic R. Bogdanovic, N. Stajic 007 , Serbia Markovic-Lipkovski Jasmina , M. Afrouzian M. Foshat glomeru focal segmental come of childhood losclerosis Heather Ruff relation to chronic ischemia to chronic relation Bile nephrosis: Pathological findings and and findings Pathological Bile nephrosis: 006 Scientific Programme a Wednesday Programme Scientific Wednesday, 3 Sept ECP 2014 · London

e Poster Sessions

a PS-01 – PS-04 Sunday, 31 August 2014

a PS-05 – PS-09 Monday, 1 September 2014

a PS-10 – PS-18 Tuesday, 2 September 2014

a PS-19 – PS-25 Wednesday, 3 September 2014

67 Poster Presentations a Sunday ECP 2014 · London

e Sunday, 31 August 2014 007 PS-01 A case of an inguinal myoepithelial carcinoma in an elderly woman PS-01 Poster Sessions Jiro Watanabe, Japan Soft Tissue and Bone Pathology Y. Murakami, K. Takagi, H. Yano Chairs: Pancras C. W. Hogendoorn, The Netherlands 008 David Hughes, United Kingdom Clinicopathological spectrum, including Roberto Tirabosco, United Kingdom molecular cytogenetic analysis of a series of spindle cell / sclerosing rhabdomyosar- 001 comas Fibrous hamartoma of infancy: About one Bharat Rekhi, India case T. Singhvi Leila Tirichine, Algeria Sunday, 31 Aug 009 R. Bennoui, N. Boudefeur, Y. Lamouti, Villonodular synovitisa series of 17 cases S. Ferhi, I. Belbeye, S. A. Oukrif and review of the literature 002 Wahiba Ouahioune, Algeria Clinico-pathological, prognosis and thera- N. Moulai, M. Guermi peutic features of desmoid tumours: About 011 11 cases and review of the literature Clear cell sarcoma of soft tissue: Review of Yahia Manel, Tunisia the last 10 years (2004 – 2014) in the Cen- B. Laabidi, M. Issam, B. A. Fakhreddine, tral University Hospital of Asturias – Spain M. Nada, B. Fethi, B. Ammar Héctor Enrique Torres Rivas, Spain 003 G. Mendoza Pacas, A. Astudillo, M. Balbín, Unusual palmar lesions – Myopericytoma, M. F. Fresno Forcelledo, A. Sánchez Pitiot Myofibroma, Angioleiomyoma: Surgical 012 management of a pathological conundrum A case of a primary angiosarcoma of the Rani Kanthan, Canada spleen with bone marrow metastasis J.-L. Senger, D. Classen Zorana Vukasinovic Bokun, Serbia 004 S. Milenkovic, Z. Cvetkovic, V. Cemerikic Solitary fibrous tumour: Report of three 013 cases Report of a rare case of solitary fibrous Leila Beddar, Algeria tumour involving the mesosigma Z. Hazmoune, S. Ketit, T. Seraoula, Z. Tebbi, Alis Dema, Romania T. Seraoula, Z. Tebbi A. Burlea, D. Ciurdariu, C. Lazureanu, 005 S. Taban Role of immunohistochemical and histo- 014 chemical profiling in H&E-based diagnosis Tumour to tumour metastasis of prostatic of scrotal leiomyosarcoma of dartos muscle carcinoma to an atypical lipomatous Piotr Lewitowicz, Poland tumour A. Wincewicz, U. Sulkowska, S. Sulkowski, Somaia Elsheikh, United Kingdom A. Horecka-Lewitowicz, D. Koziel, S. Gluszek T. McCulloch 006 015 MYC amplification status and expression Myxoid solitary fibrous tumour: A case in primary and secondary angiosarcoma of presentation breast Mariana Cruz, Portugal Jodi Carter, USA M. Ferreira, A. Silva, M. Teixeira, F. Pardal W. Sukov, W. Shon, J. Boughey, J. Jakub, K. Fritchie

68 ECP 2014 · London Poster Presentations a Sunday

019 029 Granular cell tumour of the abdominal wall Pancreatic ductal adenocarcinoma with Umit Bayol, Turkey metastasis in soft tissue: A case report S. Eryigit Kokkoz, G. Orgun Sonmez, Ana Costa Braga, Portugal PS-01 S. Unluoglu, C. Ulusoy P. Oliveira

020 030 Cutaneous Kaposi sarcoma with sarcoid Primary retroperitoneal hydatid cyst: like granuloma: A case report Report of three cases in an exceedingly Rehab Samaka, Egypt unusual location F. Ramadhan Olivia Cambero Moratalla, Spain J. C. Tardío 021 Giant cell fibroblastoma: A case report 031 Rehab Samaka, Egypt Kaposiform Hemanjioendotelioma S. Younes, M. Abd El-Wahed, A. Shams, Alp Özgüzer, Turkey I. Miligy S. Cumurcu, Z. Yildirim, S. Unluoglu, M. Uncel, U. Bayol, M. Incesu 022 Chondroid lipoma: A case report and 032

immunohistochemical analysis Soft tissue adenolipomyoepithelioma: A 31 Aug Sunday, Desislava Tashkova, Bulgaria case report G. Ivanov, I. Novakov, B. Anavi Irina Kazantseva, Russia L. Gurevich, E. Bespalova, M. Bobrov 023 A large intra-abdominal fibromyoma: Case 034 report Multiple histological aspects in a case of Umit Bayol, Turkey dermatofibrosarcoma protuberans M. Uncel, U. Kucuk, S. Ozturk, O. Cetindag, Claudiu Socoliuc, Romania Z. Yildirim A. Razvan

025 035 Rare epithelial malignancy of the radius A comparison of tuberculous and non- Santiago Ortiz, Portugal tuberculous granulomatous lymphadenitis A. Costa, M. Lemos, A. Pignatelli, D. López, Mohammad Fahad Sorefan, Mauritius I. Fernandes, J. Janeiro J.-J. Khoo, A. M. Latona, A. Gunn

026 036 A retrospective clinicopathological study of Ossifying Fibromyxoid Tumour: A rare and lymphadenopathy, to differentiate benign controversial entity from malignant etiologies Alejandra Rosell Alayza, Spain Mohammad Fahad Sorefan, Mauritius C. Rivero Colmenarez, A. Berjón García, J.-J. Khoo, A. M. Latona, A. Ramadas, A. E. Palacios Lázaro, E. López Ruiz, Gunn, L. M. Ng J. Hernández Godoy, M. Tapia Viñé, F. López Barea, J. J. Pozo Kreilinger 027 A rare case of papillary intralymphatic 037 angioendothelioma (Dabska Tumour) pre- Application of MDM2 FISH and immunohis- senting in a 62 year old man tochemistry for distinguishing high grade Najla Ben-Ghashir, United Kingdom sarcoma from differentiated liposarcoma A. Bakshi, E. West Min-Jeong Song, Republic of Korea J.-S. Song, K.-J. Cho, J.-S. Lee 028 Langerhans Cell Sarcoma: Demonstration of histopathological and immunopheno- typic variability Rasika Singh, United Kingdom C. Murray, C. Keen, P. Sarsfield

69 Poster Presentations a Sunday ECP 2014 · London

038 046 PS-01 Late recurrence of a formerly misdiag- Synovial chondromatosis: A report of 3 cases nosed low grade endometrial stromal sar- Wahiba Ouahioune, Algeria coma metastasized to the colon: N. Moulai, N. Bettaz Histological, immunohistochemical and

PS-02 047 molecular characteristics of the rare case An unusual histological picture of a cytoge- Janusz Rys, Poland netically confirmed retroperitoneal Ewing A. Kruczak, M. Vogelgesang, A. Ambicka, Sarcoma K. Halaszka, M. Przewoznik Francisca Costa, Portugal 039 A. Coelho, J. R. Vizcaíno Tumour-to-tumour metastasis: Male breast 048 carcinoma metastasis arising in an extra- Leukaemic alveolar rhabdomyosarcoma in pleural solitary fibrous tumour: A case Sunday, 31 Aug 62-year-old male with T-cell acute lympho- report blastic leukaemia Susanne Scheipl, Austria Lukasz Fulawka, Poland F. Moinfar, A. Leithner, P. Sadoghi, A. Jaskowiec, O. Dobrzynska, O. Haus, M. Jorgensen, B. Rinner, B. Liegl T. Wrobel, A. Halon 040 049 A case report of PEComa with morphologi- Deep soft tissues myopericytoma: A report cal suspicion of malignant potential of 4 cases Denitsa Serteva, Bulgaria Nabila Moulai, Algeria M. Tsvetkov, M. Kamenova Y. Yousfi, W. Ouahioune 041 050 Metastasis of alveolar soft part sarcoma to Elastofibroma: Retrospective review of 7 the brain: A case report cases of a rare soft tissue tumour Emilia Minaidou, Greece Enea Andueza, Spain T. Zogka, E. Kyrodimou, A. Vyziotis, A. Corominas Cishek, N. Cerda, V. Caamaño, E. Papaliodi M. González, M. Saiz 042 Primary Splenic Angiosarcoma: A case report PS-02 Poster Sessions Thiagarajah Balamurugan, United Kingdom Head and Neck Pathology T. Gunasekara, S. Preston, I. Bagwan Chairs: Isabel Fonseca, Portugal 043 Alessandro Franchi, Italy Malignant glomus tumour: A very rare entity Tim Helliwell, United Kingdom Paraskevi Efstathiadou, Greece E. Papakonstantinou, I. Zinovieva, 001 A. Linardou, K. Papaioannou, In vitro evaluation of Epidermal Growth A. Papaevangelou, M. Vidali, G. Liapi Factor influence in an in situ model of tum- origenesis 044 Natalia Festugatto Navarini, Brazil Custom-designed Fluorescence in Situ V. A. Montalli, N. Soares de Araújo, V. Hybridization (FISH) probe sets for the Cavalcanti de Araújo, E. Ferreira Martinez evaluation of extraskeletal myxoid chondrosarcoma 003 Julia Bridge, USA Intraepithelially-entrapped blood vessels S. Koepsell, D. Huang, P. Dal Cin, C. Fletcher, in ameloblastoma P. Nielsen Chong Huat Siar, Malaysia K. H. Ng 045 Hydatic cyst of the leg: A case report Fakhreddine Ben Abdallah, Tunisia B. Laabidi, I. Msakni, N. Mansouri, M. Yahia, F. Bougrine, A. Bouziani 70 ECP 2014 · London Poster Presentations a Sunday

004 013 Comparison of the VEGF and FGF expres- Hepatocellular carcinoma metastatic to the sion of pleomorphic adenoma and basal sphenoidal sinus-report of a case cell adenoma Agota Ilyes, Romania PS-02 Ana Amélia Souza, Brazil D. Milutin, G. Muhlfay, C. Florea, S. Mocan A. Altemani, S. Trentin Brum, F. Passador, V. 014 Cavalcanti de Araújo, A. Borges Soares Laryngeal granular cell tumour 005 Olfa Lamine, Tunisia Cribriform adenocarcinoma of the tongue A. Gabsi, A. Goucha, S. Miladi, W. Joamaa, Ghania Benkhedda, Algeria W. Rekik, S. Touati, S. Gritli, A. Gamoudi, Z. Manseur, Y. Lamouti A. El-May

006 015 Adult perithyroid and cervical thymus- Primitive laryngeal sarcoma: Report of parathyroid unit three rare entities Adriana Handra-Luca, France Olfa Lamine, Tunisia A. Desbiolles A. Gabsi, A. Goucha, S. Kedous, W. Jomaa, S. Miladi, W. Rekik, S. Touati, S. Gritli, 008 A. Gamoudi

Carcinoma ex-pleomorphic adenoma from 31 Aug Sunday, recurrence of the pleomorphic adenoma 016 show chomothripsis phenomenom by Ameloblastic fibro-odontoma: Diagnostic array comparative genomic hybridization aspects at Confocal Laser Scanning Micro- Erika Egal, Brazil scope F. V. Mariano, R. d. Oliveira Gondak, Eugenio Maiorano, Italy A. J. Tincani, R. D. Coletta, O. P. de Almeida, A. Tempesta, S. Miccoli, G. Opinto, G. Favia L. P. Kowalski, A. Altemani 017 009 Expression of podoplanin in myoepithelio- Genomic profile of primary and secondary mas metastasizing pleomorphic adenoma Hanna Majewska, Poland Erika Egal, Brazil D. Stodulski, A. Skorek, C. Stankiewicz, F. V. Mariano, R. d. Oliveira Gondak, W. Biernat A. S. Martins, R. D. Coletta, O. P. de Almeida, 018 L. P. Kowalski, A. C. Victorino Krepisc, Juxtacortical chondroblastic osteosarcoma A. Altemani of the mandible: Diagnostic aspects at Con- 010 focal Laser Scanning Microscope Benign salivary tumours-frequency and Gianfranco Favia, Italy rare entities A. Tempesta, M. Favia, F. Pettini, Alexandra Faur, Romania E. Maiorano A. Dema, A. Muresan, C. Lazureanu, 019 F. Baderca Cofilin, N-WASP and ß-parvin immunohis- 011 tochemical expression in human laryngeal Ki-67 and p53 expression in salivary gland cancer tumours Georgios Tsinias, Greece Alexandra Faur, Romania T. Papadas, C. Scopa, H. Papadaki, V. Bravou D. Alis, S. Taban, E. Lazar, M. Cornianu 020 012 Maxillary juvenile-aggressive ossifyng Salivary duct carcinoma: Our experience fibroma: Study at Confocal Laser Scanning Alexandra Faur, Romania Microscope of proliferating spindle cells S. Taban, M. Grigoras, L. Vasile, A. Galuscan Eugenio Maiorano, Italy L. Limongelli, S. Franco, M. L. Caruso, G. Favia

71 Poster Presentations a Sunday ECP 2014 · London

021 029 PS-02 Functional activity and salivary glands Calcified odontogenic epithelial tumour: A pathology in children with low birth case report weight in medical history Wahiba Ouahioune, Algeria Sergiy Morozov, Ukraine M. Guermi, F. Touhouche O. Reshetnikova 030 022 Odontogenic myxoma of the maxilla: A Mucinous cystadenoma of the parotid: A case report case report with review of the literature Wahiba Ouahioune, Algeria Wafa Rekik, Tunisia M. Guermi, Y. Ighil Agha H. Azouz, A. Zehani, I. Chelly, J. Kdous, S. 031 Haouet, N. Kchir Ceruminous gland adenoma of the exter-

Sunday, 31 Aug 023 nal auditory canal: A case report and Glomangiopericytoma (sinonasal-type he- immunohistochemicaly study mangiopericytoma): A case report of an Argiro-Ioanna Ieronimaki, Greece unusual neoplasm A. Tsavari, K. Koulia, E. Arkoumani, Georgia Mitropoulou, Greece V. Papamichali, T. Vasilakaki E. Arkoumani, A. Tsavari, D. Myoteri, 032 K. Koulia, T. Vassilakaki, K. Manoloudaki Nasal epithelial myoepithelial carcinoma 024 with high grade transformation Spindle cell lipoma of the epiglottis: A very Simona Mocan, Romania rare case report A. Ilyes, B. Casautanu, G. Muhlfay Georgia Mitropoulou, Greece 033 K. Koulia, A. Tsavari, E. Arkoumani, Water-clear cell adenoma of the parathy- K. Manoloudaki, T. Vasilakaki roid gland with squamous differentiation 025 and abundant myxoid stroma Intraparotidian paraganglioma: A case report Barbara Gazic, Slovenia Delia Gabriela Ciobanu Apostol, Romania J. Lamovec, M. Hocevar, J. Pizem G. Melian, C. Andriescu, S.-E. Giusca, 034 I.-D. Caruntu, L. Lozneanu Lacrimal pleomorphic adenoma: Two cases 026 Umit Bayol, Turkey Primary leiomyosarcoma of the mandible: G. Akoz, E. Usturali Keskin, A. Özgüzer, A case report T. Karadeniz, S. Icke, V. M. Unal Delia Gabriela Ciobanu Apostol, Romania 035 L. Lozneanu, S.-E. Giusca, I.-D. Caruntu, Correlation of p16 expression with clin- M. Balan, C. Andriescu icopathologic features in oropharyngeal 027 carcinoma Cribriform adenocarcinoma of the tongue Fatmagul Kusku Cabuk, Turkey and minor salivary glands G. Bülbül, I. Coban, N. Akdur, N. Bassullu, Sona Appukutty, United Kingdom G. Koksal, G. Alco S. Di Palma, I. Bagwan, S. Beeslaar 036 028 EBV / HPV status and KRAS / BRAF muta- Carcinoma ex pleomorphic adenoma of tion analysis in Mouthfloor / Base & Tonsil- the salivary glands: Clinico-pathological lary Region squamous cell carcinomas: 34 analysis Cases Kimihide Kusafuka, Japan Ulku Kucuk, Turkey M. Abe, T. Nakajima U. Bayol, E. U. Keskin, E. E. Pala, I. Cukurova, M. A. Colak, M. Degirmenci, O. Ozer, A. Koc

72 ECP 2014 · London Poster Presentations a Sunday

037 045 Invasive micropapillary salivary duct car- Study on laryngeal tissue speciments cinoma of the parotid gland: An uncom- ofEGFR, cyclin D1 and p53 gene amplifica- mon tumour with an unusual pattern tion and protein expression in normal, PS-02 Ebru Cakir, Turkey dysplastic, and mallignant glottic tissue: U. Bayol, U. Kucuk, E. E. Pala, M. Uncel, Fluorescent in situ hybridization and I. B. Arslan, A. Özgüzer immunohistochemical analysis Akrivi Kostopoulou, Greece 039 C. Kaisas, G. Koutsonikas, E. Kyrodimou, Sinonasal Schwannoma attached to sphe- S. Papadimitriou, D. Paulidis, noid sinus: A case report E. Zaharioudaki, D. Kandiloros, Niladri Shekhar Pal, India S. Katsaragakis, T. Nikolopoulos S. Das, S. Das 046 040 Cancerization of cutaneous flap reconstruc- Immunophenotype heterogeneity in nasal tion for oral Squamous Cell Carcinoma glomangiopericytoma (SCC): Histological, immunohistochemical Adriana Handra-Luca, France and molecular analysis of 10 cases Z. Abd Elmageed, C. Magkou, F. Sahm, Chiara Baldovini, Italy M. Lae

A. Farnedi, E. Leonardi, A. Tarsitano, 31 Aug Sunday, 041 A. Prontera, C. Marchetti, L. Morandi, Basal cell adenoma of the parotid gland: M. P. Foschini Two case reports 047 Duygu Ayaz, Turkey Squamous cell carcinoma of the tongue: D. Solakoglu Kahraman, T. Karadeniz, Tumour characteristics and therapeutic S. Sayhan approaches 042 Ilhem Bettaieb, Tunisia A case of primary malignant melanoma of S. Abdeljaoued, S. Kedous, S. Miladi, the palatine tonsil A. Goucha, W. Jomaa, S. Touati, S. Gritli, Macarena Centeno, Spain A. Gamoudi, A. El-May, A. Zehani-Kassar M. Sánchez Frías, R. Sánchez Sánchez, 048 T. Caro Cuenca, R. Ortega Salas, Histological and molecular epigenetic E. Fuentes Vaamonde, J. Salvatierra Cuenca, analysis of mucosal melanomas of the T. González Serrano, M. Medina Pérez, head and neck T. Sánchez Medianero Olivia McKinney, United Kingdom 043 A. Moore, B. Ping, L. Pitkin, S. Di Palma Cystadenocarcinoma of the parotid gland: 049 A case report Hyalinizing clear cell carcinoma with Raja Jouini, Tunisia EWSR1-ATF1 fusion gene; Report of 3 H. Henchiri, W. Koubaa Mahjoub, W. Abid, cases with molecular analyses M. Bel Haj Salah, O. Khayat, E. Ben Brahim, Hidetaka Yamamoto, Japan A. Chadli Debbiche T. Nakano, T. Nishijima, Y. Oda 044 050 Non invasive carcinoma ex pleomorphic Multiple congenital granular cell epulis: A adenoma of the sub mandibular salivary case report and immunohistochemistry gland: A challenging case profile Raja Jouini, Tunisia Patricia Bianchi, Brazil H. Henchiri, W. Koubaa Mahjoub, W. Abid, V. Cavalcanti, F. Passador-Santos, M. Bel Haj Salah, O. Khayat, A. Souissi, K. Andrada, J. W. Ribeiro, N. Araújo, E. Ben Brahim, A. Chadli Debbiche A. Soares

73 Poster Presentations a Sunday ECP 2014 · London

051 060 PS-02 Neuroectodermal tumours of the sinonasal Clinical significance of Human antigen area in a Portuguese cancer institute Receptor (HuR) and cyclooxygenase-2 Catarina Meireles, Portugal (COX-2) expression in human malignant A. Luís, A. Galaghar, M. Jácome and benign thyroid lesions Constantinos Giaginis, Greece 052 P. Alexandrou, E. Poulaki, N. Kavantzas, Morphological characteristics of oral tis- I. Delladetsima, E. Patsouris, S. Theocharis sues in alloxan-induced hyperglycemia in rats and after administration of flavonoids 062 Sergiy Morozov, Ukraine MAPK pathway expression in adenoid A. Skiba, O. Reshetnikova cystic carcinoma and pleomorphic adenoma of salivary glands 053 Renata Ianez, Brazil Sunday, 31 Aug Low grade sinonasal adenocarcinoma, C. Coutinho-Camillo, C. Pinto, D. Soave, Galactin 3 expression: A case report A. Ribeiro-Silva, C. Nagano, F. Soares, Rehab Samaka, Egypt S. Lourenço S. Younes, M. Kandil, A. Ragab 063 054 Prognostic significance of clinical para- Contribution of apoptosis to human sali- meters and expression of cyclin D1 in non- vary gland lumen formation: Importance endemic undifferentiated carcinoma of of basic science nasopharyngeal type: A Serbian report Tathyane Teshima, United Kingdom Tatjana Terzic, Serbia C. Coutinho-Camillo, R. Ianez, A. Tucker, N. Boricic, D. Brasanac, I. Boricic S. V. Lourenco 064 055 Phenotypical analysis of primary and met- Differential expression of glypican-3 in astatic adenoid cystic carcinoma of sali- aggressive odontogenic tumours and non- vary glands: Cytokeratins profile aggressive odontogenic tumours Silvia Vanessa Lourenco, Brazil Leonardo Melo, Brazil C. Pidorodeski, C. Camillo-Coutinho, C. Gurgel, R. Mendes, M. Santana, R. Dias, R. Fraga Ianez, C. Pinto, I. Fonseca F. Caló, Á. Leitão, L. Ramalho, E. Ramos, J. Nunes 065 Primary lymphoma of the thyroid: A clin- 056 icopathologic study of 21 cases Odontogenic tumours: 56 cases diagnosed Syrine Abdeljaoued, Tunisia over 20 years at Baskent University Ankara I. Bettaieb, A. Goucha, M. Z. Attia, W. Jomaa, Hospital S. Miladi, S. Touati, S. Gritli, A. Gamoudi, Aysen Terzi, Turkey A. El-May E. Deniz, B. H. Özdemir, B. Celasun 066 057 Expression profile of cell cycle regulators Vocal cord myxoma: A case report and and apoptosis mediators in tongue Squa- review of literature mous Cell Carcinoma (SCC) Khadija Bellil, Tunisia Marina Alonso Riaño, Spain M. Néji, W. Ajouli, A. Dhaoui, A. Hachicha, A. Ruiz Alonso, R. M. Garcia Martin, D. Ben Ghachem M. Martín Sánchez, M. Redondo Alamillo, 058 E. M. Andrés Esteban, C. Ballestín Carcavilla Role of osteoblast-derived osteopontin on cell migration and invasion of an oral Squamous Cell Carcinoma (SCC) cell line Lucas Novaes Teixeira, Brazil L. M. Spinola de Castro-Raucci, R. Rodrigo Fernandes, R. Della Coletta, A. Luiz Rosa, P. Tambasco de Oliveira 74 ECP 2014 · London Poster Presentations a Sunday

067 074 C-kit expression (CD117) in a six cases Mucosal malignant melanoma of inferior series of Sinonasal Mucosal Melanoma concha and nasal septum: A case report (SNMM) with mutation analysis PS-02 Carlo Bruno Marta, Spain Ismail Yilmaz, Turkey Y. Ruiz de Azua, F. Garcia Bragado, E. Erkul, G. Narli, O. A. Kurt, Z. Kucukodaci, R. Guarch Troyas, P. Sota Ochoa, G. Muñoz, M. Salihoglu, U. Berber, D. Demirel E. Mejía Urbáez, P. Fernandez Seara, 076 J. M. Elizalde, X. Tejada Caceres, A. Valero Effects of nicotine on the morphology of Torres the parotid glands of rats 068 Lara Soares, Brazil Beta-Phenethyl isothiocyanate (PEITC) W. B. Leal Filho, J. D. Silva Pinheiro, affects proliferation of oral cancer cells in L. B. Barros, M. B. Couto, xenograft subcutaneous oral cancer mouse I. M. Sousa Portela Santos, K. S. de Araújo model 077 Aroonwan Lam-Ubol, Thailand Histomorphometric analysis of the effects A. L. Fitzgerald, J. N. Myers, D. Trachootham of chronic alcoholism in the oral mucosa of 069 Rattus novergicus Comparison of microRNA miR150 and let- Lara Soares, Brazil 31 Aug Sunday, 7a expression profiles in salivary gland L. B. Barros, W. B. Leal Filho, K. S. Araújo, carcinomas and normal salivary gland I. M. Sousa Portela Santos Amy Brown, Brazil 078 A. P. Demasi, E. F. Martinez, D. F. Soave, A. Immunohistochemical (IHC) study of DOG1 Ribeiro-Silva, A. Borges Soares, in Adenoid Cystic Carcinoma and Polymor- V. Cavalcanti de Araújo, F. Passador-Santos phous Low Grade Adenocarcinoma 070 Evelyne Pedroza de Andrade, Brazil Carcinoma ex pleomorphic adenoma of V. A. Montalli, N. Freitas, V. C. de Araújo minor salivary glands: A clinicopathologic 079 study of 16 cases Well-differentiated liposarcoma of the Suzana Sousa, Brazil aryepiglotic fold: A case report and review N. Lascane, M. I. Franco, B. Sedassari of the literature 071 Aïcha Ben Lakhdar, France Relapsing Polychondritis of the nasal dia- O. Casiraghi, P. Terrier, S. Temam phragm 080 Emilia Minaidou, Greece Hunt for the primary: A new dimension E. Kyrodimou, T. Zogka, G. Bailas, Stephen Damato, United Kingdom E. Zaharioudaki, E. Papaliodi S. Winter, F. Sheerin, K. Shah 072 083 Sinonasal malignant schwannoma: A case Extramammary Paget’s Disease of the report tongue Irem Hicran Ozbudak, Turkey Irem Hicran Ozbudak, Turkey A. B. Toptas, N. Yaprak, M. Turhan, N. Yaprak, A. T. Derin, G. Özbilim, H. S. Toru O. Gunhan 073 085 Olfactory Neuroblastoma: Where do we Solitary fibrous tumour of head and neck: stand? Report of two cases Marion Classe, France Rita de Mora Féria, Portugal P. Herman, G. Mortuaire, X. Leroy, R. S. S. Oliveira, A. Costa Braga, C. Alves, M. Serova, S. Faivre, M. Wassef R. Theias Manso, M. Angel Campo, S. Loureiro dos Santos

75 Poster Presentations a Sunday ECP 2014 · London

086 094 PS-02 Salivary Gland Lymphoma: A clinicopatho- An unusual tumour of the nasal cavity: logic analysis of 18 cases from a single Angioleiomyoma center Faten Hammedi, Tunisia Ana Galaghar, Portugal M. Njima, R. Hadhri, L. Njim, S. Bouslema, M. Caldas, F. Menezes, C. Meireles, S. Souki, A. Moussa, A. Zakhama P. Monteiro, R. Henrique, M. Jácome 095 087 Spindle cell lipoma: An unusual oral Study of expression of apoptosis, tumour autophagy and cellular senescence regu- Faten Hammedi, Tunisia latory proteins in an in vitro model that I. Haddad, R. Hadhri, L. Njim, M. Njima, mimics an in situ malignant neoplasia A. Moussa, A. Zakhama Carolina Silva, Brazil Sunday, 31 Aug 096 E. Martinez, A. P. Demasi, I. Fernandes, Mantle cell lymphoma of the Waldeyer V. C. de Araújo ring: A case report and review of treat- 088 ment modalities IgG4-related disease: Salivary glands Kalliopi Diamantopoulou, Greece peculiarities and differences with V. Samaras, V. Eleftheriotis, K. Dimitriou, Sjogren´s Syndrome M. Tsopanomichalou, K. Christidis Sheyla Bologna, Brazil 097 T. Nunes, C. Coutinho-Camillo, S. Pasoto, Does BRAF mutation effect progression in B. Machado, M. Nico, S. V. Lourenco differentiated thyroid carcinomas? 090 Aysun Uguz, Turkey A morphologic, immunohistochemical and B. Totan Ates, M. Ergin, G. Sakman, O. Kara molecular study of sinonasal Intestinal 098 Metaplasia (IM) in Intestinal-type Adeno- Evaluation of microdensity of lymphatic carcinoma (ITAC) patients vessels in polymorphous low-grade adeno- Valentina Ranucci, Italy carcinoma A. Palomba Patricia Ribeiro, Brazil 091 A. Altemani, V. C. Araújo, F. Passador- Secreted Osteoclastogenic Factor of Acti- Santos, N. S. Araújo, A. Borges Soares vated T Cells (SOFAT) in bone lesions of 099 the jaws Low grade cribriform cystadenocarcinoma Lara Soares, Brazil of the parotid gland in a 16-year-old N. S. Araújo, V. C. Araújo, E. F. Martinez, female: A case report and review of the N. S. de Freitas, A. A. Souza, M. Napimoga literature 092 Liliana Santos, Portugal Evaluation immunohistochemistry of p16, C. Meireles, M. Jácome cyclin d1, rb,e2f and cdk4 in recurrent ple- 100 omorphic adenoma Angiosarcoma metastatic to the oral cav- Andresa Borges Soares, Brazil ity: A diagnostic challenge A. A. Souza, A. Altemani, F. Passador-Santos, Raffaella Santi, Italy N. S. Araújo, L. E. Cândido-Soares, V. Scotti, B. Agresti, P. Bonomo, A. Franchi V. C. Araújo 102 093 Solitary fibrous tumour of the oral cavity: Caprin1 and p16 expression in laryngeal Report of two cases Squamous Cell Carcinoma (SCC) Haddad Ines, Tunisia Havva Serap Toru, Turkey M. Adnène, H. Rym, N. Manel, L. Njim, N. Yaprak, M. Ozcan, Z. Cetin, K. Guney, H. Faten, Z. Abdelfatteh I. H. Ozbudak

76 ECP 2014 · London Poster Presentations a Sunday

104 006 Study of chemokine receptors and lym- Reliability of extemporaneous exam in phangiogenic factors expression in oral breast pathology tongue Squamous Cell Carcinoma (SCC) Issam Msakni, Tunisia PS-03 and investigation of their relationship with F. Ben Abdallah, B. Laabidi, M. Yahya, metastatic disease of the neck F. Bougrine, A. Bouziani Stefanos Milias, Greece

009 PS-02 C. Magopoulos Clinicopathologic and prognostic signifi- 105 cance of NY-BR-1 antigen expression and Adenoma of the middle ear: Report of a Anti-NY-BR-1 IgG levels in Egyptian breast case cancer female patients Vassilis Samaras, Greece Malak Zoheir, Egypt C. Poullou, F. Daglis, V. Leftheriotis, 010 G. Tsiouma, K. Christidis, K. Diamantopoulou PIK3CA mutations in breast cancer patients and its relationship with clinico- PS-03 Poster Sessions pathological features and survival Breast Pathology Ismail Yilmaz, Turkey Chairs: Anna Sapino, Italy A. Ozgun, G. Narli, U. Berber, Z. Kucukodaci, Nikita Makretsov, Canada B. Karagoz, Y. Kurt, D. Demirel, A. Haholu 31 Aug Sunday, James Going, United Kingdom 011 001 A malignant phyllodes tumour including Comparitive immunohistochemical analy- aneurysmal bone cyst-like areas in preg- sis of P63, SMA, CD10 and calponin in dis- nancy tinguishing insitu from invasive breast Esra Canan Kelten, Turkey carcinoma C. Boyaci, C. Leblebici, K. Behzatoglu, Dina Abdallah, Egypt D. Can Trabulus, S. Sari, M. A. Nazli, N. Eldeeb U. R. Gursu, D. Karacetin, E. R. Bozkurt

002 012 Is multifocality an independent prognostic Cystic hypersecretory ductal carcinoma of factor in breast cancer? the breast: A case report Simona Stolnicu, Romania Esra Canan Kelten, Turkey C. Toganel, R. Georgescu, C. Moldovan, C. Boyaci, C. Leblebici, D. Can Trabulus, S. Voidazan, I. Barsan, D. Barsan, A. Eniu, M. A. Nazli, D. Karacetin, U. R. Gursu, M. Boros E. R. Bozkurt, U. R. Gursu

003 013 Wegener’s granulomatosis of the breast Matrix-producing metaplastic carcinoma of with peculiar radiological aspect the breast: A case report Simona Stolnicu, Romania Esra Canan Kelten, Turkey A. Ilyes, D. G. Moncea, I. Barsan, C. Boyaci, C. Leblebici, D. Can Trabulus, M. D. Podeanu, R. Georgescu U. R. Gursu, M. A. Nazli, E. R. Bozkurt

005 014 Breast cancer in young woman under 40 Nodule-forming pseudoangiomatous stro- years: A study of 47 cases mal hyperplasia of the breast: 3 cases Issam Msakni, Tunisia Esra Canan Kelten, Turkey W. Ajouli, B. Ajouli, A. Ben Chaabane, C. Boyaci, C. Leblebici, M. A. Nazli, S. Aksoy, F. Bougrine, A. Bouziani D. Can Trabulus, E. R. Bozkurt

77 Poster Presentations a Sunday ECP 2014 · London

015 021 PS-03 Pleomorphic adenoma (benign mixed Primary breast angiosarcoma: A rare entity tumour) of the breast in the background Samir Miladi, Tunisia of intraductal papilloma A. Guebsi, W. Jomaa, I. Bettaieb, O. Lamine, Esra Canan Kelten, Turkey O. Gammoudi, A. El-May C. Boyaci, C. Leblebici, K. Behzatoglu, 022 S. Sirin, G. Erdem Huq, M. A. Nazli, S. Aksoy, Triple Negative Breast Cancer (TNBC): E. R. Bozkurt Experience of the Institut National 016 d’Oncologie of Rabat about 87 cases Determining the optimal breast specimen Mariam Amrani, Morocco sampling method for the assessment of H. Hachlef, R. Elochi, H. Elouazzani, N. Tazi the incidence of multiple breast carcinoma 023 Denisa Georgiana Moncea, Romania Sunday, 31 Aug The prognostic and predictive significance I. Barsan, R. Georgescu, M. D. Podeanu, of PARP-1 in locally advanced breast can- C. Moldovan, M. Boros, S. Stolnicu cer patients receiving neoadjuvant chemo- 017 therapy The nuclear grade plus proliferation grad- Hayam Abdel Samie Aiad, Egypt ing system for Invasive Ductal Carcinoma M. Kandil, M. El-Tahmody, I. Abulkheir, of the breast: Validation in a tertiary refer- F. Abulkasem, A. Elmansori, M. Aleskandarany ral hospital cohort in a white Caucasian 024 population Immunohistochemical analysis of the Maria Papadimitriou, Greece PTEN-and Muc4-associated Her2 / neu of S. Kaptanis, E. Polymeropoulos, breast cancer resistance to trastuzumab G. Mitsopoulos, D. Stogiannis, C. Caroni, Galina Khamidullina, Kazakhstan G. Apostolou, G. Vaiopoulos, E. Sereda, N. Zharkov J. G. Panayiotides, P. Karakitsos 025 018 Sentinel node handling and reporting in Ki-67 expression in sclerosing adenosis Kent: A re-audit (SA) and adjacent normal breast terminal Lorna Donovan, United Kingdom ductal lobular units (TDLUs): A nested R. Liebmann, G. Russell case / control study from the Mayo Benign Breast Disease (BBD) Cohort 026 Aziza Nassar, USA Nipple discharge and pathological findings A. Degnim, M. Frost, R. Vierkant, T. Hoskin, Petr Vážan, Czech Republic L. Hartmann, D. Radisky, D. Visscher 027 019 Activated c-Jun is a luminal-related marker Digistain: A new objective method for associated with better outcome in breast grading breast carcinoma using routinely cancer processed paraffin sections Dena Jerjees, United Kingdom Hemmel Amrania, United Kingdom R. Abduljabbar, A. Muftah, C. Nolan, L. Drummond, L. Woodley, C. Phillips, A. Green, I. Ellis, E. Rakha S. Shousha, C. Coombes 028 020 p38 MAPK is a marker of good prognosis Large-sections in breast pathology: Pre- in breast cancer and is an independent liminary report of single institution experi- predictor of better outcome in the luminal ence class Jasminka Jakic-Razumovic, Croatia Dena Jerjees, United Kingdom I. Brcic, D. Tentor, P. Podolski, M. Prutki, R. Abduljabbar, M. Al-Kaabi, C. Nolan, D. Vrbanec, D. Mijatovic A. Green, I. Ellis, E. Rakha

78 ECP 2014 · London Poster Presentations a Sunday

029 036 Breast cancer subcellular predictors in a Immunohistochemical profile of premalig- manual immunohistochemistry setting: A nant lesions in breast cancer patients from concordance analysis a hospital-based series of cases PS-03 Armando Gamboa Dominguez, Mexico Adrian Dumitru, Romania J. C. Cordova Ramon, J. Smeke-Smeke A. Iliesiu, L. Mitrache, A. Mihai, R. Z. Ionescu, O. Patrascu, 030 O. C. Ciornenchi, M. Costache, M. Sajin, Changes in HER2 status between primary M. Cirstoiu breast or gastric carcinomas and synchronous metastatic lymphnodes: Is there any 037 role for intra-tumour heterogeneity? A role of active c-Src in progression of Antonio Ieni, Italy lobular breast cancer V. Barresi, G. Branca, G. Tuccari Han-Seung Yoon, Japan D. Zou, P. Guilford, B. Humar 031 Cyclin A / Ki67 ratio is a powerful predictor 038 of future distant metastases in breast cancer Wilms’ tumour gene (WT1) is expressed in Kun Mu, People’s Republic of China mucocele-like lesions of the breast H. Yun, G. Auer, A. Zetterberg Mina Mansy, United Kingdom S. Shousha 31 Aug Sunday, 032 Expression of E-cadherin and P120 in 039 breast carcinomas with equivocal features Morphological changes of blood vessels in (Ductal / Lobular) breast cancer Alicia Cordoba, Spain Igor Vasin, Russia A. Panizo, F. Vicente, J. J. Illarramendi, M. Mnikhovich M. L. Alvarez, K. Cambra 040 033 Androgen receptor is an independent pre- Different methods of pretreatment Ki-67 dictor of outcome in breast cancer that per- labeling index evaluation in core biopsies forms better than progesterone receptor of breast cancer patients treated with neo- Rezvan Abduljabbar, United Kingdom adjuvant chemotherapy and their relation A. Green, D. Jerjees, C. Nolan, L. Buluwela, to response to therapy S. Ali, I. Ellis, E. Rakha, D. Jerjees András Vörös, Hungary 041 E. Csörgö, B. Kövári, P. Lázár, G. Kelemen, Features of apoptosis in ductal breast cancer O. Rusz, T. Nyári, G. Cserni Lev Kakturskiy, Russia 034 M. Mnikhovich Invasive ductal carcinoma arising from 042 fibroadenoma IgG4-Related Sclerosing Mastitis (IgG4- Ho-Chang Lee, Republic of Korea RSM) of the breast: Diagnostic conundrum Y.-M. Lee, S.-M. Son, O.-J. Lee on Core Needle Biopsy (CB) specimens 035 Erika Resetkova, USA Neuroendocrine ductal carcinoma in situ, A. Padula comedo type, of the breast detected by 043 screening mammography: A potentially Papillary breast carcinoma in males pre-invasive counterpart of high-grade Samira Miladi, Tunisia neuroendocrine tumours A. Guebsi, O. Lamine, W. Jomaa, I. Bettaieb, Tomonori Kawasaki, Japan A. Goucha, O. Gammoudi, A. El-May G. Bussolati, M. Suzuki, T. Kosaka, R. Sugimoto, Y. Mue, N. Uesugi, K. Ishida, R. Katoh, T. Sugai, A. Sapino

79 Poster Presentations a Sunday ECP 2014 · London

044 056 PS-03 Can cancer-associated epigenetic changes Breast cancer stromal elastosis is associ- be detected from semiquantitative ER / PgR ated with mammography screening detec- expression in 1180 patients with invasive tion, low Ki67 and a good prognosis in a ductal breast cancers? population-based study Branko Dmitrovic, Croatia Ying Chen, Norway K. Marjanovic, S. Kurbel T. A. Klingen, E. Wik, K. Liestøl, H. Aas, Ø. Garred, J. Mæhlen, L. A. Akslen, J. Lømo 047 Predicting axillary lymph node metastasis 057 in breast cancer by OSNA assay in sentinel Correlation between p27 expression and lymph nodes: Value of total tumoural load clinicopathological varibles in breast cancer Alicia Cordoba, Spain Ho-Chang Lee, Republic of Korea A. Panizo, C. Beorlegui, G. De Lima, Y.-M. Lee, S.-M. Son, O.-J. Lee Sunday, 31 Aug P. Armendariz, C. Llanos, E. Goñi 058 048 Axillary lymphadenopathy: An outstand- Correlation of breast cancer histologic ing presentation for breast implant-associ- grade and molecular profile with repro- ated ALK-negative anaplastic large cell ductive status of patient lymphoma Maia Mchedlishvili, Georgian Juan C. Tardío, Spain N. Goishvili, I. Khakhutaishvili, K. Tsomaia R. Granados

052 059 Bilateral synchronous adenosquamous car- Primary inflammatory malignant fibrous cinoma of the breast histiocytoma of the breast: A case report Rani Kanthan, Canada of a rare soft tissue sarcoma of the breast J.-L. Senger, P. Meiers Susan Foreid, Portugal A. Correia, M. Martins, F. Marcos 053 Intracystic papillary carcinoma and solic 060 papillary carcinoma of the breast. Diag- Three-dimensional observation of scleros- nostic trouble of the in situ and infiltrative ing adenosis involved by lobular carci- lesions: Two case report noma in situ using crystal analyzer-based Héctor Enrique Torres Rivas, Spain X-ray phase contrast CT C. Garcia Pravia, P. Menéndez Rodríguez, Shu Ichihara, Japan G. Mendoza Pacas, G. Mendoza Pacas K. Mori, N. Sunaguchi, Y. Tetsuya, Y. Wu, M. Ando 054 The biological and clinical significance of 061 phosphorylated mTOR (pi3k / AKt pathway Expression of nuclear FGFR2 correlates related) and its association with estrogen with PR in high-grade DCIS receptor and HER2 pathways Hanna Romanska, Poland Dena Jerjees, United Kingdom P. Potemski, R. Kusinska, R. Sadej, R. Kordek O. Nejm, S. Mirza, R. Abduljabbar, A. Green, 062 P. Tighe, V. Band, I. Ellis, E. Rakha Metaplastic breast carcinoma: Report of 055 five cases Ectopic thyroid presenting as a breast Emel Ebru Pala, Turkey mass: Case report U. Bayol, U. Kucuk, E. Cakir, C. Akdeniz, Margarida Ferreira, Portugal E. U. Keskin, S. Salimoglu, Z. Yildirim M. Cruz, S. Carvalho, A. I. Silva, M. Teixeira, F. Pardal

80 ECP 2014 · London Poster Presentations a Sunday

063 070 Expression of Epithelial-Mesenchymal Molecular subtypes, histopathological Transition (EMT) markers in phyllodes grade and survival in a historic cohort of breast tumours: An immunohistochemi- breast cancer patients PS-03 cal study Monica Engstrøm, Norway Ioanna Akrida, Greece S. Opdahl, A. I. Hagen, P. R. Romundstad, V. Bravou, I. Lilis, V. Zolota, S. Kounelis, L. A. Akslen, O. A. Haugen, L. J. Vatten, H. Papadaki A. M. Bofin

064 071 Is mammaglobin expression in breast can- TOP2A gene copy number change in breast cer associated with angiogenesis, lym- cancer phangiogenesis or cell proliferation? Monica Engstrøm, Norway Naomi Whiteoak, United Kingdom B. Ytterhus, L. J. Vatten, S. Opdahl, L. Baker, L. Hall A. M. Bofin

065 072 CD10 immunohistochemical expression in Is it invasive carcinoma developing inside apocrine lesions of the breast the fibroadenoma or fibroadenoma which Bence Kõvári, Hungary has been infiltrated by invasive carcinoma? G. Cserni Ebru Demiralay, Turkey 31 Aug Sunday, S. Yildiz, A. Demirag 066 Growth Hormone Releasing Hormone 073 Receptor (GHRH-R) expression in various The proliferation marker Ki67 in breast types of apocrine epithelial lesions: Apo- cancer: A reliability study to assess its crine breast carcinomas and cutaneous readiness for routine clinical management tumours with apocrine features Abir A. Abdelhadi Muftah, United Kingdom Bence Kõvári, Hungary M. Al-Kaabi, M. Aleskandarany, D. Jerjees, S. Vranic, L. Kocsis, A. Sapino, G. Cserni N. Alsubhi, R. Abduljabbar, C. Nolan, A. Green, I. Ellis, E. Rakha 067 Expression of Calpain-9 is associated with 074 survival following hormone therapy in Checkpoint Kinase1 (CHK1) is an important breast cancer biomarker in breast cancer related to DNA- Jillian Davis, United Kingdom damage repair mechanism and response to S. Martin, P. Patel, A. Green, E. Rakha, chemotherapy I. Ellis, S. Storr Methaq Al-Kaabi, United Kingdom A. Alashareeda, D. Jerjees, A. A. Abdelhadi 068 Muftah, N. Alsubhi, A. Green, S. Chan, Microvascular proliferation in breast can- E. Cornford, S. Madhusudan, I. Ellis, cer subtypes E. Rakha Maria Ryssdal Kraby, Norway S. Opdahl, K. Krüger, B. Ytterhus, 075 L. J. Vatten, L. A. Akslen, A. M. Bofin Does single receptor positive breast carcinoma differ with regard to age, tumour 069 grade and HER2 amplification status? Invasive lobular breast cancer: Impact of Alp Özgüzer, Turkey histopathological grade and immunohisto- U. Bayol, E. E. Pala, C. Akdeniz chemical markers Monica J. Engstrøm, Norway 077 S. Opdahl, L. J. Vatten, O. A. Haugen, Does loss of C-KIT protein in benign and A. M. Bofin non-invasive apocrine lesions indicate potential for malignant transformation? Trine Tramm, Denmark J.-Y. Kim, S. Leibl, F. Moinfar, F. Tavassoli

81 Poster Presentations a Sunday ECP 2014 · London

079 085 PS-03 Breast angiosarcoma: Evidence of lym- Impact of the new ASCO / CAP recommen- phatic origin and MYC amplification in dations for the determination of HER2 by post-radiotherapy breast angiosarcomas immunohistochemistry (IHC) M. Teresa Soler Monsó, Spain Jessica Camacho, Spain H. A. Florez, A. Petit, F. Climent, J. Temprana Salvador, S. Díaz, A. Valdivielso, M. A. Eraso, A. López Ojeda, S. Ramon y Cajal, V. Peg V. Peg, E. Condom 086 080 The enhanced role of biomedical scientists Molecular subtyping of breast invasive in the histological dissection of axillary ductal carcinomain women older than 75 lymph node clearance specimens years James Sampson, United Kingdom Ilhem Bettaieb, Tunisia Y. Bury Sunday, 31 Aug S. Abdeljaoued, A. Goucha, H. Bouzaiene, 087 S. Miladi, W. Jomaa, T. Ben Dhieb, K. Rahal, Audit of end-to-end turnaround times for A. El-May, A. Gamoudi, A. Zehani-Kassar mastectomy specimens in a District Gen- 081 eral Hospital, using locally agreed stand- International ring trial for evaluation of ards and targets from the key performance breast cancer morphology in PAXgene indicators recommended by the Royal Col- fixed tissue compared to formalin fixed lege of Pathologists samples Katharine Sheppard, United Kingdom Christian Viertler, Austria L. Kankate P. Verderio, C. M. Ciniselli, S. Pizzamiglio, 088 S. Gündisch, M. Kap, P. Riegman, K.-F. ERK1 / 2 expression in breast cancer: The Becker, K. Zatloukal, P. Regitnig impact of subcellular localisation 082 Dena Jerjees, United Kingdom Peroxisome proliferator-activated recep- O. Nejm, S. Mirza, R. Abduljabbar, tor gamma expression is useful predic- N. Alsubhi, C. Nolan, A. Green, P. Tighe, tive and prognostic tool in luminal breast V. Band, I. Ellis, E. Rakha cancer 089 Rezvan Abduljabbar, United Kingdom Deciphering the role of PTEN and its role D. Jerjees, A. Green, C. Nolan, L. Buluwela, in the DNA damage response in breast S. Ali, E. Rakha, I. Ellis cancer 083 Nouf Alsubhi, United Kingdom Frequency of MYB rearrangement in ade- W. Flesher, A. Alshareeda, A. Muftah, noid cystic carcinoma of the breast as D. Jerjees, R. Abduljabbar, M. Al-Kaabi, detected by fluorescent in situ hybridiza- A. Green, S. Madhusudan, I. Ellis, E. Rakha tion 090 Rafael Jimenez, USA Pro and anti-apoptotic profiles in molecu- W. Sukov, T. Despins, C. Reynolds, J. Garcia lar subtypes of breast carcinoma 084 Irina-Draga Caruntu, Romania Accuracy of estrogen and progesterone C. Popescu, L. Lozneanu, R. E. Avadanei, receptor immunohistochemical testing in S.-E. Giusca, C. Amalinei, R. Balan breast cancer: Canadian Immunohisto- 091 chemistry Quality Control (CIQC) program Mammary myofibroblastoma: Case report Martin Hyrcza, Canada Malgorzata Kolos, Poland N. Makretsov, S. Mallett, J. Garratt, A. Wasaznik-Jedras, A. Nasierowska-Guttmejer E. Torlakovic, C. B. Gilks

82 ECP 2014 · London Poster Presentations a Sunday

092 099 TTF-1 positive breast cancer: A cautionary Neuroendocrine Carcinoma (NEC) of the tale breast clinicopathological study of 90 NEC Peter Ellery, United Kingdom cases in conjunction with 1522 non-NEC PS-03 N. Archard, A. Saetta, M. Gandy, M. Falzon cases Tomonori Kawasaki, Japan 093 M. Suzuki, T. Kosaka, R. Sugimoto, Y. Mue, MicroRNA-21 detected in breast cancer N. Uesugi, K. Ishida, R. Katoh, T. Sugai, tissue and cells by a new electrochemical A. Sapino magnetobiosensor: A rapid, sensitive, accurate and unexpensive alternative to 100 other molecular approaches Metastases to the breast from gastric car- Rosario Granados, Spain cinoma: IPO Coimbra experience in eight S. Campuzano, R. Torrente Rodríguez, years E. López Hernández, F. Conzuelo, Marcos Guimarães, Portugal J. J. Domínguez, J. M. Jover, P. Figueiredo J. M. Sánchez Puelles, J. M. Pingarrón 101 094 Copy number abberations of oncogenes Evaluation of Ki67 as a useful routine and tumour-supressor genes in breast marker in breast cancer cancer 31 Aug Sunday, Priya Bhagwat, United Kingdom George Frank, Russia M. Ally, J. Moorehead N. Danilova, A. Petrov, L. Zavalishina, A. Matsionis, Y. Andreeva 095 High Axl expression is associated with 102 markers of poor prognosis in African Immunochistochemical characteristics of breast cancer triple negative breast cancer subtypes Lavina Ahmed, Norway Natalia Danilova, Russia H. Nalwoga, D. R. Micklem, J. B. Arnes, G. Frank, N. Nefedova, P. Malkov, H. Wabinga, L. A. Akslen L. Zavalishina, M. Gorelik, Y. Andreeva

096 103 Sensitivity and specificity of needle core ESR1 gene amplification is absent in biopsies for the diagnosis of phyllodes breast cancer, but ESR1 gene gain is asso- tumours: Twelve years experience at a ter- ciated with luminal B group (subgroup tiary referral centre with high Ki67 index): A multiplex liga- Sarah Aitken, United Kingdom tion-dependent probe amplification study E. Provenzano, M. Jimenez-Linan, of 55 cases B. Mahler-Araujo, P. Wright, V. Broecker Alexandr Matcionis, Russia L. Zavalishina, A. Petrov, I. Pavlenko, 097 N. Danilova Myxofibrosarcoma / myxoid malignant fibrous histiocytoma: A rare primary breast 104 sarcoma Evaluation of Her2 / Top2A gene amplifica- Argiro-Ioanna Ieronimaki, Greece tion and chromosome 17 centromere gain A. Tsavari, K. Koulia, E. Arkoumani, in different molecular subtypes of breast D. Myoteri, T. Vasilakaki, K. Manoloudaki cancer Alexandr Matcionis, Russia 098 I. Pavlenko, A. Petrov Rosai-Dorfman Disease of the breast: MRI findings with pathological correlation 105 Luiza Moore, United Kingdom Invasive paget disease of the breast: A P. Britton, G. Follows, P. Wright case report of an unrecognized entity Helen Trichia, Greece G. Mitropoulou, A.-I. Ieronimaki, O. Tzaida, E. Paliouri, K. Kalogerakos

83 Poster Presentations a Sunday ECP 2014 · London

106 113 PS-03 Genetic profile and morphological features Prognostic value of the kige index in male of breast cancers in the setting of Heredi- breast cancer tary Breast Cancer (HBC) syndrome Syrine Abdeljaoued, Tunisia Roberto Silva, Portugal I. Bettaieb, S. Miladi, B. Laamouri, C. Susy, F. Carneiro, I. Amendoeira J. Ben Hassouna, A. Goucha, W. Jomaa, A. Chabchoub, K. Rahal, A. El-May, 107 A. Gamoudi Lobular Breast Carcinoma (LBC) and Dif- fuse Gastric Carcinoma (DGC) in carriers 114 of CDH1 germline mutations The value of beta-catenin immunohisto- Roberto Silva, Portugal chemistry in the diagnosis of invasive lob- I. Amendoeira, F. Carneiro ular carcinoma of the breast Kate Struthers, United Kingdom Sunday, 31 Aug 108 J. Thomas, M. O’Donnell Are we assessing ER and HER2 status cor- rectly in the London Cancer Alliance (LCA, 115 West and South)? Multiple myeloma of the breast: A case Kalnisha Naidoo, United Kingdom presentation S. Pinder, London Cancer Alliance Breast Athanasia Vargiamidou, United Kingdom Group (West and South) Y. Maurice, J.-L. Findlay

109 116 The clinicopathological correlation and Breast implant associated anaplastic large prognostic significance of p53, pRB and cell lymphoma presenting as a delayed p16 expression in triple negative breast seroma: A case report cancer Charlotte Roberts, United Kingdom Anton Zawrocki, Poland M.-J. Hwang, G. Sterne, N. Momtahan K. Wazny, M. Swierblewski, W. Biernat 117 110 Clinical assessment of immunohisto- Comparative study of the automated chemistry, digital image quantification instant-quality with the manual standard and AQUA for breast biomarkers ER, PR, HER2 fluorescence in situ hybridization HER2 and Ki67 Raphaëlle Duprez-Paumier, France Michael Gandy, United Kingdom A. Maran-Gonzalez, T. Filleron, E. Mounié, K. Stone, D. Allen, P. Jones, K. Miller, M. Lacroix-Triki R. Hamoudi, M. Falzon, C. Wells

111 118 Malignant mesothelioma in Aalborg, Immunohistochemical validation of oes- North Denmark: Pathology reports of the trogen receptor clones EP1 and 6F11 Aalborg University Hospital reveal 562 Michael Gandy, United Kingdom cases and a 13-fold increase in four dec- D. Allen, P. Jones, A. Saetta, K. Miller, ades J. Linares, M. Falzon Vasiliki Panou, Denmark 119 C. Meristoudis, O. D. Røe Breast tumour-Hodgkin Lymphoma-diag- 112 nostic difficulties: Case report Is excision necessary for a core biopsy Ewa Srutek, Poland diagnosis of fibroadenoma and Lobular T. Nowikiewicz, W. Zegarski Carcinoma in situ where the imaging tar- 120 get is a mass? Breast cancer metastasis to the stomach: Cassie Fives, Ireland Report of 5 cases S. Prendeville, R. Murphy, N. Marshall, Ioannis-Petros Efstratiou, Greece L. Feeley, M. Bennett, T. J. Browne, S. Pervana, E. Pazarli, D. Alataki F. O’Connell

84 ECP 2014 · London Poster Presentations a Sunday

121 129 Androgen receptor expression as prognos- A case of male breast carcinoma leading to tic factor in ER positive breast cancer diagnosis of neurofibromatosis type 1 A. Marcell Szasz, Hungary Christos Poulios, Greece PS-03 A.-M. Tokes, L. Madaras, J. Kulka, G. Cserni T. Koletsa, V. Gourvas, K. Chatzopoulos, V. Papadopoulos, G. Karagiannopoulou, 122 P. Hytiroglou, I. Kostopoulos Selection of patients for OncotypeDx testing in breast cancer in the UK 130 Emad Rakha, United Kingdom Mammary Myofibroblastoma: A review of 5 cases with immunohistochemical fea- 123 tures Adenoid cystic carcinoma of the breast: Maria del Rosario Taco, Spain Report of three cases and literature review C. Nienow, T. Soler, F. Climent, A. Petit, Helena Fuentes Vaamonde, Spain A. Guma, M. Campos M. T. Gonzalez Serrano, M. Centeno Haro, J. Salvatierra Cuenca, M. Medina Pérez 131 Correlation of morphological aspects and 124 immunohistochemical prognostic factors Molecular classification of breast cancer in breast cancer and its clinicopathological correlations: A 31 Aug Sunday, Florica Staniceanu, Romania retrospective cohort study E. Gramada, C. Popp, A. Stoica, A. Evsei, Dimitra Koumoundourou, Greece G. Halcu, A. Stan, S. Dutulescu, S. Zurac I. Nikolatou, E. Mpota, P. Ravazoula 132 125 Clinicopathological analyse of patients Significance of the topographic expression with triple negative breast cancer of the phosphorylated translational factor Esra Canan Kelten, Turkey eIF2A at serine 51 in invasive breast carci- C. Boyaci, U. R. Gursu, S. Aksoy, nomas D. Can Trabulus, D. Karacetin, S. Sirin Lydia Nakopoulou, Greece I. Theohari, C. Patsis, A. Koromilas, 133 I. Giannopoulou, P. Alexandrou, Evaluation of BCL2 and cyclin D1, as pre- A. Keramopoulos dictive and prognostic factors in locally advanced and inflammatory breast cancer 126 treated with neoadjuvant chemotherapy A lobular carcinoma metastatic to the Amal Kouchkar, Algeria stomach: Case report and literature review L. Atif, S. Sami, N. Terki Panagiota Ravazoula, Greece H. Geropoulou, I. Nikolatou, 135 D. Koumoundourou Accuracy of preoperative diagnostic biopsy in metaplastic breast cancer 127 Luis Pérez Casanova, Spain Collagen fibre patterns in breast cancer M. T. Soler, I. Català, A. Petit, F. Climent, Anna M. Bofin, Norway E. Mancebo, M. López, M. Terricabras, A. Brabrand, I. Kariuki, M. J. Engstrøm, L. Prieto, E. Condom O. A. Haugen, L. A. Dyrnes, B. O. Åsvold, M. B. Lilledahl

128 Intratumoural heterogeneity in breast cancer: A HER2 based case study Michael Gandy, United Kingdom T. O´Grady, D. Allen, J. Starczynski, M. Falzon, E. Kay

85 Poster Presentations a Sunday ECP 2014 · London

136 143 PS-03 A three year study of the clinical and Clinical significance of cannabinoid recep- health economic impact of a combination tor 2 expression in human invasive breast of axillary ultrasound assessment with carcinoma pre-operative FNA and intra-operative Stamatios Theocharis, Greece assessment of Sentinel Lymph Nodes I. Theohari, I. Giannopoulou, P. Alexandrou, (SLN) by metasin of breast cancer patients A. Keramopoulos, L. Nakopoulou Amy Downing, United Kingdom 144 P. Gopinath, D. George, S. Jader, Quantitative immunohistochemical differ- E. Arkoumani, A.-S. Salam, A. Aylwin, ences of breast carcinomas and their lym- J. Hodson, P. Rajan, V. Sundaresan phogenous metastases 137 Tatiana Krasnokutskaya, Russia Cyclin D1 and Bcl-2 expression of breast- S. Kuznetsov Sunday, 31 Aug and salivary gland-derived adenoid cystic 145 carcinoma: An immunohistochemical study Immunohistochemical assessment of Orsolya Kiss, Hungary PDGF / PDGFR axis in breast cancer: A S. Vranic, A. Ghazalpour, N. Udvarhelyi, route towards a future hope L. Vass, Z. Gatalica, J. Kulka Andreea Jitariu, Romania 138 A. M. Cimpean, A. R. Ceausu, M. Raica Variability in Ki-67 breast carcinoma Immu- 146 nohistochemistry (IHC) staining shown by Triple-negative and basal-like breast can- UK External Quality Assessments cer in Valdivia, Chile Suzanne Parry, United Kingdom María Teresa Poblete, Chile D. Steele, K. Miller, M. Ibrahim C. Romero, P. Soto, Y. Valencia, M. Rios, 139 C. Figueroa, K. Heise Pseudoangiomatous stromal hyperplasia 147 of the breast in core needle biopsy speci- An in vitro investigation of Estrogen Recep- mens, how often and when we confront tor beta 2 (ERbeta2) nuclear speckles in with this lesion? breast cancer Esra Canan Kelten, Turkey Emily Smart, United Kingdom C. Boyaci, E. Hacihasanoglu, M. A. Nazli, V. Speirs, C. Green, T. Hughes, A. Hanby, S. Aksoy, D. Can Trabulus L. Smith 140 148 Chromogen in situ hybridization of imuno- Sebaceous carcinoma of the breast: A very histochemical HER2 equivocal invasive rare entity breast carcinomas: One year of experience Paraskevi Efstathiadou, Greece Dorela Lazureanu, Romania E. Papakonstantinou, A. Papaevangelou, A. Dema, A. Muresan, A. Vaduva, A. Linardou, I. Zinovieva, I. Pougouras, M. Derban, C. Vita G. Liapi 141 149 The impact of the new HER2 reporting Secretory carcinoma of the breast: A case ASCO guidelines on breast cancer treat- report ment and in the anatomic pathology labo- Paraskevi Efstathiadou, Greece ratory M. Perdiki, E. Papakonstantinou, A. Susan Foreid, Portugal Papaevangelou, I. Pougouras, G. Liapi C. Pontinha, M. H. Pereira, M. Oliveira

86 ECP 2014 · London Poster Presentations a Sunday

150 156 Correlation of HER-2 over-expression with Granular cell tumour of breast: Report of clinico-pathological parameters in Tuni- two cases sian breast carcinoma Evanthia Diakatou, Greece PS-03 Lobna Ayadi, Tunisia C. Patralexis, P. Ntasiou, A. Kostopoulou, G. M. Mellouli, R. Kallel, S. Charfi, I. Saguem, Xepapadakis, V. Tziortzioti, T. Choreftaki, D. M. Triki, H. Amouri, T. Boudawara Tziortziotis

151 158 Synchronous primary neuroendocrine A predictive model for axillary lymph node tumour of breast and gallbladder high- metastasis in preoperative breast cancer grade adenocarcinoma: A case report core needle biopsy Juraj Marcinek, Slovakia Han-Suk Ryu, Republic of Korea P. Slávik, M. Kalman, L. Plank I.-A. Park

152 159 Clinicopathological analyse of patients Adenoid cystic carcinoma of the breast with breast cancer from a single centre in with high-grade transformation Turkey Antonio De Leo, Italy Esra Canan Kelten, Turkey A. Rizzo, L. Laurino, M. Sironi, M. P. Foschini C. Boyaci, D. Can Trabulus, S. Aksoy, 31 Aug Sunday, 160 U. R. Gursu, D. Karacetin, S. Sirin, Pleomorphic Lipoma of the breast: A case M. A. Nazli, E. R. Bozkurt report 153 Diogo Gonçalves, Portugal Neoadjuvant chemotherapy in cancer of C. Antunes, A. Oliveira the breast response rate according to the 161 molecular phenotype: A case series of 137 The role of histological grade in discrimina- cases tion between Luminal A-like and Luminal Khadija Benhayoune, Morocco B-like subtypes in a series of premenopau- H. El-Fatemi, H. Ameuretesse, A. Amarti sal breast cancer patients 154 Anna Ehinger, Sweden Comparative study: Economic impact of P.-O. Bendahl, C. W. Elston, P. Malmström, axillary assessment by conventional 2-step D. Grabau, M. Fernö axillary node sampling & clearance with 162 one-step intra-operative Metasin assess- Association of hypothyroidism with mam- ment mary gland changes: Study in an animal Vasi Sundaresan, United Kingdom model M. Sundaresan, S. Payne George Agrogiannis, Greece 155 V. Pergialiotis, K. Kontzoglou, D. Perrea, Metasin detects metastatic disease in sen- E. Patsouris tinel lymph nodes in breast cancer: Is dis- 163 cordance between Metasin and Histology The introduction of a molecular intraoper- due to Tissue Allocation Bias (TAB)? ative sentinel node assay, Metasin at mul- Vasi Sundaresan, United Kingdom tiple sitesC clinical and axillary outcome P. Sai-Giridhar, D. George, P. Gopinath, N. perspective Agrawal, S. Al-Ramadhani, S. El-Sheikh, S. Preethi Gopinath, United Kingdom Al-Sam, S. Jader, E. Arkoumani, J. McKenzie N. Agrawal, D. George, P. Sai-Giridhar, S. Al-Ramadhani, V. Sundaresan, C. Yiangou, R. Mansel, S. El-Sheikh, S. Holt, I. Cree

87 Poster Presentations a Sunday ECP 2014 · London

164 004 PS-03 The coexistence of synchronous BRCA-1 Generalized Arterial Calcification of positive breast lobular carcinoma with Infancy (GACI) a rare case of neonatal BRCA-1 negative endometrial endometri- acute heart failure: Molecular analysis and oid adenocarcinoma role for cardiac transplantation PS-04 Tatjana Zablocka, Latvia Paola Francalanci, Italy S. Isajevs, L. Osipova, A. Mitildzans, I. Giovannoni, P. Cogo, A. Amodeo, I. Liepniece-Karele A. Secinaro, M. El-Hachem, C. Bizzarri, R. Boldrini, F. Callea 165 Concordance of Ki67-labelling index in 005 core biopsies and related surgical speci- The correlation between apoptosis of car- mens of luminal breast cancers diomyocytes and the square of microcircu- Cornelia Focke, Germany latory bed in patient during the healing of Sunday, 31 Aug T. Decker myocardial infarction Yulia Korneva, Russia 167 A. Dorosevich Her2 positive G1 invasive breast carcinoma: A fact and an artefact 007 Gorana Gasljevic, Slovenia An unusual case of a metastasized aortic P. Drev, B. Gazic, J. A. Contreras intimal sarcoma in a 68-year-old woman Semih Buz, Germany 168 M. Zeh, K. Hauptmann, R. Hetzer, Change in ER, PR, HER2 status and Ki-67 K. Wassilew after primary chemotherapy in breast cancer 008 Ana Maria Petit, Spain The role of macrophages in cardiac remod- C. Loayza, L. Pérez Casanova, J. Cañellas, eling in the late post-transplant course C. Falo, J. Perez, T. Soler, F. Climent, M. Gil, Anna Knoblich, Germany S. Pernas, E. Condom D. Kemper, J. Kzhyshkowska, R. Hetzer, K. Wassilew

PS-04 Poster Sessions 010 Cardiovascular Pathology Intimal sarcoma of the pulmonary artery: Chairs: Allard van der Wal, The Nether- A long-term survival case, in spite of lands metastases Mary Sheppard, United Kingdom Macarena Centeno, Spain R. Ortega Salas, R. Sánchez Sánchez, 001 A. González Menchen, T. Caro Cuenca, Histopathology of aspirated thrombi dur- E. Fuentes Vaamonde, T. González Serrano, ing primary percutaneous coronary inter- J. Salvatierra Cuenca, M. Medina Pérez, vention in patients with acute myocardial T. Sánchez Medianero infarction Ivo Steiner, Czech Republic 011 J. Spacek, A. Matejková, J. Vojácek YKL-40 expression in human mitral valve disease: An immunohistochemical study 002 Elisavet Thanopoulou, Greece Familial non-marfan thoracic aortic aneu- V. Bravou, A. Alexopoulos, I. Lilis, rysms: A case report and literature analysis L. Kaklamanis, H. Papadaki Ernest Iakovlev, United Kingdom L. Errett, V. Iakovlev 012 Sudden cardiac death in cardiac transplant 003 patients: Morphological findings in the Rheumatoid nodules of cardiac valves: A heart rare histological finding Slaveya Yancheva, United Kingdom Gayani Pitiyage, United Kingdom M. A. Montero-Fernandez, M. Sheppard S. Hughes

88 ECP 2014 · London Poster Presentations a Sunday

013 024 A single centre retrospective clinicopatho- The role of cardiac troponin in post-mor- logic study of endomyocardial biopsies tem diagnosis of Ischaemic Heart Disease after heart transplantation at Baskent Uni- as a primary cause of sudden death PS-04 versity Hospital in Ankara 1993 – 2014 Joe Zhang, United Kingdom Aysen Terzi, Turkey I. Taylor, F. Alibhai, S. Sangaralingam, A. Sezgin, M. Z. Tunca, E. Deniz, E. S. Ayva, P. Gopinath, S. Thomas, V. Sundaresan N. Haberal, H. Müderrisoglu, B. H. Özdemir 025 014 Deaths following a recent hospital dis- Getting to the cor of CMV pericarditis charge. What is missed? Kalnisha Naidoo, United Kingdom Lukasz Adamczyk, United Kingdom S. George H. Lowes, S. Growcott, B. Kirk, P. J. Gallagher 015 Cardiac sarcoidosis in endomyocardial 026 biopsies Apoptosis in cardiomyocytes in AA- and Ivana Kholová, Finland AL-amyloidosis T. Paavonen Margarita Rybakova, Russia I. Kuznetsova, J. Tikhonova

016 31 Aug Sunday, Ventricular assistance and heart trans- 027 plantation following myocardial infarction Experimental myocardial infarction: Effects due to Takayasu´s arteritis of bone marrow mononuclear cell fraction María Belén Goiburú Chenú, Spain and cell homogenate injection into the myo- L. A. Rojas Scheffer, A. Berjón García, cardium T. González Pessolani, L. Sartor, J. J. Pozo Margarita Rybakova, Russia Kreilinger E. Markusevich, I. Kuznetsova

017 028 Giant cell arteritis presenting with ascend- Comparative study between confocal and ing aortic aneurysm and chronic aortic dis- light microscopy section: A case report Jeremias Schmidt, Germany Golub Samardzija, Serbia E. Potapov, R. Hetzer, J. Kzhyshkowska, S. Nicin, N. Cemerlic Adjic, O. Adjic, K. Wassilew D. Debeljacki, A. Lovrenski, M. Milic 029 021 Mitral valve “Lipomatous Hamartoma”: A The prevalence of cardiac diseases among rare entity but a possible cause of sudden cases of autopsy conducted at Salvador – death... Brazil Rosa Henriques de Gouveia, Portugal Luisa Ciuffo, Brazil A. Francisco, S. Ramos, J. Pinheiro, R. Anjos R. Amorim dos Santos Félix, D. Athanazio, 030 M. Bina, P. Soares, V. Batista da Silva Filho Alternatively activated macrophages are 022 present in stenotic aortic valves Pulmonary artery dissection: A post-mor- Grzegorz Lis, Poland tem study U. Czubek, E. Jasek, J. Nessler, J. Sadowski, Cornelia Amalinei, Romania J. A. Litwin C. Teodorescu, L. Knieling 031 023 Immunoglobulin G4 positive cells in mitral Adult heart and pericardial tumours: 20 valve endocarditis years experience in Coimbra Timo Paavonen, Finland Lina Carvalho, Portugal E. Niinimäki, H. Kajander, I. Kholová, J. Saraiva, A. Gomes, P. Antunes, M. Antunes A. Mennander

89 Poster Presentations a Sunday ECP 2014 · London

032 037 PS-04 Atherosclerosis and pathological findings Morphometric evaluation of carotid with in the myocardium: The association atherosclerosis in autopsied patients between coronary raised lesions and myo- Renato Rios Câmara, Brazil cardial interstitial fibrosis L. Santos Ramalho, L. Ferreira Oliveira, Mauro Tupiniquim Bina, Brazil P. Aparecida Figueira Rezende, L. Allen Ciuffo, V. Batista da Silva Filho, P. Fonseca Ferraz, C. Lourencini Cavellani, P. Arnon Bremer Soares, D. Abensur F. Aparecida Oliveira, V. d. Paula Antunes Athanazio, R. Amorim dos Santos Félix Teixeira, M. L. Lourencini Cavellani, S. Aparecida de Lima Pereira 033 Coronary atherosclerosis in youth: Risk 038 factors and degree of stenosis in autopsied Quantification of fibrosis in heart of autop- aged between 15 and 34 years sied patients with hypertensive heart dis- Sunday, 31 Aug Mauro Tupiniquim Bina, Brazil ease L. Allen Ciuffo, V. Batista da Silva Filho, Renato Rios Câmara, Brazil P. Arnon Bremer Soares, D. Abensur G. R. Juliano, L. Santos Ramalho, L. Ferreira Athanazio, R. Amorim dos Santos Félix Oliveira, F. Aparecida Oliveira, C. Lourencini Cavellani, A. P. Espíndula, V. d. Paula 034 Antunes Teixeira, M. L. da Fonseca Ferraz Thromboembolic death: The contribution of a series... 039 Rosa Henriques de Gouveia, Portugal Alternative view on morphology of occlus- B. Silva, F. Corte Real, D. N. Vieira, sive processes in main arteries in patients J. Pinheiro with peripheral atherosclerosis disease of lower extremities vessels 035 Asel Kudaybergenova, Russia Idiopathic Infantile Arterial Calcification: D. Maystrenko, M. Generalov, D. Granov, A rare cause of sudden unexpected death F. Zherebtsov, A. Ivanov, I. Tileubergenov, in infancy S. Shapoval, A. Maystrenko, A. Oleschuk Faten Hammedi, Tunisia M. Njima, R. Hadhri, L. Njim, I. Haddad, 040 A. Moussa, A. Zakhama Deaths in infants and children with congenital heart disease: Autopsy experience 036 from a specialist center Evaluation of the thickness of the basilar Emma Reid, United Kingdom artery with atherosclerosis in autopsied A. R. Bamber, M. T. Ashworth, J. Pryce, adult encephala N. J. Sebire Renato Rios Câmara, Brazil P. Aparecida Figueira Rezende, D. Cândido de Oliveira, L. Ferreira Oliveira, M. H. Soares, L. Santos Ramalho, C. Lourencini Cavellani, V. d. Paula Antunes Teixeira, M. L. da Fonseca Ferraz

90 ECP 2014 · London Poster Presentations a Monday e Monday, 1 September 2014 009 Ratio of lymph node metastasis in gastric carcinoma

PS-05 Poster Sessions PS-05 Petr Vážan, Czech Republic Digestive Diseases Pathology I: Upper gastrointestinal tract 010 Chairs: Paula Chaves, Portugal Prognostic significance of MUC1, MUC2 Ioanna Delladetsima, Greece and MUC5AC immunohistochemical ex- Marco Novelli, United Kingdom pressions in gastric carcinoma Sorina Taban, Romania 001 D. Lazar, M. Cornianu, C. Lazureanu, Primitive gastric lymphomas: Epidemio- A. Vaduva, O. Vita, A. Dema logical, clinical and pathologic study of 20 011 cases The correlation between immunohisto- Issam Msakni, Tunisia chemical expression of E-cadherin, VEGF E. Bouhajila, B. Laabidi, R. Silini, and clinicopathological factors in patients F. Bougrine, A. Bouziani with gastric cancer 004 Sorina Taban, Romania Small intestinal gastrointestinal stromal D. Lazar, M. Cornianu, A. Dema tumour in a young adult female: A case 012 report and review of literature PTEN and p53 expression in esophageal Suzana Manxhuka-Kerliu, Albania squamous cell carcinomas A. Tolaj, V. Sahatciu-Meka, I. Kerliu, Mi-Jin Gu, Republic of Korea A. Juniku-Shkololli, L. Kerliu, M. Kastrati, W.-J. Sung V. Kotorri, D. Saliu 013 005 Peculiarities of mucosal microcirculation Undifferentiated carcinoma vs. GIST: Mor- in patients with chronic gastric erosions phological patterns useful in the differen- Olena Kuryk, Ukraine tial diagnosis G. Solovyova, A. Svintsitskiy, I. Korendovych Bohuslava Kokoskova, Czech Republic 1 Sept Monday, O. Daum, M. Sedivcova, M. Dubova, 014 M. Michal Types of metaplastic changes and frequency of dysplasia of esophageal mucosa 006 in patients with Barrett’s esophagus Parameters affecting lymph node yield in Olena Kuryk, Ukraine gastro-oesophageal cancer specimens V. Yakovenko, G. Solovyova, I. Korendovych Abed Zaitoun, United Kingdom J. Davis, S. Parsons 015 Segmental absence of intestinal muscula- 007 ture: Presentation in a 10-year-old boy Gastrointestinal tumour arising from gas- with an extensive involved segment tric duplication cyst as a first case report Daniel Athanazio, Brazil of this entity in gastric localization M. Amaral Rocha, A. Mattos, T. C. Medrado Piotr Lewitowicz, Poland Ribeiro, N. C. Boa Sorte, L. A. Rodrigues de J. Matykiewicz, D. Koziel, A. Horecka- Freitas, L. Rodrigues Silva Lewitowicz, A. Wincewicz, S. Gluszek 016 008 Primary small intestine epithelioid angio- Histology-based prediction of lymph node sarcoma: A case report metastases in early gastric cancer Kseniia Shelekhova, Russia Timo Gaiser, Germany C. Lippert, R. Grobholz, G. Kähler, U. Ronellenfitsch, A. Marx

91 Poster Presentations a Monday ECP 2014 · London

017 024 PS-05 Gastrointestinal Stromal Tumours (GISTs): Granular cell tumours of the gastrointesti- One year experience in one center nal tract: Report of a Romanian series of 14 Luminita Mitrache, Romania cases with special emphasis on non- A. V. Dumitru, O. Patrascu, A. Mihai, esophageal and multifocal locations R. Z. Ionescu, O. C. Ciornenchi, M. Costache, Diana Pasov, Romania A. Iliesiu, M. Sajin R. Iacob, M. Dumbrava, M. Gherghiceanu, A. Pop, V. Enache, C. Gheorghe, 018 M. Diculescu, G. Becheanu Rhabdoid gastrointestinal stromal tumour of the duodenum: A case review 025 Milena Cosic Micev, Serbia Clinicopathological characteristics and M. Micev, M. Andrejevic, J. Jotanovic, clinical outcome of endoscopic removal A. Djikic Rom, M. Spuran, V. Dugalic of esophageal squamous papillomas in Korean patients 019 Young-Seok Cho, Republic of Korea Characterization of inflammatory cells in O.-R. Shin, H.-K. Kim, S. S. Kim, H.-S. Chae esophageal biopsies of patients with acha- lasia 026 Manuel Doehla, Germany Triple synchronous tumours in a patient: I. Gockel, L. Lundell, R. J. Rieker, M. Vieth, Gastric adenocarcinoma, omental gastro- L. Veits intestinal stromal tumour and renal angiomyolipoma 020 Sevinc Sahin, Turkey Double whammy in a duodenal biopsy: A S. Seçkin, E. Arslan, K. Çaglayan, K. Zengin, case report Monday, 1 Sept S. Tanik Roopa Paulose, India I. Siyad 027 Expression of yes-associated protein in 021 gastric dysplasia and carcinoma High Fibroblast Activating Protein (FAP) Kyung-Hee Kim, Republic of Korea expression is related to low tumour cell H.-J. Sul density and poor survival in Japanese patients with oesophageal adenocarci- 028 noma A novel prognostic marker in gastric can- Rebecca Watson, United Kingdom cer: Prox1 expression and its clinical L. Hewitt, S. Hasegawa, A. Wright, impact in primary gastric carcinoma T. Aoyama, T. Yoshikawa, H. I. Grabsch Oana Taban, Romania A. M. Cimpean, S. Olariu, M. Raica 022 Endoscopic biopsies from gastrointestinal 029 carcinomas and their suitability for molec- Report of a rare case of papillary carci- ular analysis: A review of the literature noma of the stomach with psammoma Matthew Hale, United Kingdom bodies G. Takuji, J. D. Hayden, H. I. Grabsch Fariba Abbasi, Iran L. Mahmudzadeh 023 Coeliac disease diagnosis: Compliance 030 with NICE guidance Mixed adenoneuroendocrine carcinoma Tracy Sorkin, United Kingdom with amphicrine features: Case report M. Osborn Emel Ebru Pala, Turkey O. Akman Sezer, U. Kucuk, E. Cakir, U. Bayol, E. Usturali Keskin, A. Özgüzer

92 ECP 2014 · London Poster Presentations a Monday

031 040 Her2 expression in gastric cancer: About A case of enteropathy-associated T cell forty cases lymphoma type 1 of the jejunum in a Heifa Kamoun Azouz, Tunisia 62-year-old woman with an extremely PS-05 A. Khadhar, K. Bellil, S. Haouet, N. Kchir recent diagnosis of coeliac disease Francesca Portelli, Italy 032 M. Trombatore, C. Rimi, E. Orlando, Gastric perforation caused by cytomegalo- E. Maresi virus infection in patients receiving chemotherapy 041 Ebru Demiralay, Turkey Solitary splenic metastasis from gastric S. Yildic, B. Koc cancer: Report of a case and review of the literature 033 Antonio Galzerano, Portugal Multiple gastrointestinal stromal tumours A. Ribeiro in an individual: Arguments in favour of synchronous sporadic tumours 042 Andreea Contolenco, Romania Gastric adenocarcinoma and GIST: An A. Calu, A. Pop, A. Muntean, C. Gheorghe, unusual collision tumour I. Popescu, O. Stanciulea, G. Becheanu Corwyn Rowsell, Canada N. Coburn 034 Russel body gastritis: A rare, challenging 043 entity Immunohistochemical detection of trastu- Adela-Corina Nechifor-Boila, Romania zumab binding in gastric cancer: Compari- O. Brusnic, M. Decaussin-Petrucci, S. Mocan son with conventional HER2 immunohistochemistry 035 Tomio Arai, Japan Multiple, synchronous, co-localized gas- M. Kinoshita, H. Shirahata, Y. Hamashima, tric tumours of different histogenesis A. Suzuki, Y. Matsuda, J. Aida, K. Takubo, Arnis Abolins, Latvia H. I. Grabsch I. Strumfa, A. Vanags, J. Gardovskis Monday, 1 Sept Monday, 044 036 The apoptotic pathways in the progression Helicobacter pylori association MUC1, to oesophageal adenocarcinoma: The role MUC5AC ans CK7 expression common- of Survivin ness in Barrett’s eosophagus Ignazio Puccio, United Kingdom Ece Hacer Ozcan, Turkey M. A. Butt, D. Oukrif, S. Khan, R. J. Haidry, T. Anuk, M. Ulasli, A. Arslan, B. I. Edizer, M. Banks, M. Novelli, L. Lovat, N. Koksal, S. Avci, T. Olcan, H. Ustun M. Rodriguez-Justo 037 045 Immunohistochemical (IHC) expression Clinicopathologic characteristics of gas- levels of MUC1, MUC2, MUC5AC, CK7 and trointestinal stromal tumour: A retrospec- P27 in Barrett’s esophagus associated car- tive analysis of 32 cases in Tunisian center cinogenesis Manel Mellouli, Tunisia Ece Hacer Ozcan, Turkey L. Ayadi, R. Kallel, S. Charfi, M. Triki, N. Koksal, A. Arslan, T. Anuk, B. I. Edizer, I. Saguem, I. Bahri, N. Gouiaa, T. Boudawara N. Bayazit, T. Olcan, S. Avci, H. Ustun 046 039 Autoimmune gastritis: OLGA / OLGIM staging Comparative evaluation of neoadjuvant chem- Khadija Bellil, Tunisia oradiotherapy effectiveness in spreaded gas- W. Ajouli, A. Balbouli, M. Néji, A. Dhaoui, tric adenocarcinomas T. Jomni, D. Ben Ghachem Sergei Kuznetsov, Russia A. Lachkova

93 Poster Presentations a Monday ECP 2014 · London

047 055 PS-05 C-met and her2 co-expression in gastric Gastrointestinal stromal tumours: Results cancers of molecular testing in Slovenian patients Anna Maria Chiaravalli, Italy Zvezdana Dolenc Strazar, Slovenia L. Cimetti, O. Rita, B. Barbara, T. Maria D. Glavac Grazia, S. Fausto 056 048 Correlation between Her2 expression and Mesenteric fibromatosis mimicking gas- clinicopathological features of invasive trointestinal stromal tumour recurrence: gastric carcinoma Report of a case Georgeta Camelia Cozaru, Romania Gokcen Gundogdu, Turkey M. Aschie, A. Mitroi, G. I. Baltatescu, G. Yegen, Y. Ozluk, M. Keskin, S. Öztürk Sari, A. A. Nicolau, I. Poinareanu E. Balik, B. Bilgic, M. Gulluoglu 057 050 Gastric cancer: Expression of E-cadherin Prognostic and predictive value of tumour in the primary tumour and sentinel lymph infiltrating immune cells in stage II / III node Japanese gastric cancers Vadim Baykov, Russia Sophie Earle, United Kingdom D. Alexeyev T. Aoyama, A. I. Wright, Y. Miyagi, 058 L. C. Hewitt, T. Yoshikawa, H. H. Thygessen, Adenocarcinoma progression in Barrett A. Tsuburaya, H. I. Grabsch Oesophagus, association with DNA meth- 051 ylation changes Pathologists are able to reliably differen- Alberto Valero Torres, Spain Monday, 1 Sept tiate duplicated lamina propria from sub- C. Hörndler, E. Chueca, J. J. Lozano, mucosa in oesophageal endomucosal M. A. García González, M. Strunk, Á. Lanas, resections B. Roche, N. Gurrea Vidal, N. Torrecilla Philip Kaye, United Kingdom Idoipe, E. Piazuelo M. O‘Donovan, N. Mapstone, M. Novelli, 059 B. Disep, K. Ragunath Expression of MMP3 in gastric carcinomas 052 Leonid Gaganov, Russia Her2 expression in gastric cancer in Alba- L. Gurevich, I. Kazantseva nian population and histopathological cor- 060 relation Synchronous primary carcinomas of differ- Majlinda Ikonomi, Albania ent histogenesis in the digestive tract: S. Kadare Report of three cases 053 Alexandra Oniga, Romania Mesenteric fibromatosis with intestinal S. Zurac, E. Gramada, C. Popp, G. Pop, involvement: A mimicker of GIST F. Staniceanu George Kalodimos, Greece 061 M. Madentzoglou, D. Lytras, I. Malamouli, Gastrointestinal stromal tumours accom- A. Kerasioti, A. Feritsean panying other neoplasms 054 Muge Calik, Turkey Synchronous gastric gastrointestinal stro- B. Doganavsargil, C. Caliskan, O. Firat, mal tumours: Case report M. Sezak, T. Akalin Liana Sticlaru, Romania 062 A. Evsei, C. Popp, S. Zurac, L. Nichita, Leiomyosarcoma of small intestine G. Micu, F. Staniceanu Thanikachalam Pasupati Meenakshi, Malaysia

94 ECP 2014 · London Poster Presentations a Monday

063 069 Epidemiologic study on HER2 (+) early / The initiation of intestinal metaplasia in advanced stage gastric cancer: An evalua- the stomach tion on HER2 positivity in gastric and gas- Marnix Jansen, United Kingdom PS-05 troesophageal junction cancers S. McDonald, T. Graham, S. Meijer, Sibel Erdamar, Turkey S. Sekine, N. Wright N. Kepil, A. Dursun, O. Ekinci, O. Sagol, 070 S. Sarioglu, B. Doganavsargil, M. Sezak, Amphicrine gastric carcinoma in a patient F. Ozdener, K. Ustundag with Lynch Syndrome 064 Filipa Moreno, Portugal Expression of Polo-Like Kinase 1 and J. Garcia, A. Duarte, M. Santos Geminin is up-regulated in the squamous- 071 metaplasia-dysplasia-carcinoma sequence „A strange look... A lucky look“ – Brunner and correlates with aneuploidy Glands Hyperplasia: A bad face of a benign Mohammed Adil Butt, United Kingdom entity R. J. Haidry, D. Oukrif, J. Dunn, S. Khan, Helder Oliveira Coelho, Portugal I. Puccio, E. Bloom, M. Banks, R. Barosa, J. Nogueira, J. Neta, R. Loureiro, M. Rodriguez-Justo, L. Lovat, M. Novelli J. Freitas, M. J. Brito 065 072 Replication protein A in gastric cancer: Double reporting of high grade dysplasia Correlations with conventional prolifera- in Barrett‘s oesophagus at Addenbrooke‘ s tion markers and clinicopathological Hospital, Cambridge parameters Luiza Moore, United Kingdom Hariklia Gakiopoulou, Greece M. O‘Donovan E. Fourtziala, N. Alexakis, D. Linardoutsos, E. Poulaki, P. Korkolopoulou, E. Patsouris 073 Clinical correlations between the immuno- 066 histochemical expression of cyclooxyge- Variability in staining and interpretation nase 2 (COX-2), clinicopathological factors in gastric HER2 Immunohistochemistry 1 Sept Monday, and survival in patients with gastric cancer (IHC): Findings of the UK National Exter- Daniela Lazar, Romania nal Quality Assessment Service (UK S. Taban, A. Dema, M. Cornianu, A. Goldis, NEQAS ICC & ISH) E. Lazar, I. Sporea Suzanne Parry, United Kingdom D. Steele, K. Miller, M. Ibrahim 074 Duodenal bulb biopsies in the diagnostic 067 work-up of Coeliac Disease (CD): A feature Localized amyloidosis and primary gastric of early disease MALT lymphoma with Helicobacter pylori Hilal Ozakinci, Turkey infection: A rare association S. Kus, M. Musayeva, B. Savas, Z. Senturk, Wafa Rekik, Tunisia A. Ensari S. Ben Kahla, A. Zehani, H. Azouz, I. Chelly, K. Riahi, S. Haouet, N. Kchir 075 Expression patterns of human epidermal 068 growth factor receptor proteins in early Submucosal duct extension is universal in gastric cancer flat type oesophageal Squamous Cell Car- Arez Mohamed, United Kingdom cinoma (ESCC) M. Gandy, A. Butt, V. Sehgal, I. Puccio, Marnix Jansen, United Kingdom R. Hamoudi, R. J. Haidry, M. Novelli, D. Scholvinck, R. Kushima, S. Sekine, B. M. Banks, L. Lovat, M. Rodriguez-Justo Weusten, S. Dawsey, D. Fleischer, S. Meijer, I. Oda, J. Bergman

95 Poster Presentations a Monday ECP 2014 · London

076 084 PS-05 Positive Immunostaining for TTF-1 in Pathologists show poor reproducibility Squamous Cell Carcinomas (SCC) of in differentiating low grade (LGD) from Oesophagus High Grade Dysplasia (HGD) in Barrett‘s Caroline Hughes, United Kingdom Oesophagus (BO) E. Fryer, M. Tripathi, E. Collantes, Philip Kaye, United Kingdom L. M. Wang S. Atwal, S. Menon, S. Gill, R. Harrison, C. Richards, M. Ilyas, K. Ragunath 077 p53 interpretation is at least as reproduci- 085 ble as dysplasia diagnosis in Barrett‘s dys- KISS1 and KISS1R expression in corectal plasia amongst GI and general pathologists and gastric cancer Philip Kaye, United Kingdom George Agrogiannis, Greece S. Atwal, C. Richards, S. Gill, S. Menon, I. Kostakis, A. Vaiopoulos, E. Mylona, R. Harrison, K. Ragunath, M. Ilyas G. Kouraklis, M. Koutsilieris, N. Kavantzas, E. Patsouris 078 Gastrointestinal stromal tumours in single 086 institution in Egypt, 2004 – 2013 HER2 status in gastric adenocarcinoma: A Randa Amin, Egypt possible role of stromal reaction Gulcicek Ayranci, Turkey 079 I. Erbarut Seven, C. Ataizi Celikel Experience of Hospital Universitario Virgen del Rocio of Seville, Spain, in 087 determination of HER2 status in patients Histopathological findings in duodenal with advanced gastric or gastroesopha- biopsies of patients with Common Varia- Monday, 1 Sept geal carcinoma ble Immunodeficiency (CVID) Katherine Maria Gallardo Rodriguez, Spain Basak Doganavsargil, Turkey F. Garcia Machado, D. Castillo Palomino, B. Pehlivanoglu, M. Sezak, O. Ardeniz M. Japon Rodriguez 088 080 Clinicopathologic characteristics of gas- Immunohistochemical expression and sub- tric carcinomas with signet ring cell cellular localization of Toll-like Receptors 2 component: Cerrahpasa Medical Faculty (TLR2) in helicobacter pylori gastritis experience Eiman Adel Hasby, Egypt Sibel Erdamar, Turkey F. Harras, S. Bessa, M. Hanafy Mahmoud B. Mergen, B. Tulu, C. Oba, E. Ozmen

081 089 Evaluation of Her-2 neu status in gastric Experimental ground for tissue sealing adenocarcinoma: A retrospective study of method of the front abdominal wall wound 44 cases Ganna Mylovydova, Ukraine Faten Hammedi, Tunisia V. Boyko, A. Lelytsia N. Ben Abdeljelil, R. Hadhri, S. Souki, 090 L. Njim, A. Moussa, A. Zakhama Morphological features of experimental 082 animals stomach mucous coat under the Rare but intriguing lesions of gastrointes- conditions of permanent lighting and cor- tinal tract: Parasitic infestations rective effect of melatonin injections Burcin Pehlivanoglu, Turkey Ganna Mylovydova, Ukraine B. Doganavsargil, M. Sezak, M. Korkmaz G. Gubina-Vakulik, N. Kolousova, A. Lelytsia, S. Sushkov 083 Effects of proton pump inhibitors on gastric corpus mucosa Kamuran Acar, Turkey B. Doganavsargil, M. Sezak, S. Bor

96 ECP 2014 · London Poster Presentations a Monday

PS-06 Poster Sessions 010 Biphasic alveolo-squamoid renal carci- Uropathology noma (BASRC): Light and immunohisto-

Chairs: Dilek Baydar, Turkey PS-06 chemical study of 3 cases Svitlana Bachurska-Yovcheva, Alexandra Corominas Cishek, Spain Bulgaria M. González, V. Caamaño, E. Andueza, Dan Berney, United Kingdom N. Cerda, J. I. López

003 011 Impact of treatment on the kinetics of the Primary genitourinary lymphomas prostatic specific antigen in patients with Wen-Chih Huang, Taiwan lesions of chronic prostatitis on the first C.-C. Tsai prostate biopsy: Prospective randomized 012 controlled study Comparative morphometric study of the Fethi Bougrine, Tunisia testicles of fetus in antenatal period J. Ghorbel, R. Khiari, I. Msakni, B. Laabidi, Dmitry Kozlov, Russia N. Ben Rais, A. Bouziani K. Bunkov 004 013 Use of 20 core pattern technique for initial Grading of non-invasive papillary urothe- prostate biopsy: Impact on prostatic can- lial tumours: Evaluation of the Royal Col- cer detection lege of Pathologists minimum dataset Fethi Bougrine, Tunisia guidelines I. Msakni, B. Laabidi, N. Ben Rais, A. Ian Roberts, United Kingdom Bouziani I. Prematilleke, C. Griffiths, H. Cui 005 014 Tubulocystic carcinoma of kidney: A dis- Parameters predicting intratumor hetero- tinct entity with a challenging diagnosis geneity in clear cell renal cell carcinoma Gaiane Iakovleva, Canada Alexandra Corominas Cishek, Spain G. Yousef, M. Ordon R. Guarch, A. Erramuzpe, L. Zaldumbide, Monday, 1 Sept Monday, 006 N. Cerda, E. Andueza, V. Caamaño, Benign prostate hyperplasia and prostate M. González, J. M. Cortés, J. I. López carcinogenesis after the Chernobyl acci- 015 dent in Ukraine Morphological and immunohistochemical Alina Romanenko, Ukraine study of clear cell papillary renal cell carci- S. Vozianov, V. Grygorenko, A. Chekalova, noma: Study of seven cases A. Yurakh, P. Harkonen Naoto Kuroda, Japan 007 016 Malakoplakia of transplanted kidney: 14-year experience with intraoperative Mimicker of neoplasia frozen section examination of testicular Gaiane Iakovleva, Canada lesions in a tertiary university center S. Jothy, V. Iakovlev Patricia Caseiro Silverio, Switzerland 008 F. Schoofs, C. Iselin, J.-C. Tille Diagnosis of prostate ductal adenocarci- 017 noma in needle biopsy Utility of ERG-antibody in diagnosis of Tatyana Fedorina, Russia high-grade prostate adenocarcinoma in S. Poletaeva the needle biopsies Svitlana Bachurska-Yovcheva, Bulgaria D. Staykov, I. Bakardzhiev, G. Ivanov, V. Belovezhdov

97 Poster Presentations a Monday ECP 2014 · London

018 025 PS-06 Multifocal testicular capillary haemangi- Histological classification of urothelial oma: A case report lesions chemically-induced in the male rat Shikha Singhal, United Kingdom model M. D. Thyveetil Ana Isabel Faustino-Rocha, Portugal C. Pinto, H. Vala, R. Ferreira, P. A. Oliveira 019 Pigmented microcystic chromphobe renal 026 cell carcinoma: A pathological study of 4 Implementation of humane endpoints on cases bladder cancer research Atilio Andres Cabrera Cantoni, Argentina Mónica Catarina Castro Oliveira, Portugal M. J. Labanca, N. Cerda, E. Andueza, M. A. I. Faustino-Rocha, H. Vala, P. A. Oliveira González, V. Caamaño, A. Corominas Cishek, 027 J. I. López Urothelial carcinoma with myxoid stroma: 020 A pathological study of 3 cases Papillary renal cell carcinoma within a Atilio Andres Cabrera Cantoni, Argentina renal oncocytoma: A case report of a rare M. J. Labanca, N. Cerda, E. Andueza, combined tumour of the kidney V. Caamaño, M. Gonzales, A. Corominas Billur Cosan Sarbay, Turkey Cishek, J. I. López G. Kir, C. S. Topal 030 021 Optimisation of prostate core biopsy pro- Kidney tumours: A clinicopathologic study cessing: How much impact does it have on of 54 cases histopathological analysis? Ghania Benkhedda, Algeria Ahmed Ali, United Kingdom Monday, 1 Sept H. Rahmani, Y. Lamouti I. Ghebrenegus, A. Coumbe, M. Mohamed

022 031 Aggressive and non-aggressive transloca- The relation between heterogeneity of ERG tion t(6;11) renal cell carcinoma: Compara- protein expression and TMPRSS2-ERG gene tive study of 6 cases fusion pattern in prostate cancer Kvetoslava Peckova, Czech Republic Ja-Hee Suh, Republic of Korea P. Martinek, S. Vranic, B. Kokoskova, K.-C. Moon M. Hora, M. Michal, O. Hes 032 023 Frequency of morphologic criteria for the Renal cell carcinoma with leiomyomatous diagnosis of prostate adenocarcinoma in stroma-further immunohistochemical and 305 consecutive needle biopsies with an molecular genetic characteristics of unu- emphasis on the location and number of sual entity nucleoli Kvetoslava Peckova, Czech Republic Daniel Athanazio, Brazil P. Grossmann, S. Bulimbasic, M. Sperga, A. Oliveira Cruz, A. L. Santos Santana, M. Hora, M. Michal, O. Hes A. Carvalho dos Santos

024 033 Urinary tract Perivascular Epithelioid Cell Solitary fibrous tumour of prostate: Report tumour (PEComa): Clinical, histological, of a rare entity and immunohistochemical study of Rheb / Betül Ünal, Turkey mTOR / p70s6k cascade in 9 cases C. I. Bassorgun, O. Ipekci, F. Celik, Niurka Cerda, Spain M. A. Ciftcioglu M. Planelles, L. Macías, S. Bulimbasic, G. Peiró, A. Robles, V. Caamaño, M. González, M. Michal, O. Hes, J. I. López

98 ECP 2014 · London Poster Presentations a Monday

034 041 Micro RNA 100, 145 and 373 in prostate Alpha-Fetoprotein expression on mela- cancer: From gene regulation to apoptosis noma involving the testis: A case report Alexandre Iscaife, Brazil Margarida Ferreira, Portugal PS-06 D. R. Morais, S. T. Reis, N. I. Viana, B. Katz, M. Cruz, S. Carvalho, A. I. Silva, M. Teixeira, C. Moura, N. Dip, M. Srougi, K. R. Moreira F. Pardal Leite 042 035 Plaque-like adrenal-renal fusion Nuclear parameters and ERG status in the Umit Bayol, Turkey carcinoma of the prostate M. Uncel, T. Karadeniz, Z. Yildirim, F. Zorly, Krzysztof Okon, Poland A. Özgüzer G. Dyduch, M. Bialas, K. Kaczmarczyk, 043 K. Ciesielska, T. Szopinski, P. Chlosta Unilateral sencrone three primary tumours 036 of the kidney: Case report The expression of the transcriptional fac- Umit Bayol, Turkey tor COUP-TFII correlates with increased M. Uncel, U. Kucuk, C. Yildiz Akdeniz, lymphangiogenesis and lymph node F. Zorlu, S. Isoglu, Z. Yildirim metastasis in prostate adenocarcinoma 044 Ioannis Lilis, Greece Zinner Syndrome patient with squamous H. Papadaki, V. Bravou, K. Gyftopoulos cell carcinoma arising from squamous 037 metaplasia of the seminal vesicle: A case Altered expression of markers of epithe- report lial-to-mesenchymal transition at the lead- Young-Hoon Kim, Republic of Korea ing edge of locally invasive prostate K.-C. Moon cancers 045 Clare Verrill, United Kingdom Metastatic malignant melanoma of the uri- C. McKee, L. Cerundolo, F. Hamdy, R. Bryant nary bladder: Case report 038 Cumhur Selçuk Topal, Turkey Monday, 1 Sept Monday, A unique case of primary Neuroendocrine G. Kir, B. C. Sarbay, M. I. Tosun Tumour (NET) of the urinary bladder with 046 the presence of in situ neuroendocrine Peritumoral retraction clefting and the component expression of collagen IV in Ta and T1 pap- Georgia Mitropoulou, Greece illary urothelial carcinoma of the urinary D. Papagiannopoulou, I. Kasselaki, D. Petsis, bladder G.-P. Vecchini, I. Iakovidou Tihana Dzombeta, Croatia 039 B. Kruslin Cyclooxygenase-2 expression in prostate 047 carcinoma Non-neuroendocrine synaptophysin ex- Alis Dema, Romania pression in prostatic adenocarcinoma is S. Taban, A. Borda, M. Cornianu, associated with high grade tumours A. Muresan, D. Herman, D. Anderco, Nuria Juanpere, Spain A. Loghin, R. Cornea, C. Lezureanu J. A. Merino, M. Lorenzo, L. Agell, 040 J. A. Lorente, S. Hernández, R. Albero, Prostate lymphangiolipomatosis: A real I. Vázquez, L. Fumadó, S. Serrano, J. Lloreta entity or an illusion? 049 Alis Dema, Romania The prognostic significance of differentia- R. Minciu, A. Borda, D. Anderco, A. Loghin, tion and necrosis in invasive urothelial S. Taban carcinomas Ulku Kucuk, Turkey E. E. Pala, E. Cakir, O. Sezer, U. Bayol, R. T. Divrik, O. Cakmak 99 Poster Presentations a Monday ECP 2014 · London

052 057 PS-06 Urinary bladder metastases from carci- PTEN loss and ERG expression in 58 noma of the breast patients with prostate cancer: Immuno- Maria López Macías, Spain histochemical evaluation and correlation A. Rubio Fernandez, W. Toro Zambrano, with Gleason score, serum PSA levels, J. J. Fernández de Mera, A. Hernández tumour stage and surgical margins Amate, A. M. Campos de Orellana, Akrivi Kostopoulou, Greece I. Catalina Fernández, M. Díaz Delgado, C. Karabogias, N. Chaleplidis, E. Kyrodimou, J. Sáenz de Santamaría, A. Rubio Fernandez, A. Roumelioti, T. Choreftaki, E. Papaliodi M. López Macías 058 053 Plasmacytoid variant of urothelial carci- Somatostatin receptor expression includ- noma of the urinary bladder: Report of two ing type 2A in small cell carcinoma of the cases and literature review bladder: A multicenter study of Urooncol- Nikolaos Chaleplidis, Greece ogy Society, Turkey A. Dimitriadi, S. Pappa, E. Tsiliaka, Nalan Nese, Turkey A. Kostopoulou, T. Choreftaki B. Sarsik Kumbaraci, D. Ertoy Baydar, I. 059 Kilicaslan, A. Akder Sari, S. Sen, I. Isik Gonul, Expression of CD44 in urothelial cell carci- D. Kankaya, Members of Urooncology noma of the urinary bladder: Correlation Society, Turkey, K. Yorukoglu with prognostic factors and recurrence 054 Khadija Bellil, Tunisia Mixed epithelial-stromal kidney tumours: W. Ajouli, A. Saidani, M. Néji, A. Dhaoui, Report of a case and revision of fourteen M. Ben Ali, H. Khouni, D. Ben Ghachem

Monday, 1 Sept years from archives of the Hospital Clinic 060 of Barcelona Fibromyxoid nephrogenic adenoma aris- Laura Herrero, Spain ing in a renal cortical cyst C. Montironi, I. Aldecoa, J. de la Oliva, Radia Khedaoui, Spain C. Nicolau, M. Musquera, C. Mallofré B. Encabo, J. C. Tardío 055 061 CD117 (c-kit) expression in Leydig Cell Renal cell carcinomas associated with Tumours of the testis Xp11.2 translocations: Regarding two iso- Marco Ferreira, Portugal lated cases E. Gavin, C. Matos, A. Alves, G. Gasparinho Connie Ferrara, Spain 056 E. Sola, A. García, K. Ahmed, M. Martín, Immunohistochemical expression of C. López, I. Peligros c-Myc a member of mTOR pathway in 54 062 patients with urothelial carcinoma of HER2 and TOP2A gene amplification and urinary bladder: Correlation with histo- protein expression in upper urinary tract logic grade, pathologic stage and lymph urothelial carcinoma node metastasis Klaus Aumayr, Austria Akrivi Kostopoulou, Greece S. Shariat, T. Klatte, G. Locker, S. Sevcenco, T. Zogka, E. Minaidou, E. Tsiliaka, B. Neudert, P. Birner, M. Susani, A. Haitel E. Kyrodimou, A. Roumelioti, T. Choreftaki, E. Papaliodi 063 Inflammatory myofibroblastic tumour of the bladder: A case report Umit Bayol, Turkey E. Usturali Keskin, O. Sezer, F. Zorlu, M. Yoldas, S. Isoglu

100 ECP 2014 · London Poster Presentations a Monday

064 071 Fibroblast Growth Factor Receptor (FGFR) Expression of Ki-67 in non invasive blad- amplifications in bladder cancer: A rare der cancer: Correlation with prognostic event factors and recurrence PS-06 Nadine Gaisa, Germany Khadija Bellil, Tunisia A. Fischbach, A. Rogler, R. Erber, R. Stoehr, M. Néji, W. Ajouli, A. Dhaoui, R. Boulma, R. Poulsom, B.-S. Schneevoigt, S. Hauke, H. Khouni, D. Ben Ghachem A. Hartmann, J. Veeck, R. Knuechel 072 065 SLC45A3-ERG rearrangement is a marker Primary Squamous Cell Carcinoma (SCC) of progression within the group of of the male urethral diverticulum mimick- TMPRSS2-ERG rearranged tumours of the ing prostate cancer: Case report and prostate review of the literature Silvia Hernández, Spain Zubeyde Yildirim, Turkey A. Font, N. Juanpere, S. De Muda, L. Agell, R. G. Ekin, F. Zorlu, U. Bayol M. Lorenzo, S. Serrano, J. Lloreta

066 073 Additional anterior apical cores to the ini- Five gene signature in urine after prostatic tial 12-core prostate biopsy: Does it massage for prostate cancer screening increase detection probability of prostatic Pedro Luis Fernandez, Spain cancer? D. Abia, L. Izquierdo, L. Mengual, A. Alcaraz, Rahmi Gokhan Ekin, Turkey T. Thomson, R. Bermudo Z. Yildirim, F. Zorlu, U. Bayol 074 067 Translocation renal-cell carcinoma t(6;11) Nephrogenic adenoma and urothelial car- (p21;q12) in an adult patient cinoma of the urinary bladder: A case Pio Zeppa, Italy report A. D´Antonio, D. Memoli, A. Caleo Helen Trichia, Greece 075 M. Puglisi, G. Galanopoulos, Assessment of intravascular granulomas D. Papagiannopoulou, D. Petsis, 1 Sept Monday, and histiocytic aggregates in testicular G.-P. Vecchini seminomas 068 Michelle Downes, Canada Renal cell carcinoma types in Hungary C. Cheung, P. Chung, T. van der Kwast diagnosed according to the ISUP Vancou- 076 ver classification criteria: A single-institu- Determination of the association beween tion study on 612 consecutive cases MRI and Gleason patterns: A proof of prin- Levente Kuthi, Hungary ciple study A. Jenei, L. Pajor, B. Iványi Michelle Downes, Canada 069 E. Gibson, J. Sykes, A. Ward, T. van der Kwast Sarcomatoid urothelial carcinoma with 077 heterologous elements: Presentation of Audit of central histology reporting of three cases penile neoplasia Nikolaos Chaleplidis, Greece Joshua Bilbie, United Kingdom V. Leodara, C. Karabogias, A. Dimitriadi, J. Dormer G. Koutsonikas, G. Gkialas, T. Choreftaki 078 070 Morphofunctional features of erythrocytes Adrenal myelolipoma: A case report in oncourological patients Khadija Bellil, Tunisia Tatyana Pavlova, Russia W. Ajouli, M. Néji, A. Dhaoui, M. Ben Ali, M. Chaplygina, V. Markovskaya, I. Pavlov, K. Sassi, D. Ben Ghachem D. Bessmertniy

101 Poster Presentations a Monday ECP 2014 · London

079 087 PS-06 Metachronous ipsilateral testicular metas- A rare variant of nephroblastoma: Two tasis of a clear cell renal cell carcinoma: A examples of Botryoid type case report Yasemin Ozluk, Turkey Vasileia Leodara, Greece S. Dogan, P. Maulid, I. Kilicaslan C. Karabogias, G. Liadakis, T. Zogka, 088 K. Ntoumas, E. Papaliodi Moesin expression in normal foreskin epi- 080 thelium and in squamous cell penile carci- Analysis of E-cadherin, Beta-catenin and noma Snail protein expressions for determining Juliana Bartholo de Andrade, Brazil epithelial-mesenchymal transition in pros- F. A. Soares tatic adenocarcinomas 089 Tumay Ipekci, Turkey Pleomorphic giant cell carcinoma of the B. Ünal, F. Ozden, O. Ipekci, C. Sezer urinary bladder: A case report 081 Hampar Akkaya, Turkey Primary malignant melanoma of renal pel- M. B. Hoscan, H. Özdemir vis with extensive clear cell change 090 Eleftheria Lakiotaki, Greece Metastases from primary renal cell carci- H. Sarlanis, G. Baltatzis, E. Poulaki, G. Liapis noma with Xp 11.2 translocation and TFE3 082 gene fusions mimicking a primary ovarian Renal tumours in adults with congenital clear cell carcinoma: Case report renal anomalies: Documentation of five Andrada Loghin, Romania cases M. Decaussin-Petrucci, S. Stolnicu, T. Moso, Monday, 1 Sept Rahmi Gokhan Ekin, Turkey M. Turcu, S. Gazzo, F. F. Nogales, A. Borda Z. Yildirim, U. Bayol, F. Zorlu 091 083 Unusual metastases from colorectal ade- Glomus tumour: A rare mesenchymal tu- nocarcinoma: A case report mour of the kidney Dimitrios Minotakis, Greece Angela Borda, Romania E. Goupou, G. Moustakas, G. Panselinas, A. Dema, A. Loghin, C. Chibelean, S. Giatzos, A. Nikolaidou A. C. Nechifor-Boila, A. S. Comsa, N. Berger 092 084 Integrin beta6: A potential marker for the Bilateral renal angiomyolipoma not associ- early malignant transformation in prostate ated with tuberous sclerosis: A case report cancer Adelina Birceanu-Corobea, Romania Wanzhong Wang, Sweden M. Hortopan, M. Comanescu, R. Chirculescu, L. Gao, E. Wang I. Sinescu, G. Birceanu-Corobea, V. Herlea 093 085 Small Cell Carcinoma (SCC) of urinary Micropapillary variant of urothelial carci- bladder: Review of four cases noma: A report of 2 cases and literature Ulku Kucuk, Turkey review E. Cakir, E. E. Pala, G. Akoz, U. Bayol, Liana Sticlaru, Romania O. Cakmak, A. Özgüzer S. Zurac, M. D. Cioplea, C. Socoliuc, L. 094 Nichita, V. Cauni, F. Staniceanu Immunohistochemical sub-classification of 086 diffuse large B cell lymphoma: A retrospec- Postradiation angiosarcoma of urinary tive seventeen year pathology case review bladder: A case report Sherley Diaz Mercedes, Spain Nilsen Erdogan, Turkey J. Camacho, J. Temprana, J. Castelvi, A. Akyildiz Igdem, S. Bektas, E. Sahan, S. Landolfi, S. Ramon y Cajal, I. De Torres N. Erdogan, F. Yilmaz, M. B. Can Balci, U. Karinoglu 102 ECP 2014 · London Poster Presentations a Monday

095 103 Diagnostic and prognostic multiplex Anti-EGFR therapy in renal cell cancer: A Immunohistochemistry (IHC) on transrec- case series of 7 cases tal and transperineal core biopsy of pros- Khadija Benhayoune, Morocco PS-06 tate H. El-Fatemi, H. Ameuretesse, A. Amarti Sarah Wedden, United Kingdom 104 K. Miller, N. Afzal, T. Thomas, J. Mikel, Cytokeratin 23 is a potentially useful M. Aseem, J. Halsall, P. Harris, S. Hansford, marker of invasion in prostatic adenocar- M. Kirchmair, C. D´Arrigo cinoma 096 Claudia Wiewiora, Poland Ipsilateral synchronous urothelial carci- P. Czapiewski, A. Gorczynski, W. Biernat noma involving both renal pelvis and ure- 105 ter: Analysis of 51 cases from single Scoring PD-1 in patients affected by cas- institute with special emphasize on prog- tration-resistant prostate adenocarcinoma nostic factors Anna Caliò, Italy Yi-Ying Lee, Taiwan A. Eccher, C. Ghimenton, S. Knuutila, W.-J. Wu, C.-N. Huang, C.-C. Li, C.-F. Li M. Chilosi, A. Scarpa, G. Martignoni, 097 M. Brunelli Expression of the chloride channel regula- 106 tory subunit Barttin in renal tumours Urachal adenocarcinoma: A rare case report Federica Pedica, Italy and review of the literature P. M. Luigi Chetta, M. G. Cangi, F. Invernizzi, Saime Sezgin Ramadan, Turkey G. Magliacane, R. Lucianò, M. Freschi, C. H. Baloglu, Y. Yildirim, C. Uygur Doglioni 107 098 Exacerbated granulomatous reaction in Case report: Amyloidosis of the renal pel- seminoma: Role of special stains vis. A harbinger of mammary carcinoma? Sergiu Sebastian Gheorghita, Romania Tom Grigor, United Kingdom L. Nichita, A. Bastian, S. Zurac, A. Dragusin, T. Grigor, J. Mathew, L. Waldron 1 Sept Monday, M. Busca, V. Cauni, F. Staniceanu 099 108 Renal malakoplakia extending to transvers Simultaneous occurrence of well-differen- colon: A case report tiated papillary mesothelioma of the peri- Gizem Narli, Turkey toneum and prostate adenocarcinoma: A I. Yilmaz, Ö. Yilmaz, T. Senkul, Z. case report Kucukodaci, U. Berber, D. Demirel Maria Emmanouela Kopaka, Greece 100 M. Lekarakou, V. Stoukas, V. Poulakis, Biphasic malignant mesothelioma of tes- C. Petraki tis: A case report 109 Evanthia Diakatou, Greece Expression of molecular biomarkers at A. Kostopoulou, V. Theodoropoulos, G. various stages of prostate cancer growth Haramis, T. Choreftaki and tumour progression 102 Yuriy Rogov, Belarus Malignant transformation of the prostatic T. Liatkouskaya, E. Cherstvoy, V. Zakharava, adenostromal hyperplasia with stromal I. Masansky, L. Sagalchik, M. Ivanovskaya cell atypia 110 Yuriy Rogov, Belarus A new orthotopic localy advanced animal T. Liatkouskaya, N. Kornev, E. Parhovchenko, model of prostatic cancer O. Solodkaya Edgar Tavares-Silva, Portugal A. M. Abrantes, C. Oliveira, A. C. Mamede, S. Guerra, P. Simões, A. Mota, L. Prado e Castro, M. F. Botelho 103 Poster Presentations a Monday ECP 2014 · London

111

PS-06 PS-07 Poster Sessions Dextran accumulation in the bladder: A Dermatopathology previously unreported phenomenon Chairs: Thomas Brenn, United Kingdom Ozgur Ozkayar, Turkey Pedram Gerami, USA K. Kosemehmetoglu, A. Akdogan, D. Ertoy

PS-07 Nigel Kirkham, United Kingdom Baydar

112 002 A case of tubulovillous adenoma of the uri- Expressions of p63 or / and its isoform, nary bladder associated with high grade p40, are not correlated with the prognosis urothelial carcinoma: An immunohisto- of Japanese and British patients with Mer- chemical characterization kel cell carcinoma Ahmed Ismail, Egypt Michiko Matsushita, Japan M. Ahmed S. Kuwamoto, D. Nonaka, T. Iwasaki, K. Nagata, I. Murakami, M. Kato, 113 Y. Kitamura, K. Hayashi Role of Prostaglandin E2 in EGFR-Medi- ated DU145 prostate cancer growth and 003 epithelial mesenchymal transition Comparative analysis of B cell-related Raffaella Santi, Italy marker and immunoglobulin expressions S. Donnini, F. Finetti, E. Terzuoli, M. Ziche, between MCPyV-positive and MCPyV- G. Nesi negative Merkel cell carcinomas Kazuhiko Hayashi, Japan 114 D. Nonaka, M. Matsushita, K. Takata, Plasmacytoid urothelial bladder carci- T. Iwasaki, S. Kuwamoto, M. Kato, noma: A case report and literature review Monday, 1 Sept K. Nagata, Y. Kitamura, T. Yoshino, Javier Martin Lopez, Spain I. Murakami C. Corbacho Cuevas, C. Salas, L. Martín Fragueiro, M. Sánchez Yuste 004 Merkel cell carcinoma recurrent: A case 115 report Histologic changes associated to Acquired Leila Beddar, Algeria Renal Cystic Disease: Revision of ten years F. Benhadad, F. Hamaizia, Y. Boulekzaz, cases from Hospital Clinic of Barcelona Z. Tebbi, K. Merghem Carme Mallofré, Spain L. Herrero, J. De la Oliva, M. Musquera, 005 I. Aldecoa Effects of intense pulsed light on skin carcinogenesis 119 Ana Isabel Faustino-Rocha, Portugal Kaposi sarcoma of the kidney: Report of a A. Gama, D. Rodrigues, B. Colaço, H. Vala, case M. J. Pires, P. A. Oliveira Vassilis Samaras, Greece F. Daglis, C. Poullou, K. Dimitriou, 006 P. Brotzakis, K. Diamantopoulou A case report of isolated reactive angioen- dotheliomatosis Marc Rassy, Lebanon G. Abadjian

007 Primary extramammary Paget‘s Disease: Report of two cases Anastasia Konstantinova, Russia K. Shelekhova

104 ECP 2014 · London Poster Presentations a Monday

008 016 Is Spitz nevus still a challenge for patholo- Langerhans CD208+ cells in malignant gists? melanoma Joanna Lakomy, Poland Grzegorz Dyduch, Poland PS-07 A. Zawrocki, B. Wasag, A. Matyskiel, J. Szpor, M. Bialas, S. Demczuk, K. Okon J. Limon, W. Biernat 017 009 Immunohistochemical detection of Intravascular large B-cell lymphoma in a BRAFV600E mutation in patients with 65-year-old woman: Case report diagnosed metastatic melanoma and correlation through skin biopsy with molecular methods Tatyana Pirdopska, Bulgaria Akrivi Kostopoulou, Greece I. Terziev, P. Troianova, B. Vladimirov A. Dimitriadi, S. Pappa, E. Kyrodimou, D. Theodosiou, H. Gogas, D. Tsoutsos, 010 T. Choreftaki, E. Papaliodi Direct immunofluorescence in dermatopathology: Audit of local guidelines in a ter- 018 tiary centre Lymph node and tumoural melanosis: Duaa Saeed, United Kingdom Report of two cases and literature review K. Amarasinghe, L. Ffolkes George Koutsonikas, Greece E. Souka, A. Dimitriadi, A. Kostopoulou, 011 T. Choreftaki, K. Frangia, E. Papapliodi Nevus sebaceus with basal cell carcinoma, poroma and verruca vulgaris: The 3rd NS 019 case containing poroma in the literature Primary cutaneous sweat gland tumours: 7 Ali Fuat Cicek, Turkey cases of rare adnexal skin tumours A. Aykan, M. Demiriz, S. Ozturk, A. K. Yapici Alexandra Corominas Cishek, Spain N. Cerda Hernandez, M. Gonzalez Vadillo, 012 V. Caamaño Villaverde, E. Andueza Otsoa, Lymphomatoid papulosis: A rare lym- O. Guergue, J. L. Díaz Ramón, V. Velazco phoproliferative disease with new variant Benito, M. J. Labanca simulating aggressive lymphomas Monday, 1 Sept Monday, Alia Zehani-Kassar, Tunisia 020 A. Khadhar, I. Chelly, H. Azouz, I. Zaraa, Cutaneous metastasis of chordoma S. Haouet, N. Kchir María Cámara, Spain M. Alonso, M. C. Garrido, J. L. Rodriguez 013 Peralto Buschke-Loewenstein disease in a 27 year old male 021 Oana Maria Patrascu, Romania Lupus miliaris disseminatus faciei: Case M. Sajin, A. Dumitru, O. C. Ciornenchi, A. report Calu, O. Simionescu, M. Costache Anna Wasaznik-Jedras, Poland M. Kolos, A. Nasierowska-Guttmejer, 014 M. Slowinska Granuloma faciale: A diagnostic challenge requiring correlation of the clinical and 022 histological data Diffuse dermal angiomatosis of the breast, Agota Ilyes, Romania a rare but distinct pathological entity D. Dorobantu, S. Mocan, D. Milutin Najla Ben-Ghashir, United Kingdom A. Bakshi, R. Azurdia, E. Pang, T. Brenn 015 Spindle cell lipoma, a rare variant of lipo- 023 mas: Case report B-cell cutaneous lymphoid hyperplasia Mariana Costache, Romania (B-cell pseudolymphoma) related to vacci- M. Sajin, O. Patrascu nation: Study of five cases Gloria Pérez-Esteve, Spain F. Climent, M. Varela, R. Bosch, C. Muniesa, E. Condom, O. Servitje 105 Poster Presentations a Monday ECP 2014 · London

024 032 PS-07 Immunreactivity for CTLA-4 in anterior Plasmacytoid dendritic cells in primary pituitary gland cells and neutrophils sug- cutaneous melanoma gest antibody dependent cytotoxicity to William Vermi, Italy trigger Ipilimumab induced hypophysitis R. Vescovi, M. Simbolo, L. Benerini, Daniel Bjasch, Switzerland L. Melocchi, M. Chiudinelli, M. Fassan, E. Marquez Maggio, A. Fitsche, H. Moch, C. Farisoglio, A. Scarpa, A. Manganoni, S. M. Goldinger, R. Dummer, D. Mihic-Probst F. Facchetti

025 034 A review of patients with primary cutane- Buschke-Ollendorf Syndrome: Report of a ous diffuse large B-cell lymphoma, leg family type in a tertiary oncology unit Anastasios Papanastasiou, Greece Nina Farquharson, United Kingdom Z. Stamou, M. Nifora, N. Maltezos, P. Shenjere, L. Menasce, P. Shenjere M. Repanti

026 035 Differential expression of E-cadherin in T-lymphocytes and their subpopulations in melanocytic lesions In Situ Squamous Cell Carcinoma (SCC) of Sidhika Dandona, United Kingdom the skin and actinic keratosis N. Ali, N. Francis, R. Ramakrishnan Helen Kourea, Greece A. Stravodimou, V. Tzelepi, H. Papadaki, 027 C. Scopa Immunohistochemical analysis of FOXP3+ T regulatory lymphocytes in cutaneous 036 melanocytic lesions Basal cell carcinoma with matrical differ- Monday, 1 Sept Vladimir Zidlik, Czech Republic entiation: A case report S. Brychtova, J. Nieslanik, D. Ziak, Anamaria Pop, Romania J. Dvorackova, M. Uvirova, M. Dvoracek I. Margaritescu, F. Vasilescu, D. Chirita

028 037 Thyroid Transcription Factor-1 (TTF1) Multiple glomus tumours: A case report immunoreactivity in a case of Merkel Cell Veronica Caamaño Villaverde, Spain Carcinoma (MCC) V. Velasco, N. Cerda, M. González, Alexander Iliadis, Greece A. Corominas, E. Andueza, A. Perez I. Kostopoulos, T. Koletsa, K. Chatzopoulos, 038 V. Tzioufa Langerhans cell histiocytosis: About 11 029 cases Non-tumoural skin diseaseas following Alia Zehani-Kassar, Tunisia kidney transplantation L. Bel Hadj Kacem, I. Chelly, H. Azouz, Merih Tepeoglu, Turkey S. Haouet, N. Kchir B. H. Özdemir, F. Z. Taslica, M. Haberal 039 030 Neuroendocrine differentiation in basal Malignant eccrine carcinoma suggestive cell carcinoma: An immunohistochemical for hidradenocarcinoma in a child: A case study of 33 cases report Alia Zehani-Kassar, Tunisia Andrei Razvan, Romania L. Bel Hadj Kacem, I. Chelly, H. Azouz, C. Socoliuc I. Zaraa, S. Haouet, N. Kchir

031 Tenascin-C splice variant expression in cutaneous Squamous Cell Carcinomas (SCC) and pre-cursor lesions Victoria Rathbone, United Kingdom D. Moore, L. Potter, A. Fletcher, J. H. Pringle

106 ECP 2014 · London Poster Presentations a Monday

040 048 Proliferative nodules in a giant congenital Apocrine gland cyst with dermatofibroma- melanocytic nevus: A rare case in an like stroma eldery patient Renata Dias, Portugal PS-08 Emilia Minaidou, Greece F. Moreno, A. Duarte E. Kyrodimou, A. Kostopoulou, A. Kritharis, 051 K. Frangia, E. Papaliodi

The influence of aids in aging skin PS-07 041 Renato Rios Câmara, Brazil Cutaneous T cell pseudolymphoma associ- G. K. N.A. Ribeiro, A. C. S. da Silva, L. Santos ated with molluscum contagiosum Ramalho, L. Ferreira Oliveira, M. L. da Anastasia Dimitriadi, Greece Fonseca Ferraz, V. d. Paula Antunes Teixeira, E. Minaidou, N. Chaleplidis, G. Kakiopoulos, C. Lourencini Cavellani T. Choreftaki, E. Papaliodi 052 042 EMA positivity in Non-Schwannian Granu- Grade of keratinocytic intraepithelial neo- lar Cell Tumour of the skin: A potential plasia in actinic keratosis and the risk of diagnostic pitfall: Case report developing invasive Squamous Cell Carci- Giuseppe Palumbieri, Italy noma (SCC) Sabina Zurac, Romania PS-08 Poster Sessions C. Popp, M. Radu Busca, G. Pop, R. Andrei, Paediatric and Perinatal Pathology V. Mageriu, I. Velicu, L. Nichita, L. Sticlaru, Chairs: Jens Stahlschmidt, United Kingdom C. Salavastru, F. Staniceanu Luiz Cesar Peres, United Kingdom 043 Jane Dahlstrom, Australia Squamous Cell Carcinoma (SCC) and anaplastic large-cell lymphoma in a collision 003 tumour of the skin Reducing the population genomic load of Sabina Zurac, Romania heterozygous deleterious mutations R. Andrei, R. Chirculescu, A. Birceanu, Alexis Collins, United Kingdom

S. S. Gheorghita, S. Iacob, I. Marinescu, G. Long, A. Armstrong, J. Morris 1 Sept Monday, F. Staniceanu 004 045 The genomic load of heterozygous delete- A histopathological evaluation of patterns rious mutations: Relevance to fetal, infant of alopecia in a large UK centre and childhood death Marium Khan, United Kingdom Grace Long, United Kingdom M. S. Gill, K. Kulkarni, I. Leach A. Armstrong, A. Collins, J. Morris

046 005 Histological features approach of tricho- The male excess of fetal, infant and child- blastic carcinomas: A report of four cases hood deaths: A possible role for X linked and review of the literature deleterious mutations Nabila Moulai, Algeria Alice Armstrong, United Kingdom W. Ouahioune A. Collins, G. Long, J. Morris

047 006 Keratoacanthoma-like Squamous Cell Car- Intrauterine fetal death in advanced preg- cinoma (SCC) arising in nevus sebaceous nancy caused by citomegalovirus infection Sergiu Sebastian Gheorghita, Romania Ana Belen Roche, Spain E. Gramada, R. Andrei, G. Micu, A. Oniga, M. Yus, D. Rosero, E. Mejia, M. Alastuey, C. Socoliuc, F. Staniceanu N. Torrecilla, A. Valero, S. Simon

107 Poster Presentations a Monday ECP 2014 · London

007 018 PS-08 Case report: Identical twins with Congeni- Placental findings in cases of adolescent tal Abnormal Myelopoeisis / Leukaemia pregnancy, complicated with iron defi- Aoife McCarthy, Ireland ciency anemia E. Doyle, A. Green, M. Cotter Olga Reshetnikova, Ukraine M. Melnikova 008 ICAM-1 is upregulated on immune cells in 019 placental villitis Placental remodeling in cases of maternal Erika Egal, Brazil congenital heart disease F. V. Mariano, V. A. Montalli, M. H. Blotta, Olga Reshetnikova, Ukraine A. Altemani L. Rudiuk

011 020 Renal cell carcinomas in pediatric popula- Pediatric genitourinary tumours: A clinico- tion: A comprehensive molecular profiling pathologic study of a series of 24 cases of 7 cases Raja Jouini, Tunisia Marina Kos, Croatia L. Bouhajja, W. Koubaa Mahjoub, S. Vranic, S. Djuricic, O. Hes, G. Basu, H. Henchiri, H. Bouthour, M. Bel Haj Salah, Z. Gatalica O. Khayat, E. Ben Brahim, A. Chadli Debbiche 012 Morphological features of the hepatic and 021 biliary system of fetuses from mothers Autopsy of an infrequent fetal circulation: with complicated pregnancy Congenital absence of the ductus venosus Iryna Sorokina, Ukraine Santiago Ortiz, Portugal Monday, 1 Sept E. Procenko, S. Sherstuk, T. Ospanova, A. Costa e Silva, A. Melo, A. B. Sousa I. Korneyko 022 014 Lissencephaly: A report of two autopsy Maternal infections as a factor leading to a cases small birth-weight infant Yi-Kyeong Chun, Republic of Korea Iryna Sorokina, Ukraine H.-S. Kim, H.-S. Jeong, S.-R. Hong V. Markovsky, M. Myroshnychenko, O. Pliten, 023 T. Ospanova, D. Sorokin Ascariasis: An autopsy report in Brazil 015 Juliana Melo, Brazil A case report of twin reversed arterial per- F. Timbó Albuquerque, L. Belizarte Pontes fusion syndrome based on autopsy exami- Pereira, G. Alencar de Sousa, D. Nunes nation in pregnancy without prior prenatal Oliveira diagnosis 024 Martyna Trzeszcz, Poland „Delayed Villous Maturation“ in placental M. Mazurec, M. Jelen reporting: Concordance amongst consult- 016 ant paediatric pathologists at a single spe- Sudden cardiac death in a normally devel- cialist centre oped male infant: An atypical presentation Alia Nasir, United Kingdom of Kawasaki Disease M. Al-Adnani, A. Marnerides, S. George, Victoria Bryant, United Kingdom M. Weber S. George 025 017 A retrospective audit of products of con- Analysis of the bone tumours in children ception at the Maidstone and Tunbridge Dmitry Rogozhin, Russia Wells NHS Trust Histopathology Depart- I. Boulytcheva, N. Kushlinskiy, A. Talalaev, ment over a twelve month period D. Konovalov, A. Ektova, V. Roshin, Alia Nasir, United Kingdom D. Abramov, A. Mitrofanova G. Rushton

108 ECP 2014 · London Poster Presentations a Monday

026 034 A fatal case of Langerhans cell hystiocyto- Embryonal rhabdomyosarcoma of the ura- sis in a 5 month infant chus in a child with Costello Syndrome Pedro Luis, Portugal Jennifer Costa, Portugal PS-08 A. Alves, E. Vitorino, A. Ferrão H. Barroca

027 035 Fetal kidney and bladder agenesis: A rare The phenotypic diversity of caudal dyspla- case sia: Necropsy study of two fetuses Susan Foreid, Portugal Ana Luís, Portugal D. Antunes, J. Correia, R. Fernandes L. Costa, N. Botelho, C. Bartosch, O. Brandão

028 036 Congenital cytomegalovirus infection: An Holoprosencephaly and associated anoma- autopsy case lies in perinatal autopsy Ebru Sebnem Ayva, Turkey Anca Mitroi, Romania H. Akkaya, B. H. Özdemir M. Aschie, D. Capatina, I. Poinareanu, G. C. Cozaru 029 Pulmonary Interstitial Glycogenosis (PIG): 037 A developmental disorder? Potter Sequence: Autosomal Recessive Alba Hernandez Gallego, Spain Polycystic Kidney Disease (ARPKD) L. Serrano Munné, S. Roca, I. Ojanguren Patricia Sota, Spain C. B. Marta, G. Muñoz Gonzalez, E. 030 Aurensanz Clemente, T. Castiella Muruzabal, Epithelial Wilms Tumours (nephroblastoma) P. Ventura Faci, E. Mejía Urbáez, A. Valero in the SFCE / SIOP2001 protocol: Clinical, Torres pathological and molecular analysis Marie-Laure Baranne, France 038 L. Dainese, B. Ribault, A. Blaise, Mesomelic dysplasia mimicking Robert‘s S. Boudjemaa, Y. Le Bouc, S. Chantot Syndrome Bastaraud, C. Bergeron, A. Vershuur, Havva Serap Toru, Turkey Monday, 1 Sept Monday, F. P. and Pathologic Group, A. Coulomb B. Guzel Nur, C. Y. Sanhal, E. Ayik, S. Yakut, L´Hermine Z. Cetin, N. Semerci, E. Mihci

031 039 New pathomorphological approaches to Adnexal torsion in pediatric female popu- study of appendicitis in children lation: Trousseau Hospital experience Tatyana Pavlova, Russia Sabah Boudjemaa, France A. Lysov, A. Nesterov, I. Bashuk M.-L. Baranne, L. Dainese, R. Jourjon, H. Ducou Le Pointe, M. Larroquet, 032 A. Coulomb Rare congenital pulmonary malformation with diagnostic challenging: Congenital 040 Pulmonary Lymphangiectasia, report of Siamese thoracopagus twins: An autopsy four autopsy cases report Havva Serap Toru, Turkey Juliana Melo, Brazil C. Y. Sanhal, G. Tasova Yilmaz, L. Martins Menezse, D. Nunes de Melo I. H. Ozbudak, I. Mendilcioglu, G. Özbilim Braga, D. Nunes Oliveira, N. Martins Menezes, B. Pinheiro Aquino, M. Rêgo Mota 033 da Rocha Filho, D. Araújo Andrade, Diagnostic pitfall for placeta: Placental A. Cavalcante Brasil, G. Alencar de Sousa, mesenchymal dysplasia A. L. Florêncio de Góis Havva Serap Toru, Turkey E. Cobankent Aytekin, C. Y. Sanhal, S. Yakut, Z. Cetin, I. Mendilcioglu, H. E. Pestereli

109 Poster Presentations a Monday ECP 2014 · London

041

PS-08 PS-09 Poster Sessions Bilateral renal agenesis associated with Endocrine Pathology left lung agenesis, cleft-lib, hydrocephalus Chairs: Anne Couvelard, France and placental malformation: Is it on a spec- Paul Komminoth, Switzerland trum of the so-called Potter‘s Syndrome?

PS-09 Tu Vinh Luong, United Kingdom Havva Serap Toru, Turkey C. Y. Sanhal, G. Tasova Yilmaz, S. Yakut, 001 Z. Cetin Expression of PTEN, pERK and pAKT in 042 anaplastic thyroid carcinoma Hemangioma of the umbilical cord: A Zorka Milovanovic, Serbia report of two cases with distinct outcomes Z. Milosevic, J. Stojsic, M. Pesic, T. Stankovic, and review of the literature J. Dinic, R. Dzodic, N. Tanic, J. Bankovic Liliana Santos, Portugal 002 C. Bartosch, A. Ferreira, U. Ramos, Poorly differentiated thyroid carcinoma O. Brandão with gross internal jugular vein invasion 043 and multiple lung metastasis Factors that hamper the correlation Yong-Moon Lee, Republic of Korea between histopathological diagnosis and J.-H. Park, J.-J. Choi, K.-S. Bae, S. J. Kang cytogenetic findings in early spontaneous 003 abortions Exceptional association: Myelolipoma and Xiaogang Wen, Portugal primary hydatid cyst of the adrenal gland T. Maia, L. Costa, N. Botelho, M. Rodrigues, in a patient with peritonéal tuberculosis E. Rios, S. Dória, C. Bartosch, O. Brandão Ghania Benkhedda, Algeria Monday, 1 Sept 044 I. Djadja, F. Z. Belharrat, Y. Lamouti Antenatal diagnosed Rhabdoid tumour of 004 kidney Neurondocrine tumours of the stomach Wafa Koubaa Mahjoub, Tunisia Nikolay Karnaukhov, Russia R. Juini, R. Ben Abdallah, H. Henchiri, M. Bel Haj Salah, O. Khayat, E. Ben Brahim, 005 A. Chadli Debbiche TRAbs production induced by Epstein- Barr virus reactivation in cultured-PBMCs 045 from Graves‘ disease patients and healthy Insulin like growth factor 1 and Growth controls hormone expression in embryonic and Keiko Nagata, Japan fetal period Y. Nakayama, K. Higaki, H. Miyauchi, George Agrogiannis, Greece M. Matsushita, S. Kuwamoto, M. Kato, E. Patsouris, A. Konstantinidou I. Murakami, T. Iwasaki, H. Kimura, K. Hayashi 046 006 Adrenocortical tumour: Report of a pediat- Correlation between her-2 oncoprotein ric presentation expression and some prognostic factors in Nihed Abdessayed, Tunisia papillary thyroid carcinoma R. Jouini, W. Koobaa, E. Ben Brahim, Mohammadreza Jalali Nadoushan, Iran M. Bel Haj Salah, A. Chadli Debbiche S. Rabiee

007 Increased lymphangiogenesis in IgG4- related thyroid disease (Riedel thyroiditis) José Cameselle Teijeiro, Spain M. J. Ladra, I. Abdulkader, C. Eloy, P. Soares, F. Barreiro Morandeira, M. Sobrinho Simões, A. Beiras Iglesias

110 ECP 2014 · London Poster Presentations a Monday

008 016 Prediction of malignancy and distribution Breast metastasis as first clinical manifes- of primary diagnoses by thyroid fine nee- tation of ileal neuroendocrine tumour: dle aspiration cytology Challenging diagnosis with relevant clini- PS-09 Olena Dotsenko, United Kingdom cal implications T. Stephenson Stefano La Rosa, Italy S. Casnedi, R. Maragliano, G. Goyault, 010 J.-C. Weber, B. Louis, E. Schlund, F. Sessa Mixed thymic and parathyroid cyst in the neck 017 Somaia Elsheikh, United Kingdom Triphasic medullary thyroid carcinoma: P. Kaye, M. Khan A hitherto undescribed morphological pattern 011 Patrick Shenjere, United Kingdom Clinico-pathologic study of 11 ACTH- D. Bisset, L. Menasce secreting pancreatic neoplasms associated with Cushing‘s Syndrome 018 Stefano La Rosa, Italy Correlation of Ki67 immunoexpression R. Maragliano, L. Albarello, A. Vanoli, and overall and disease-free survival in 26 M. Milione, O. Basturk, D. S. Klimstra, pancreatic neuroendocrine tumours C. Capella, A. Scarpa, F. Sessa Alejandro Rubio Fernandez, Spain M. López Macías, W. Toro Zambrano, 012 M. Díaz Delgado, J. J. Fernández de Mera, Primary sclerosing mucoepidermoid carci- A. Hernández Amate, A. M. Campos de noma with eosinophilia of thyroid gland Orellana, I. Catalina Fernández, J. Sáenz de Liliya Selivanova, Russia Santamaría A. Tertychnyy 019 013 Thyroid sporadic goiter with adult bone Multifocal sclerosing thyroiditis: Morpho- metaplasia logical, immunohistochemical and molec- Adriana Handra-Luca, France ular study of three cases M. Bendib, P. Anagnostis 1 Sept Monday, José Cameselle Teijeiro, Spain K. Hernández Carrillo, C. Eloy, M. Sánchez 020 Ares, C. Arce Fricke, I. Abdulkader, Oncocytic thyroid tumours: About 32 cases M. Sobrinho Simões Heifa Kamoun Azouz, Tunisia A. Khadhar, A. Zheni, I. Chelly, S. Haouet, 014 N. Kchir Dyshormonogenetic multinodular goiter: Clinicopathologic study of two cases 021 Delia Gabriela Ciobanu Apostol, Romania Immunohistochemical features of macro- C. Andriescu, L. Lozneanu, A. Grigorovici, follicular variant of papillary thyroid car- R. Danila, L. Ionescu, V. Mogos, C. Vulopoi cinoma: Is NF-kappaB useful in the differential diagnosis? 015 Ayse Gül Gülay, Turkey Review of our patients with papillary P. Temiz microcarcinoma detected incidentally in thyroidectomy materials 022 Ebru Demiralay, Turkey Somatostatin receptor PET-CT in the H. Y. Bircan, S. Yildiz detection of neuroendocrine tumour of the pancreas: Radiologic-pathologic correlation of two cases Vanderlei Segatelli, Brazil E. Christie de Oliveira, L. Y. Itaya Yamaga, A. Luiz de Vasconcellos Macedo

111 Poster Presentations a Monday ECP 2014 · London

023 030 PS-09 An exceptional nodule in the thyroid gland Identification of microRNAs differetially Santiago Ortiz, Portugal expressed in lung carcinoid subtypes and F. Tortosa, T. Pereira, M. Mendes de Almeida progression Ida Rapa, Italy 024 A. Votta, B. Felice, L. Righi, J. Giorcelli, Histopathological classification of pitui- A. Scarpa, E.-J. Speel, G. V. Scagliotti, M. tary tumours and lesions: The last 10 years Papotti, M. Volante in the Reference Center in Portugal Santiago Ortiz, Portugal 031 F. Tortosa Macrofollicular variant of Papillary Thy- roid Carcinoma with Hashimoto Thyroidi- 025 tis: A case report Evaluation of micronuclei and nuclear Houria Belkralladi, Algeria buds with emerin Immunohistochemistry F. Kermas, B. Bouzouira, A. Tou (IHC) in well differentiated epithelial les- ins of Thyroid 032 Ipek Coban, Turkey Well-differentiated pancreatic neuroendo- G. Bulbul Dogusoy, T. D. Kokenek Unal, crine tumours: A single-institution experi- A. Erdogan Cakir, E. Karakilic, N. Bassullu, ence N. Akdur, F. Kusku Cabuk Luis Pérez Casanova, Spain T. Serrano, C. Navas, R. Salazar, C. 026 Villabona, C. Valls, J. Fabregat, E. Condom Clinico-pathologic study of goblet cell carcinoid of the appendix 033 Daisuke Nonaka, United Kingdom One Step Nucleic Acid Amplification Monday, 1 Sept I. Borghol, P. Fulford, P. Bishop, (OSNA) assay to evaluate lymph node B. Chakrabarty status in papillary thyroid carcinoma Carmela Iglesias Felip, Spain 027 J. Temprana Salvador, O. Gonzalez, C. Zafon, Recurrent thyroid carcinomas have less A. Garcia-Burillo, E. Caubet, X. Serres, intratumoural microvessels and more peri- J. Castell, S. Ramon y Cajal tumoural lymphatic vasculature Ivana Kholová, Finland 034 T. Hakala, J. Sand, H. Huhtala, R. Leinonen, Immunofluorescence analysis of P53-bind- P. Kellokumpu-Lehtinen ing protein 1 (53BP1) in thyroid follicular tumours: Possibility for preoperative diag- 028 nosis Mismatch repair deficient pancreatic neu- Ryota Otsubo, Japan roendocrine tumour with ductulo-insular K. Matsuda, S. Miura, H. Shindo, complexes and peliosis of the nontumour- M. Hirokawa, A. Miyauchi, T. Nagayasu, ous islets in a patient with Lynch Syn- M. Nakashima drome Ozgur Mete, Canada 035 S. Hafezi-Bakhtiari, A. Pollett, S. Gallinger Anaplastic transformation of papillary thyroid carcinoma in late extrathyroidal 029 metastasis Severity and extend of hemorrhagic Ji-Yun Jeong, Republic of Korea changes in tumours of adrenal medulla J.-Y. Park, T.-I. Park (pheochromocytoma) depends on the type of surgical excision technique 036 Magdalena Bialas, Poland Squamous cell metaplasia of the thyroid G. Dyduch, J. Dudala, M. Lankosz, gland: Report of 2 cases A. Budzynski, K. Okon Nouha Ba, Tunisia R. Hadhri, F. Hammedi, L. Njim, A. Moussa, A. Zakhama

112 ECP 2014 · London Poster Presentations a Monday

037 043 Immunohistochemical expression of BRAF Calcitonin and parathyroid hormone co- V600E mutation in thyroid lesions expression in a case of parathyroid carci- Efi Kyrodimou, Greece noma PS-09 G. Koutsonikas, A. Kostopoulou, E. Minaidou, Shamlal Mangray, USA L. Papanastasiou, D. Theodosiou, D. Treaba, R. DeLellis, E. Yakirevich T. Choreftaki 045 038 Parathyroid carcinoma: A difficult histo- One Step Nucleic Acid Amplification logical diagnosis report of two cases (OSNA) for lymph node assessment in pap- Manel Mellouli, Tunisia illary thyroid carcinoma: Preliminary study N. Gouiaa, R. Kallel, S. Charfi, I. Bahri, Jordi Temprana Salvador, Spain I. Achour, M. Triki, S. Makni, T. Boudawara C. Zafon, O. Gonzalez, J. Castellví, 046 J. Camacho, S. Díaz, A. Garcia-Burillo, Multiple adrenal ganglioneuromas: A case E. Caubet, R. Vilallonga, S. Ramon y Cajal, report C. Iglesias Rita S. S. Oliveira, Portugal 039 R. de Mora Féria, A. Costa Braga, Comparative study of macroscopic exami- R. Theias Manso, S. Loureiro dos Santos nation, cytology and histology in the diag- 047 nosis of thyroid cancer: A review of 210 Adrenal myelolipoma: Report of five cases cases Saadia Makni, Tunisia Besma Laabidi, Tunisia L. Ayadi, F. Gargouri, M. Mellouli, S. Charfi, W. Ajouli, F. Ben Abdallah, I. Msakni, S. Makni, N. Mhiri, T. Boudawara N. Mansouri, M. Yahia, F. Bougrine, A. Bouziani 048 Radiological and cytological assessment of 040 thyroid nodules Neuroendocrine carcinoma associated Muhammad Shafiq Gill, United Kingdom with full spectrum endocrine prolifera- I. Au-Yong, M. Khan tions in a primary retroperitoneal muci- 1 Sept Monday, nous adenocarcinoma 049 Anna Pesci, Italy Plasma cell granuloma of the thyroid: A P. Castelli, G. Bogina, L. Bortesi, rare diagnosis M. Ceccaroni, M. Scioscia, F. Bruni, Francisca Costa, Portugal G. Zamboni A. Coelho, A. Duarte, J. R. Vizcaíno

041 050 brafv600e mutational status of papillary The utility of frozen section evaluation for thyroid carcinomas in Turkish population follicular thyroid lesions: The Tunisian and its prognostic significance experience Guzide Ayse Ocak, Turkey Salsabil Attafi, Tunisia H. S. Toru, G. B. Cansu, M. Ozcan, L. Charfi, R. Doghri, I. Abbes, N. Boujelbène, M. Turkay, C. Arici, I. E. Gurer, M. K. Balci M. Driss, R. Sellami Dhouib, S. Sassi, K. Mrad

042 051 Thyroid pathology findings in patients Encapsulated mixed medullary-follicular with PTEN-hamartoma tumour syndrome carcinoma coexisting with a papillary José Cameselle Teijeiro, Spain microcarcinoma in the same thyroid lobe J. M. Cabezas Agricola, R. M. Reyes-Santías, Jose Garcia, Portugal N. Alfonsín Barreiro, I. Abdulkader, R. Sampaio, F. Moreno, A. Duarte F. Casanueva, A. Vega Gliemmo

113 Poster Presentations a Monday / Tuesday ECP 2014 · London

052 e Tuesday, 2 September 2014 PS-09 Diffuse sclerosing variant of papillary thyroid carcinoma in a patient with Graves PS-10 Poster Sessions Disease Ana Galaghar, Portugal Digestive Diseases Pathology II: Lower PS-10 L. P. Afonso, R. Celestino, C. Eloy gastrointestinal tract Chairs: Cord Langner, Austria 053 Magali Svrcek, France Pitfalls in genetic analysis of Pheochromo- Manuel Rodriguez-Justo, United cytomas / Paragangliomas: A case report Kingdom Raffaella Santi, Italy L. Canu, E. Rapizzi, T. Ercolino, M. Mannelli, 001 G. Nesi Detection of Cytomegalovirus by immunohistochemistry in complicated chronic 054 inflammatory bowel disease Two exceptional cases of parathyroid Issam Msakni, Tunisia related hypercalcemia A. Ben Chaabane, B. Laabidi, W. Ajouli, Deepa Jacob, United Kingdom F. Bougrine, A. Bouziani B. Mathew 002 055 MSH-2 antibody in the diagnosis of Hered- Intergenerational pancreatic effects in F1 itary non Polyposis Colorectal Cancer and F2 mice offspring from pre-gestational (HNPCC) maternal obesity Issam Msakni, Tunisia Vanessa Souza-Mello, Brazil W. Ajouli, B. Laabidi, A. Ben Chaabane, F. Graus-Nunes, D. Magliano, A. Penna de Monday, 1 Sept F. Bougrine, A. Bouziani Carvalho, E. Frantz, C. Mandarim de Lacerda 003 A survey of reporting of colorectal cancer in Scotland: Compliance with guidelines and effect of proforma reporting Yvonne Woods, United Kingdom S. Mukhtar, P. McClements, J. Lang, R. Steele, F. Carey

004 Assessment of extramural vascular inva- Tuesday, 2 Sept sion in colorectal cancer David McClelland, United Kingdom G. Murray

005 The pathological features of screen detected colon cancers David McClelland, United Kingdom G. Murray

006 CYP26B1 is a prognostic biomarker of colorectal cancer Graeme Murray, United Kingdom G. Brown, B. Cash, A. Alnabulsi

114 ECP 2014 · London Poster Presentations a Tuesday

009 017 Does further fixation of colorectal cancer PTEN expression in colorectal adenomas: specimens find additional and significant Relationship to morphology and cell het- lymph nodes? erogeneity PS-10 Joanne Horne, United Kingdom Mouna Bendib, France N. Carr, I. Ryder, B. Green A. Badescu, A. Handra-Luca

010 018 Correlation between high microvessel A case of small intestinal signet ring cell density and presence lymph node metasta- carcinoma in Crohn´s Disease ses in colorectal carcinomas Maria Alastuey, Spain Elena Koshyk, Ukraine C. Yus, D. Rosero, E. Mejia, N. Torrecilla, R. Ishchenko A. Valero, S. Simon, B. Roche

011 019 The experience of immunohistochemical Clinicopathologic and molecular features detection MMR proteins expression in of colorectal cancers with Annexin A10 colorectal carcinomas expression Elena Koshyk, Ukraine Gyeong-Hoon Kang, Republic of Korea J.-M. Bae, N.-Y. Cho 012 Morphological features of serrated colo- 020 rectal adenocarcinoma Molecular landscape of pseudomyxoma Richard Colling, United Kingdom peritonei E. Fryer, E. Collantes Ari Ristimäki, Finland P. Nummela, L. Saarinen, A. Thiel, 013 R. Lehtonen, P. Järvinen, A. Lepistö, Colon cancer with prominent granuloma- H. Järvinen, L. A. Aaltonen, S. Hautaniemi tous inflammatory response mimicking Crohn‘s Disease and normal expression of 021 mismatch repair proteins Prevalence of different types of colon ade- Miriam Mitchison, United Kingdom nomas in patients with newly diagnosed M. Rodriguez-Justo superficial colorectal neoplasms Olena Kuryk, Ukraine 014 A. Svintsitskiy, G. Solovyova, V. Yakovenko, The significance of heterogeneity of I. Korendovych COX-2 expression in colon adenomas as a potential target for NSAIDs chemopre- 022 ventive role Evaluation of concordance in KRAS muta- Piotr Lewitowicz, Poland tion status between primary tumour and D. Koziel, J. Matykiewicz, A. Horecka- corresponding liver metastases after neo- Lewitowicz, A. Wincewicz, A. Nasierowska- adjuvant treatment in 44 patients with Guttmejer, S. Gluszek colorectal cancer

Alicia Cordoba, Spain 2 Sept Tuesday, 015 I. Amat, D. Guerrero, M. L. Gomez Are we meeting RCPath standards for Dorronsoro, J. Suarez, M. C. Llanos, reporting extramural vascular invasion in M. R. Mercado, G. De Lima, L. Alavarez, colorectal carcinoma? B. Larrinaga Joanne Horne, United Kingdom N. Carr, M. Walker 023 Regulatory T-cells in mucosa in patients 016 with Inflammatory Bowel Disease (IBD) Idiopathic myointimal hyperplasia of mes- Zhanna Sharoyan, Russia enteric veins: A rare mimic of Inflamma- L. Selivanova, T. Birg, A. Tertychnyy tory Bowel Disease Miriam Mitchison, United Kingdom M. Alizzi

115 Poster Presentations a Tuesday ECP 2014 · London

024 031 PS-10 Improvement in stage and prognostic Stromal macrophages closely interact with parameters in colorectal cancer in the infiltrating tumour cells in the tumour post-screening era: A single institution microenvironment of colorectal cancer study Viktor H. Koelzer, Switzerland Abed Zaitoun, United Kingdom K. Canonica, H. Dawson, E. Karamitopoulou, A. Mukherjee, A. Abbas, J. Williams, M. Ilyas A. Lugli, I. Zlobec

025 032 CD1a-positive dendritic cells significantly Clear cell change in colonic adenoma: increased in tumour stroma of MSI colo- Morphological variant or a distinct clone? rectal cancer patients Lothar Veits, Germany Maya Gulubova, Bulgaria C. Falkeis, R. J. Rieker, M. Vieth, W. Sterlacci J. Ananiev, T. Vlaykova 033 026 Expression of cancer stem cell markers Defective apoptosis in intestinal and mes- correlates with haematogeneous liver enteric adipose tissue of Crohn‘s Disease metastases but not with peritoneal carci- patients nomatosis in colorectal cancer Cilene Dias, Brazil Jens Neumann, Germany V. N. Horita, M. Milanski, M. Portovedo, L. Löhrs, M. Albertsmeier, S. Reu, M. Guba, M. L.S. Ayrizono, C. S.R. Coy, N. Planell, T. Kirchner, M. Angele L. A. Velloso, L. R. Meirelles, R. F. Leal 034 027 Can we still do something for the „lost pol- HER2 status in colorectal cancer: Its clini- yps“ of gastrointestinal system? cal significance and the relationship Armagan Gunal, Turkey between HER2 gene amplification and 035 expression A case-control study to assess whether An-Na Seo, Republic of Korea p53-abnormalities are predictive of cancer J.-Y. Jeong, S.-J. Lee, G.-Y. Choe, Y.-J. Kwak, development risk in patients with Crohn‘s W.-H. Kim, H.-S. Lee Disease 028 Manuel Rodriguez-Justo, United Kingdom Micropapillary pattern and poorly differ- F. Benthani, T. Diss, P. Jones, P. DuParcq, entiated clusters: Do they represent the T. Graham same biological phenomenon in colorectal

Tuesday, 2 Sept 036 cancer? Correlation between hypoxia, cellular pro- Valeria Barresi, Italy liferation, stem cell markers, mutation sta- G. Branca, E. Vitarelli, G. Tuccari tus and prognosis in colorectal cancer 029 Manuel Rodriguez-Justo, United Kingdom Poorly Differentiated Clusters (PDC) as a P. Kamalathevan, A. Bowman, B. Ganeshan, novel histological predictor of nodal S. Wang, A. Engledow, J. Paterson, A. Groves metastases in pT1 colorectal cancer 037 Valeria Barresi, Italy Image cytometry and DNA ploidy abnor- G. Branca, A. Ieni, L. Reggiani Bonetti, malities in colorectal cancer prognosis L. Baron, S. Mondello, G. Tuccari Manuel Rodriguez-Justo, United Kingdom 030 D. Oukrif, P. Kamalathevan, B. Ganeshan, Morphological evaluation of Interstitial S. Wang, A. Groves, M. Novelli Cells of Cajal (ICC) in patients with Severe 038 Colonic Inertia (SCI) requiring colectomy Heterotopic mesenteric ossification of ile- Dominique Cazals-Hatem, France ostomy M. Cohen, Y. Panis, J. M. Sabate, Triantafyllia Koletsa, Greece A. Lavergne Slove, M. Grossin, B. Coffin F. Tsiompanou, G. Raptou, K. Sapalidis, T. M. Strati, I. Anastasiadis, E. Vrettou 116 ECP 2014 · London Poster Presentations a Tuesday

041 048 Detection of chromosomal anomalies in Melanoma of the anal canal: A rare and colorectal carcinoma using multi-target challenging disease FISH technique Heifa Kamoun Azouz, Tunisia PS-10 Chang Lim Hyun, Republic of Korea A. Khadhar, A. Zehani, I. Chelly, S. Haouet, W.-Y. Jeon, H.-S. Ryu N. Kchir

042 049 Sessile serrated polyps in the NHS-Bowel Comparative analysis of K-ras and Micro Cancer Screening Programme (BCSP): An Satellite Instability (MSI) status in Dukes‘ audit in the London screening centres A, B and C colorectal cancers Manuel Rodriguez-Justo, United Kingdom Thiagarajah Balamurugan, United Kingdom S. Sah, H. Chong, P. Cohen, N. Collins, B. Ping, P. Pingle, I. Bagwan V. Sheshappanavar, E. Lanaspre, H. Li 050 043 Does endoscopic tattooing of early colonic Does the completeness of excision status tumours enhance lymph node harvesting in small adenomas contribute to surveil- and detection of node metastasis? lance protocol in small polyps in the NHS- Iban Aldecoa, Spain Bowel Cancer Screening Programme C. Montironi, N. Planell, M. Pellisé, Bridget Fergie, United Kingdom S. Delgado, L. Herrero, A. Saco, B. Gonzalez, J. Stein, M. Rodriguez-Justo A. B. Larque, D. Momblan, M. Cuatrecasas

044 051 Goblet cell carcinoid of the appendix: A Ectopic sebaceous glands in the esopha- study of three observations gus: Report of two cases Raja Jouini, Tunisia Juliana Melo, Brazil N. Abdessayed, W. Koubaa Mahjoub, C. Gleidiston Lima da Silva, M. I. Jovino H. Henchiri, N. Haoues, M. Bel Haj Salah, Silva, H. Torres de Melo Moura, F. A. Vieira O. Khayat, E. Ben Brahim, A. Chadli Coelho, D. I. Magno Cavalcante, D. Nunes Debbiche Oliveira

045 052 Peritumoral lymphoid aggregates and An extended RAS analysis in patients with tumour infiltrating immune cells in colo- untreated metastatic colorectal cancer rectal cancer from the PRIME and PEAK studies Juha Väyrynen, Finland Meinolf Karthaus, Switzerland S. Sajanti, K. Klintrup, J. Mäkelä, K.-H. J. R. Hecht, J.-Y. Douillard, L. Schwartzberg, Herzig, T. Karttunen, A. Tuomisto, S. Siena, J. Tabernero, F. Rivera, K. Oliner, M. Mäkinen H. Yu, Y. Tian, A. S. Jung, W. Y. Go

046 053 Prevalence, morphology and predilection Image analyzer-based assessment of factors of colonic serrated polyps in tumour-infiltrating T cell subsets and their 2 Sept Tuesday, asymptomatic participants of colon cancer prognostic values in colorectal carcinomas screening programme in years 2000 – 2004 Young-Hoon Kim, Republic of Korea Andrzej Mroz, Poland J.-M. Bae, N.-Y. Cho, G.-H. Kang M. Kiedrowski, E. Kraszewska, M. Kaminski, 054 J. Regula Audit of compliance with Royal College of 047 Pathologists dataset for colorectal cancer KRAS-mutation status in Brazilian patients resections (2nd edition) with colorectal cancer Christopher Ligory, United Kingdom Vanderlei Segatelli, Brazil P. Simcock E. Christie de Oliveira, A. Ramos da Costa,

E. Sobroza de Mello, V. Avancini Ferreira 3 Sept Wednesday, Alves

117 Poster Presentations a Tuesday ECP 2014 · London

057 067 PS-10 Mixed Adenoneuroendocrine Carcinoma Case of leiomyosarcoma involving both (MANEC) arising at the ileocolic anasto- rectum and anal canal mosis in Crohn‘s Disease Nilsen Erdogan, Turkey Abdul Badran, United Kingdom A. Muratli, S. Bektas, E. Sahan M. Abulafi, A. Arnaout 068 058 Intra- and interobserver agreement for Prognosis value of CDX2 in colorectal car- the histological diagnosis of Aberrant cinoma Crypt Foci (ACF) Khadija Bellil, Tunisia Mireya Jimeno, Spain H. Rachdi, M. Néji, W. Ajouli, A. Dhaoui, M. Cuatrecasas, I. Quintanilla, M. López H. Cherif, D. Ben Ghachem, H. Rachdi, Cerón, C. Rodríguez de Miguel, J. Camps, D. Ben Ghachem F. Balaguer, J. Llach, M. Pellisé

059 069 Tumoural form of intestinal infections Prognostic value of some histologic Khadija Bellil, Tunisia parameters in ulcerative colitis – is there W. Ajouli, M. Néji, A. Dhaoui, Z. I. Abdelaali, hope for a reliable marker? D. Ben Ghachem Florica Staniceanu, Romania C. Popp, G. Micu, C. Neacsu, V. Mageriu, 060 A. Stoica, T. Voiosu, B. R. Mateescu, S. Zurac Colorectal carcinoma screening: The Por- tuguese experience 070 Lina Carvalho, Portugal Endometrial carcinoma type II arising in T. Ferreira, M. J. d´Aguiar, A. Alarcão, endometriosis of colorectum: Case report M. R. Silva, A. Ladeirinha Michal Kalman, Slovakia P. Szepe, P. Slávik, J. Marcinek, L. Plank 061 Role of Neuropeptide Y and Lipoprotein 071 Lipase polymorphisms in colorectal ade- Association of epidermal growth factor nocarcinoma development receptor immunostaining with the tumour Lina Carvalho, Portugal stage of colorectal adenocarcinoma S. Balseiro, A. M. Sampaio, M. R. Silva, Ehsen Ben Brahim, Tunisia A. Alarcão, T. Ferreira, M. J. d´Aguiar S. Atafi, W. Koubâa, R. Jouini, N. Haoues, R. Nooman, O. Khayat, A. Cherif, A. Chadli 062

Tuesday, 2 Sept Colonic signet-ring cell carcinoma in a 072 21-year old male Role of immunohistochemical markers to Dussadee Sakonlaya, Thailand identify dysplasia in colorectal polyps in E. Sri-Asadaporn Inflammatory Bowel Diseases (IBD) Ehsen Ben Brahim, Tunisia 065 R. Ben Sidhom, R. Jouini, W. Koubâa, Colorectal cancer stratification: The estab- N. Haoues, R. Noomen, D. Gargouri, lishment of routine colorectal cancer strat- A. Chadli ification in a small UK District General Hospital 073 Sarah Wedden, United Kingdom Visualizing Phosphodiesterase 8A: A novel K. Miller, R. Osborne, A. Talwar, J. Mikel, therapeutic target for autoimmune and T. Teresa, C. D´Arrigo inflammatory diseases Amanda Vang, Faroe Islands 066 K. R. Nielsen, M. Kaminski Characterization of endometriosis of the intestinal tract Jessie M. Wu, United Kingdom A. Zaitoun, N. Gandhi, J. Abercrombie

118 ECP 2014 · London Poster Presentations a Tuesday

074 081 Annexin A10 as an immunohistochemical Ipilimumab associated colitis: A modern marker for serrated colorectal adenocarci- mimic of Inflammatory Bowel Disease (IBD) noma Monika Tripathi, United Kingdom PS-10 Sara Sajanti, Finland E. Fryer, K. D. Williamson, I. Karydis, J. Väyrynen, K. Klintrup, J. Mäkelä, A. Gupta, S. Keshav, M. Middleton A. Tuomisto, M. Mäkinen 082 075 Loss of CDX2 / CK20 in MSI unstable colo- Overexpression of CPS1 confers an inde- rectal carcinoma is a marker for poor out- pendent negative prognostic impact in come rectal cancers receiving concurrent chem- Monika Tripathi, United Kingdom oradiotherapy E. Fryer, C. Hughes, B. Phillips, I. Roxanis, Yi-Ying Lee, Taiwan D. Roskell C.-F. Li 083 076 The link between systemic and local Depth and width of submucosal invasion inflammatory response to colorectal can- as a measure of risk in early polyp cancer cer: The role of CD36 of the colorectum Georgios Malietzis, United Kingdom Richard Colling, United Kingdom G. Han Lee, S. C. Knight, J. T. Jenkins, P. Gill, E. Fryer, L. M. Wang, R. Chetty H. O. Al-Hassi, M. Moorghen

077 084 Alpha-Methylacyl-CoA Racemase expres- The relationship between local inflamma- sion in a jejunal adenocarcinoma with tory response and body composition in minor micropapillary component patients with primary operable colorectal Shamlal Mangray, USA cancer N. Shillingford, M. Resnick, E. Yakirevich Georgios Malietzis, United Kingdom G. H. Lee, H. O. Al-Hassi, S. C. Knight, 078 M. Moorghen, J. T. Jenkins A multicentre inter-observer study on tumour budding using a 10HPF method in 085 colorectal cancer: A study from the Swiss Immunohistochemical and molecular anal- Association of Gastrointestinal Pathology yses of brafv600e mutation in colorectal (SAGIP) cancers Viktor H. Koelzer, Switzerland Nora Sahnane, Italy I. Zlobec, G. Cathomas, K. Dirschmid, C. Placidi, L. Cimetti, S. Uccella, D. Furlan, F. Offner, G. Puppa, L. Tornillo, M. D. Berger, F. Sessa, A. M. Chiaravalli M. Borner, H. Dawson, M. Hädrich, 086 M. Mallaev, B. Schnüriger, D. Inderbitzin, Expression of notch pathway components A. Lugli (Numb, Itch and Siah-1) in colorectal

079 tumours 2 Sept Tuesday, Genomic heterogeneity in metastatic colo- Sinem Cil Gonulcu, Turkey rectal cancer (CRC) demonstrated by Copy B. Ünal, M. Ozcan, S. Toru, C. I. Bassorgun, Number Variation (CNV) H. S. Coskun, S. Gunduz, G. Ö. Elpek Timothy Palmer, United Kingdom 087 H. Wood, M. Taylor, W. Fateen, P. Chambers, Clonal evolution of stem cells and crypts A. Hindley, I. Carr, P. Quirke in normal, preneoplastic and neoplastic 080 colon The impact of miscrosatellite instability on Marnix Jansen, United Kingdom colorectal carcinoma grading by quantify- A.-M. Baker, B. Cereser, S. Melton, ing poorly differentiated cell clusters A. Fletcher, M. Rodriguez-Justo, Jeong-Won Kim, Republic of Korea S. McDonald, N. Wright, B. Simons, M.-K. Shin, B.-C. Kim T. Graham

119 Poster Presentations a Tuesday ECP 2014 · London

088 002 PS-10 Parallel immunohistochemical investiga- Infiltrating duct carcinoma of the parotid tion of PTEN-loss in colorectal carcinomas gland: Particular entity to know with different antibodies Olfa Lamine, Tunisia Tamás Micsik, Hungary A. Gabsi, A. Goucha, S. Touati, S. Gritli, PS-11 E. Agoston, K. Fekete, G. Bodoky, J. Kulka, A. Gamoudi, A. El-May J. Timar, L. Harsányi, M. Szasza 003 089 Fine needle aspiration of a case of thyroid The role of tumoural microenvironment in carcinosarcoma: A case report primary and secondary colorectal tumours Randa Amin, Egypt Caetano Oliveira, Portugal 004 090 Intranodal palisaded myofibroblastoma: A Comparison of Chromosomal Instability rare and benign tumour (CIN) and Microsatellite and Chromosome Cioly Rivero Colmenarez, Spain Stability (MACS) using targeted next gen- A. Berjón García, A. Rosell Alayza, P. López eration sequencing Ferrer, J. J. Pozo Kreilinger, J. M. Viguer Mohammad Ilyas, United Kingdom García, F. López Barea, B. Vicandi Plaza H. Karim, G. Cross, K. Manger 005 091 Sperm associated antigen 9: A novel diag- Evaluation of right sided and left sided nostic marker for breast carcinoma in fine colon tumours: Review of 963 cases needle aspiration cytology Fatma Yildirim, Turkey Hala El-Rebey, Egypt B. Doganavsargil, M. Sezak, T. Yoldas, R. Samaka, M. Kandil, A. El-Habashi, M. Tuncyurek A. Mahrous

094 006 Ets-1 expression occurs in precancerous Endoscopic ultrasound-guided fine-needle colorectal lesions aspiration cytology (EUS-FNAC) in pan- Agota Ilyes, Romania creaticobiliary carcinomas: The utility of Z. Pap, Z. Pavai, S. Mocan cell-block procedure to improve a diagnostic immunocytochemical algorithm 097 Antonio Ieni, Italy Misinterpretation of the origins and com- V. Barresi, P. Todaro, R. Cardia, G. Tuccari position of staging data and its impact on

Tuesday, 2 Sept colorectal cancer survival 008 Michael Eden, United Kingdom An audit of the accuracy of lymph nodes B. Rous, J. Rashbass aspiration cytology in the diagnosis of lymphoid lesions, in the department of PS-11 Poster Sessions Cellular Pathology, Northwick Park Hospi- tal, Harrow, UK Cytopathology Lama Zakarneh, United Kingdom Chairs: Ambrogio Fassina, Italy Y. Alwahab, N. Aqel Lukas Bubendorf, Switzerland Amanda Herbert, United Kingdom 009 Logistic regression analysis of cytolomor- 001 phologic characteristics of low grade pap- Evaluation of thyroid nodules in 2,194 illary urothelial carcinoma in liquid-based patients: Comparison among ultrasono- voided urine cytology graphic, cytological and histological diag- Han-Suk Ryu, Republic of Korea noses C. L. Hyun, Y.-R. Chung, J.-J. Jang Chan Choi, Republic of Korea J.-L. Park, W.-Y. Choi, W.-S. Choi, S.-S. Kim, J.-S. Lee, H.-C. Kang, K.-S. Park

120 ECP 2014 · London Poster Presentations a Tuesday

010 018 Case report: Fine-needle aspiration cytol- The role of fine needle aspiration cytology ogy of early-stage subacute (De Quervain) in the diagnosis of metastatic disease in Thyroiditis lymph nodes: A retrospective study of 380 PS-11 Ioannis Provatas, Greece cases O. Ignatova, M. Vrontaki, K. Dimitrios, Ioannis Provatas, Greece P. Giagkazoglou, S. Plyta O. Ignatova, M. Vrontaki, D. Klis, G. Mitropoulou, G. Vecchini, S. Plyta 011 Metastatic breast carcinoma to the colon 019 identified by free abdominal fluid cytology: The significance of fine needle aspiration Report of an unusual case cytology in the diagnosis of patients with Ioannis Provatas, Greece axillary lymphadenopathy T. Olympia, O. Ignatova, M. Vrontaki, Ioannis Provatas, Greece E. Paliouri, A. Alexiadou O. Ignatova, M. Vrontaki, D. Klis, P. Giagkazoglou, G. Galanopoulos, G. Vecchini, 012 S. Plyta Diagnosis of Adenoid Cystic Carcinoma of the breast using Fine Needle Aspiration 020 Cytology: A case report Ultrasound guided fine-needle aspiration Ilkay Tosun, Turkey cytology of thyroid nodules: A 5-year ret- G. Kir, O. Sarica, D. Demirel rospective study and classification according to Bethesda System of 3061 nodules 013 Ioannis Provatas, Greece Langerhans cell histocytosis: A case report O. Ignatova, M. Vrontaki, D. Klis, I. Tzaves, of CT guided FNAB and immunocytochem- G. Papadakis, A. Alexiadou, S. Plyta istry Rehab Samaka, Egypt 021 A. El-Habashi Cyto-histological and molecular confronta- tion in detection of HPV: A series of 33 014 cases Skin scrape cytology in the diagnosis of Nada Mansouri, Tunisia basal cell carcinoma: Is it an accurate tool? B. Laabidi, N. Haffar, I. Msakni, R. Nefzi, Mustafa Mohamed, United Kingdom F. Ben Abdallah, Y. Manel, A. Bouziani, A. Nayar, A. Ali F. Bougrine 015 023 Small biopsies in the diagnosis of der- The boundaries of the cytological diagno- matofibrosarcoma protuberans sis of „benign thyroid lesion“: Is it a real Henryk Domanski, Sweden safe diagnosis for the patient? P. Rissler, E. Bakula-Zalewska Esther Rossi, Italy 016 G. Fadda, P. Straccia, A. Pontecorvi, Cytopathological evaluation and clinician V. Bernet, A. Nassar Tuesday, 2 Sept Tuesday, perspectives in pleural effusion 024 Dalia Hussein, Egypt Comparison of the Cobas HPV and HPV Y. Akl, G. Nakhla, A. El-Hindawi genotyping tests for detection of high-risk 017 HPV in cervical specimens of the women Fine-needle aspiration cytology of thyroid who test consecutive cytology-negative or nodules correlated with histological data: ASC but are HPV-positive A 5-year retrospective study of 281 cases Sun-Young Jun, Republic of Korea Ioannis Provatas, Greece E.-S. Park, J.-Y. Kim, J. Kang, J.-J. Lee, O. Ignatova, M. Vrontaki, D. Klis, Y.-J. Bae, S.-I. Kim, L.-S. Maeng I. Keramidas, K. Moustakas, G. Vecchini, S. Plyta

121 Poster Presentations a Tuesday ECP 2014 · London

025 033 PS-11 Endoscopic Ultrasound-Guided Fine-Nee- Fine needle cytology improves the diag- dle Aspiration Biopsy (EUS-FNAB) of pan- nostic accuracy of the clinical and imaging creatic lesions: A seven years analysis of in the breast cancer follow-up single institution material Pio Zeppa, Italy Jaroslava Duskova, Czech Republic I. Cozzolino, L. Di Pietto, A. Cascone, T. Krechler, M. Dvorak A. Vetrani

026 034 Bronchial brushing sample are superior to An evaluation of Thy3 category in thyroid biopsy samples for EGFR mutation testing cytology: A hospital based study in non-small cell lung cancer Somaia Elsheikh, United Kingdom Jong-Hee Nam, Republic of Korea M. Khan Y.-D. Choi, C.-S. Park, S.-S. Kim 035 027 EGFR mutation analysis on cytologic Esfoliative cytology in urine samples: A material in non-small cell lung cancer: single-center experience Cytology and histology correlation Pedro Luis, Portugal Yasemin Ozluk, Turkey R. Luís, M. Cardoso, A. Alves, D. López-Presa P. Firat, G. Yegen, J. Hocaoglu, D. Yilmazbayhan 028 Metastatic ewing sarcoma / primitive neu- 036 roectodermal tumour in neck lymph node Cervical cancer screening, organized or from anterior mediastinum: A case report opportunistic: An experience for both pro- Woo Jung Sung, Republic of Korea grammes M.-J. Gu, S.-J. Lee Majlinda Ikonomi, Albania S. Kadare, G. Cekodhima 030 Adequacy of fine needle aspiration cytol- 037 ogy of benign breast lesions: SurePath liq- p16 / Ki67 Dual Staining (DS) and HPV uid-based technique versus conventional detection for anal cancer screening in HIV smears positive homosexual males (MSM) Diane Isabelle Magno Cavalcante, Brazil Manel Solé, Spain A. Aragão, J. Eleutério Junior R. Esteve, I. Fuertes, L. Alós, J. L. Blanco, J. Ordi 031

Tuesday, 2 Sept Tissue microarray in exhumed human 038 bones: Histological sections with reduced Endoscopic ultrasound-guided fine needle sample loss aspiration from pancreatic ductal adeno- Edna Iwamura, Brazil carcinoma: Usefulness of Cd10 in identify- R. B. de Mello, C. Mautoni, M. R. Regis Silva, ing gastrointestinal contaminants R. D. Astolphi, M. A. Guimarães, Elena Vigliar, Italy R. A. Francisco, M. T. de Seixas Alves, A. Iaccarino, A. Vetrani, G. Troncone, J. Soares de Almeida C. Bellevicine

032 039 Papanicolaou smear findings in solid Endoscopic Ultrasound – Fine Needle organ transplant recipients compared Aspiration (EUS-FNA) in the evaluation of with the normal population according to solid pancreatic masses the Bethesda 2001 Jorge Pinheiro, Portugal Merih Tepeoglu, Turkey J. Lopes, H. Barroca A. Ok Atilgan, A. N. Haberal, E. Kuscu, B. H. Özdemir, M. Haberal

122 ECP 2014 · London Poster Presentations a Tuesday

040 008 Solid pseudopapillary tumour of pancreas. Spinal cord pathology in Multiple Sclero- Cytological diagnosis and updated in the sis: A proposal for classifying spinal cord Immunohistochemical (IHC) profile: Four lesions PS-12 cases report Paul van der Valk, The Netherlands Héctor Enrique Torres Rivas, Spain D. Vogel, M. Breur, R. Peferoen-Baart, N. Fuentes Martínez, G. Mendoza Pacas C. Dijkstra, S. Amor PS-11 041 009 Cytologic diagnosis of an unusual pancre- Study of the methylation status of atic tumour in a child O-6-methylguanine-DNA methyltransfer- Sirine Bouslema, Tunisia ase in glioblastomas and related overall L. Njim, N. Abdessayed, R. Hadhri, survival S. Hidouri, F. Hammedi, M. Njima, Alejandro Rubio Fernandez, Spain A. Moussa, A. Zakhama M. López Macías, W. Toro Zambrano, A. M. Campos de Orellana, I. Catalina PS-12 Poster Sessions Fernández, M. Díaz Delgado, J. J. Fernández de Mera, A. Hernández Amate, J. Sáenz de Neuropathology Santamaría Chairs: Joanne Martin, United Kingdom Federico Roncaroli, United 010 Kingdom Isolated leptomeningeal-intraparenchymal Teresa Ribalta, Spain Rosai-Dorfman disease mimicking plasma cell granuloma 003 Eva Tejerina, Spain An autopsy case of posterior spinal artery L. De Reina, D. García Fresnadillo, C. Bellas syndrome showing marked swelling of the spinal cord: A clinico-pathological study 011 Jun Matsubayashi, Japan Desmoplastic fibroma of partial bone of T. Nagao skull in an infant: A case report Rehab Samaka, Egypt 004 A. R. Zwayed, S. Al-Lawatiah Coexistence of intracranial marginal zone B-cell lymphoma and meningioma 012 Ebru Cakir, Turkey Marginal zone lymphoma of lumbar dura Z. Yildirim, U. Kucuk, E. E. Pala, M. Uncel, presenting with disc prolapse symptoms A. O. Binatli, U. Bayol, A. Özgüzer Dimitra Bantouna, Greece V. Zolota, D. Konstantinou 005 Incidental finding of gangliocytoma in 016 autopsy about a case OLIG2 immunohistochemistry expression Leila Beddar, Algeria in central nervous system normal tissue, F. Bouledjnib, N. Bougherra, Z. Tebbi oligodendrogliomas and glioblastomas Alejandro Rubio Fernandez, Spain 2 Sept Tuesday, 006 W. Toro Zambrano, M. López Macías, Primary sources and IHC profiles of brain I. Catalina Fernández, M. Díaz Delgado, metastases J. J. Fernández de Mera, A. Hernández Daniil Rotin, Russia Amate, A. M. Campos de Orellana, J. Sáenz O. Paklina, V. Krivopuskov de Santamaría

007 017 Expession of proteinase-activated recep- Primary well-differentiated neuroendo- tor 2 in human prion diseases crine carcinoma of the filum terminale Zdenek Rohan, Czech Republic Eva Tejerina, Spain M. Smetakova, T. Olejar, R. Matej J. M. Revuelta, D. García Fresnadillo, C. Bellas

123 Poster Presentations a Tuesday ECP 2014 · London

018 026 PS-12 Pleiotropic effects of myosin: Va mutation Calcifying pseudoneoplasm of the neu- in a rat model roaxis: Case report George Stoica, USA Emilia Minaidou, Greece G. Lungu C. Karabogias, S. Pappa, A. Kostopoulou, E. Kyrodimou, H. Zorzos, T. Choreftaki 019 Heterogeneity of Ki-67 and p53 expression 027 in glioblastomas Clinical and detailed histopathologic fea- Arvids Jakovlevs, Latvia tures of hemangioblastoma cases I. Strumfa, A. Vanags, J. Gardovskis Zubeyde Yildirim, Turkey E. Cakir, U. Kucuk, E. E. Pala, U. Bayol 020 Lipoastrocytoma of the spinal cord mim- 028 icking lipoma CD95 modified paclitaxel-loaded polylac- Arvids Jakovlevs, Latvia tic-co-glycolic acid microparticles induced I. Strumfa, A. Vanags, J. Gardovskis cell death in glioblastoma Difei Wang, United Kingdom 021 D. D. Ateh, G. Pilkington, J. E. Martin Left temporal lobe necrosis after radiotherapy for nasopharyngeal lymphoepite- 029 lioma Immunohistochemical expression of pitui- Niurka Cerda, Spain tary tumour transforming gene in menin- A. Corominas Cishek, A. Pérez, P. Cabrerizo, giomas of different WHO grade M. González, V. Caamaño, E. Andueza, Christos Poulios, Greece A. Cabrera, L. Mosteiro, L. Zaldumbide D. Kanakis, G. Karkavelas

022 030 Meningeal hemangiopericytoma: Report Primary brain tumour with abscess forma- of four cases tion: A case report Veronica Caamaño Villaverde, Spain Mihaela Mera, Romania M. González, A. Corominas, N. Cerda, D. Crisan, C. Georgiu, M. Petrescu E. Andueza, A. Pérez, L. Zaldumbide 031 023 A case of exceptionally long progression- Tumours of the pineal region: A single free survival after radiation and chemo- center review therapy in the patient with glioblastoma

Tuesday, 2 Sept Gloria Pérez-Esteve, Spain with very low MGMT expression N. Vidal, I. Ferrer, E. Condom Dmitry Matsko, Russia M. V. Matsko, E. N. Imyanitov, N. M. Volkov, 024 E. A. Zhelbunova, A. G. Ievleva, Prognostic, or not, that is the question: E. V. Zavgorodnyaya DNA Topoisomerase II alpha in WHO grade II astrocytomas 032 Rosilin K. Varughese, Norway Ligand-activated transcription factors S. H. Torp, T. Lind-Landström PPARγ and PPARα expression in human glioma 025 Harry Haynes, United Kingdom Ependymoma with diffuse signet ring fea- M. Ginty, K. Kemp, B. Ede, H. Williams, tures S. Pollard, P. White, N. Scolding, A. Wilkins, Albino Eccher, Italy K. Kurian L. Cima, G. Pinna, M. Brunelli, C. Ghimenton

124 ECP 2014 · London Poster Presentations a Tuesday

033 042 Specific cellular distribution of DNA dem- Diagnosis of polymyocytis and dermato- ethylation intermediates in smooth muscle myocytis in Formalin-fixed Paraffin- and myenteric plexus of the gastrointesti- embedded (FFPE) section: Making a PS-12 nal tract in normal bowel, myopathy and diagnostic flow chart in adult patient megarectum Ja-Hee Suh, Republic of Korea Joanne Martin, United Kingdom S.-H. Kim D. Vedage, L. Woo, L. Pratt, N. Colbeck, 043 M. Branco Chordoid glioma of the third ventricle: 034 Case report and review of the literature Asymptomatic intracranial mature tera- Radia Khedaoui, Spain toma incidentally found during autopsy H. Téllez Safina, A. M. Martín Liana Sticlaru, Romania 044 M. D. Cioplea, S. Zurac, L. Nichita, A. Primary intracranial melanocytoma with Bastian, M. Nitu, F. Staniceanu an unpredictable biologic behaviour 035 Anastasia Dimitriadi, Greece Ki-67 / MIB-1 immunostaining in human T. Zogka, C. Karabogias, H. Zorzos, meningiomas D. Katsianis, N. Georgakoulias, T. Choreftaki Anne Jarstein Skjulsvik, Norway 046 A. Kepka, S. H. Torp Case report: Primary intra-cerebral undif- 036 ferentiated spindle cell sarcoma present- Supratentorial hemangioblastoma: An ing with acute intracerebral hemorrhage. unusual case A rare clinical presentation of a rare entity Spyridon Sfikas, Greece Tom Grigor, United Kingdom E. Kyrodimou, E. Minaidou, A. Kostopoulou, T. Grigor, R. Phadke N. Gkekas, N. Georgakoulias, T. Choreftaki 047 037 Histopathological features of meningeal High-grade meningiomas: A study of 53 hemangiopericytomas and solitary fibrous cases tumours: A single institutional series Alia Zehani-Kassar, Tunisia Irune Ruiz Díaz, Spain L. Bel Hadj Kacem, I. Chelly, H. Azouz, M. D. Carmen Gómez Mateo, M. C. Caballero S. Haouet, N. Kchir Martínez, M. Rezola Bajineta, J. Comba Miranda 038 Diffuse and focal spindle cell pattern of 048 central nervous system tumours: A chal- Griscelli‘s syndrome with central nervous lenging diagnosis system haemophagocytic lymphohistocy- Dorela Lazureanu, Romania tosis A. Dema, S. Taban, M. Cornianu, D. Herman, Laura Zaldumbide, Spain

R. Cornea E. Andueza, A. Gaafar, L. Galbarriatu, 2 Sept Tuesday, E. Ruiz de Gopegui, A. Corominas, N. Cerda, 039 M. González Vadillo, V. Caamaño, A rare / under-recognized complication of M. J. Labanca, A. A. Cabrera Cantoni a very common disease: Diabetic myone- crosis – case presentation 049 Alexandra Oniga, Romania Neurocytomas: Related to oligodendro- A. Bastian, S. Zurac, G. Halcu, A. Evsei, glioma? A. Dumitru, F. Staniceanu Niurka Cerda, Spain A. Corominas Cishek, V. Caamaño, 041 M. González, E. Andueza, J. Altamirano, Diagnostic problems of cerebral infarction J. Iglesias, I. Escudero, B. Mateos, Aigul Sapargaliyeva, Kazakhstan L. Mosteiro, L. Zaldumbide U. Alsheriyeva, A. Nartayeva, B. Bastimiyeva, E. Shumkova, D. Zhanybekov, A. Oradova 125 Poster Presentations a Tuesday ECP 2014 · London

050 003 PS-12 Atypical Teratoid / Rabdoid Tumour (AT / RT), Pathological anatomy of kidneys of foetus cytological findings in 3 cases and newborns in case of pregnancy pathol- Elaine Mejía Urbáez, Spain ogy and mother‘s chronic pyelonephritis J. Alfaro Torres, C. Del Agua Camisón, Maida Tussupbekova, Kazakhstan PS-13 I. Marquina Ibañez, D. S. Rosero Cuesta, G. Imanbayeva, L. Stabayeva M. Alastuey Aisa, N. Torrecilla Idoipe, 004 A. Valero Torres, A. B. Roche Latasa, Mercury-associated nephrotic syndrome: S. Simón Portero; S. Vicente Arregui A case report and review of the literature 051 Malgorzata Wagrowska-Danilewicz, Poland Brain weight in sudden unexpected death M. Danilewicz, Z. Zbrog in infancy: No association with unex- 005 plained deaths Pathomorphology of the adaptive pro- Andrew R. Bamber, United Kingdom cesses of the great arteries based on the S. M. L. Paine, D. Ridout, T. S. Jacques, age related changes N. J. Sebire Dmitry Kozlov, Russia 052 006 Histopathological features of the pineal Sitagliptin ameliorates kidney lesions in a gland in patients who died from gastric rat model of type 2 diabetes due to anti- ulcer or duodenal ulcer complications inflammatory and anti-apoptotic effects Ganna Mylovydova, Ukraine Catarina Marques, Portugal G. Gubina-Vakulik, N. Kolousova, A. Lelytsia, C. Mega, A. Gonçalves, P. Rodrigues-Santos, S. Sushkov H. Vala, E. Teixeira de Lemos, F. Teixeira, C. Fontes-Ribeiro, F. Reis, R. Fernandes PS-13 Poster Sessions Nephropathology 007 Chairs: Candice Roufosse, United Kingdom Influence of simvastatin on angiogenesis Ingeborg Bajema, The Netherlands and interstitial fibrosis in renal allografts Stewart Fleming, United Kingdom that were under simvastatin therapy pre and post transplantation for the treatment 001 of sensitization Value of electron microscopy in the diag- B. Handan Özdemir, Turkey nosis of concurrent antibody-mediated F. N. Özdemir, G. Moray, M. Haberal rejection in post-transplant IgA nephropa- Tuesday, 2 Sept 009 thy Prognostic significance of Claudin-1 Hyeon-Joo Jeong, Republic of Korea expression in renal cell carcinoma H.-J. Kwon, M.-S. Kim, B.-J. Lim, K.-H. Huh, Hala El-Rebey, Egypt S.-I. Kim, B.-S. Kim, Y.-S. Kim H.A. Samie Aiad

002 010 Cholesterol crystal embolism as a cause of C4d immunohistochemical staining as a adult glomerulocystic kidney in a patient diagnostic tool in idiopathic membranous with papillary renal cell carcinoma nephropathy Jose Ignacio Lopez Fernandez De Abeer Altahrawi, Egypt Villaverde, Spain S. Fadda, H. Ali, S. Anis A. Corominas Cishek, E. Andueza, M. González, N. Cerda, V. Caamaño, M. J. Labanca

126 ECP 2014 · London Poster Presentations a Tuesday

011 018 Focal necrotizing glomerulonephritis with Acute humoral rejection in a renal trans- mesangial deposition of IgM and comple- plantectomy ment in a patient with infective endocardi- Maria Teresa Gonzalez Serrano, Spain PS-13 tis caused by s. viridians: A case report R. Ortega Salas, R. Sánchez Sánchez, and review of the literature M. Centeno Haro, M. Medina Pérez Yaroslav Zboromyrskyy, Spain 019 J. Gimeno Beltran, E. Rodriguez Garcia, Crescentic glomerulonephritis by antiglo- M. J. Soler Romeo, S. Serrano Figueras merular basement antibodies associated 012 with lung carcinoma Decrease tubular kidney Thy-1 expression Rosa Ortega, Spain in cisplatin treated rats with 5-aminoiso- R. Sánchez Sánchez, M. Centeno Haro, quinoline PARP inhibitor improve renal M. Espinosa Hernández, M. Medina Pérez function 020 Francisco O‘Valle, Spain Tubulointerstitial nephritis and uveitis R. Wangensteen, M. Caba Molina, syndrome: Mast cells and T-lymphocyte R. Ríos Pelegrina, A. Osuna, F. Vargas, disease R. García del Moral, M. Gómez Morales Rosa Ortega, Spain 013 R. Sánchez Sánchez, A. Hurtarte Sandoval, Phenotypic analysis of T cell subsets in M. Centeno Haro, M. Espinosa Hernández, acute kidney transplant T cell-mediated P. Aljama García rejection 021 Susan Swee-Shan Hue, Singapore Glomerular mesangiolysis with tubular R. Li, N. Yusof, C. He, D. Haase, B. Lee, damage secondary to spontaneous bilat- J. Iqbal, A. H.-Liang Loh, O. Rotzschke, eral renal subcapsular effusion: A case F. Salcido Ochoa report 014 Joon-Joon Khoo, Malaysia Smoking aggravates renal function and C.-K. Chin histology in IgA nephropathy patients 022 Hyeon-Joo Jeong, Republic of Korea Rapidly progressing glomerulonephritis Y.-J. Cha, Y.-H. Kim, B.-J. Lim preceding Extranodal NK / T cell lym- 015 phoma. An uncommon paraneoplastic syn- Impact of cytomegalovirus on angiogene- drome of a rare malignant lymphoma: Case sis in renal allografts and its association report and review of literature with interstitial fibrosis and graft survival Joon-Joon Khoo, Malaysia B. Handan Özdemir, Turkey C.-K. Chin, K.-E. Chan F. N. Özdemir, S. Sezer, E. Baskin, 023 M. Haberal Autopsy-determined causes of death fol-

016 lowing kidney transplantation 2 Sept Tuesday, The expression and significance of neu- Ebru Sebnem Ayva, Turkey ronal Iconic proteins in podocytes B. H. Özdemir, E. Akar Ozkan, A. Ok Atilgan, Zhigang Zhang, People‘s Republic of China M. Haberal Y. Sun, X. Mao, M. Guo 024 017 Structural parameters in baseline biopsies Tubular renal cell carcinoma with promi- from human kidney grafts: A quantitative nent cytoplasmic vacuolization: Report of study with 14 years follow-up two cases of a previously non described Anne R. Ellingsen, Denmark phenotype K. A. Jørgensen, R. Østerby, S. E. Petersen, Veronica Caamaño Villaverde, Spain M. Madsent, J. R. Nyengaard, N. Marcussen J. I. López, E. Andueza, M. González, N. Cerda, A. Corominas, A. Cabrera

127 Poster Presentations a Tuesday ECP 2014 · London

025 003 PS-13 EBV-positive lymphoid infiltrate in a renal Anaplastic large cell lymphoma, ALK1 (-), surveillance biopsy mimicking subclinical CD30 (+) with aberrant immunohistochem- T-cell mediated rejection ical expression of EMA and cytokeratin: A Candice Roufosse, United Kingdom case report PS-14 T. Al-Johani, M. Willicombe, J. Galliford, Dimitar Mitkov, Bulgaria A. McLean, D. Taube, R. Charif A. Vlahova, T. Dikov, E. Petrova, S. Christova, M. Mekjanov, T. Praznikova, L. Shemelekova 026 Renal arteriovenous malformation pre- 004 senting with abundant retroperitoneal Non Hodgkin‘s Lymphomas of the palatine hemorragia: A case report tonsil: A study of 52 cases Filiz Yilmaz, Turkey Olfa Lamine, Tunisia N. Erdogan, A. Igdem, S. Bektas, E. Baylan A. Gabsi, A. Goucha, S. Touati, W. Jomaa, S. Miladi, S. Gritli, A. El-May, A. Gamoudi 028 Bile cast nephropathy and association 005 with HCV-related cirrhosis Sclerosing angiomatoid nodular transfor- Michelle Foshat, USA mation of the spleen: Report of three cases H. Ruff, M. Afrouzian Wei-Chin Chang, Taiwan C.-L. Lee 029 Light chain deposition coincident with 006 fibrillary glomerulonephritis: A case report Necrotizing Lymphadenitis (NEL) is char- Hariklia Gakiopoulou, Greece acterized by blastic transformation of S. Lionaki, E. Poulaki, J. Boletis, E. Patsouris CD8+ cells and apoptosis of CD4+ cells Shigeyuki Asano, Japan 030 K. Mori, K. Yamazaki, H. Wakasa Case report: Familial medullary cystic kidney disease with an undetermined genetic 007 anomaly. An evolving genetic paradigm? Primary cardiac diffuse large B cell lym- Tom Grigor, United Kingdom phoma: A case report T. Grigor, H.-B. Smethurst, P. Johnston, Daniela Necula, Israel L. Waldron S. Aviel-Ronen, G. Schiby- Brilliant, I. Barshack, Y. Kassif, T. Davidson

PS-14 Poster Sessions 008

Tuesday, 2 Sept Haematopathology Family case of extranodal NK / T-cell lym- Chairs: Laurence de Leval, Switzerland phoma, nasal type: Case report Teresa Marafioti, United Kingdom Siona Growcott, United Kingdom Richard Byers, United Kingdom J. Pawade

001 009 The role of the micro-environment in The clinicopathological characteristies of human immunodeficiency virus-associ- lymphomas in adults of Algeria ated classical Hodgkin Lymphoma Leila Beddar, Algeria Athanasios Koulis, United Kingdom N. Bougherra, T. Seraoula, Z. Tebbi P. Trivedi, H. Ibrahim, M. Bower, 010 K. Naresh Fatal Kikuchi-like necrotising lymphadeni- 002 tis associated with connective tissue dis- Primitive intestinal lymphomas: Epidemio- ease logical, clinical and pathologic study of 10 Vijay Sharma, United Kingdom cases R. Rankin Issam Msakni, Tunisia E. Bouhajila, R. Silini, B. Laabidi, F. Bougrine, A. Bouziani

128 ECP 2014 · London Poster Presentations a Tuesday

011 019 Particular case of Burkitt lymphoma Identification of unfavourable paired cell Lucian Ceacaru, Romania interactions in follicular lymphoma using H. Urechescu, E. Ianes, D. Lazar, C. Solovan, Hypothesized Interaction Distribution (HID) PS-14 F. Baderca analysis Lilli Nelson, United Kingdom 012 J. Mansfield, R. Lloyd, K. Linton, C. Rose, Spontaneous rupture of the spleen on a R. Byers patient with splenic hemangiomaand multiple cystic lesions in kidney and liver: 023 Case report and literature review Clinicopathologic features of mycosis fun- Andreea Iliesiu, Romania goides: A comparative retrospective study O. C. Ciornenchi, M. Sajin, A. V. Dumitru, Triantafyllia Koletsa, Greece O. Patrascu, R. Z. Ionescu A. Patsatsi, D. Sotiriadis, G. Raptou, I. Kostopoulos 013 Solitary lesion of subcutaneous pannicu- 024 litis-like T cell lymphoma in a case of a Blastic plasmacytoid dendritic cell neo- 18-months year-old boy plasm, a fatal case Monica-Gheorghina Weber, Romania Macarena Centeno, Spain E. I. Vana, D. Gheban A. González Menchen, C. Pérez- Seoane Orduña, R. Sánchez Sánchez, T. Caro 014 Cuenca, R. Ortega Salas, E. Fuentes A case of sinonasal extranodal nk / t-cell Vaamonde, J. Salvatierra Cuenca, lymphoma with indolent behaviour and T. González Serrano, M. Medina Pérez low-grade morphology Valentina Tabanelli, Italy 025 E. Sabattini, R. Valli, M. Zanelli, S. Righi, Nonmediastinal Castleman Disease: Docu- A. Gazzola, C. Mannu, S. Pileri mentation of seven cases Umit Bayol, Turkey 015 E. E. Pala, E. Usturali Keskin, O. Sezer, Quantitative image analysis of the MIB-1 G. Akoz proliferation index in non Hodgkin Lym- phoma and its correlation with semiquan- 027 titated values and survival Splenic hamartoma: Remembering a rare Nairi Tchrakian, Ireland benign mimicker T. Nehhozina, L. Daly, R. Flavin Marco Ferreira, Portugal G. Gasparinho, M. Reis 016 Autoimmune Lymphoproliferative Syn- 028 drome (ALPS) presenting in adulthood. T HHV-8 and HIV negative Castleman‘s Dis- cell clonal expansion should not be inter- ease preted as evidence of lymphoma! Arnis Abolins, Latvia

Patrick Shenjere, United Kingdom M. Abolina, I. Strumfa, S. Nikulsins, 2 Sept Tuesday, G. Hall, L. Menasce, M. Helbert J. Gardovskis

017 029 An exceptional case of synchronous B-Cell Bone marrow manifestations in Multicen- Lymphocytic Leukemia (BCLL) and meta- tric Castleman Disease static invasive ductal carcinoma of the Hazem Ibrahim, United Kingdom breastin axillary lymph nodes K. Naresh, M. Bower, K. Balachandran Olympia Tzaida, Greece 030 G. Mitropoulou, M. Kotsopoulou, E. Trichia, Inflammatory pseudotumour-like follicular D. Papagiannopoulou, C. Valavanis dendritic cell sarcoma of the spleen Alia Zehani-Kassar, Tunisia I. Chelly, H. Azouz, W. Rekik, S. Haouet, N. Kchir 129 Poster Presentations a Tuesday ECP 2014 · London

031 040 PS-14 EBV driven lymphoproliferative disorders Unusual presentation of indolent T-cell in patients with treated Inflammatory lymphoproliferative disease of the gastro- Bowel Disease (IBD): Presentation of two intestinal tract involving full thickness of distinct entities with prognostic and thera- the colon peutic significance Ji-Yun Jeong, Republic of Korea Isabel Woodman, United Kingdom G.-S. Yoon, T.-I. Park, Y.-H. Ko D. Chambers, J. Schofield 042 032 Chronic lymphocytic leukemia and Crystalline inclusions in IgG lambda Hodgkin´s Disease involving the bone restricted plasma cell myeloma: A case marrow: A case report of a variant of report Richter´s Syndrome Ana Costa Braga, Portugal Leda De Carvalho, Brazil R. S. S. Oliveira, R. de Mora Féria, M. Angel F. Fernandes Silva Zacchi, A. Freire Sandes, Campo, S. Loureiro dos Santos C. S. Chiattone, A. Chiattone

033 043 Inguinal lymph nodes enlargement: A case Intranodal Palisaded Myofibroblastoma report in a pregnant woman (IPM) (intranodal hemorrhagic spindle cell Ana Costa Braga, Portugal tumour with amianthoid fibers) affecting R. S. S. Oliveira, R. de Mora Féria, M. Angel multiple lymph nodes Campo, S. Loureiro dos Santos Eirini Papaspirou, Greece D. Vlachos, K. Katsos, C. Poulou, 034 P. Katafygiotis Langerhans cell histiocytosis: An autopsy case report 044 Ana Costa Braga, Portugal Primary non-Hodgkin ovarian lymphoma R. de Mora Féria, R. S. S. Oliveira, M. Angel Eirini Papaspirou, Greece Campo, S. Aparício, S. Loureiro dos Santos M. Chantziara, D. Riga, D. Vlachos, C. Poulou, P. Katafygiotis 035 ALK positive large B-cell lymphoma: A 045 rare diagnostic pitfall A retrospective analysis of head and neck Patrick Shenjere, United Kingdom extranodal lymphomas at a Tertiary Can- A. Yates, L. Menasce cer Centre Olivia McKinney, United Kingdom

Tuesday, 2 Sept 037 R. Kurian, S. Di Palma, S. Whittaker, Plasmablastic lymphoma of the ileum in an I. Bagwan immunocompetent patient Jennifer Costa, Portugal 046 A. Canelhas, P. Pereira Plasmablastic lymphoma: An entity with a challenging differential diagnosis 038 Ana María Gutiérrez Pecharromán, Spain Unique extranodal-thyroidal presentation E. Romio, M. E. Reguero, A. Santón, of NLPHL in a 38 year-old female patient M. García Cosío with Hashimoto thyroiditis Zarifa Yusifli, Turkey 047 O. Ozkayar, S. Aksoy, A. Uner Potential prognostic and predictive factors in diffuse large B-cell lymphoma 039 Patrik Flodr, Czech Republic Langerhans‘ Cell Histiocytosis in an infant P. Latalova, M. Tichy, Z. Kubova, T. Papajik, manifested as lymphadenopathy M. Svachova, L. Radova, M. Jarosova Ebru Sebnem Ayva, Turkey E. Akar Ozkan, B. H. Özdemir

130 ECP 2014 · London Poster Presentations a Tuesday

049 057 Variation and distribution of mast cells in P53 expression in myelodysplasia benign and malignant lymphoid lesions Jodie Chalmers, United Kingdom Mirela Daniela Cioplea, Romania J. Pawade, U. Johansson, T. Clench PS-14 S. Zurac, L. Sticlaru, S. Dutulescu, A. Stan, 058 C. Popp, A. Oniga, G. Pop, M. Tevet, V. Chitu, EBV-associated Inflammatory pseudo F. Staniceanu tumour like follicular dendritic cell sar- 050 coma of the spleen Establishment and characterization of new Maria Pané Foix, Spain Diffuse Large B-Cell Lymphoma (DLBCL) L. Ferrazza Martín, F. Climent Esteller, cell lines, cell line-based and primary M. López Zambrano DLBCL cell-based mouse xenograft mod- 059 els Study of a histiocytic sarcoma Radek Jaksa, Czech Republic Nerea Torrecilla, Spain L. Lateckova, P. Vockova, M. Klanova, C. Hörndler, E. Mejia, D. Rosero, P. Dundr, M. Trneny, P. Klener M. Alastuey, A. Valero, B. Roche, S. Simon, 051 E. de Alava, M. González TCR clonality and IRF4 translocation: Two 060 useful tools to identify aggressive transfor- Blastic plasmacytoid dendritic cell neo- mation of Mycosis Fungoides (MF) and plasm Cutaneous Anaplastic Large Cell Lym- Joana Pardal, Portugal phoma (C-ALCL) J. Pinheiro, E. Fonseca José Luis Subirats, Spain J. L. Mate, A. Muñoz, J. Alvaro, M. Martín, 061 A. Ariza MALT type lymphoma associated with Hashimoto‘s Thyroiditis 052 Renata Dias, Portugal Post-transplant lymphoproliferative dis- F. Moreno, A. Duarte ease, type II enteropathy associated intestinal T-cell lymphoma in patient with renal 062 transplant CD4+ / CD56+ hematodermic neoplasm Ana Teijo Quintans, Spain presenting in the skin: A Tunisian case report and current review of the literature 053 Achour Bechir, Tunisia Cerebellar lymphoma: Recurrence after 20 H. Regaieg, N. Ben Sayed, E. Bouslema, years Y. Ben Youssef, B. Sriha, S. Hmissa, Zafer Kucukodaci, Turkey M. T. Yaacoubi, A. Khelif G. Narli, I. Yilmaz, U. Berber, D. Demirel 063 054 Nasopharyngeal / nasal type NK / T lym- MYC testing by FISH in diffuse large B-cell phoma: Analysis of 23 cases and current lymphomas in a West of Scotland popula- 2 Sept Tuesday, review of the literature tion Achour Bechir, Tunisia Victoria Lynch, United Kingdom H. Regaieg, N. Ben Sayed, E. Bouslema, J. Mac Mahon, M. Leach, R. Jackson Y. Ben Youssef, B. Sriha, S. Hmissa, 055 M. T. Yaacoubi, A. Khelif In vitro study of 15-Deoxy-D12,14-Prosta- 064 glandin J2 as an antineoplastic agent in Primary testicular lymphoma: A study of terms of oxidative stress 11 cases Marcelo Sperandio, Brazil Achour Bechir, Tunisia A. P. Demasi, E. Martinez, A. Duarte, H. Regaieg, N. Ben Sayed, M. Romdhani, F. Pericole, S. Saad, N. S. Araújo, Y. Ben Youssef, B. Sriha, S. Hmissa, V. C. Araújo, M. Napimoga M. T. Yaacoubi, A. Khelif

131 Poster Presentations a Tuesday ECP 2014 · London

065

PS-14 PS-15 Poster Sessions Human herpes virus 8 related Castleman Other Topics Disease and Kaposi Sarcoma: A case Chairs: Fred Bosman, Switzerland report in a HIV negative patient Pierre Bedossa, France Caetano Oliveira, Portugal

PS-15 Fátima Carneiro, Portugal C. Abrantes, P. Rodrigues, M. J. Julião, L. Prado e Castro 001 066 Evaluation of the histological changes in Clinico-pathological study of 6 cases of an experimental model of cardiopulmo- HIV / AIDS associated lymphomas nary contusion Horvath Emoke, Romania Svitlana Bachurska-Yovcheva, Bulgaria N. Elod Erno, K. Iringo, C. Liliana, T. Mihai I. Novakov, D. Staykov, D. Delev

067 002 Antimyeloma in vitro activity of 15-deoxy- The risk level associated with the use of delta12,14-prostaglandin J2 is associated formaldehyde in laboratories of pathology with endoplasmic reticulum stress Issam Msakni, Tunisia Ana P. Demasi, Brazil A. Ben Chaabane, A. Gasmi, B. Laabidi, M. Napimoga, E. Martinez, A. Duarte, F. W. Ajouli, F. Bougrine, A. Bouziani Pericole, S. Saad, M. Sperandio, N. Araújo, 004 V. Araujo Results of pathology review at the Institut 068 National d‘Oncologie of Rabat (Morocco) Essential thrombocythemia and multiple Mariam Amrani, Morocco myeloma in the same patient: About one H. Hachlef, R. Elochi, H. Elouazzani, case N. Mansouri, N. Tazi Haifa Ragaieg, Tunisia 005 B. Achour, N. Ben Sayed, E. Bouslema, Case presentation of a primary low grade Y. Ben Youssef, B. Sriha, S. Hmissa, leiomyosarcoma of left femur with final M. T. Yaacoubi, A. Khelif diagnosis after immunohistochemistry 069 Doina Pop, Romania Follicular lymphoma: A retrospective study F. Pop Haifa Ragaieg, Tunisia 006 B. Achour, M. Romdhani, N. Ben Sayed, Detecting chemical modification on tis- Y. Ben Youssef, B. Sriha, S. Hmissa,

Tuesday, 2 Sept sues by scanning acoustic microscopy M. T. Yaacoubi, A. Khelif Katsutoshi Miura, Japan 070 H. Fukamizu, S. Yamamoto Primary Cutaneous follicular B lymphoma 009 Haifa Ragaieg, Tunisia Histopathological evaluation of farm ani- B. Achour, N. Ben Sayed, E. Bouslema, mals living near a uranium mine as senti- Y. Ben Youssef, B. Sriha, S. Hmissa, nels of human‘s exposure and health M. T. Yaacoubi, A. Khelif hazards Joana Lourenço, Portugal S. Marques, H. Vala, F. Esteves, F. Carvalho, R. Pereira, S. Mendo

010 Immunofluorescence method to detect apoptotic events in the duodenum after a situation of hypoperfusion – preliminary results Ana Liza Ortiz, Spain H. Vala, C. Garcia, R. Cruz, C. Venâncio, A. Silva, D. Ferreira 132 ECP 2014 · London Poster Presentations a Tuesday

011 019 Characterising changes in the immune cell The Dako Omnis platform: An automated population of the tumour microenviron- in situ hybridization solution ment following treatment with external David Hersi Smith, Denmark PS-15 beam ionising radiation and a TLR7 ago- M. Ruvolo, S. H. Matthiesen, M. Lindberg, nist M. Larsen, L. Kofoed, S. Teilmann Charlotte Pollard, United Kingdom 020 A. Adlard, J. Honeychurch, T. Illidge, Littoral cell angioma of the spleen S. Dovedi Vesna Stitic, Slovenia 012 T. Bujas, R. Kavalar Primary angiosarcoma of the spleen: An 021 oncological enigma Autopsy examination and removal of the Despoina Myoteri, Greece skull base structures: The pituitary gland G. Mitropoulou, A.-I. Ieronimaki, Santiago Ortiz, Portugal E. Arkoumani, A. Zizi-Sermpetzoglou F. Tortosa 013 022 Osteosarcoma study of 81 cases Mitochondrial DNA analysis of formalin- Wahiba Ouahioune, Algeria fixed paraffin-embedded tissue samples: Y. Yousfi, L. Benrezki Effect of formalin on DNA stability and its 014 implications in genetic studies Vasoactive intestinal peptide gene-trans- Zulma Soraya Quintero Niño, Spain fected mesenchymal stem cells improve S. Cardoso, X. Elcoroaristizabal, I. Guerra histopathological features of peripheral Merino, M. Martinez de Pancorbo nerve regeneration in rat model 023 Francisco O‘Valle, Spain Hyperacute aspergillus infection after car- M. Toledo Romero, R. Gómez Sánchez, diac transplantation M. Delgado, M. Aguilar, V. Crespo Lora, Macarena Centeno, Spain M. D. Rodríguez Martínez, M. Cámara, T. Caro Cuenca, R. Sánchez Sánchez, F. Martín, P. Hernández Cortés M. Medina Pérez 015 024 Vasoactive intestinal peptide reduces the Towards the application of Raman spec- severity of atherosclerotic plaques in troscopy in colorectal cancer diagnostics acute and chronic models of apolipopro- Riana Gaifulina, United Kingdom tein E-deficient mice K. Lau, M. Rodriguez-Justo, G. Rhys Lloyd, Francisco O‘Valle, Spain C. Kendall, G. Thomas V. Delgado Maroto, M. L. Vizoso, J. A. Retamero, J. F. González Sanchez, 025 J. Aneiros Fernández, D. Aguilar, F. Martín, Peritoneal mesothelioma: Clinopathologi- P. Hernández Cortés, M. Delgado cal study of 32 cases Tuesday, 2 Sept Tuesday, Juan C. Tardío, Spain 016 R. Khedaoui, H. Téllez, G. Ortega, Acquiring diagnostic experience in renal R. Granados neoplastic pathology through HIPON web course 026 Eleftheria Lakiotaki, Greece Poland syndrome and Osteoblastoma: A C. Vrasidas, G. Armenski, L. Brcic, I. Brcik, case report A. Smeets, G.-E. Thomopoulou, S. Seiwerth, Eranga Nissanka-Jayasuriya, United Kingdom H. van Krieken, A. C. Lazaris J. van der Walt 017 A review on bariatric surgeries Sivesh Kathir Kamarajah, United Kingdom

133 Poster Presentations a Tuesday ECP 2014 · London

027 036 PS-15 Up regulation of E2F1 is a determinant of Qualitative histopathological analysis of dismal outcome in non Hodgkin‘s Lym- compact bones exhumed in tropical cli- phoma of Egyptian patients without rela- mate for forensic purposes tionship to SV40 Rafael Astolphi, Brazil Rehab Samaka, Egypt V. Eduardo Arias, M. A. Guimarães, M. Kandil, N. Asaad, H. A. Samie Aiad, R. Arrabaça Francisco, R. Barrios Mello, N. Houla A. Carlos Souza, M. R. Regis Silva, E. Iwamura 028 Desmoplastic fibroma of the rib: A case 037 report Curcumin inhibits IL1ß-induced VEGF Leda De Carvalho, Brazil expression in chondrosarcoma cells G. G. R. Monteiro, F. F. H. Khodr, Norbert Nass, Germany F. B. Bolfarini, G. C. Del Gerra, D. Ramos, A. Roessner, T. Kalinski A. G. A. Aranha 038 029 Post radiation periosteal osteogenic sar- Autopsy investigation of complications coma radiologically simulating conven- after radiofrequency ablation for atrial tional osteogenic sarcoma fibrillation Shamlal Mangray, USA Keluo Yao, USA N. Shillingford, E. Yakirevich, R. Terek C. Zola, P. Allenby, C. Hitchcock, R. Ziegler, 039 B. Miller, M. Ball, S. Brodsky Lobar holoprosencephaly in a 22 week 030 gestational age fetus autopsy with histo- Pathomorphological aspects of thermal logical evidence of agenesis of the septum trauma pellucidum Tatyana Pavlova, Russia Guillermo Mendoza, Spain V. Markovskaya, I. Bashuk, D. Kolesnikov H. E. Torres Rivas, A. Astudillo Gonzalez, M. Fresno Forcelledo 031 A pigmented Squamous Cell Carcinoma 040 (SCC) of the skin: A case report An incidental perivascular epithelioid cell Dimitra Koumoundourou, Greece neoplasm arising in a pelvic lymph node P. Mposgana, M. Gkermpesi, P. Ravazoula Anshuman Chaturvedi, United Kingdom S. Nicholson, M. Scott

Tuesday, 2 Sept 032 The influence of nanoparticles on biologi- 041 cal objects Local amyloidosis in the oral cavity in Tatyana Pavlova, Russia patients with metabolic syndrome A. Nesterov, L. Pavlova, I. Bashuk, Margarita Rybakova, Russia I. Goncharov, D. Kolesnikov L. Orekhova, A. Barmasheva, I. Kuznetsova

034 042 MMP-9 expression in odontogenic cysts Giant epidermoid cyst of the spleen: and tumours Report of a case Aleksandra Sejda, Poland Mehmet Lari Gedik, Turkey A. Starzynska, T. Szmuda, W. Biernat U. M. Yildiz, N. Erdogan, O. Z. Öner, F. N. Köksoy 035 Abnormal protein deposits in the gastric 043 wall predispose to Mallory-Weiss Syn- Polyarteritis nodosa presenting as orcheoe- drome pididymitis Vadim Baykov, Russia Anastasia Dimitriadi, Greece I. Kuznetsova, K. Solovyev N. Chaleplidis, F. Platsouka, A. Elafros, E. Papaliodi

134 ECP 2014 · London Poster Presentations a Tuesday

044 003 Six year review including autopsy analysis Vilem Dusan (Fedorovich) Lambl: Interna- of in-hospital deaths after Neck of Femur tional and inspiring (190th anniversary of fracture birth) PS-17 Dafydd Locker, United Kingdom Jaroslava Duskova, Czech Republic T. Manakova 046

A simple and cost-effective method to PS-16 identify axillary lymph nodes in specimens PS-17 Poster Sessions from breast cancer patients after neoadju- IT in Pathology vant chemotherapy Chairs: Konradin Metze, Brazil

Savelina Popovska, Bulgaria Marius Nap, The Netherlands PS15 I. Ivanov Rifat Hamoudi, United Kingdom

047 003 Chondroblastoma: Review of fifty-five cases Two and three dimensional reconstruction Basak Doganavsargil, Turkey of the anal sphincters to aid low rectal can- M. Argin, B. Kececi, M. Sezak, cer surgery B. Pehlivanoglu, G. Basdemir, F. Oztop Claire Walklett, United Kingdom 048 N. Roberts, M. Hale, D. Magee, D. Treanor, Histological findings in decomposition; P. Quirke, N. West Implications for conclusions drawn at 005 autopsy A new biobank concept to optimize the Renan De Menezes, United Kingdom quality of data-rich specimens W. Heywood, K. Mills, N. J. Sebire, Hinrich B. Winther, Germany A. R. Bamber C. Brochhausen, M. Brochhausen, 050 U. Topaloglu, C. J. Kirkpatrick Could fungi be incriminated in tumorogen- 006 esis? Or could fungi eat thus treat A new tool to search tumour samples for tumours? research across Europe: BIOPOOL Wafa Koubaa Mahjoub, Tunisia Mónica Saiz, Spain H. Selmani, R. Jouini, M. Bel Haj Salah, O. Belar, B. de Jong, M. Kap, A. Bereciartua, M. N. Labbene, O. Khayat, E. Ben Brahim, R. Ruiz, A. Viguri, R. Rezola, E. De Miguel, A. Chadli Debbiche, A. Chouchen A. Saiz, S. Fernández, A. Gaafar, B. Catón, J. Aguirre, M. Doukas, E. Muñoz, F. Gandon, PS-16 Poster Sessions P. Riegman, R. Bilbao History of Pathology 007 Chairs: Gabriella Nesi, Italy Detection of aneuploidy by flow cytometry Nick A. Wright, United Kingdom and fluorescence in situ hybridization in the diagnosis of malignant pleural effusion 001 2 Sept Tuesday, Débora Rosolen, Brazil Conceptual duality of the term „disease“ A. R. N. Dutra, G. Bottura, V. Martins, in the history of medicine – a key to under- V. L. Capelozzi, F. S. Vargas, L. Antonangelo standing of diseases Alexandr Ivantsov, Russia 008 M. Kleshchov Autofluorescence reduction and cross-talk correction in a whole-slide digital pathol- 002 ogy system Influence of culture of the societies on the James Mansfield, USA prevalence of diseases C. Hoyt, K. Johnson, P. Miller Alexandr Ivantsov, Russia M. Kleshchov 009 Electronic skin cancer reporting Michael Eden, United Kingdom

135 Poster Presentations a Tuesday ECP 2014 · London

007

PS-18 PS-18 Poster Sessions Determination of S100A8 and A9 expres- Ophthalmic Pathology sion in ptergium Chairs: Geeta Vemuganti, India Betül Ünal, Turkey Sarah Coupland, United Kingdom G. Ö. Elpek, H. D. Ilhan, C. I. Bassorgun, N. Erin 001 We see mainly what we look for: Plasma 008 cell neoplasm presenting as a retinal Genetic factors of Pseudoexfoliation (PEX) tumour: Report of a case syndrome Lyubomira Dimitrova, Bulgaria Margarita Papadopoulou, Greece T. Dikov, A. Vlahova, D. Todorieva V. Zolota, E. Papadaki, E. Geropoulou, S. Gartaganis 002 Conjunctival fibroma 009 Jose Carlos Lopez, Spain Teratoma for an eye: A case of a congenital N. Fernandez, J. Cuevas cystic teratoma Rita de Mora Féria, Portugal 003 A. Costa Braga, R. S. S. Oliveira, C. Alves, Acute Head Trauma: Beta-Amyloid Precur- M. Angel Campo, S. Loureiro dos Santos sor Protein (beta-APP) and ubiquitin immunohistochemical staining of the ret- 010 ina and optic nerve in traumatic and non- CD68 positive corneal cells may play a role traumatic pediatric deaths in pathogenesis of keratoconus Robert Verdijk, The Netherlands Eiman Adel Hasby, Egypt B. Bais, W. Karst, B. Kubat H. A. Saad

004 011 Biopsy-proven recurrence of unilateral Ocolarmelanoma: A retrospective series of IgG4-related orbital inflammation after 20 6 cases years Meriem Boughattas, Tunisia Robert Verdijk, The Netherlands S. Mistiri, S. Fouli, N. B. Abdejlil, P. Heidari, W. van den Bosch, D. Paridaens E. Boudebous, M. Belhaj, M. Mokni

005 012 The prognostic value of extraocular exten- Investigation of the impact of nerve sion in relation to monosomy 3 and gain of growth factor intravitreal administration

Tuesday, 2 Sept chromosome 8q in uvealmelanoma on ganglion cell degeneration in an exper- Robert Verdijk, The Netherlands imental model of elevated intraocular J. van Beek, A. Koopmans, J. Vaarwater, pressure J. de Rooi, D. Paridaens, N. Naus, George Agrogiannis, Greece A. de Klein, E. Kilic A. Karydis, L.-M. Korou, E. Doukiantzakis, I. Doulamis, T. Panagiotis, V. Ioannis, N. 006 Kavantzas, D. Perrea, E. Patsouris Lacrimal sac tumours in Manchester: A 12 year review Luciane Irion, United Kingdom R. Bonshek, A. Dharmasena, J. Yu, A. Cook, S. Attaullah, A. Sadiq

136 ECP 2014 · London Poster Presentations a Wednesday e Wednesday, 3 September 2014 009 High expression of protein tyrosine kinase 7 significantly associates with invasive-

PS-19 Poster Sessions PS-19 ness and poor prognosis in intrahepatic Digestive Diseases Pathology III: Liver / cholangiocarcinoma Biliary Yue Wang, Republic of Korea Chairs: Stefan Hübscher, United Kingdom J. Jin, H.-S. Ryu, K.-B. Lee, J.-J. Jang Uta Drebber, Germany Massimo Pignatelli, United 010 Kingdom Clinicopathologic implications of sonic hedgehog pathway activation on remnant 001 extrahepatic bile duct of biliary atresia Digital image analysis and immunohisto- Hyun-Ah Shin, Republic of Korea chemistry in estimation of fibrosis in HCV H.-Y. Jung, K.-B. Lee, J.-J. Jang chronic Hepatitis 012 Dina Abdallah, Egypt A study of vimentin, p53, ki67 and CD44 P. Salem expression in surgically resected pancre- 003 atic ductal adenocarcinoma Unusual retroperitoneal tumours as malig- Despoina Myoteri, Greece nancy mimics: Two cases of pancreatic A.-I. Ieronimaki, E. Arkoumani, heterotopia and a 15-year surgical pathol- G. Mitropoulou, A. Zizi-Sermpetzoglou ogy review 013 Rani Kanthan, Canada CD10 expression in carcinomas of the pan- J.-L. Senger, R. Chibbar, S. Kanthan creas, bile duct and ampulla 005 Abed Zaitoun, United Kingdom Pigmented hepatocellular carcinoma with S. Storr, S. Madhusudan, D. Lobo, A. Arora beta-catenin mutation and serum amyloid 014 A expression Evaluation of epithelial and stromal com- Lara Neves Souza, United Kingdom ponent in pancreatic ductal adenocarci- R. Martino, R. Thompson, S. Strautnieks, noma P. Foskett, N. Heaton, A. Quaglia Oxana Paklina, Russia 006 G. Setdikova, D. Rotin Pimary monophasic synovial sarcoma of 015 the liver: Case report Secondary (metastatic) tumours of pan- Daniil Rotin, Russia creas E. Moroz, A. Stroganova Oxana Paklina, Russia 007 G. Setdikova, D. Rotin Clinical and pathologic features of 45 amp- 016 ullary adenocarcinomas True (primary) intraductal tumours of the Iraklis Perysinakis, Greece pancreas E. Minaidou, V. Leontara, E. Papaliodi- Oxana Paklina, Russia Peroulaki, H. Tsipras, I. Margaris, G. Setdikova, D. Rotin, E. Gordienko G. Kouraklis 017 008 Ultrastructural findings solid: Pseudopap- Immunohistochemical pattern in ampul- illary tumour of the pancreas and granu- lary cancer losa cell tumours of the ovary (adult type) Iraklis Perysinakis, Greece Elena Gordienko, Russia V. Leontara, E. Minaidou, E. Papaliodi- O. Paklina, I. Chekmareva, D. Rotin, Peroulaki, H. Tsipras, I. Margaris, G. Setdikova G. Kouraklis Wednesday, 3 Sept Wednesday,

137 Poster Presentations a Wednesday ECP 2014 · London

018 027 PS-19 Renal cell carcinoma metastatic to the Comparison of clinicopathological fea- ampulla of Vater: Case report and review tures of pancreatic solid pseudopapillary of the literature neoplasm in men and women Francesca Sarocchi, Italy Kenichi Hirabayashi, Japan M. Gilg, F. Schreiber, R. Fiocca, C. Langner A. Maruno, S. Kurokawa, N. Nakamura

019 028 Primary mesenchymal tumours of the pan- Prognostic significance of hormonal creas: Single-center experience over 16 expression in pancreatic neuroendocrine years tumour (PanNET) Joo-Young Kim, Republic of Korea Joo-Young Kim, Republic of Korea J.-S. Song, H.-S. Park, J.-H. Byun, K.-B. Song, K.-S. Kim, K.-B. Song, H.-J. Jang, E. Yu, K.-P. Kim, S.-C. Kim, S.-M. Hong S.-C. Kim, S.-M. Hong, J. Y. Park

020 029 Dieulafoy‘s Disease of the gallbladder CD99 paranuclear dot staining pattern: A Abed Zaitoun, United Kingdom diagnostic marker of Solid Pseudopapillary J. M. Wu, I. Beckingham Neoplasm (SPN) of pancreas Roopa Paulose, India 022 A. Rajendran, A. Jojo Malignant gangliocytic paraganglioma of the ampullary region: A case review 030 Marjan Micev, Serbia Correlation between the mucin expression J. Jotanovic, M. Cosic Micev, A. Djikic Rom, profile and the malignant potential of M. Bjelovic, B. Popovic, D. Macut intraductal papillary mucinous tumours of the pancreas 023 Katalin Borka, Hungary Infection with Fasciola hepatica mimick- B. Tihanyi, B. Barkaszi, L. Nehéz, ing liver tumour L. Harsányi, T. Tihanyi, J. Tímár Viviane Trak-Smayra, Lebanon L. Menassa-Moussa, F. Daniel, O. Helwé, 031 C. Sader-Ghorra Diagnosis of suspected benign liver lesions lacking the Magnetic Resonance Imaging 024 (MRI) diagnostic features of Focal Nodular Pancreatic ductal adenocarcinoma with Hyperplasia (FNH): An eight years single foamy gland pattern: A case report center experience of 45 biopsied lesions Viviane Trak-Smayra, Lebanon Aurelie Sannier, France R. Noun, S. Naderi, C. Sader-Ghorra J. Cazejust, M. Lequoy, O. Scatton, 025 O. Rosmorduc, D. Wendum Morphological analysis of human cirrhotic 032 livers Histopathologic changes of bile duct after Peter Nagy, Hungary biliary instrumental insertion: Review of A. Rókusz, D. Veres, E. Nagy, K. Dezso, 139 consecutive pancreaticoduodenec- A. Szucs, E. Bugyik, V. Szabó, S. Paku tomy cases 026 So-Yeon An, Republic of Korea Extrahepatic primary Hepatocellular Car- H. Park, E.-S. Yu, S.-M. Hong Wednesday, 3 Sept cinoma (HCC) with stem cell features 033 Shreya Raman, United Kingdom Correlation between liver biopsy and clini- B. Haugk cal liver function: A series of 90 cases Fethi Bougrine, Tunisia N. Mansouri, I. Msakni, B. Laabidi, F. Ben Abdallah, M. Yahia, A. Bouziani

138 ECP 2014 · London Poster Presentations a Wednesday

034 041 A very rare case of inflammatory myofibro- Phenotypic characterization of early bil- blastic tumour arising in the gallbladder iary carcinomas Carlos Abrantes, Portugal Toshihiro Haga, Japan PS-19 M. R. Silva, M. A. Cipriano, L. Prado e Castro T. Yoshizawa, H. Hirai, M. Takatsuna, H. Seino, Y. Wu, S. Morohashi, H. Kijima 035 A case of mixed hepatocellular carcinoma 042 and cholangiocarcinoma in a 59 years-old CD4 and CD8 lymphocytes in the liver male tumoural microenvironment Guillermo Mendoza, Spain Simona-Eliza Giusca, Romania H. E. Torres Rivas, C. Garcia Pravia, A. Grigoras, I.-D. Caruntu, R. E. Avadanei L. Fernández Fernández, M. Fresno 043 Forcelledo Vascular and ductal elastotic changes in 036 pancreatic cancer Synchronous serous cystadenoma of the Eleftheria Lakiotaki, Greece pancreas and abdominal pseudocyst: A S. Sakellariou, K. Evangelou, G. Liapis, case report I. Delladetsima Umit Bayol, Turkey 044 G. Akoz, M. Uncel, D. Ayaz, V. Erol Immunohistochemistry utility in pancreatic 037 intraepithelial neoplasia PIVKA-II for prediction of microvascular Cornelia Amalinei, Romania invasion in hepatocellular carcinomas L. Knieling, A. Grigoras, D. Bulgaru-Iliescu, Nicolas Poté, France S.-E.Giusca, I.-D. Caruntu F. Cauchy, M. Albuquerque, H. Voitot, 045 J. Belghiti, L. Castera, H. Puy, P. Bedossa, Olfactomedin 4 expression is associated V. Paradis with less aggressive behaviour of the 038 extrahepatic bile duct carcinomas Small-cell carcinoma of the gallbladder: A Sun-Young Jun, Republic of Korea case report and literature review S.-Y. An, J.-Y. Chung, E.-S. Yu, S.-M. Hong Mónica Saiz, Spain 046 E. García, A. Corominas Cishek, N. Cerda, Liver focal nodular hyperplasia in 2 month M. González, V. Caamaño, E. Andueza old child with diaphragmatic hernia 039 Magdalena Bialas, Poland A study of primary hepatic vascular W. Szczepanski, G. Dyduch, K. Okon tumours in adult and paediatric population 047 with emphasis on diagnostic, prognostic Immunohistochemical study of proliferat- and treatment issues ing bile duct epithelium in chronic liver Mukta Ramadwar, India disease M. Bal, K. Deodhar, S. Qureshi, M. Goel, Sun-Jae Lee, Republic of Korea S. Medhi, S. Arya, N. Ashwini, I. Arora W.-J. Sung, H.-K. Oh, C.-H. Cho, J.-B. Park, 040 Y.-I. Maeng, J.-Y. Jeong, K.-K. Park A problematic case of unclassified multi- 048 cystic biliary tumour with adenofibroma Neoadjuvant therapy in resectable and features borderline pancreatic adenocarcinomas Gülsum Özlem Elpek, Turkey Luis Pérez Casanova, Spain B. Ünal, C. I. Bassorgun, E. Ayik T. Serrano, J. Fabregat, C. Valls, B. Laquente, E. Condom Wednesday, 3 Sept Wednesday,

139 Poster Presentations a Wednesday ECP 2014 · London

049 056 PS-19 Augmenter of Liver Regeneration (ALR) The influences on apoptosis and nitric gene expression in human colon cancer oxide synthase of tadalafil and pentoxifyl- cell lines and clinical tissue samples line on liver ischemia / reperfusion injury Stamatios Theocharis, Greece Sibel Bektas, Turkey M. Mantzourani, C. Giaginis, A. Giagini, K. Karakaya, M. Can, B. Bahadir, B. Güven, E. Patsouris, G. Kouraklis, E. Gatzidou N. Erdogan, S. O. Ozdamar

050 057 Elevated Pregnane X Receptor (PXR) and Glomus tumour of the pancreas: A case Retinoid X Receptors (RXRs) expression is report associated with less tumour aggressive- Santiago Ortiz, Portugal ness in patients with pancreatic adenocar- R. Luis, A. Alves, M. Ferreira, A. Ribeiro, cinoma R. Fonseca, P. S. de Oliveira, H. Nogueira Stamatios Theocharis, Greece 058 I. Koutsounas, C. Giaginis, A. Zizi, Immunohistochemical mucin profiles and E. Patsouris, G. Kouraklis control proteins in relation with survival 051 between intraductal papillary mucinosus CDX2 in diagnosis of pancreatic ductal pancreatic neoplasm and conventional adenocarcinoma ductal adenocarcinoma Khadija Bellil, Tunisia Ana Belen Roche, Spain M. Néji, W. Ajouli, A. Dhaoui, A. Sdiri, C. Hörndler, D. Rosero, E. Mejia, D. Ben Ghachem M. Alastuey, A. Valero, N. Torrecilla, S. Simon 052 How long should a liver biopsy be? Advice 059 to radiologists from pathologists Frequency and significance of epithelial- Rebecca Halas, United Kingdom mesenchymal transition and CD44 in pan- J. Smith, D. Treanor, A. Wright, J. Wyatt creatic endocrine tumours Zane Simtniece, Latvia 053 I. Strumfa, A. Vanags, J. Gardovskis Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is 060 associated with less aggressive tumour Microvascular density in pancreatic ductal phenotype and favourable prognosis in adenocarcinoma and pancreatic endocrine patients with pancreatic adenocarcinoma tumours Constantinos Giaginis, Greece Zane Simtniece, Latvia I. Koutsounas, P. Alexandrou, A. Zizi, I. Strumfa, A. Vanags, J. Gardovskis I. Karavokyros, E. Patsouris, G. Kouraklis, 061 S. Theocharis Useful immunohistochemistry markers in 055 the diagnosis of pancreatic solid-pseudo- Intestinal and pancreatobiliary differentia- papillary tumour tion in ampullary carcinoma: The role of Ehsen Ben Brahim, Tunisia mucins B. Medini, W. Koubâa, R. Jouini, N. Haoues, Raja Jouini, Tunisia R. Noomen, O. Khayat, A. Cherif, A. Chadli W. Koubâa, N. Abdessayed, H. Henchiri, Wednesday, 3 Sept 062 A. Souissi, N. Haoues, E. Ben Brahim, Solid pseudopapillary tumour of the pan- A. Chadli Debbiche creas: A case report Eleni Papakonstantinou, Greece P. Efstathiadou, I. Zinovieva, A. Linardou, M. Vidali, H. Salla, G. Liapi

140 ECP 2014 · London Poster Presentations a Wednesday

063 072 Graft-versus-host disease after liver trans- VEGF and VEGF-R2 prognostic signifi- plantation: A case report cance in liver metastases Vanderlei Segatelli, Brazil Simona-Eliza Giusca, Romania PS-20 E. Christie de Oliveira, A. Silva Evangelista, I.-D. Caruntu, A. Grigoras, R. E. Avadanei, B. Della-Guardia, M. Dias de Almeida, S. Teleman R. Andrey Rocco, D. Cunha Pasqualin,

073 PS-19 N. Hamerschlak Quantitative measurements of area of 064 sinusoidal vessels by CD31using image A limited effective panel for determining analysis in liver grafts to predict and eval- primary site in metastatic adenocarcinoma uate of postoperative complications to the liver Asel Kudaybergenova, Russia Philip Kaye, United Kingdom I. Tileybergenov, S. Shapoval, D. Granov, D. Maystrenko, F. Zherebcov, K. Pozharissky, 065 V. Borovik, I. Rutkin Intraductal Papillary Mucinous Neoplasms of the Pancreas (IPMNs): 11 cases of Hac- 074 ettepe experience The effect of lazaroid (21-aminosteroid Meral Bugdayci, Turkey U-74389G) on pancreas ischemia – reper- A. Akyol, C. Sokmensuer, G. Gedikoglu fusion injury in a swine model George Agrogiannis, Greece 066 D. Chrysikos, E. Patsouris, G. Zografos, A rare overlap syndrome: Autoimmune A. Papalois, E. Patsouris Hepatitis and primary Sclerosing Cholan- gitis in a Crohn‘s Disease patient Helder Oliveira Coelho, Portugal PS-20 Poster Sessions R. Barosa, J. Nogueira, J. Neta, J. Freitas, Molecular Pathology M. J. Brito Chairs: Falko Fend, Germany Winand Dinjens, The Netherlands 067 Mohammad Ilyas, United Kingdom Clear cell ductal adenocarcinoma of the pancreas: A case report of a rare entity 002 Ana Galaghar, Portugal Genomic characterization of endometrial A. L. Cunha stromal sarcomas by array CGH 069 Elisabeth Smolle, Austria Primitive neuroectodermal tumour of the K. Flicker, F. Moinfar, M. Speicher, pancreas: Case report J. Haybaeck Raluca Chirculescu, Romania 003 A. Birceanu-Corobea, C. Vasilescu, Antioxidative, antiinflammatory and anti- A. Croitoru, V. Herlea lipidemic effects of bitter kola seeds- 070 derived biflavonoid complex (kolaviron) in Adult hepatoblastoma with multiple recur- the blood of diabetic rats rency: A case report Oluwafemi Oguntibeju, South Africa Adelina Birceanu-Corobea, Romania O. Ayepola, N. Brooks R. Chirculescu, C. Pecheanu, I. Popescu, 005 D. Hrehoret, A. Croitoru, V. Herlea Frequency of alk gene rearrangement in 071 Saudi lung cancer Solid pseudo-papillary tumours of the pan- Fouad Al-Dayel, Saudi Arabia creas: Report of 5 cases H. Al-Husaini, S. Mohammed, A. Tulbah, Salsabil Attafi, Tunisia K. Al-Kuraya L. Charfi, R. Doghri, N. Boujelbène, I. Abbes, S. Sassi, M. Driss, R. Sellami Dhouib, K. Mrad Wednesday, 3 Sept Wednesday,

141 Poster Presentations a Wednesday ECP 2014 · London

006 013 PS-20 Prospective immunohistochemical analy- ROCK1 as a novel prognostic marker in sis of BRAF V600E mutation in melanoma vulvar cancer Ari Ristimäki, Finland Erica Akagi, Brazil A. Thiel, M. Moza, S. Kytölä, A. Orpana, A. M. Lavorato-Rocha, B. M. Maia, T. Jahkola, M. Hernberg, S. Virolainen I. S. Rodrigues, K. C. Carvalho, G. Baiocchi, Y. Sato-Kuwabara, S. R. Rogatto, 007 F. A. Soares, R. M. Rocha Inter-laboratory pre-validation of the FOCUS4 personalised therapy trial 014 Susan Richman, United Kingdom Design and transfection of sponge microR- R. Adams, B. Jasani, R. Butler, G. Hemmings, NAs as a therapeutic strategy in meta- H. Stuart, M. James, S. Wozniak, static vulvar carcinomas T. Maughan, P. Quirke Beatriz De Melo Maia, Brazil H. Ling, P. Monroig, G. Calin, R. Malagoli 008 Rocha Assessment of tumour KRAS status in lung adenocarcinoma patients using the Seque- 015 nom‘s MassARRAY technology. Why and Usefulness of high throughput screening how? of theranostic biomarkers in lung oncol- Marius Ilie, France ogy using a large collection of tissue N. Guibert, V. Hofman, N. Ebran, P. Brest, microarrays O. Bordonne, K. Ilc, M. Poudenx, Véronique Hofman, France C. H. Marquette, G. Milano, P. Hofman M. Ilie, E. Long-Mira, S. Lassalle, C. Butori, C. Bence, S. Lalvée, P. Hofman 009 Cross-site validation of the Affymetrix 016 OncoScan Array as a robust multiplex clin- Optimal protocol for IHC and FISH analy- ical tool for guiding tumour therapy sis of PTEN in formalin-fixed, paraffin- Joseph Foster, United Kingdom embedded tissues A. Oumie, M. Taylor, I. Halfpenny, F. Togneri, Oscar Maiques, Spain D. McMullan, P. Quirke, K. Keating, D. Cuevas, M. Santacana, A. Velasco, M. Griffiths, F. Brew, K. Spink M. Romero, S. Gatius, S. Müller, H. C. Pedersen, X. Dolcet, X. Matias-Guiu 010 Circulating miRNAs in lung cancer 017 patients: Toward promising biomarkers of F-actin regulators are implicated in human brain metastases onset colorectal cancer progression Marius Ilie, France Helen Aggelou, Greece V. Hofman, E. Long-Mira, F. Barlesi, P. Xristou, A. Papanastasiou, I. Lilis, H. P. Métellus, J. Mouroux, N. Vénissac, Papadaki, V. Bravou C. H. Marquette, M. Beau-Faller, P. Hofman 018 011 MiR-92a potentially modulates survival of CISH analysis for HER2 gene amplification metastatic colorectal carcinoma patients in colorectal cancer via PTEN signalization Maria Lucia Caruso, Italy Ottó Dócs, Hungary M. Di Maggio, I. R. Lolli, R. Armentano, A. Gyongyosi, F. Fazakas, L. Beke, Wednesday, 3 Sept M. Pirrelli, A. M. Valentini B. L. Balint, C. Andras, Z. Horvath, G. Mehes

012 019 KRAS in gastric cancer patients MicroRNA profile in site-specific head and Maria Lucia Caruso, Italy neck squamous cell cancer M. Di Maggio, R. Armentano, M. Pirrelli, Marie Ludvikova, Czech Republic A. M. Valentini D. Kalfert, M. Pesta, V. Kulda, A. Ryška, J. Laco

142 ECP 2014 · London Poster Presentations a Wednesday

020 028 Molecular pathology disease-based gene Evaluation of the THxIDTM BRAF in vitro panel testing: Twelve months of external diagnostics test approved for melanoma quality assessment samples, on colorectal and lung cancer PS-20 Jennifer Fairley, United Kingdom samples Z. Deans Valerie Costes Martineau, France J. Marchand, J. Solassol 021 Colorectal cancer patients in two Austrian 029 regions are differentiated by their micro- A RNA based external quality assessment RNA expression profiles pilot scheme for the molecular testing of Marlies Moshammer, Austria sarcomas M. Kalipciyan, F. Offner, W. Sterlacci, Sandi Deans, United Kingdom G. G. Steger, R. M. Mader, R. Sedivy J. Fairley

022 030 Assessment of chromosomal aberrations CpG island methylation of the RIL and in colorectal adenoma and cancer p15INK4b genes in patients with multiple Irina Sokolova, USA myeloma and monoclonal gammopathy of M. Song, J. Panella, S. Sitailo, F. Policht undetermined significance Pavla Latalova, Czech Republic 023 K. Smesny-Trtkova, J. Minarik, L. Navratilova Identification of differentially expressed miRNAs and their targets in adenoid cystic 031 carcinoma of the breast Investigating the biological role of CD24 in Anatole Ghazalpour, USA the development of colorectal cancer O. Kiss, S. Vranic, J. Kulka, Z. Gatalica, Hassan Otifi, United Kingdom R. Bender M. Ilyas

024 033 The frequency of EML4-ALK gene rear- Nuclear Cten as a regulator of cancer cell rangement in primary lung adenocarci- stemness noma cases of Turkish patients Hannah Thorpe, United Kingdom Handan Kaya, Turkey M. Akhlaq, M. Ilyas E. Bozkurtlar, E. Kombak, H. Toper 034 025 Introduction of a novel realtime PCR assay A real-time PCR assay for detection of for KRAS mutations detection BRAF V600E / K / D mutations in melanoma Ankur Shah, USA and colorectal cancer W. Choi, M. Szostak, R. Wiesneth, Hong Su, USA E. Granados, S. Ho, K. Abravaya B. Erickson, D. Murray, W.-B. Mak, J. Voss, 036 S. Brankley, B. Kipp, K. Halling, K. Abravaya, KRAS / BRAF mutations in colorectal carci- S. Huang noma by cancer mutation array kit: A com- 026 parative study between real-time PCR and Stability of nucleic acids in archived For- Chip-hybridization PCR based technology malin and PAXgene® tissue fixed, paraf- Javier Hernandez Losa, Spain fin-embedded (FFPE and PFPE) blocks of J. Bonde, R. Somoza, H. Pedersen, tissue M. L. Villahermosa, J. Moscoso, R. Mares, Daniel Groelz, Germany S. Landolfi, S. Ramon y Cajal N. Dettmann, I. Blassnig, E. Provencer Wednesday, 3 Sept Wednesday,

143 Poster Presentations a Wednesday ECP 2014 · London

039 047 PS-20 Expression of some genes in adult su- Activating B-Raf V600E mutation in pratentorial primitive neuroectodermal aggressive pediatric Langerhans cell histi- tumours ocytosis: Demonstration by Allele-specific Dmitry Matsko, Russia PCR / Direct sequencing and immunohisto- M. V. Matsko, E. N. Imyanitov, N. M. Volkov, chemistry E. A. Zhelbunova, A. G. Iyevleva, G. A. Yanus Gabor Mehes, Hungary G. Irsai, J. Bedekovics, L. Beke, F. Fazakas, 040 T. Rózsa, C. Kiss Prevalence of human papillomavirus in the anal canal of women with cervical intraep- 048 ithelial neoplasia grade III Regulation of Cten levels by Calpains Evgeniya Kogan, Russia Maham Akhlaq, United Kingdom N. Fayzullina, T. Demura, A. Kozachenko S. Martin, M. Ilyas

041 049 Mutations in the Epidermal Growth Factor Promoter CpG island hypermethylation of Receptor (EGFR) gene in triple-negative Decoy Receptor 1 (DCR1) is associated breast cancer: Analysis by pyrosequencing with poor response to irinotecan in meta- in a series of 60 cases static colorectal cancer Ruben Carrera, Spain Linda Bosch, The Netherlands C. Blanzquez, M.-R. Escoda, E. Saez, G. Trooskens, P. Snaebjornsson, J. C. Haan, L. Palacio, E. Dalmau, M.-C. Ramos, M. Koopman, J. Tol, T. de Meyer, J.-A. Vázquez, F. J. Andreu J. Louwagie, L. Dehaspe, N. C. T. van Grieken, B. Ylstra, H. Verheul, 042 M. van Engeland, I. Nagtegaal, J. G. Herman, Comparison of HER2 status in breast can- C. J. A. Punt, W. van Criekinge, B. Carvalho, cer versus gastric carcinoma G. A. Meijer Mariana Aschie, Romania A. Mitroi, I. Poinareanu, G. C. Cozaru 050 Mutation analysis of nine chordoma speci- 043 mens by targeted next generation cancer Histologic and genotypic re-evaluation of panel sequencing non-small cell lung cancer disease: A Susanne Scheipl, Austria monocentric study C. Fischer, A. Zopf, A. Deutsch, M. Jorgensen, Simona Vatrano, Italy D. Carvalho, B. Lohberger, E.-V. Froehlich, T. Vavalà, M. Busso, S. Cappia, A. Veltri, A. Leithner, B. Liegl, B. Rinner G. V. Scagliotti, S. Novello, L. Righi, M. G. Papotti 051 BRAF L597S gene mutation in metastatic 044 melanoma as a target for a new therapy: The role of tyrosine phosphorylation in Case report regulating Cten function Gordana Zamolo, Croatia Maham Akhlaq, United Kingdom M. Katunaric, D. Dekanic, M. Grahovac, M. Ilyas B. Grahovac 045 052 Mutational analysis of melanomas: Clin- Molecular surveillance of helicobacter Wednesday, 3 Sept icopathological associations infection following eradication therapy Angelica Saetta, Greece Philippe Brunner, Switzerland I. Chatziandreou, P. Tsioli, E. A. Trigka, G. Cathomas, A. Frank, N. Willi I. Giannopoulou, S. Sakellariou, G. Levidou, E. Patsouris, P. Korkolopoulou

144 ECP 2014 · London Poster Presentations a Wednesday

053 061 hMLH1 loss in carcinosarcoma is restricted Phosphatidylinositol 3,4,5-trisphosphate- to uterine origin dependent Rac exchanger 1 functions as Piotr Czapiewski, Germany an oncogene that promotes proliferation PS-21 M. Kunc, A. Gabrych, B. Rekawiecki, migration and invasion in colorectal cancer A. Gorczynski, W. Biernat Hussain Almasmoum, United Kingdom W. Fadhil, D. Jackson, M. Ilyas

054 PS-20 GNAS1 mutations are not detected in 062 parosteal osteosarcomas Protein tyrosine phosphatase, non-recep- Carolina Salinas-Souza, United Kingdom tor type 1 gene functions as an oncogene N. Presneau, S. Aitken, H. Ye, N. Pillay, and promotes cell motility in colorectal R. Tirabosco, F. Amary, A. Flanagan cancer Hussain Almasmoum, United Kingdom 055 W. Fadhil, D. Jackson, M. Ilyas Analysis BRAF gene mutations (V600) in malignant mlanomas of the uvea 063 Libor Stanek, Czech Republic Histone 3.3 mutation detection in osteo- N. Hajkova, S. Lisova, P. Dundr clast-rich soft tissue tumours Sangeetha Kalimuthu, United Kingdom 056 N. Pillay, F. Amary, R. Tirabosco, Progress in phase two of the Cancer N. Presneau, A. Flanagan Research UK Stratified Medicine Pro- gramme: A national molecular profiling 064 initiative for lung cancer Automated tumour annotation and analy- Emily Shaw, United Kingdom sis for molecular pathology using Tissue- M. Smith, L. Thompson, H. Stuart, R. Mark® Cummings, M. Jones, I. Mirabile, N. Soper, Peter Hamilton, United Kingdom I. Walker, P. W. M. Johnson Y. Wang, D. McCleary, J. Diamond, E. Regan, N. Montgomery, J. Tunstall, D. Boyle, 057 M. Loughrey, M. Salto-Tellez BRAF mutation testing on melanoma brain metastases Valeria Barresi, Italy PS-21 Poster Sessions A. Simone, R. Scarfì, G. De Luca, M. Lentini, Electron Microscopy R. Caltabiano, S. Lanzafame, M. Antonelli, Chairs: Josep Lloreta-Trull, Spain G. Giuffrè Alessandro Franchi, Italy Bart Wagner, United Kingdom 058 Tissue and circulating microRNAs in lumi- 001 nal breast cancer metastatic progression A case of cerebral autosomal dominant Lourdes Sánchez Cid, Spain arteriopathy with subcortical infarcts and M. Muñoz, J. J. Lozano, I. Alonso, X. leukoencephalopathy diagnosed on elec- Caparrós, P. L. Fernandez, T. M. Thomson tron microscopy from reprocessed paraf- 059 fin-embedded brain biopsy tissue Determination of KRAS mutation in lung Hwei-Yee Lee, Singapore adenocarcinomas using biofilm chip based L.-H. Sii, D. M. Giron, C. S.-Lyn Ding, microarray technology K.-L. Chuah, W.-M. Yap Ozlem Ceren Uzun, Turkey 003 G. Özbilim Stages of biofilm formation by a combination of microscopical methods Ruth Scully, United Kingdom M. Walker, J. Hobot Wednesday, 3 Sept Wednesday,

145 Poster Presentations a Wednesday ECP 2014 · London

004 003 PS-21 The anatomical variation in normal human The role of IL-28, IFN-gamma and TNF- glomerular basement membrane thick- alpha in predicting response to pegyla- ness: Preliminary observations ted interferon / ribavirin in chronic HCV Christopher von Ruhland, United Kingdom patients PS-22 R. Scully, D. Griffiths Asmaa Gaber Abdou, Egypt N. Asaad, N. Ehsan, M. El-Tahmody, 005 M. El-Sabaawy, S. Elkholy, N. Elnaidany Electron microscopy in the differential diagnostic chordoma, myoephitelioma and 004 chondrosarcoma A case report of alveolar echinococcosis Veronica Alba Amarillo, Spain adverting to increasing incidence in previ- L. Garrote, M. Simon, Y. Zboromyrskyy, ously nearly unaffected coutries in Central A. Lloret, B. Lloveras, M. Salido, Europe N. Juanpere, S. Serrano, J. Lloreta Helena Skalova, Czech Republic L. Kolarova, L. Stanek 006 Pectus Excavatum-first ultrastructural 005 findings of a potential ciliopathy Autoptic evaluation of infectious diseases Christoph Brochhausen, Germany in transplant recipients: A prospective N. V. Bethencourt, S. Turial, C. J. Kirkpatrick study Katharina Wassilew, Germany 007 R. Baretti, D. Kemper, T. W. Gromann, Ultrastructural characteristics of bone R. Hetzer marrow aspirate in congenital asplenia: A case report 006 Tamara Martinovic, Serbia Four pathogens causing brain lesions D. Ciric, O. Markovic, D. Trpinac, simultaneously V. Bumbasirevic, T. Kravic Stevovic Vsevolod Zinserling, Russia V. Karev, N. Fedorova, N. Semenov 009 Renal case: Conventional and the latest 007 technology in Transmission Electron Tuberculous Meningitis (TBM) as cause of Microscopy (TEM) death in children and young adults Andrew Yarwood, United Kingdom Alexandra Enache, Romania M. Balys M.-M. Koumpanaki, A. Deliligka, F. Chatzinikolaou

PS-22 Poster Sessions 008 Infectious Diseases Pathology Spread of actinomyces infection often Chairs: Vsevolod Zinserling, Russia results in cervical lymphadenopathy Abbas Agaimy, Germany Banita Gurung, Nepal Sebastian Lucas, United Kingdom 009 001 Rare extrapulmonary tuberculosis: Report The role of obesity in the immune response of three cases during sepsis Delia Gabriela Ciobanu Apostol, Romania Anastasia S. Kolyva, Greece C. Ungureanu, M. Danciu, E. Cotea, A. Dima Wednesday, 3 Sept V. Zolota, D. Mpatsoulis, G. Skroubis, 010 I. G. Habeos, C. A. Gogos Rare locations of hydatid cyst: Self experience with 4 cases Delia Gabriela Ciobanu Apostol, Romania L. Lozneanu, S.-E.Giusca, I.-D. Caruntu, R. Danila, L. Ionescu, C. Andriescu

146 ECP 2014 · London Poster Presentations a Wednesday

011 002 Disseminated extrapulmonary Pneumocys- Ectopic thymoma presenting as a thyroid tosis: Case report and review of the topic mass Alberto Berjón García, Spain Olympia Tzaida, Greece PS-23 A. Rosell Alayza, M. B. Goiburú Chenú, G. Galanopoulos, C. Valavanis, C. Rivero Colmenarez, J. J. Pozo Kreilinger, G. Mitropoulou, A.-I. Ieronimaki, M. E. García Fernández, C. Morales Bastos G.-P. Vecchini PS-22 012 003 All of the rhinocerebral fungal infections Ganglioneuroblastoma of the posterior are not exclusively due to mucorales and mediastinum in adult: A case report Aspergillus! Yanina Slavova, Bulgaria Cazorla Arnault, France M. Kamenova, G. Yankov, D. Marinova, C. Marion, W. Michel, A.-B. Homa, R. Petkov, D. Petrov A. Alexandre, B. Stephane, P. Vironneau, 004 K. Romain Primary thymic atypical carcinoid tumour 013 and neuroendocrine carcinoma: Two cases The frequency of Enterobius Vermicularis Dudu Solakoglu Kahraman, Turkey infestation in appendicectomy specimens: U. Bayol, M. Uncel, G. Akoz, Z. Aydogdu, An observational study G. Piskin, A. Y. Engin Jeffrey Rubasingham, United Kingdom 005 014 Mediastinal mature teratoma with soma- Natural killer cells in chronic HIV infection tic-type malignancies Sabina Zurac, Romania Jhon Comba Miranda, Spain L. Nichita, L. Sticlaru, A. Bastian, M. Radu G. Cancho, C. Caballero, M. Rezola, Busca, A. Oniga, S. S. Gheorghita, M. D. Carmen Gómez Mateo, C. Lobo, C. Gheorghe Neacsu, A. Streinu Cercel, M. Silva, N. Segues, A. Juaristi, F. Staniceanu M. Garmendia, I. Ruiz

015 006 The spleen in elderly patients acquired TTF-1 expression discriminates thymoma immune deficiency syndrome type AB from other thymomas Renato Rios Câmara, Brazil Todd Smith, United Kingdom A. C. S. da Silva, G. K. N.A. Ribeiro, F. Mauri, K. Naresh L. Ferreira Oliveira, L. Santos Ramalho, 007 M. L. da Fonseca Ferraz, V. d. Paula Antunes Incidental post-mortem ectopic thymus Teixeira, C. Lourencini Cavellani versus intrapericardial thymoma Cornelia Amalinei, Romania PS-23 Poster Sessions L. Knieling, S.-E. Giusca, I.-D. Caruntu, Thymic and Mediastinal Pathology A. Grigoras Chairs: Alexander Marx, Germany Helmut Popper, Austria

001 Anterior mediastinal cysts and pericarditis are an important differential diagnosis: A case report and literature analysis Ernest Iakovlev, United Kingdom L. Errett, R. Siddiqui, V. Iakovlev Wednesday, 3 Sept Wednesday,

147 Poster Presentations a Wednesday ECP 2014 · London

008

PS-24 PS-24 Poster Sessions Epithelial ovarian tumours: A review study Gynaecological Pathology of 86 cases Chairs: Maria Rosaria Raspollini, Italy Leila Beddar, Algeria Simona Stolnicu, Romania A. Loucif, I. Azebaoui, K. Boudaoud, Z. Tebbi Glenn McCluggage, United Kingdom 010 Assesment of clinical and ultrasound exam 001 findings in diagnosis of ovarian pathologi- Changing dimensions of Cervical Conisa- cal disorders tion specimens over time: A single institu- Reza Mozaffari Kermani, Iran tion experience S. Izadi Caitlin Beggan, Ireland 011 D. Carolan, G. Flannelly, P. Downey Lipoleiomyosarcoma of the Uterine Corps: 002 A report of 2 cases with fluorescence in An extraneural ependymoma arising in the situ hybridisation analysis pelvic cavity: A case report Shiho Asaka, Japan Elisabeth Smolle, Austria A. Yoshizawa, K. Sano, K. Shingu, M. Smolle, F. Ronaghi, H. Rogatsch, H. Matoba, Y. Han-Seung, T. Honda J. Haybaeck 012 003 Intravascular adenomyomatosis: A rare Malignant lymphomas of the female geni- variant of intravascular leiomyomatosis tal tract: A clinicopathologic study of 2 Billur Cosan Sarbay, Turkey cases G. Kir, F. Gursoy Iulia Barsan, Romania 013 D. G. Moncea, E. Horvath, C. Molnar, Malignant struma ovarii with a predomi- S. Stolnicu nant component of anaplastic carcinoma 004 Masaharu Fukunaga, Japan Retained fetal bones in utero 014 Ghania Benkhedda, Algeria Coexistence of mature teratoma and ade- I. Djadja, Y. Lamouti nocarcinoma in situ within atypical prolif- 005 erative mucinous tumour of ovary: A case Squamous carcinoma coexistent with tera- report of 35-year-old woman toma of ovary: A clinicopathological study Piotr Lewitowicz, Poland of twelve cases diagnosed over 10-year A. Wincewicz, O. Adamczyk-Gruszka, period at a Tertiary Cancer Referral Centre S. Sulkowski, L. Kanczuga-Koda, M. Koda Bharat Rekhi, India 015 P. Parikh, K. Deodhar, S. Menon, Levonorgestrel impregnated intrauterine A. Maheshwari, R. Kerkar, J. Bajpai, device can reduce occurrence of hyper- J. Ghosh, S. Gupta plastic polyps: A population-based follow- 006 up cohort study Explanted surgical meshes: What patholo- Marit Arnes, Norway gists and industry failed to do for 50 years I. Pettersen, B. T. G. Moe, A. Orbo

Wednesday, 3 Sept Vladimir Iakovlev, Canada 016 007 Expression of HE4 can predict malignant Cancer of the cervix: A casuistic study potential in endometrial polyps Leila Beddar, Algeria Anne Orbo, Norway I. Azebaoui, T. Seraoula, Z. Tebbi B. Hvingel, L. M. Lyså, M. Arnes, I. Pettersen, B. T. G. Moe

148 ECP 2014 · London Poster Presentations a Wednesday

017 025 Levonorgestrel impregnated intrauterine Microsatellite instability and dendritic cell device is efficient as therapy for endome- count in patients with endometrial cancer trial hyperplasia: A national multi-centre Koni Ivanova, Bulgaria PS-24 randomised controlled trial M. Gulubova, J. Ananiev, S. Stoyanov, Anne Orbo, Norway V. Velev, M. M. Ignatova, T. Vlaykova A. B. Vereide, M. Arnes, I. Pettersen, B. T. 026 G. Moe, K. Hanssen, L. M. Lyså, B. Straume Cervical intraepithelial neoplasia in HIV-1 018 positive African patients (HARP study): Consistency of endometrial adenocarci- Impact of pathology review in endpoint noma FIGO grade between biopsy and hys- determination terectomy Valerie Costes Martineau, France Hala Rashed, United Kingdom T. Omar, O. Lompo Goumbi, S. Doutre, L. Brown O. Clavero, S. Zan, A. Chikandiwa, H. Kelly, P. Mayaud 019 Clinical significance of HPV mRNA detec- 027 tion in double positive (2+ve) cotesting Significance of trophoblastic infiltration result women for triage of HSIL+ patients: into the tubal wall in ampullary pregnancy: Pilot study A clinico-pathological study Martyna Trzeszcz, Poland Onur Erol, Turkey M. Mazurec, M. Jelen B. Ünal, D. Suren, C. Sezer, M. Karaca

020 028 Psammocarcinoma of the ovary: A case A retrospective review of microinvasive cer- report and review of the literature vical squamous cell carcinoma in Slovenia Sevil Sayhan, Turkey Helena Gutnik, Slovenia D. Solakoglu Kahraman, T. Karadeniz, J. P. Matisic, M. Primic Žakelj, M. Strojan D. Ayaz, A. Dogan Fležar

021 029 Clear cell sarcoma of vulva: Case report A rare lesion: Blue nevus of the cervix Kristyna Nemejcova, Czech Republic uteri P. Dundr, L. Stanek, I. Krajsova Sevinc Sahin, Turkey S. Seçkin, L. Seçkin 023 A case of paraneoplastic cerebellar degen- 030 eration associated with serous adenocarci- A case of a primary peritoneal carcinoma: noma of the ovary Complete tumour regression after neoad- Duaa Saeed, United Kingdom juvan chemotherapy L. Gupta Ayse Nur Ihvan, Turkey G. Kir, C. S. Topal 024 Placental inflammatory histopathology 031 classification in small age gestations: A Pecoma of the ovary: A case report retrospective appraisal Milanka Mrcela, Croatia Ionescu Zamfir-Radu, Germany 032 M. Sajin, A. V. Dumitru, L. Mitrache, Ovarian clear cell adenocarcinoma arising O. Patrascu, M. Andreea, O. C. Ciornenchi, in association with endometriosis: A clin- G.-C. Oprea, M. Cirstoiu icopathological study of 20 cases Neli Basheska, Republic of Macedonia B. Ognenoska-Jankovska, S. Veljanoska- Petreska Wednesday, 3 Sept Wednesday,

149 Poster Presentations a Wednesday ECP 2014 · London

033 040 PS-24 Endometrial biopsy diagnosis: The binary Apparent unique male to female sexual system and the WHO system are equiva- transmission of transitional cell carcinoma lent of the bladder Denis Nastic, Sweden Stuart Brown, United Kingdom J. Carlson H. Clouston, M. Wells

034 041 A common benign mammary lesion with a Correlation of p53 with macroscopic and rare vulvar presentation: Vulvar fibroade- microscopic criterias of ovarian epithelial noma, case report tumours Sevil Sayhan, Turkey Fariba Abbasi, Iran D. Ayaz, T. Karadeniz, D. Solakoglu A. Esmaili, Z. Yekta, A. Saffarifard Kahraman, M. Sanci 042 035 Metastasis of pancreatic carcinoma to A rare benign lesion of uterus prediag- benign ovarian fibroma nosed as widespread adenomyosis: Plexi- Emel Ebru Pala, Turkey form tumorlet U. Kucuk, U. Bayol, E. Cakir, S. Eryigit, Sevil Sayhan, Turkey M. Adiyeke, A. Özgüzer T. Karadeniz, M. Gokcu, D. Ayaz, 043 D. Solakoglu, M. Sanci Adenomatoid tumour of the genital tract: 036 A retrospective review of 18 cases Evaluation of HPV positivity by immuno- Marta Gonzalez Vadillo, Spain histochemistry in cervical biopsies with a A. Corominas Cishek, N. Cerda Hernandez, diagnosis of ascus cytologically V. Caamaño Villaverde, E. Andueza Otsoa, Ebru Demiralay, Turkey L. Andrés, M. Saiz Camín G. Aksan Desteli, S. Yildiz, A. Ayhan, 044 T. Gursu Transitional cell carcinoma of the ovary: 037 Case report Progesterone alters PI3K and M-TOR Duygu Ayaz, Turkey sinalling in endometrial cancer cell lines S. Sayhan, T. Karadeniz, D. Solakoglu Rita Kral, Norway Kahraman, M. Sanci T. Berg, B. T. G. Moe, G. Sager, A. Ørbo 045 038 Adenomatoid tumour of the uterus: A clin- Mesonephric adenocarcinoma of the uter- icopathological analysis of 25 cases with ine cervix: A case report and without renal transplantation Mariana Cruz, Portugal Nagako Maeda, Japan M. Ferreira, A. Silva, M. Teixeira, F. Pardal T. Tsuzuki

039 046 Mixed tumour of the Endometrium: High Stromal luteoma of the ovary: A case report grade neuroendocrine tumour and endo- Dudu Solakoglu Kahraman, Turkey metroid adenocarcinoma. A rare associa- T. Karadeniz, D. Ayaz, S. Sayhan, M. Ozeren tion 047 Wednesday, 3 Sept Guillermo Mendoza, Spain The GROIN: An unusual location of endo- H. E. Torres Rivas, L. Fernández, metriosis. Groupe Hospitalier Paris Est M. V. Folgueras, C. Garcia Pravia, experience C. Gonzalez del Rey, M. Fresno Forcelledo Najat Mourra, France M. Bennis, A. Cortez

150 ECP 2014 · London Poster Presentations a Wednesday

048 054 Lectin-binding patterns in preeclampsia Expression and prognostic value of Natalia Niziaeva, Russia Hepatoma up Regulated Protein (HURP) in M. Ziganshina, G. Kulikova, Y. Volkova, endometrial carcinoma PS-24 A. Shchegolev, N. Kan, A. Nikolaeva, O. Maria Lambropoulou, Greece Vavina, N. Bovin, G. Sukhikh T. Gkouleli, T.-E. Deftereou, G. Trypsianis, A. Kiziridou, E. Chatzaki, S. Kakolyris, 049 M. Koffa, N. Papadopoulos HPV16 prevalence stratified in age groups: Comparative analysis with other high risk 055 genotypes Myxoid solitary fibrous tumour of the Maria López Macías, Spain vulva A. Rubio Fernandez, W. Toro Zambrano, Yi-Kyeong Chun, Republic of Korea J. J. Fernández de Mera, A. M. Campos de H.-S. Kim, H.-S. Jeong, S.-R. Hong Orellana Gomez, I. Catalina Fernández, 056 A. Hernández Amate, M. DÍaz Delgado, J. EG-VEGF expression in different subtypes Sáenz de Santamaria of ovarian carcinoma 050 Irina-Draga Caruntu, Romania Prevalence of women diagnosed with M. Raica, C. Amalinei, R. Balan, HSIL and HPV16, stratified by age groups: A. M. Cimpean, L. Lozneanu Comparative analysis with other high risk 057 genotypes Vulvar tubuler apocrine adenoma: A case Maria López Macías, Spain report W. Toro Zambrano, A. Rubio Fernandez, Sevil Sayhan, Turkey J. J. Fernández de Mera, A. Hernández M. Uncel, D. Solakoglu Kahraman, D. Ayaz, Amate, A. M. Campos de Orellana Gomez, T. Karadeniz, D. Özkale Okyay I. Catalina Fernández, M. DÍaz Delgado, J. Sáenz de Santamaria 058 Diagnostic algorithm for work-up of endo- 051 metrial stromal tumours Chondrosarcoma of the uterine body: A Elwira Bakula-Zalewska, Poland case report M. Kowalewska, A. Danska-Bidzinska, Reiko Watanabe, Japan A. Piascik, M. Bidzinski, A. Nasierowska- I. Ito, Y. Hirashima, Y. Akiyama, T. Nakajima Guttmejer 052 059 Placental site trophoblastic tumour: A Axillary lymph nodes involvement by diagnostic pitfall in the cervical tumour ovarian serous tumours of low malignant biopsy potential: A report of two cases Sevil Sayhan, Turkey Raluca Guran, United Kingdom T. Karadeniz, D. Ayaz, D. Solakoglu R. Dina Kahraman, Y. Yildirim 060 053 Leydig-cell tumour of the mesosalpinx Uterine leiomyosarcoma with florid intra- Argiro-Ioanna Ieronimaki, Greece vascular component („Intravenous leio- G. Galanopoulos, G. Gavalas, E. Trichia, myosarcomatosis“) C. Valavanis, I. Iakovidou Laura Castillo, Spain F. Idrovo Mora, L. Nájera Botello, 061 V. M. Castellano Megías Analysis of gynecologic pathology frozen sections in a tertiary referral hospital in India: Audit of 3 years (2011 – 13) Kedar Deodhar, India P. Sachdev, B. Rekhi, S. Menon, Wednesday, 3 Sept Wednesday, A. Maheshwari, T. S. Shylasree, R. Kerkar

151 Poster Presentations a Wednesday ECP 2014 · London

064 072 PS-24 Squamous Cell Carcinoma (SCC) arising in Vulva, a rare site of Phyllodes tumour: A mature cystic Teratoma: A case report case report Sabina Shrestha, Nepal Vasileia Leodara, Greece C. Karabogias, C. Filis, G. Kakiopoulos, 065 E. Papaliodi Transitional cell carcinoma of the ovary: A potential pitfall 073 Helen Trichia, Greece Cervical Papillary Adenofibroma (PA): A P. Manikis, G. Mitropoulou, I. Lekka, case report E. Paliouri, A. Grivas Eirini Papaspirou, Greece K. Katsos, D. Riga, D. Vlachos, P. Katafygiotis 066 Adenoid basal carcinoma combined with 074 invasive squamous cell carcinoma foci of Granular Cell Tumour (GCT) of the vulva: A uterine cervix: A case of report of 55-year case report old woman Eirini Papaspirou, Greece Mariusz Koda, Poland K. Katsos, D. Riga, D. Vlachos, L. Kanczuga-Koda, A. Wincewicz, P. Katafygiotis, C. Poulou P. Lewitowicz, U. Sulkowska, S. Sulkowski, 075 S. Urbaniak-Wasik, P. Laudanski, A. Horecka- A rare-autopsy case of Small Cell Carci- Lewitowicz, O. Adamczyk-Gruszka noma coexisted with leiomyosarcoma in 067 the cervix Coincidence of well differentiated endome- Mihoko Yamamoto, Japan trioid adenocarcinoma and uterine tumour A. Nishijima, S. Toda resembling ovarian sex cord tumour: A 076 case report of 64-year-old woman Overexpression of caveolin-1 in the peritu- Mariusz Koda, Poland moral stromal cells is associated with good L. Kanczuga-Koda, A. Wincewicz, prognosis in ovarian serous tumours L. Frackowiak, K. Maruszak, P. Laudanski, Sevil Sayhan, Turkey W. Famulski, S. Sulkowski T. Karadeniz, D. Ayaz, D. Solakoglu 069 Kahraman, G. Diniz, M. Gokcu Issues in the study of utero-placental blood 077 flow in severe gestosis Heterologous type uterine carcinosarcoma Tatyana Pavlova, Russia with an obvious osteosarcoma component V. Petrukhin, A. Selivanova, I. Goncharov, (malignant mixed mullerian tumour): Case D. Kolesnikov report 070 Dudu Solakoglu Kahraman, Turkey Malignant mixed Mullerian tumour of S. Sayhan, D. Ayaz, T. Karadeniz, M. Sanci, uterus: A case report S. Alanyali Vasileia Leodara, Greece 078 C. Karabogias, C. Filis, G. Kakiopoulos, A comparative study of neoplastic trasfor- T. Choreftaki mation of intestinal and ovarian endome- 071 triosis

Wednesday, 3 Sept Uterine smooth muscle tumours of uncer- Anna Pesci, Italy tain malignant potential and gastric leio- P. Castelli, L. Bortesi, G. Bogina, myosarcoma: A case report M. Ceccaroni, G. Ruffo, G. Zamboni Vasileia Leodara, Greece 081 N. Chaleplidis, A. Dimitriadi, V.-V. Palla, Cervical smears with atypical glandular S. Antoniou, E. Papaliodi cells: Diagnostic and treatment algorithms Evgeniya Kogan, Russia A. Asaturova, L. Ezhova, N. Fayzullina

152 ECP 2014 · London Poster Presentations a Wednesday

082 091 Structural characteristics and the mathe- Diagnostic challenges in endometrial matical model of reparative and neoplastic pathology epithelial-mesenchymal spheroid struc- Florica Staniceanu, Romania PS-24 tures in HPV-associated chronic cervicitis E. Gramada, M. Olariu, M. D. Cioplea, and cervical intraepithelial neoplasia S. S. Gheorghita, A. Dumitru, M. Nitu, S. Evgeniya Kogan, Russia Iacob, A. Dragusin, A. Bastian V. Namiot, T. Demura, N. Fayzullina, 092 G. Sukhikh Histological and immunohistochemical 084 study of extragenital endometriosis Three cases of metastatic endocervical Eugeniu Cazacu, Moldovan adenocarcinoma masquerading as ovarian 093 primaries Immunohistochemical expression of GATA Alastair Ironside, United Kingdom 3 in vulvar Paget disease A. Faruqi, N. Singh Maria Del Carmen Gómez Mateo, Spain 085 I. Ruiz Díaz, M. Rezola Bajineta, Leiomyoadenomatoid tumour of uterus: M. C. Caballero Martínez, M. J. Silva Presentation of 2 cases Carmona Sevil Sayhan, Turkey 094 T. Karadeniz, M. Gokcu, D. Ayaz, A primary diffuse large B-cell lymphoma of D. Solakoglu Kahraman the cervix: A case report 086 Dimitra Koumoundourou, Greece The importance of immunostaining HPV G. Adonakis, G. Androutsopoulos, G. Michail, antibodies in cervical premalignant lesions D. Pavlopoulou, P. Ravazoula Ionut Poinareanu, Romania 095 M. Aschie, A. Mitroi, M. Enciu, A rare case of collision tumour of the G. I. Baltatescu, G. C. Cozaru uterus 087 Krasimir Dangalov, Bulgaria Lipoleiomyoma of ligamentum latum mim- D. Staikov, H. Ivancheva, V. Belovezhdov icking an ovarian mass in a post menopau- 096 sal women: A case report Conservative surgical management of ade- Nilsen Erdogan, Turkey nocarcinoma in situ of the cervix: An F. Yilmaz, E. Sahan, S. Bektas, N. Erdogan, assessment of treatment options and their S. S. Ketenci, M. Cin association with positive margins and sub- 089 sequent repeat procedures Adenofibroma of Cervix: Case report John Aird, Ireland Sevil Sayhan, Turkey P. Downey, R. Sarkar, G. Flannelly, T. Karadeniz, M. Uncel, D. Solakoglu E. Mooney, D. Gibbons Kahraman, D. Ayaz, E. Mat 097 090 A case of uterine tumour resembling ovar- The evaluation of the caveolin-1 expres- ian sex-cord tumours, misdiagnosed as sion in uterine smooth muscle tumour of endometrial stromal sarcoma uncertain malignant potential Isik Baris, Turkey Dudu Solakoglu Kahraman, Turkey C. Ceylan, U. P. Ahmed Maulid, E. Yavuz, D. Ayaz, S. Sayhan, T. Karadeniz, G. Diniz, H. R. Ilhan H. Tosun Yildirim, M. Sanci 099 Expression of p16 protein in Müllerian adenosarcoma Hsin-Ni Li, Taiwan Wednesday, 3 Sept Wednesday, F.-Y. Lee, J. Wang

153 Poster Presentations a Wednesday ECP 2014 · London

100 108 PS-24 Malignant Perivascular Epithelioid Cell Giant endometrial polyp in a postmeno- Tumour (PEComa) of uterus: A case report pausal woman with no hormone treatment Gizem Narli, Turkey Betül Ünal, Turkey A. Haholu, I. Yilmaz, Z. Kucukodaci, S. Dogan, G. Erdogan, S. Karaveli, T. Simsek U. Berber, I. Gün, A. Yilmaz, D. Demirel 109 102 Analysis of collagen fibers in the cervix of Glassy cell carcinoma of the endocervix: A autopsied patients with the Acquired case report Immunodeficiency Syndrome Evanthia Diakatou, Greece Renato Rios Câmara, Brazil V. Tziortzioti, E. Minaidou, A. Kostopoulou, B. Gonçalves Silva Torquato, M. Mendes D. Tziortziotis Porto Azevedo, A. P. Espíndula, L. Santos Ramalho, L. Ferreira Oliveira, M. H. Soares, 103 C. Lourencini Cavellani, V. d. Paula Antunes Primary peritoneal serous carcinoma: Teixeira, M. L. da Fonseca Ferraz Clinicopathological study of 11 cases Salsabil Attafi, Tunisia 110 L. Charfi, R. Doghri, N. Boujelbène, I. Abbes, p16ink4a expression in different types of S. Sassi, M. Driss, R. Sellami Dhouib, endocervical adenocarcinoma K. Mrad Diane Isabelle Magno Cavalcante, Brazil J. Eleutério Junior, T. Silva, A. C. Rodrigues 104 de Andrade, A. Pascoal Sertoli-Leydig tumour (androblastoma) with heterologous fetal type cartilage: A 111 case report Ovarian seromucinous borderline tumour: Evanthia Diakatou, Greece A case report V. Tziortzioti, A. Kostopoulou, I. Kalogirou, Sarra Fouli, Tunisia D. Tziortziotis S. Ziadi, S. Mestiri, E. Boudabous, M. Boughattas, N. Ben Abdeljelil, M. Mokni 105 Significance of immunohistochemical ex- 112 pression of P16INK4a in the differentiation Quantitative measurements of cell density of inflammatory and preneoplastic cervical and proliferative markers by image analy- lesions sis of endometrial carcinoma Božana Babic, Bosnia and Herzegovina Asel Kudaybergenova, Russia R. Gajanin, Ž. Gajanin, R. Vilendecic, V. Ecim S. Gladkov, I. Stolyarova, K. Posharisski Zlojutro, P. Budakov 113 106 Primary peritoneal malignant mixed Mülle- ER, PR and p53 expression in the progres- rian tumour (carcinosarcoma): Case report sion of endometrial endometrioid carcino- Claudia Mateoiu, Sweden mas: An evaluation of metastases and 114 matched primary tumours Ovarian anastomosing hemangioma with Carla Bartosch, Portugal stromal luteinization R. Vieira, A. Pereira, C. Jerónimo, Idaira Jael Exposito Afonso, Spain J. M. Lopes M. B. Leynis Isabel, V. F. Abián, E. González

Wednesday, 3 Sept 107 Arnay, R. Méndez Medina Extrauterine adenomyoma of the abdomi- 115 nal wall: A rare case Sero-mucinous ovarian cystadenofibroma: Rita Sampaio, Portugal A fortuitous discovery J. Garcia, J. R. Vizcaíno Nihed Abdessayed, Tunisia F. Hammedi, R. Hadhri, S. Souki, S. Bouslema, M. Njima, I. Haddad, L. Njim, A. Moussa, A. Zakhama

154 ECP 2014 · London Poster Presentations a Wednesday

PS-25 Poster Sessions 009 p16 FISH in malignant pleural and perito- Pulmonary Pathology neal mesothelioma: Assessment of both

Chairs: Richard Attanoos, United Kingdom PS-25 homozygous and heterozygous deletions Susan Davies, United Kingdom based on cutoff values Kazuki Nabeshima, Japan 001 M. Hamasaki, S. Matsumoto, T. Kamei, Two rare cases with vascular pathology in K. Hiroshima, K. Kawahara, T. Tsujimura, the lungs of children A. Iwasaki Tzana Praznikova, Bulgaria D. Metodiev, E. Petrova 010 Intrapulmonary schwannoma: A challeng- 002 ing case Hydatid cysts: Clinical and histological Sorina Taban, Romania study of new physical method of treatment O. Vita, M. Cornianu, R. Cornea, A. Dema in surgery Dinar Kaliyeva, Kazakhstan 011 M. Tussupbekova, Y. Turgunov Photodynamic therapy for lung cancer treatment: Development of an orthotopic 003 animal model Comparative study of cytology and histol- Jörg Lindenmann, Portugal ogy of primitive lung cancers: Study of 981 M. Laranjo, A. M. Abrantes, K. Santos, cases C. Oliveira, E. Tavares-Silva, A. Serra, Yahia Manel, Tunisia M. Pineiro, A. Rocha Gonçalves, L. Carvalho, B. Laabidi, M. Issam, M. Nada, F. Botelho B. A. Fakhreddine, B. Fethi, B. Ammar 012 004 Serum levels of mature microRNAs in Tracheobronchopathia osteochondroplas- DICER1-mutated pleuropulmonary blas- tica: A rare benign disorder toma Mileta Golubovic, Montenegro Matthew J. Murray, United Kingdom F. Vukmirovic, E. Zvrko, G. Mijovic, S. Bailey, K. L. Raby, H. K. Saini, L. de Kock, Z. Vlahovic G. A. Burke, W. D. Foulkes, A. J. Enright, 005 M. Tischkowitz, N. Coleman EGFR mutation-specific antibodies and 013 total EGFR protein expressions in lung Diagnostic mutation profiling and valida- adenocarcinoma:biopsies vs. resection tion of non small cell lung cancer small specimens biopsy samples using a high throughput Jin-Young Yoo, Republic of Korea platform S. Park Anne Marie Quinn, United Kingdom 006 N. Hickson, M. Adaway, L. Priest, C. Keeling, The malignant masquerade of pulmonary A. Wallace, D. Nonaka, R. Byers, W. amyloidosis Newman, F. Blackhall Rani Kanthan, Canada 014 P. Dokouhaki The impact of smoking: Changes in glu- 007 cose metabolism in non-small cell lung Mediastinal Yolk Sac tumour as a mimic of cancer primary non-small cell lung carcinoma Agnes Csanadi, Germany Jan von der Thüsen, The Netherlands C. Otto, M. Donauer, S. Wiesemann, E. Comans, C. Baur M. Werner, G. Kayser Wednesday, 3 Sept Wednesday,

155 Poster Presentations a Wednesday ECP 2014 · London

015 024 PS-25 Intra-tumour EGFR mutation status heter- Problems in frozen section diagnosis of ogeneity in lung adenocarcinoma is asso- primary lung carcinomas ciated with reduced survival Ipek Coban, Turkey Dov Hershkovitz, Israel G. Bulbul Dogusoy, A. Toker, K. Ayalp, E. Simon, E. Prinz, T. Shentzer, L. Chekinsky, O. Demirhan, E. Kaba, N. Bassullu, N. Akdur, E. Sabo, O. Ben-Izhak F. Kusku Cabuk

018 025 Adaptation of UroVysion kit for the diag- Pulmonary necrotizing sarcoid granulo- nosis of malignant pleural effusion matosis: Case report Leila Antonangelo, Brazil Ljiljana Tadic-Latinovic, Bosnia and D. Rosolen, A. R. N. Dutra, G. Bottura, Herzegovina V. Martins, V. L. Capelozzi Z. Eri, B. Babic, L. Novakovic Lackovic, S. Kneževic Ušaj, M. Panjkovic, M. Stanetic 019 Clinicopathological prognostic factors in 026 operated for pulmonary carcinoid tumour Survival of patients with specific molecu- patients lar profile of non-small cell lung carcinoma Dora Marinova, Bulgaria and neoadjuvant chemotherapy Y. Slavova, E. Goranov, D. Petrov Jelena Stojsic, Serbia T. Stankovic, Z. Milovanovic, V. Milinkovic, 020 S. Stojskovic, J. Dinic, M. Pesic, A. Podolski- External Quality Assessment (EQA) of pre- Renic, N. Tanic, J. Bankovic dictive markers in non-small cell lung cancer within the European Thoracic Oncology 027 Platform (ETOP) Lungscape project Benign lymphoid proliferations in lung Lukas Bubendorf, Switzerland nodules and IgG4-positive plasma cells: A K. M. Kerr, H. Hager, S. Finn, V. Tischler, case series E. Verbeken, W. Biernat, I. Sansano, Danielle Costigan, Ireland A. Marchetti, E. Thunnissen A. Fabre

021 028 Our experience with CT-guided transtho- The spectrum of idiopathic pulmonary racic fine needle aspiration cytology of neuroendocrine cell hyperplasia and peripheral pulmonary lesions tumourlets till typical carcinoid tumour: Ivana Jelicic, Serbia A rare case D. Tegeltija, A. Lovrenski, M. Panjkovic, Carlos Abrantes, Portugal Z. Eri, B. Jelicic J. Saraiva, J. Bernardo, L. Carvalho

022 029 Inflammatory pseudotumour of the lung: Mucinous adenocarcinoma arose in con- Review of 9 cases of a very rare pulmonary genital pulmonary airway malformation: A tumour case report with molecular study María José Labanca, Spain Moon-Young Kim, Republic of Korea A. Corominas Cishek, V. Caamaño, J.-M. Koh, S. Kim, H.-J. Go, Y.-K. Jeon, M. González, N. Cerda Hernandez, D.-H. Chung, C.-H. Kang, S.-H. Park E. Andueza, M. Saiz Camín Wednesday, 3 Sept 030 023 Primary lung cancer coexisting with lung Interobserver agreement among line of metastasis: A potential pitfall differentiation and diagnosis in primary Helen Trichia, Greece non-small cell carcinomas of lung G.-P. Vecchini, M. Papazian, N. Mpolanos, Ipek Coban, Turkey A.-I. Ieronimaki, A. Grivas G. Bulbul Dogusoy, A. Toker, K. Ayalp, O. Demirhan, E. Kaba, N. Bassullu, N. Akdur, F. Kusku Cabuk

156 ECP 2014 · London Poster Presentations a Wednesday

031 039 ROS1 in adenocarcinomas of the lung Immunochistochemical double staining Lina Carvalho, Portugal panel thyroid transcription factor-1/p63 M. R. Silva, A. Alarcão, T. Ferreira, and epidermal growth factor receptor PS-25 M. J. d´Aguiar, A. Ladeirinha, V. Sousa, analysis allows accurate diagnosis of lung D. Reis cancers in small biopsy specimens Krasimir Dangalov, Bulgaria 032 S. Genova, Z. Peshev, S. Bichev, Human antigen Receptor (HuR) and V. Belovezhdov Cyclooxygenase-2 (COX-2) expression in human non-small cell lung carcinoma: 040 Associations with clinicopathological para- Malignant pleural mesothelioma: Analysis meters, tumour proliferative capacity and of biopsy samples from umhat „St. George“ patients‘ survival Bulgaria for the period 2008 – 2013 Constantinos Giaginis, Greece Krasimir Dangalov, Bulgaria P. Alexandrou, N. Tsoukalas, I. Sfiniadakis, Z. Peshev, S. Genova, I. Novakov, N. Kavantzas, E. Agapitos, E. Patsouris, V. Belovezhdov, Z. Peshev S. Theocharis 041 033 Decreased sirtuin expression in lung ade- Features optical biopsy surgical material nocarcinoma in patients with COPD in the native lung tissue and formalin fixa- Darja Isajeva, Latvia tion studied ex-vivo S. Isajevs, G. Strazda, I. Silins, I. Taivans Fedor Zabozlaev, Russia 042 A. Sorokina, O. Danilevskaya, D. Sazonov, Is the cell pellet alone sufficient for diag- A. Averyanov nosis in Endobronchial Ultrasound-guided 034 Transbronchial Needle Aspirations (EBUS- Possibility of quantitative data analysis of TBNA)? optical biopsy of pulmonary pathology Slaveya Yancheva, United Kingdom Fedor Zabozlaev, Russia M. E. Elhassan, M. A. Montero, A. Rice, O. Deryagin, O. Danilevskaya, D. Sazonov, A. Bell, P. Viola, A. Velani, S. Chikte, P. Shah, A. Averyanov A. Barlow, A. G. Nicholson

035 043 Evaluation of ALK gene rearrangement Reclassifying pulmonary Squamous Cell with FISH analysis in lung carcinoma: Carcinoma (SCC): CK7 and isolated p63 Experience from a tertiary care center in expression correlated with EGFR muta- Turkey tions in three cases Aysegul Uner, Turkey Lina Carvalho, Portugal M. Ç. Aydin, S. Onder M. R. Silva, A. Alarcão, A. Ladeirinha, M. J. d´Aguiar, T. Ferreira, V. Sousa 036 Desmoplastic malignant Mesothelioma 044 (DMM) of the pleura TTF-1 as marker to screen bronchial-pul- Eirini Papaspirou, Greece monary carcinomas for EGFR mutations D. Riga, M. Chantziara, D. Vlachos, search K. Katsos, P. Katafygiotis Lina Carvalho, Portugal A. Alarcão, M. R. Silva, A. Ladeirinha, 038 T. Ferreira, M. J. d´Aguiar, V. Sousa A case report of 36-year-old male with pulmonary blatoma 045 Tsvetomir Garev, Bulgaria Ectopic thymoma of pleura mimicking O. Bogdanova, M. Kamenova mesothelioma: Case report Irem Hicran Ozbudak, Turkey

M. Karakurt Eryilmaz, H. S. Toru, L. Dertsiz, 3 Sept Wednesday, F. Aydin, G. Özbilim, O. Ozbudak

157 Poster Presentations a Wednesday ECP 2014 · London

046 055 PS-25 Plexogenic pulmonary arteriopathy asso- The difficulty of subtyping mesothelioma ciated with mixed connective tissue disor- from biopsy material: The effects on surgi- der: An autopsy case cal management and room for improve- Rita S. S. Oliveira, Portugal ment A. Costa Braga, R. Mora de Féria, Annabel Sharkey, United Kingdom R. Madureira, H. Oliveira J. Le Quesne, D. Fennell, A. Nakas, C. Richards, D. Waller, S. Muller 048 Diagnostic value of tumour markers in 056 lung adenocarcinoma-associated cytologi- Role of mRNA helicases in the malignant cally positive and negative pleural effu- phenotype in pulmonary adenocarcinoma sions Farheen Raza, United Kingdom Cheng-Chuan Su, Taiwan J. Le Quesne T.-C. Hsieh, C.-L. Lai, S.-M. Tsao 057 049 An evaluation of pre-operative diagnosis Lung cancer resection specimens in a can- in pulmonary neoplasms cer institute: A clinicopathological charac- Muhammad Shafiq Gill, United Kingdom terization I. Soomro Diana Felizardo, Portugal 058 C. Meireles, F. Menezes, L. Santos, Experimental pulmonary fibrosis is modu- N. Coimbra, C. Castro, A. L. Cunha lated by increased expression of collagen 051 V, endothelin-1 and TGF-b Pulmonary lymphangioleiomyomatosis: An Vanessa Martins, Brazil extended immunohistochemical investiga- M. Antunes, D. Bernardo Lopes, A. Todorovic tion Fabro, E. Roger Parra, V. Capelozzi Ilze Strumfa, Latvia 059 E. Vasko, A. Vanags, Z. Simtniece, A. Jukna, A case of mixed solitary endobronchial A. Abolins, J. Gardovskis papilloma in a 64 year old man 052 Guillermo Mendoza, Spain Lung cancer with atypical ALK rearrange- A. Astudillo, H. E. Torres Rivas ments 060 Lina Carvalho, Portugal Granulomatous inflammation at frozen M. R. Silva, A. Alarcão, T. Ferreira, section with clinical follow up and implica- M. J. d´Aguiar, D. Reis, V. Sousa tions for laboratory safety: A 2 year retro- 053 spective audit Epithelioid hemangioendothelioma pre- David Moore, United Kingdom senting with endobronchial lesion: Case C. Richards, D. Purnell, J. Le Quesne, report S. Muller Irem Hicran Ozbudak, Turkey 061 H. S. Toru, O. Ozbudak, H. S. Coskun Laser Capture Microdissection of early 054 invasive lung adenocarcinoma provides Pathological features of response to neo- suitable material for genomic characteri-

Wednesday, 3 Sept adjuvant chemotherapy in malignant pleu- sation of these tumours ral mesothelioma David Moore, United Kingdom Annabel Sharkey, United Kingdom C. Jones, J. Edwards, J. Le Quesne J. Le Quesne, D. Fennell, A. Nakas, C. Richards, D. Waller, S. Muller

158 ECP 2014 · London Poster Presentations a Wednesday

062 065 The detection of EML4-ALK fusion onco- New lung primary carcinoma(s) in women gen in non-small cell lung cancer by with previous breast cancer: A clinico- Immunohistochemistry (IHC) assay with pathological series PS-25 two different antibodies Aurelie Fabre, Ireland Rosa Maria Garcia Martin, Spain N. Faheem0 S. Ponce Aix, E. Riveiro, A. B. Enguita Valls 066 063 Standardizing EML4-ALK and B-Raf Small cell lung carcinoma: A cases series V600E IHC testing using HDx‘s defined of 54 patients reference standards Khadija Benhayoune, Morocco Farah Patell-Socha, United Kingdom H. El-Fatemi, H. Ameuretesse V. Spivey, C. Thorne, J. Frampton, K. Schmitt, P. Morrill 064 Preneoplastic lesions supporting bron- 068 chial adenosquamous carcinoma and Primary malignant melanoma of a lung: A micropapillary acinar adenocarcinoma: case report Two illustrative cases Giuseppe Palumbieri, Italy Paula Serra, Portugal L. Carvalho Wednesday, 3 Sept Wednesday,

159 ECP 2014 · London

ESP General Assembly Wednesday, 3 September 2014 12:00 – 13:00 · ICC Auditorium

Annual General Meeting Pathological Society Wednesday, 3 September 2014 13:00 – 14:00 · ICC Capital Suite Room 1

160 ECP 2014 · London

e Congress Information

161 Congress Information ECP 2014 · London e Congress Venue e Registration Fees ExCeL London ESP Member / One Western Gateway Member of Pathological Society* 640,00 EUR Royal Victoria Dock Non-Member 790,00 EUR London E16 1XL, UK Resident ** 350,00 EUR Accompanying person The main entrance for ECP 2014 of an ESP Member/ is the East Entrance. Member of Pathological Society 60,00 EUR of a Non-Member 80,00 EUR e Congress and Exhibition Office * In good standing (membership fee for 2014 paid). ** Residents must submit a formal declaration from the Head of Department or the responsible for the training programme. CPO HANSER SERVICE GmbH Registration Fee for ESP Members, Members Paulsborner Str. 44 of Pathological Society, Non-Members and 14193 Berlin, Germany Residents includes: Phone: +49 – 30 – 300 669-0 a Admission to all scientific sessions Fax: +49 – 30 – 305 73 91 a Admission to Opening Ceremony and Wel- Email: [email protected] come Reception a Admission to poster exhibition and techni- e Congress Registration Counter cal exhibition All congress materials and documentations are a Coffee breaks and lunches from Sunday to available at the congress registration counter. Wednesday The congress counter will be located in a Congress materials (delegate bag, final the lobby area of the East Entrance of the programme, abstract book etc.) ExCeL London. Registration Fee for Accompanying Persons Opening hours includes: Saturday 30 Aug 2014 16:00 – 19:00 a Admission to Opening Ceremony and Wel- Sunday 31 Aug 2014 07:00 – 19:00 come Reception Monday 1 Sept 2014 08:00 – 19:00 a Half day city sightseeing tour of London Tuesday 2 Sept 2014 08:00 – 19:00 Wednesday 3 Sept 2014 08:00 – 19:00 Advance registration for the sightseeing tour for accompanying persons on 31 August, 1 or During these opening hours the congress 3 September 2014 is required. Please book counter can be reached at: your included tour at least one day prior at the Phone: +44 207 069 6001 congress counter. e ESP / Pathological Society Booth e Social Programme The joint booth of the European Society of Pa- CONGRESS CONCERT thology and the Pathological Society of Great a 1 September 2014 · Central Hall West- Britain and Ireland will be located in the Level minster / Great Hall 0 Boulevard near the Registration Counter. Member (cost contribution) 10 EUR Non-Member (cost contribution) 20 EUR e On-site Registration On-site registration will be processed on a first- CONGRESS PARTY come, first-served basis. Priority will be given a 3 September 2014 · Museum of London to pre-registered delegates. Depending on the Docklands number of on-site registered delegates, availa- Member (cost contribution) 10 EUR bility of congress material may be limited. Non-Member (cost contribution) 50 EUR Availability is limited, so tickets for the social events will be sold on a first-come, first-served basis. Please purchase your ticket at least one day prior to the event at the congress counter. 162 ECP 2014 · London Congress Information e Name Badges Stop carrying around piles of paper and Participants are kindly requested to wear quickly find your way through the most up- their name badge at all times during the con- to-date congress schedule. Just take the congress including the Opening Ceremony and gress with you, wherever and whenever you Welcome Reception. want. The colours of the name badges have the fol- a Send questions to the chairman during a lowing significance: session. l Green – Participants a Quickly find your way through the most up- l Yellow – Accompanying Persons to-date congress schedule. l Light Blue – Exhibitors a Mark your favorite sessions and personalise l Red – Staff your experience. a Access vital information around the con- e Congress Information System gress. For the 26th ECP, the web based Congress In- The App is completely free and provides formation System CO CONGRESS ONLINE® iPhone / iPad and Android users at the 26th has been installed: www.esp-congress.org ECP 2014 in London with on-the-go access to the congress’ most exciting interactive The delegates can set up and print out their features. personal congress programme schedule. The Questions & Answers tool is available CO CONGRESS ONLINE® provides: in the following rooms: ICC Auditorium, ICC a Updated scientific programme Capital Suite Room 7 / 12 and ICC Capital Sui- a Programme by day te Room 8 / 11. a Programme by format a Programme search a List of participants (who is who) a List of exhibitors and sponsors The ECP 2014 App is powered by GLOBIT’s acclaimed a General congress information CONGRESS MOBILE® software. a Private mailbox e Speakers’ Preview Room e Congress Language The Speakers’ Preview Room is located in The official language of the 26th European Room ICC Capital Suite 6 / 13 on Level 3 of Congress of Pathology is English. the ExCeL London. Speakers are asked to hand in their CD-ROM or USB stick contai- e Certificate of Attendance ning the PowerPoint presentation (IBM for- Participants can print out their certificates of mat or compatible, no multisession) prefe- attendance at the terminals near the regist- rably one day before their presentation, but ration counter. at the latest three hours prior to the presentation. On-site technical staff will offer support. e Abstract Book Due to time and technical reasons we kindly All abstracts are published in Virchows Ar- ask the speakers not to use their own note- chiv, Volume 465, Supplement 1. Participants book. In the Speakers’ Preview Room there will receive a copy of the final programme and are several PC working stations, where spea- the abstract book with the congress material. kers can also work on their presentation charts in a quiet area. Technical staff will be e Programme Changes happy to assist. The organisers cannot assume liability for any changes in the conference programme Opening hours due to external or unforeseen circumstances. Saturday 30 Aug 2014 16:00 – 19:00 Sunday 31 Aug 2014 07:00 – 19:00 e ECP 2014 App Monday 1 Sept 2014 07:30 – 19:00 Get the ECP 2014 App for your ECP Tuesday 2 Sept 2014 07:30 – 19:00 Smartphone now and experience 2014 Wednesday 3 Sept 2014 07:30 – 17:30 the congress at your fingertips. 163 Congress Information ECP 2014 · London e Poster Exhibition e Technical Exhibition Poster sessions will be held from Sunday, 31 The 26th ECP will be accompanied by a major August to Wednesday, 3 September 2014 in technical exhibition taking place in the ICC the ICC Capital Hall of the ExCeL London. Capital Hall of the ExCeL London. These sessions offer an effective forum for the exchange of information and a means to Exhibition hours communicate ideas, research, and program- Saturday 30 Aug 2014 20:00 – 22:00 mes. Sunday 31 Aug 2014 09:00 – 17:00 Poster authors will be required to be availa- Monday 1 Sept 2014 09:00 – 17:00 ble for questions and further information at Tuesday 2 Sept 2014 09:00 – 17:00 their poster board during the morning session break (09:30 – 10:30) from Sunday, 31 e Internet Centre and WiFi August to Wednesday, 3 September 2014. As a courtesy to all participants several in- At this congress, posters will be grouped by ternet terminals and a WiFi area in the ICC topics for the convenience of those attending Capital Hall of the ExCeL allow easy access the sessions. Posters will be changed daily to the internet. and are on display for the entire day of the respective poster session. They will be sorted Please select the WiFi network ECP 2014, no by topics and will be numbered within those password will be required. topics. The poster exhibition is open to all registered Opening hours delegates: Saturday 30 Aug 2014 20:00 – 22:00 Sunday 31 Aug 2014 09:00 – 17:00 Poster Discussion Times for Monday 1 Sept 2014 09:00 – 17:00 a PS-01 to PS-04 Tuesday 2 Sept 2014 09:00 – 17:00 Sunday, 31 Aug 2014: 09:30 – 10:30 Wednesday 3 Sept 2014 09:00 – 17:00 a PS-05 to PS-09 Monday, 1 Sept 2014: 09:30 – 10:30 The Internet Centre is kindly supported by a PS-10 to PS-18 Amgen Europe GmbH. Tuesday, 2 Sept 2014: 09:30 – 10:30 a PS-19 to PS-25 Wednesday, 3 Sept 2014: 09:30 – 10:30 e Coffee Breaks Interested participants can meet the authors Coffee and tea will be served free of charge for discussions of their poster presentation to all registered delegates during the morning during the time of the poster presentation. and afternoon coffee breaks, 09:30 – 10:30 and 16:15 – 17:00 from Sunday, 31 August Posters need to be set up and dismantled on through Tuesday, 2 September 2014 and the day of the respective poster session 09:30 – 10:30 and 16:00 – 16:30 on Wednes- within the following times: day, 3 September 2014. Coffee stations are lo- Set-up: cated in the exhibition area in the ICC Capital Sunday 31 Aug 2014 07:30 – 09:00 Hall. Monday 1 Sept 2014 07:30 – 09:00 Tuesday 2 Sept 2014 07:30 – 09:00 e Lunch Breaks Wednesday 3 Sept 2014 07:30 – 09:00 Lunches are served for registered partici- Dismantling: pants from 13:00 to 14:30 from Sunday, 31 17:00 – 18:00 on the day of the presentation. August through Tuesday, 2 September 2014 Posters which have not been removed within and 13:00 to 14:00 on Wednesday, 3 Septem- the indicated dismantling time will be dispo- ber 2014. The catering stations are located in sed of. the exhibition area in the ICC Capital Hall on the ground floor of the ExCeL.

164 ECP 2014 · London Congress Information e Cloakroom e How to get from the City Centre A cloakroom can be used free of charge to the Convention Centre from Saturday, 30 August 2014, early eve- By Rail ning to Wednesday, 3 September 2014. ExCeL London is well connected with 3 onsite Participants can also store their luggage DLR (Docklands Light Railway) stations and here. The cloakroom is located in the Level easy access to London Underground (Jubi- 0 Boulevard near the Registration Counter. lee Line). Alight at Prince Regent for ExCeL (east) and ICC London ExCeL. e Car Park All onsite parking is pay and display, with the Tube exception of the Royal Victoria multi-storey London's Underground rail network or 'the car park, which is located at the west end of Tube' as it is universally known to London- the site. Parking in the Royal Victoria multi- ers, is normally the quickest and easiest way storey car park can be paid for at one of the of travelling around London. three pay points located within the car park at Greater London is served by 12 Tube lines, the end of your visit (the machines are located along with the Docklands Light Railway on level two and level zero and all machines (DLR) and an interconnected local train net- accept both cash and credit card). work. Trains generally run between 5am and Parking is £ 15,00 for up to 24 hours at the fol- midnight, Monday to Saturday. Operating lowing locations: Royal Victoria multi-storey hours are reduced on Sunday. car park, Undercroft parking (Orange and Purple) and the East Car Park. e Taxis If you wish to travel by taxi once arrived at a Safety Heathrow airport, you have two options: Please make sure to take off your name badge Black cabs are available to hail at the airport and congress bag when you go sightseeing and take 5 people and average luggage. They in downtown London. Wearing the name and don’t have to be pre-booked however you bag identifies you as a tourist which might might have to queue. attract pickpockets. Black cabs are metered and based on travel time so depending on traffic you could end e First Aid up paying more. First Aid will be provided during ECP tenancy The average cost from London Heathrow and hours at the ExCeL. In case of emergency, Central London on a black cab is £45 - £85 please contact the First Aid Centre which is and the journey takes 30-60 minutes. There located on Level 0 between halls N10 and are no additional charges for luggage howe- N11. ver from Heathrow airport there is an extra charge of £2.80. e Insurance / Liability The other option is to pre-book a taxi which ESP and Pathology London 2014 Ltd do not will be waiting for you at your given pick up accept any liability for damages and / or losses location. Unlike the Black cabs, pre-booked of any kind which may be incurred by the cars have fixed rates so there are no hidden congress participants or by any person ac- costs, however some charge waiting time. companying them, during either the official Heathrow airport to central London is usually activities or excursions. Delegates participate around £70 whilst from central London to Ex- in all tours / events at their own risk. Partici- CeL it is £30. A recommended taxi company pants are advised to take out insurance is Addison Lee, the largest and oldest taxi against loss, accidents or damage that could company in London, working 24 hours and be incurred during the congress. providing prompt service to the customers. You can book your taxi via their App or call +44 (0)844 556 0707

165 Dako Omnis – A generation ahead in IHC & ISH

Perform both IHC and ISH on the same platform, with same day results. Please visit us for a demonstration at Booth #6

Be sure to take advantage of our scientific symposium and seminar:

Current Challenges in Breast Cancer Diagnosis: New Guidelines and Implementation in Clinical Practice Monday, September 1, 2014, from 1 p.m. - 2:30 p.m.

Introducing NGS into the Pathology Workflow Tuesday, September 2, 2014 from 7 p.m. - 9 p.m.

For more information on either meeting, please come by our booth.

Visit us at Booth #6

3209 25JUN14 www.dako.com

3209 ECP14 Advert final program_version3_09JUL14.indd 1 10-07-2014 14:20:13 ECP 2014 · London

e Industry Symposia

167 - - 12 / London · 2014 ECP Industry Symposium Industry ICC Capital Suite Room 7 ICC Capital Ki-67 dual-stain technology in Ki-67 dual-stain technology / LS-02 13:00 – 14:30 Biomarker Technology Using Advanced Disease Diagnosis of Cervical to Aid in the (Roche) 001 The p16 Biomarker: the chal Addressing lenges of CIN diagnosis , USA Darragh Teresa 002 Utility of p16 cytology & HPV posi the triage of abnormal tive results Denton, United Kingdom Karin Industry Symposium Industry ICC Capital Suite Room 1 ICC Capital , USA Ian Ellis, United Kingdom

Sunday, 31 August 2014 August 31 Sunday, Chair: (Genomic Health) Molecular Medicine comes of Age Molecular Medicine LS-01 07:15 – 08:15 Ian Ellis, United Kingdom Close 006 Panel Discussion and Q&A Panel Rick Baehner Rick 005 Future Perspectives in Molecular Testing in Molecular Perspectives Future 004 , Ireland Walshe Janice Testing Clinical Implications for Oncotype DX® Clinical Implications 003 Elizabeth Mallon, United Kingdom for Breast Cancer for Breast Changing the Paradigm in Molecular Testing in Molecular Testing Changing the Paradigm 002 Ian Ellis, United Kingdom Chair’s Welcome and Introduction Chair’s Welcome 001 168

e Breakfast and Luncheon Industry Symposia Industry Luncheon and Breakfast Sunday, 31 Aug Wolfram Klapper Q&A andclosing 006 Panel discussion 005 Laurence deLeval,Switzerland Wolfram Klapper cussion of CD30 detection: an interactive casedis Pathologists’ perspectiveonthechallenges 004 Peter Borchmann, Germany gist’s perspective ECP 2014 ·London The needforCD30detection:ahaematolo 003 PaoloPier Piccaluga,Italy The emerging role ofCD30 002 Wolfram Klapper Welcome andintroduction 001 Chair: (Takeda) haematological malignancies first stepstoward optimaltreatment of Pathologists’ role inCD30detection:the 13:00 –14:30 LS-03 Wolfram Klapper ICC CapitalSuiteRoom8 , Germany , Germany , Germany Industry Symposium , Germany Breakfast andLuncheon IndustrySymposia / 11 - - Patrick Pauwels, Belgium Concluding remarks andQ&A 004 Fernando Lopez-Rios,Spain ers intoroutine moleculartesting? How canweincorporate more lungbiomark 003 Phillipe Taniere, UnitedKingdom ence ments inNSCLC: TheBirminghamexperi Routine testingforALKgenerearrange 002 Patrick Pauwels, Belgium Molecular testingofNSCLC inthereal world 001 (Abbott GmbH) flow ofmolecularpathology cer; Current issuesandimproving thework Automating MolecularTesting inLungCan 13:00 –14:30 LS-04 ICC CapitalSuiteRoom9 Industry Symposium / 169 10 - - - - - Sunday, 31 Aug - - - - - 10 11 / / London · 2014 ECP Industry Symposium Industry Symposium Industry ICC Capital Suite Room 9 ICC Capital Suite Room 8 ICC Capital Telepathology Practice in a Multi- in a Practice Telepathology / LS-07 13:00 – 14:30 Sequencing: Next Generation Ion Torrent Molecular analysis of colon and lung tu a single sample -A from starting mours in the pathology research. new paradigm and OncoNetwork consor Presentation Discussion tium Panel (Life Technologies) LS-06 13:00 – 14:30 pa and research in routine Digitalisation thology (3DHISTECH) Laurent Puig, France Laurent , USA Vaughn P. Cecily , Portugal José Luis Costa Nishio, Japan Kazuto , Italy Nicola Normanno Orla Sheils, Ireland , The Netherlands Bastiaan Tops , The Netherlands Marjolijn Ligtenberg Ian Cree, United Kingdom 001 of cell density Quantitative measurements by image analysis markers and proliferative to make the pathology report as approach objective more , Russia Asel Kudaybergenova 002 Interhospital Routine Digital Pa Validated thology in Turkey institutional Health Group Ümit Ince, Turkey 003 slide scanning in The use of digital whole The power of having academic research. everything warts and all! , United Kingdom March Peter 004 Quantification of brightfield and multi-color signal in normal tissues and in fluorescent tumours using digitally scanned serial sec tions , USA Romin Yevgeniy - - 12 / Industry Symposium Industry ICC Capital Suite Room 7 ICC Capital Kenneth Bloom, USA Kenneth

Monday, 1 September 2014 1 September Monday, Chair: (Dako) tion in Clinical Practice Practice tion in Clinical Current Challenges in Breast Cancer Di Cancer in Breast Challenges Current guidelines and implementa agnosis; new LS-05 13:00 – 14:30 002 Kenneth Bloom, USA Kenneth Introduction 001 170 Kenneth Bloom, USA Kenneth Perspectives Implementing new technologies and Future Implementing new technologies and Future 005 , USA Reis-Filho Jorge How to handle triple negative breast cancers How to handle triple negative breast 004 Ian Ellis, United Kingdom practice. The EU experience practice. Implementation of guidelines in clinical Implementation of guidelines 003 guidelines – Background and US perspective guidelines – Background , USA Press Michael Navigating the changing breast cancer breast Navigating the changing

e Breakfast and Luncheon Industry Symposia Industry Luncheon and Breakfast Monday, 1 Sept e ECP 2014 ·London Closing remarks 006 Fátima Carneiro, Portugal The HGF/METpathwayingastriccancer 005 Q&A andpaneldiscussion Nicola Normanno, Italy Testing methodsandqualityassurance Meinolf Karthaus, Switzerland A clinicalperspective colorectal cancer Testing forRASmutationsinmetastatic 002 /003004 Fátima Carneiro, Portugal Welcome andintroduction 001 Chair: (Amgen) sions thologist’s role inguidingtreatment deci Precision medicine in GI cancers: the pa 13:00 –14:30 LS-08 Tuesday, 2September2014 Fátima Carneiro, Portugal ICC CapitalSuiteRoom7 Industry Symposium Breakfast andLuncheon IndustrySymposia / 12 - - Keith Kerr Recommendations andcalltoaction 006 to facilitatereflex testing? Panel discussion: Whatsolutionsare needed 005 Manfred Dietel,Germany Testing? Can pathologistsplayanactiverole in ALK 004 NSCLC barriers preventing reflex testingforALK+ Panel discussion: Whatare theeveryday 003 Lucio Crino,Italy testing isessential Leave nopatientbehind:whyreflex ALK 002 Keith Kerr reflex testinga reality Welcome &Introduction –MakingALK 001 Chair: (Pfizer Oncology) ALK+ NSCLC –Leavenopatientbehind 13:00 –14:30 LS-09 Keith Kerr , UnitedKingdom , UnitedKingdom ICC CapitalSuiteRoom8 , UnitedKingdom Industry Symposium / 171 11

Tuesday, 2 Sept Acknowledgements ECP 2014 · London

The ESP gratefully acknowledges the support of the following companies (as of 31 July 2014): a Major Sponsors

3DHISTECH LTD. Dako An Agilent Technologies Company

Amgen Europe GmbH Roche

a Further Sponsors and Exhibitors

A. Menarini Diagnostics S.R.L. European Society of Pathology / Pathological Abbott GmbH & Co. KG Society of Great Britain and Ireland Abcam EXAKT Advanced Technologies GmbH Advanced Cell Diagnostics Fimmic Oy Affymetrix GE Healthcare Applied Spectral Imaging, Inc Genomic Health Inc Biocartis NV Hamamatsu Photonics UK Ltd BioGenex Laboratories, Inc. Hitachi Data Systems Bio-Optica Milano SPA Horizon Discovery Ltd. BMJ (British Medical Association) Huron Technologies Bruker Daltonik GmbH INFOPIA Co., Ltd. CELL MARQUE Corporation Labquality Oy CENTURION Scientific Ltd Life Technologies Cirdan Imaging Limited Mawell UK Ltd Covaris Ltd Medite GmbH Cromwell Medical Staffing LTD MEDITHEQUE BOOKSHOP Cytocell Ltd microDimensions GmbH DEFINIENS AG Milestone srl DIAPATH S.p.A. MORPHISTO Evolutionsforschung & Emmonya Pharmatech Bulgaria Ltd Anwendung GmbH ENEA BRIVIO di Simone Brivio Multiplicom NV

172 ECP 2014 · London

a Further Sponsors and Exhibitors

Objective Imaging Ltd QIAGEN OLYMPUS EUROPA SE & CO. KG Sakura Finetek Europe B.V. Patholab-Tecnolab Sectra Imaging IT Solutions AB Pathology Group Sensovation AG PathXL Serosep Ltd. PerkinElmer Inc The Pathologist pfm medical ag Thermo Fisher Scientific Pfizer Oncology UKNEQAS - ICC & ISH Philips Healthcare, Digital Pathology Vela Diagnostics Germany GmbH Pixcelldata Ltd. Visiopharm PreAnalytiX Wisepress Ltd. Primera Technology Europe WOLFVISION UK LTD Princess Alexandra Hospital NHS Trust a Additional support

The ESP thanks the City of London for supporting the Presidential Dinner.

173 Exhibition Floor Plan ECP 2014 · London e ICC Capital Hall on Level 0

Poster Area

56 61

Catering Area

55 54

36 46 40 41 58 45 60 d 53 42 59 49 35 46 46 48 a c 50 34 39 43 47 51 33 37 Internet 38 44 52 Service Centre 32 21 20 19 31 17 A 25 29 26 22 18 24 16

30 28 23 15 31 27 9 9 3

14 10 2 5 13

6 7 12 8 9 4 1 11

Main Entrance 174 ECP 2014 · London List of Exhibitors a Exhibitors in Alphabetical Order (as of 31 July 2014)

Booth Booth Company Company No. No. 3DHISTECH LTD. 7 European Society of Pathology / Level 0 Pathological Society of Great A. Menarini Diagnostics S.R.L. 50 Boulevard Britain and Ireland Abbott GmbH & Co. KG 9 EXAKT Advanced Technologies 40 Abcam 54 GmbH Advanced Cell Diagnostics 36 Fimmic Oy 32 Affymetrix 31A GE Healthcare 1 Amgen Europe GmbH 48 Genomic Health Inc 4 Applied Spectral Imaging, Inc 59 Hamamatsu Photonics UK Ltd 29 Biocartis NV 8 Horizon Discovery Ltd. 30 BioGenex Laboratories, Inc. 2 Huron Technologies 49 Bio-Optica Milano SPA 10 INFOPIA Co., Ltd. 12 BMJ (British Medical Association) 63 Labquality Oy 15 Bruker Daltonik GmbH 33 Life Technologies 46a CELL MARQUE Corporation 51 Mawell UK Ltd 41 CENTURION Scientific Ltd 27 Medite GmbH 25 Cirdan Imaging Limited 35 MEDITHEQUE BOOKSHOP 58 Covaris Ltd 11 microDimensions GmbH 24 Cromwell Medical Staffing LTD 26 Milestone srl 52 Cytocell Ltd 16 MORPHISTO Evolutionsfor- 40 schung & Anwendung GmbH Dako An Agilent Technologies 6 Company Multiplicom NV 46d DEFINIENS AG 47 Objective Imaging Ltd 17 DIAPATH S.p.A. 21 OLYMPUS EUROPA SE & CO. KG 5 Emmonya Pharmatech Bulgaria Ltd 28 Patholab-Tecnolab 38 ENEA BRIVIO di Simone Brivio 55 Pathology Group 13

175 ECP 2014 · London a Exhibitors in Alphabetical Order (as of 31 July 2014)

Booth Company No. PathXL 3 PerkinElmer Inc 37 pfm medical ag 19 Philips Healthcare, Digital 22 Pathology Pixcelldata Ltd. / 20 Hitachi Data Systems PreAnalytiX 44 Primera Technology Europe 42 Princess Alexandra Hospital 61 NHS Trust QIAGEN 43 Roche 23 Sakura Finetek Europe B.V. 53 Sectra Imaging IT Solutions AB 14 Sensovation AG 34 Serosep Ltd. 39 The Pathologist 62 Thermo Fisher Scientific 18 UKNEQAS - ICC & ISH 45 Vela Diagnostics Germany 31 GmbH Visiopharm 60 WILEY 57 Wisepress Ltd. 56 WOLFVISION UK LTD 46c

176 ECP 2014 · London List of Exhibitors a Exhibitors by Booth Number (as of 31 July 2014)

Booth Booth Company Company No. No. DIAPATH S.p.A. 21 European Society of Pathology / Level 0 Pathological Society of Great Philips Healthcare, Digital Boulevard 22 Britain and Ireland Pathology Roche 23 GE Healthcare 1 microDimensions GmbH 24 BioGenex Laboratories, Inc. 2 Medite GmbH 25 PathXL 3 Cromwell Medical Staffing LTD 26 Genomic Health Inc 4 CENTURION Scientific Ltd 27 OLYMPUS EUROPA SE & CO. KG 5 Emmonya Pharmatech Bulgaria Ltd 28 Dako – An Agilent Technologies 6 Company Hamamatsu Photonics UK Ltd 29 3DHISTECH LTD. 7 Horizon Discovery Ltd. 30 Biocartis NV 8 Vela Diagnostics Germany GmbH 31 Abbott GmbH & Co. KG 9 Affymetrix 31A Bio-Optica Milano SPA 10 Fimmic Oy 32 Covaris Ltd 11 Bruker Daltonik GmbH 33 INFOPIA Co., Ltd. 12 Sensovation AG 34 Pathology Group 13 Cirdan Imaging Limited 35 Sectra Imaging IT Solutions AB 14 Advanced Cell Diagnostics 36 Labquality Oy 15 PerkinElmer Inc 37 Cytocell Ltd 16 Patholab-Tecnolab 38 Objective Imaging Ltd 17 Serosep Ltd. 39 Thermo Fisher Scientific 18 EXAKT Advanced Technologies 40 GmbH pfm medical ag 19 MORPHISTO Evolutionsfor- Pixcelldata Ltd. / 40 20 schung & Anwendung GmbH Hitachi Data Systems

177 ECP 2014 · London a Exhibitors in Alphabetical Order (as of 31 July 2014)

Booth Company No. Mawell UK Ltd 41 Primera Technology Europe 42 QIAGEN 43 PreAnalytiX 44 UKNEQAS - ICC & ISH 45 Life Technologies 46a WOLFVISION UK LTD 46c Multiplicom NV 46d DEFINIENS AG 47 Amgen Europe GmbH 48 Huron Technologies 49 A. Menarini Diagnostics S.R.L. 50 CELL MARQUE Corporation 51 Milestone srl 52 Sakura Finetek Europe B.V. 53 Abcam 54 ENEA BRIVIO di Simone Brivio 55 Wisepress Ltd. 56 WILEY 57 MEDITHEQUE BOOKSHOP 58 Applied Spectral Imaging, Inc 59 Visiopharm 60 Princess Alexandra Hospital 61 NHS Trust The Pathologist 62 BMJ (British Medical Association) 63

178 ECP 2014 · London

e Social Events

e Tours

179 Social Events ECP 2014 · London

Availability is limited, so tickets for the social events will be sold on a first-come, first-served basis. Please purchase your ticket at least one day prior to the events. e Opening Ceremony Please allow enough travel time to the venue and Welcome Reception (approx. 30 minutes from the ExCeL).

Saturday, 30 August 2014 Cost contribution per person a 19:00 – 22:00, ExCeL London a Member: EUR 10 a Non-Member: EUR 20 Join the official Opening Ceremony of the 26th ECP in the ICC Auditorium of ExCeL London. e Congress Party During the ceremony, there will be words of welcome by the ESP President. An amazing Wednesday, 3 September 2014 show of Irish dancers as well as a Welsh choir a 20:30 – 24:00, Museum of London Dock- performing classical Welsh songs get you in lands, No.1 Warehouse, West India Quay, the mood for the congress in London. The London E14 4AL Opening Ceremony will be followed by a Wel- come Reception in the ICC Capital Hall. Don’t miss the Grande Finale of the 26th ECP – the Congress Party at the Museum of e Congress Concert London Docklands. This unique venue traces the 2000 year history of London's river, port Monday, 1 September 2014 and people, from the arrival of the Romans to a 20:30 – 22:30, Central Hall Westminster / the rise of Canary Wharf. Located over five Great Hall, Storey's Gate, London SW1H 9NH floors of a splendid late Georgian warehouse, the Museum is Canary Wharf's only Grade 1 Central Hall Westminster was built in 1912 listed venue. Built in 1802, the warehouse and is a Grade II listed building adjacent to which is home to Museum of London Dock- the Houses of Parliament and Big Ben, and lands was originally used to store vast quan- opposite Westminster Abbey. tities of rum, molasses, coffee, pimento and The “Great Hall” which will be used for the cotton from the West Indies. exclusive ECP Concert, holds Europe's lar- Spend an unforgettable evening with a buf- gest self-supporting domed ceiling – a stun- fet dinner and The B-Side Beatles – a popup ning location for a classical concert. acoustic tribute to The Beatles. You will get to enjoy a potpourri of classical Transportation to and from the Museum of music across 300 years performed by the fa- London Docklands to be arranged individually. mous Royal Philharmonic Concert Orchestra and conducted by Barry Wordsworth. a How to get there Leave the ExCeL at the East Entrance and go a How to get there to the DLR station “Prince Regent” and take Leave the ExCeL at the East Entrance and go the train towards DLR station “Tower Gate- to the DLR station “Prince Regent” and take way” and change the railway after 6 stops at the train towards DLR station “Tower Gate- “Poplar” DLR station. Then take the DLR to- way” or “Stratford International” and change wards “Canary Wharf” and get off the train at the train at “Canning Town Underground “West India Quay”. You will find the “Muse- Station”. Then take the Jubilee line towards um of London Docklands” on your right hand “Stanmore Underground Station”, “Willesden side (2 minutes walk). Green Underground station” or “Wembley Please allow enough travel time to the venue Park Underground Station” and get off the (approx. 25 minutes from the ExCeL). tube at “Westminster Underground Station”. You will find “Central Hall Westminster” on Cost contribution per person the opposite side of “Westminster Abbey” a Member: EUR 10 (3 minutes walk). a Non-Member: EUR 50

180 ECP 2014 · London Tours

During the ECP 2014, the officially appointed e Following the footsteps of the local partner KUONI Destination Manage- British Monarchy ment will offer various guided tours in and around London for participants and their Monday, 1 Sept 2014 a 14:00 – 18:00 accompanying persons. All tours are accompanied by an English-speaking guide. Please If you were a King or a Queen for a day in note that all tours will start and end at the London, what would you do? East Entrance of the ExCeL London. Would you wear the most famous diamond in the world? Would you marry 6 women (and e Modern & traditional London decapitate two)? From stunning royal dresses, to the Crown Sunday, 31 Aug 2014 a 14:00 – 18:00 Jewels, to the State Apartments, to cere- Monday, 1 Sept 2014 a 09:00 – 13:00 monial carriages, London has everything! Wednesday, 3 Sept 2014 a 09:00 – 13:00 You will get the chance to visit the Tower For registered accompanying persons this of London and admiring the Jewels of the tour is included in the registration fee. Please Crown, afterwards move on to Bucking- note that advance registration is required. ham Palace, to see the Palace of the home of royalty. Moving along The Mall also pass We will start a sightseeing tour of London St James‘s palace and Clarence house. that will take in all the major sights. Your tour will take you pass Westminster Abbey, Price per person: a GBP 45 the scene of 38 coronations and 14 Royal (Price includes: Ticket for Tower of London, weddings. Journey up the Mall to witness transportation and English-speaking guide) the Changing of the Guards at Buckingham Palace in all its colorful pageantry and ceremony set to the stirring tunes of the Regi- mental band. Our journey around the West End will take us past many of the famous sights, including Trafalgar Square, The Hou- ses of Parliament and Piccadilly Circus. We continue our tour through the City of Lon- don, and see St. Paul's Cathedral, Sir Chris- topher Wren's masterpiece, which lies in the heart of London's financial centre, where we are guided past such sites as the Stock Ex- change, Bank of England, Mansion House (the home of the Lord Mayor of London), to name but a few. We then move on to the To- wer of London – the home of the Beefeaters and the Crown Jewels.

Price per person a GBP 25

Big Ben and Westminster Bridge © Visit London, Buckingham Palace 181 Tours ECP 2014 · London e Windsor & Windsor Castle e James Bond London Tour

Tuesday, 2 Sept 2014 a 10:00 – 16:00 Wednesday, 3 Sept 2014 a 10:00 – 14:00

This tour will take you out to the beauti- Step into the dangerous world of 007 and ful Windsor Castle. This is the official other secret agents as we take you on a residence of The Queen and the largest oc- James Bond Tour of London visiting movie cupied castle in the world. A royal palace locations and sites linked with Ian Fleming and fortress for over 900 years, the Castle and 007 including locations from the latest remains a working palace today. Bond film Skyfall, such as: Dukes Hotel, Bu- Visitors can walk around the State Apart- ckingham palace, MI6, Whitehall etc. ments, extensive suites of rooms at the On this James Bond tour you’ll travel by heart of the palace. Within the Castle com- coach and visit James Bond London film loca- plex there are many additional attractions, tions and other places familiar to James Bond including the Drawings Gallery, Queen author Ian Fleming who lived in London. See Mary's dolls' house, and the fourteenth- where fiction becomes reality as we take you century St. George's Chapel, the burial to actual spy locations associated with the place of ten sovereigns and setting for real world of espionage. many Royal weddings. After the visit of the Learn how the James Bond films were made, castle guests will have an opportunity of get an insight into the secret world of spies, some free time for lunch or shopping be- discuss some of the classic James Bond Lon- fore heading back to London. don settings and novels plus trivia about the actors behind them. Price per person: a GBP 65 Along the way you’ll have plenty of oppor- (Price includes: Ticket for Windsor Castle tunities to take pictures and walk in the and St. Georges Chapel, transportation and footsteps of Ian Fleming, Sean Connery, Pier- English-speaking guide) ce Brosnan and real life spies.

Price per person a GBP 26 (Price includes: Ticket for Tower of London, transportation and English-speaking guide)

e General Conditions

e Full payment in advance is required. e All tours will be conducted in English. e All tours are based on a minimum of 25 participants. The organisers reserve the right to cancel the tours if the minimum number of participants is not reached. Full refunds will be available after the congress ends, for tours which will not take place. e You will receive your tour tickets at the Tour Desk at the Congress Centre. e All tours start and end at the congress venue, ExCeL London, if not otherwise mentioned. e Meeting point will be the Tour Desk.

brought to you by 9 Journals. 1 Location.

Look. Click. Learn.

Focus on What Matters Most to You Pathology Network is your online resource for current full-text articles from the LWW pathology journal collection—in one convenient location!

Search less. Read more.

Updated content sorted into Channels that matter to you!

Visit PathNetwork.com to start your FREE TRIAL today!

4-Q781 In relapsed or refractory Hodgkin lymphoma with prior ASCT1,2

75% 33% 40.5 MONTHS ORR CR MEDIAN OS (95% ci. 28.7 to not estimable) ADCETRIS: DEMONSTRATED INNOVATIVE ANTI-TUMOUR In relapsed or refractory sALCL3,4 CD30-TARGETED EFFICACY THERAPY 86% 59% AFTER 33.4 MONTHS ORR CR MEDIAN OS NOT REACHED (95% ci. 21.3 to not estimable)

ASCT: autologous stem cell transplant; ORR: overall response rate; CR: complete remission OS: overall survival

Abbreviated Prescribing Information: Adcetris (brentuximab vedotin) (Refer to Summary of Product Characteristics (SmPC) before prescribing)

Presentation: 50 mg powder for concentrate for solution for infusion. permanently discontinued if anaphylactic reaction occurs. Infusion thrombocytopenia, constipation, diarrhoea, vomiting, pyrexia, peripheral Indication: Treatment of adult patients with relapsed or refractory should be interrupted if infusion reaction occurs (see SmPC). Patients motor neuropathy and peripheral sensory neuropathy, hyperglycaemia, CD30+ Hodgkin lymphoma (HL) following autologous stem cell with rapidly proliferating tumour and high tumour burden are at risk demyelinating polyneuropathy, tumour lysis syndrome and Stevens- transplant (ASCT) or following at least two prior therapies when ASCT of tumour lysis syndrome; these patients should be monitored and Johnson syndrome. Pharmaceutical Precautions: Store vial in a or multi-agent chemotherapy is not a treatment option; Treatment of managed according to best medical practice. Adcetris may cause refrigerator (2°C-8°C), protected from light. After reconstitution/dilution, adult patients with relapsed or refractory systemic anaplastic large peripheral neuropathy which is reversible in most cases. Patients should chemical and physical in-use stability has been demonstrated for 24 cell lymphoma (sALCL). Dosage & Administration: Adcetris should be monitored for symptoms of neuropathy. Patients experiencing new or hours at 2°C-8°C. PI Date of Preparation: Jan 2014 PI approval be administered under the supervision of a physician experienced worsening peripheral neuropathy may require delay and dose reduction code: UK/ADC/1403/0019 Legal category: POM Basic NHS Price brentuximab vedotin in the use of anti-cancer agents. Recommended dose is 1.8 mg/ or discontinuation of Adcetris (see SmPC). Grade 3 or 4 anaemia, & Marketing Authorisation: £2,500 for each Adcetris 50 mg vial kg administered as an intravenous infusion over 30 minutes every 3 thrombocytopenia and neutropenia can occur with Adcetris. Refer to (EU/1/12/794/001) Further information is available from: Takeda AdcetRis, a novel cd30-targeted weeks (If the patient’s weight is more than 100 kg, the dose calculation SmPC for dose adjustments if neutropenia develops. Patients should UK Ltd. Takeda House, Mercury Park, Wooburn Green, High Wycombe, should use 100 kg). Treatment should be continued until disease be monitored for fever and managed according to best medical practice Bucks HP10 0HH. Tel: 01628 537900 Fax: 01628 526617. Adcetris® antibody-drug conjugate, provides progression or unacceptable toxicity. Patients who achieve stable if febrile neutropenia develops. If Stevens-Johnson syndrome occurs, is a registered trademark. disease or better should receive a minimum of 8 cycles and up to a treatment with Adcetris should be discontinued and appropriate medical antitumour efficacy for relapsed or maximum of 16 cycles. Complete blood counts should be monitored therapy administered. Elevations in alanine aminotransferase (ALT) and Adcetris has received a conditional marketing authorisation in Europe. prior to administration of each dose of this treatment. Patients aspartate aminotransferase (AST) have been reported; liver function A conditional marketing authorisation is granted to a medicinal product refractory Hodgkin lymphoma and should be monitored during and after infusion. For reconstitution and should be routinely monitored in patients receiving Adcetris. Any patient that fulfils an unmet medical need when the benefit to public health of administration instructions please refer to SmPC section 6.6 Dose who experiences an event of hyperglycaemia should have their serum immediate availability outweighs the risk inherent in the fact additional sALcL patients2 Adjustments: If neutropenia develops during treatment it should be glucose monitored and managed appropriately. MMAE clearance data are still required. The European regulatory agency will review new managed by dose delays (see SmPC). If peripheral sensory or motor might be affected by moderate and severe renal impairment, and by information on Adcetris at least every year and the summary of product neuropathy emerges or worsens during treatment patients may require low serum albumin concentrations (see SmPC). Adcetris contains a characteristics will be updated as necessary. delay and dose reduction or discontinuation of Adcetris (see SmPC). maximum of 2.1 mmol (or 47 mg) of sodium per dose. Pregnancy & • For the treatment of adult patients with relapsed Renal or hepatic impairment: No data available regarding use in renal or lactation: No data available. Studies in animals have shown reproductive Please refer to the summary of product characteristics or refractory CD30+ Hodgkin lymphoma: hepatic failure. Elderly patients (≥65yrs): No data available. Paediatric toxicity. Fertility: In non-clinical studies, Adcetris treatment has resulted for details on the full side-effect profile and drug patients (<18 yrs): No data available. In nonclinical studies thymus in testicular toxicity, and may alter male fertility. Drug Interactions: 1. following autologous stem cell transplant (ASCT) or depletion has been observed. Contraindications: Hypersensitivity to Co-administration of Adcetris with strong CYP3A4 and P-gp inhibitors, interactions of Adcetris. 2. following at least two prior therapies when the active substance or to any of the excipients listed. Combined use such as ketoconazole, may increase the incidence of neutropenia; with Adverse events should be reported. of bleomycin and Adcetris causes pulmonary toxicity. Warnings and rifampicin, a strong CYP3A4 inducer, did not alter the plasma exposure Reporting forms and information can be found at ASCT or multi-agent chemotherapy is not a Precautions: Progressive multifocal leukoencephalopathy (PML) has to Adcetris however, it reduced exposure to MMAE; and midazolam, a www.mhra.gov.uk/yellowcard. treatment option been reported in patients who received Adcetris after receiving multiple CYP3A4 substrate, did not alter the metabolism of midazolam therefore, Adverse events should also be reported to prior chemotherapy regimens; patients should be closely monitored Adcetris is not expected to alter the exposure to medicines that are Takeda UK Ltd 01628-537900 • For the treatment of adult patients with relapsed or for new or worsening neurological, cognitive, or behavioural signs or metabolized by CYP3A4 enzymes. Adverse Effects: Very common refractory systemic anaplastic large cell lymphoma symptoms, which may be suggestive of PML. Adcetris dosing should be (>10%): Infection, neutropenia, peripheral sensory neuropathy, UK/ADC/1407/0036 Date of preparation July 2014 held for any suspected case of PML and permanently discontinued if a diarrhoea, nausea, vomiting, alopecia, pruritus, myalgia, fatigue, pyrexia, (sALCL) diagnosis of PML is confirmed. Acute pancreatitis has been observed infusion-related reactions. Common (≥1/100 to <1/10): Sepsis/septic References: 1. Gopal AK, et al. Poster abstract no. 4382 presented at • Manageable adverse event profile; peripheral in patients treated with Adcetris. Patients should be monitored for shock, upper respiratory tract infection, herpes zoster, pneumonia, American Society of Hematology, December 2013, New Orleans, LA, abdominal pain suggestive of acute pancreatitis. Adcetris dosing should anaemia, thrombocytopenia, hyperglycaemia, peripheral motor USA. 2. Adcetris Summary of Product Characteristics 2014. neuropathy is generally low grade, reversible and be held if acute pancreatitis is suspected and permanently discontinued neuropathy, dizziness, demyelinating polyneuropathy, cough, dyspnoea, 3. Pro B, et al. J Clin Oncol 2012; 30: 2190-2196. 4. Pro B, manageable through dose modification if a diagnosis is confirmed. Pulmonary toxicity has been reported in constipation, alanine aminotransferase/aspartate aminotransferase et al. Poster abstract no. 1809 presented at American Society of patients receiving Adcetris. In the event of new or worsening pulmonary (ALT/AST) increased, rash, arthralgia, back pain, chills. Uncommon Hematology, December 2013, New Orleans, LA, USA. • Patients who achieve stable disease or better should symptoms, a prompt diagnostic evaluation is required and patients (≥1/1000 to <1/100): Oral candidiasis, Pneumocystis jiroveci receive a minimum of 8 cycles and up to a maximum treated appropriately. Patients should be monitored during treatment for pneumonia, staphylococcal bacteraemia, Tumour lysis syndrome, the emergence of possible serious and opportunistic infections (including acute pancreatitis, Stevens-Johnson syndrome. Frequency not known of 16 cycles (approximately 1 year) sepsis/septic shock). Immediate and delayed infusion-related reactions (cannot be estimated from the available data): Progressive multifocal (IRR), as well as anaphylactic reactions, have been reported. Monitor leukoencephalopathy, febrile neutropenia, anaphylactic reaction. Serious • Contraindicated for patients who are hypersensitive to patients during and after infusion. Adcetris should be immediately and adverse drug reactions in the phase 2 population were: neutropenia,ADCETRIS and are trademarks ofADCETRIS Millennium and Pharmaceuticals, are trademarks Inc. of Millennium Pharmaceuticals, Inc. the active substance or any of the excipients In relapsed or refractory Hodgkin lymphoma with prior ASCT1,2

ASCT: autologous stem cell transplant; ORR: overall response rate; CR: complete remission OS: overall survival

Abbreviated Prescribing Information: Adcetris (brentuximab vedotin) (Refer to Summary of Product Characteristics (SmPC) before prescribing)

Presentation: 50 mg powder for concentrate for solution for infusion. permanently discontinued if anaphylactic reaction occurs. Infusion thrombocytopenia, constipation, diarrhoea, vomiting, pyrexia, peripheral Indication: Treatment of adult patients with relapsed or refractory should be interrupted if infusion reaction occurs (see SmPC). Patients motor neuropathy and peripheral sensory neuropathy, hyperglycaemia, CD30+ Hodgkin lymphoma (HL) following autologous stem cell with rapidly proliferating tumour and high tumour burden are at risk demyelinating polyneuropathy, tumour lysis syndrome and Stevens- transplant (ASCT) or following at least two prior therapies when ASCT of tumour lysis syndrome; these patients should be monitored and Johnson syndrome. Pharmaceutical Precautions: Store vial in a or multi-agent chemotherapy is not a treatment option; Treatment of managed according to best medical practice. Adcetris may cause refrigerator (2°C-8°C), protected from light. After reconstitution/dilution, adult patients with relapsed or refractory systemic anaplastic large peripheral neuropathy which is reversible in most cases. Patients should chemical and physical in-use stability has been demonstrated for 24 cell lymphoma (sALCL). Dosage & Administration: Adcetris should be monitored for symptoms of neuropathy. Patients experiencing new or hours at 2°C-8°C. PI Date of Preparation: Jan 2014 PI approval be administered under the supervision of a physician experienced worsening peripheral neuropathy may require delay and dose reduction code: UK/ADC/1403/0019 Legal category: POM Basic NHS Price brentuximab vedotin in the use of anti-cancer agents. Recommended dose is 1.8 mg/ or discontinuation of Adcetris (see SmPC). Grade 3 or 4 anaemia, & Marketing Authorisation: £2,500 for each Adcetris 50 mg vial kg administered as an intravenous infusion over 30 minutes every 3 thrombocytopenia and neutropenia can occur with Adcetris. Refer to (EU/1/12/794/001) Further information is available from: Takeda AdcetRis, a novel cd30-targeted weeks (If the patient’s weight is more than 100 kg, the dose calculation SmPC for dose adjustments if neutropenia develops. Patients should UK Ltd. Takeda House, Mercury Park, Wooburn Green, High Wycombe, should use 100 kg). Treatment should be continued until disease be monitored for fever and managed according to best medical practice Bucks HP10 0HH. Tel: 01628 537900 Fax: 01628 526617. Adcetris® antibody-drug conjugate, provides progression or unacceptable toxicity. Patients who achieve stable if febrile neutropenia develops. If Stevens-Johnson syndrome occurs, is a registered trademark. disease or better should receive a minimum of 8 cycles and up to a treatment with Adcetris should be discontinued and appropriate medical antitumour efficacy for relapsed or maximum of 16 cycles. Complete blood counts should be monitored therapy administered. Elevations in alanine aminotransferase (ALT) and Adcetris has received a conditional marketing authorisation in Europe. prior to administration of each dose of this treatment. Patients aspartate aminotransferase (AST) have been reported; liver function A conditional marketing authorisation is granted to a medicinal product refractory Hodgkin lymphoma and should be monitored during and after infusion. For reconstitution and should be routinely monitored in patients receiving Adcetris. Any patient that fulfils an unmet medical need when the benefit to public health of administration instructions please refer to SmPC section 6.6 Dose who experiences an event of hyperglycaemia should have their serum immediate availability outweighs the risk inherent in the fact additional sALcL patients2 Adjustments: If neutropenia develops during treatment it should be glucose monitored and managed appropriately. MMAE clearance data are still required. The European regulatory agency will review new managed by dose delays (see SmPC). If peripheral sensory or motor might be affected by moderate and severe renal impairment, and by information on Adcetris at least every year and the summary of product neuropathy emerges or worsens during treatment patients may require low serum albumin concentrations (see SmPC). Adcetris contains a characteristics will be updated as necessary. delay and dose reduction or discontinuation of Adcetris (see SmPC). maximum of 2.1 mmol (or 47 mg) of sodium per dose. Pregnancy & • For the treatment of adult patients with relapsed Renal or hepatic impairment: No data available regarding use in renal or lactation: No data available. Studies in animals have shown reproductive Please refer to the summary of product characteristics or refractory CD30+ Hodgkin lymphoma: hepatic failure. Elderly patients (≥65yrs): No data available. Paediatric toxicity. Fertility: In non-clinical studies, Adcetris treatment has resulted for details on the full side-effect profile and drug patients (<18 yrs): No data available. In nonclinical studies thymus in testicular toxicity, and may alter male fertility. Drug Interactions: 1. following autologous stem cell transplant (ASCT) or depletion has been observed. Contraindications: Hypersensitivity to Co-administration of Adcetris with strong CYP3A4 and P-gp inhibitors, interactions of Adcetris. 2. following at least two prior therapies when the active substance or to any of the excipients listed. Combined use such as ketoconazole, may increase the incidence of neutropenia; with Adverse events should be reported. of bleomycin and Adcetris causes pulmonary toxicity. Warnings and rifampicin, a strong CYP3A4 inducer, did not alter the plasma exposure Reporting forms and information can be found at ASCT or multi-agent chemotherapy is not a Precautions: Progressive multifocal leukoencephalopathy (PML) has to Adcetris however, it reduced exposure to MMAE; and midazolam, a www.mhra.gov.uk/yellowcard. treatment option been reported in patients who received Adcetris after receiving multiple CYP3A4 substrate, did not alter the metabolism of midazolam therefore, Adverse events should also be reported to prior chemotherapy regimens; patients should be closely monitored Adcetris is not expected to alter the exposure to medicines that are Takeda UK Ltd 01628-537900 • For the treatment of adult patients with relapsed or for new or worsening neurological, cognitive, or behavioural signs or metabolized by CYP3A4 enzymes. Adverse Effects: Very common refractory systemic anaplastic large cell lymphoma symptoms, which may be suggestive of PML. Adcetris dosing should be (>10%): Infection, neutropenia, peripheral sensory neuropathy, UK/ADC/1407/0036 Date of preparation July 2014 held for any suspected case of PML and permanently discontinued if a diarrhoea, nausea, vomiting, alopecia, pruritus, myalgia, fatigue, pyrexia, (sALCL) diagnosis of PML is confirmed. Acute pancreatitis has been observed infusion-related reactions. Common (≥1/100 to <1/10): Sepsis/septic References: 1. Gopal AK, et al. Poster abstract no. 4382 presented at • Manageable adverse event profile; peripheral in patients treated with Adcetris. Patients should be monitored for shock, upper respiratory tract infection, herpes zoster, pneumonia, American Society of Hematology, December 2013, New Orleans, LA, abdominal pain suggestive of acute pancreatitis. Adcetris dosing should anaemia, thrombocytopenia, hyperglycaemia, peripheral motor USA. 2. Adcetris Summary of Product Characteristics 2014. neuropathy is generally low grade, reversible and be held if acute pancreatitis is suspected and permanently discontinued neuropathy, dizziness, demyelinating polyneuropathy, cough, dyspnoea, 3. Pro B, et al. J Clin Oncol 2012; 30: 2190-2196. 4. Pro B, manageable through dose modification if a diagnosis is confirmed. Pulmonary toxicity has been reported in constipation, alanine aminotransferase/aspartate aminotransferase et al. Poster abstract no. 1809 presented at American Society of patients receiving Adcetris. In the event of new or worsening pulmonary (ALT/AST) increased, rash, arthralgia, back pain, chills. Uncommon Hematology, December 2013, New Orleans, LA, USA. • Patients who achieve stable disease or better should symptoms, a prompt diagnostic evaluation is required and patients (≥1/1000 to <1/100): Oral candidiasis, Pneumocystis jiroveci receive a minimum of 8 cycles and up to a maximum treated appropriately. Patients should be monitored during treatment for pneumonia, staphylococcal bacteraemia, Tumour lysis syndrome, the emergence of possible serious and opportunistic infections (including acute pancreatitis, Stevens-Johnson syndrome. Frequency not known of 16 cycles (approximately 1 year) sepsis/septic shock). Immediate and delayed infusion-related reactions (cannot be estimated from the available data): Progressive multifocal (IRR), as well as anaphylactic reactions, have been reported. Monitor leukoencephalopathy, febrile neutropenia, anaphylactic reaction. Serious • Contraindicated for patients who are hypersensitive to patients during and after infusion. Adcetris should be immediately and adverse drug reactions in the phase 2 population were: neutropenia,ADCETRIS and are trademarks ofADCETRIS Millennium and Pharmaceuticals, are trademarks Inc. of Millennium Pharmaceuticals, Inc. the active substance or any of the excipients Submit your next article to The Clinical Journal of Pathology

The Clinical Journal of Pathology is the peer reviewed journal for rapid dissemination of high quality studies that illuminate the clinical relevance of pathological research. The Journal welcomes investigative diagnostic, prognostic, and biomarker studies New with clear clinical relevance, that advance open access our understanding of the journal mechanisms of human disease.

Reasons to publish with The Clinical Journal of Pathology: • High standard, rigorous peer review • Rapid publication • Open Access – published articles are licensed under Creative Commons and authors are the copyright holder • Compliant with open access mandates • Wide dissemination and discoverability via Wiley Online Library

Visit www.clinicaljournalofpathology.com for more information and to submit your article 14 - 66840 ECP 2014 · London Index of Authors

A Aiad, H. A. Samie 78, 126, 134 Ali, N. 106 Aaltonen, L. A. 115 Aida, J. 93 Ali, S. 79, 82 Aas, H. 80 Aird, J. 153 Alibhai, F. 89 Abadjian, G. 104 Aitken, S. 58, 83, 145 Alimoglu, O. 30 Abbaci, M. 50 Ajioka, Y. 30 Alis, D. 71 Abbas, A. 116 Ajouli, B. 77 Alizzi, M. 115 Abbasi, F. 92, 150 Ajouli, W. 74, 77, 93, 100, Aljama García, P. 127 Abbes, I. 113, 141, 154 101,113, 114, Al-Johani, T. 128 Abdallah, D. 49, 77, 137 118, 132, 140 Al-Kaabi, M. 78, 81, 82 Abd Allah, R. 59 Akagi, E. 142 Al-Kuraya, K. 141 Abdelaali, Z. I. 118 Akalin, T. 94 Al-Lawatiah, S. 123 Abdelfatteh, Z. 76 Akar Ozkan, E. 127, 130 Allenby, P. 134 Abdeljaoued, S. 73, 74, 82, 84 Akdeniz, C. 80, 81 Allen Ciuffo, L. 90 Abd Elmageed, Z. 73 Akder Sari, A. 100 Allen, D. 62, 84, 85 Abd El-Wahed, M. 59, 69 Akdogan, A. 104 Allum, W. 31 Abd Elzaher, E. 49, 59 Akdur, N. 72, 112, 156 Ally, M. 83 Abdessayed, N. 110, 117, 123, Akhlaq, M. 143, 144 Almangush, A. 50 140, 154 Akiba, J. 30 Almasmoum, H. 145 Abdou, A. G. 146 Akiyama, Y. 151 Alnabulsi, A. 114 Abduljabbar, R. 78, 79, Akkaya, H. 102, 109 Alonso, I. 145 80, 81, 82 Akl, Y. 121 Alonso, M. 105 Abdulkader, I. 110, 111, 113 Akman Sezer, O. 92 Alonso Riaño, M. 74 Abe, M. 72 Akoz, G. 72, 102, 129, Alós, L. 122 Abensur Athanazio, D. 90 139, 147 Alper, M. 46 Abercrombie, J. 118 Akrida, I. 81 Alpoim, M. C. 62 Abia, D. 101 Aksan Desteli, G. 150 Al-Ramadhani, S. 87 Abián, V. F. 154 Akslen, L. A. 80, 81, 83 Al-Sam, S. 53, 87 Abid, W. 73 Aksoy, S. 77, 78, 85, Alshareeda, A. 42, 46, 82 Abolina, M. 129 86, 87, 130 Alsheriyeva, U. 125 Abolins, A. 93, 129, 158 Akyildiz Igdem, A. 102 Alsubhi, N. 81, 82 Abramov, D. 108 Akyol, A. 37, 141 Altahrawi, A. 126 Abrantes, A. M. 59, 103, 155 Al-Adnani, M. 108 Altamirano, J. 125 Abrantes, C. 132, 139, 156 Alaggio, R. 55 Altemani, A. 71, 76, 108 Abravaya, K. 143 Alaghehbandan, R. 38 Alvarez, M. L. 79 Abulafi, M. 118 Alanyali, S. 152 Alvaro, J. 131 Abulkasem, F. 78 Alarcão, A. 49, 62, 118, Alves, A. 65, 100, 109, Abulkheir, I. 78 157, 158 122, 140 Acar, K. 96 Alashareeda, A. 81 Alves, C. 75, 136 Achour, B. 132 Alastuey Aisa, M. 126 Alves jr., M. 53 Achour, I. 113 Alastuey, M. 107, 115, Alwahab, Y. 120 Adamczyk-Gruszka, O. 148, 152 131, 140 Amalinei, C. 82, 89, 139, Adamczyk, L. 45, 89 Alataki, D. 84 147, 151 Adams, R. 142 Alavarez, L. 115 Amann, K. 57 Adaway, M. 155 Alba Amarillo, V. 146 Amaral Rocha, M. 91 Adegbaju, O. 64 Albarello, L. 111 Amarasinghe, K. 105 Adiyeke, M. 150 Albero, R. 99 Amarti, A. 87, 103 Adjic, O. 89 Albertsmeier, M. 116 Amary, F. 145 Adlard, A. 133 Albuquerque, M. 139 Amat, I. 115 Adnène, M. 76 Alcaraz, A. 101 Ambicka, A. 70 Adonakis, G. 153 Alco, G. 72 Ameisen, D. 42, 53 Afonso, L. P. 114 Al-Dayel, F. 141 Amendoeira, I. 84 Afrouzian, M. 66, 128 Aldecoa, I. 59, 100, Ameuretesse, H. 87, 103, 159 Afzal, N. 103 104, 117 Amin, R. 96, 120 Agaimy, A. 44, 55, 146 Alencar de Sousa, G. 108, 109 Ammar, B. 68, 155 Agapitos, E. 157 Aleskandarany, M. 78, 81 Amodeo, A. 88 Agell, L. 99, 101 Alexakis, N. 95 Amorim dos Aggelou, H. 142 Alexandre, A. 147 Santos Félix, R. 89, 90 Agoston, E. 120 Alexandrou, P. 46, 50, 74, 85, Amor, S. 123 Agrawal, N. 87 86, 140, 157 Amouri, H. 87 Agresti, B. 76 Alexeyev, D. 94 Amr, S. 60 Agrogiannis, G. 87, 96, 110, Alexiadou, A. 121 Amrania, H. 78 136, 141 Alexopoulos, A. 88 Amrani, M. 78, 132 Aguilar, D. 133 Alfaro Torres, J. 126 An, S.-Y. 138, 139 Aguilar, M. 133 Alfonsín Barreiro, N. 113 Anagnostis, P. 111 Aguirre, J. 135 Algaba, F. 40 Ananiev, J. 116, 149 Ahmed, F. 46 Al-Ghamdi, S. 36 Anastasiadis, I. 116 Ahmed, K. 100 Al-Hassi, H. O. 119 Anavi, B. 69 Ahmed, L. 83 Al-Husaini, H. 141 Anderco, D. 99 Ahmed, M. 104 Ali, A. 98, 121 Ando, M. 80 Ahmed Maulid, U. P. 153 Ali, H. 126 Andrada, K. 73 187 Index of Authors ECP 2014 · London

Andras, C. 142 Arnes, M. 148 B Andreea, M. 149 Arnon Bremer Soares, P. 90 Ba, N. 112 Andreeva, Y. 83 Arora, A. 137 Baandrup, U. 45 Andrei, R. 107 Arora, I. 139 B. Abdejlil, N. 136 Andrejevic, M. 92 Arrabaça Francisco, R. 134 Babic, B. 154, 156 André, M. d. P. 38 Arslan, A. 93 Bachurska-Yovcheva, S. 47, 97, Andrés Esteban, E. M. 74 Arslan, E. 92 132 Andrés, L. 150 Arslan, I. B. 73 Back, M. 51 Andreu, F. J. 144 Arya, S. 139 Baderca, F. 71, 129 Andrey Rocco, R. 141 Asaad, N. 134, 146 Badescu, A. 115 Andriescu, C. 72, 111, 146 Asaka, S. 148 Badoual, C. 28 Androutsopoulos, G. 153 Asano, S. 128 Badran, A. 118 Andueza, E. 70, 97, 98, 106, Asaturova, A. 152 Baehner, R. 168 124, 125, 126, Aschie, M. 94, 109, 144, 153 Bae, J.-M. 115, 117 127, 139, 156 Aseem, M. 103 Bae, K.-S. 110 Andueza Otsoa, E. 105, 150 Ashton, G. 53 Bae, Y.-J. 121 Aneiros Fernández, J. 133 Ashwini, N. 139 Bagwan, I. 50, 70, 72, 117, 130 Angel Campo, M. 75, 130, 136 Ashworth, M. T. 90 Bahadir, B. 140 Angele, M. 116 Asioli, S. 50 Bahadoran, P. 37 Angus, E. 64 Assouly, N. 50 Bahri, I. 93, 113 Anis, S. 126 Astolphi, R. 134 Bailas, G. 75 Anjos, R. 89 Astolphi, R. D. 122 Bailey, D. 48 Anstee, Q. 54 Astudillo, A. 68, 158 Bailey, S. 49, 155 Antoine, M. 37 Astudillo Gonzalez, A. 134 Baiocchi, G. 142 Antonangelo, L. 135, 156 Åsvold, B. O. 85 Bais, B. 136 Antonelli, M. 145 Atafi, S. 118 Bajema, I. 52, 126 Antoniou, S. 152 Ataizi Celikel, C. 96 Bajpai, J. 148 Antunes, A. 33 Ateh, D. D. 124 Bakardzhiev, I. 97 Antunes, C. 87 Athanazio, D. 89, 91, 98 Baker, A.-M. 119 Antunes, D. 109 Atif, L. 85 Baker, L. 81 Antunes, M. 89, 158 Atmodimedjo, P. 36 Bakshi, A. 69, 105 Antunes, P. 89 Atsaves, V. 66 Bakula-Zalewska, E. 121, 151 Antunes Teixeira, V. d. P. 90, 107, Attafi, S. 113, 141, 154 Bal, M. 139 147, 154 Attanoos, R. 28, 155 Balachandran, K. 129 Anuk, T. 93 Attaullah, S. 136 Balague Ponz, O. 46 Aoyama, T. 31, 92, 94 Attia, M. Z. 74 Balaguer, F. 118 Aparecida de Lima Pereira, S. 90 Atwal, S. 96 Balamurugan, T. 70, 117 Aparecida Figueira Rezende, P. 90 Auer, G. 79 Balan, M. 72 Aparecida Oliveira, F. 90 Aumayr, K. 100 Balan, R. 82, 151 Aparicio, S. 42 Aurensanz Clemente, E. 109 Balbín, M. 68 Aparício, S. 130 Aust, D. 44 Balbouli, A. 93 Apostolou, G. 78 Au-Yong, I. 113 Balci, M. B. Can 102 Appukutty, S. 72 Avadanei, R. E. 82, 139, 141 Balci, M. K. 113 Aqel, N. 120 Avancini Ferreira Alves, V. 117 Baldacchino, S. 46 Aragão, A. 122 Avci, S. 93 Baldovini, C. 73 Arai, T. 31, 93 A. Velloso, L. 116 Balestro, E. 63 Aranha, A. G. A. 134 Averyanov, A. 157 Balfe, P. 45 Araújo Andrade, D. 109 Aviel-Ronen, S. 128 Balharek, T. 63 Araújo, K. S. 75 Ayad, E. 42 Balik, E. 94 Araújo, N. 73, 132 Ayadi, L. 87, 93, 113 Balint, B. L. 142 Araújo, N. S. 76, 131 Ayala, G. 51 Ball, M. 134 Araujo, V. 132 Ayalp, K. 156 Ballestín Carcavilla, C. 74 Araújo, V. C. 76, 131 Ayaz, D. 73, 139, 149, 150, Baloglu, H. 103 Arber, D. 41 151, 152, 153 Balseiro, S. 118 Arce Fricke, C. 111 Aydin, F. 157 Baltatescu, G. I. 94, 153 Archard, N. 62, 83 Aydin, M. Ç. 38, 157 Baltatzis, G. 102 Ardeniz, O. 96 Aydogdu, Z. 147 Balys, M. 146 Aretini, P. 59 Ayepola, O. 141 Bamber, A. R. 37, 49, 90, Argin, M. 135 Ayhan, A. 150 126, 135 Arici, C. 113 Ayik, E. 109, 139 Band, V. 46, 80, 82 Ariza, A. 54, 56, 131 Aykan, A. 105 Bankovic, J. 110, 156 Arkoumani, E. 53, 72, 83, 86, Aylwin, A. 86 Banks, M. 93, 95 87, 133, 137 Ayranci, G. 96 Bantouna, D. 123 Armendariz, P. 80 Ayva, E. S. 65, 89, 109, Baranne, M.-L. 109 Armenski, G. 133 127, 130 Barbara, B. 94 Armentano, R. 142 Azebaoui, I. 148 Barcelos Baldoni, M. 30 Armstrong, A. 107 Aziz, A. 30 Baretti, R. 146 Arnaout, A. 118 Azouz, H. 72, 95, 105, 106, Baris, I. 153 Arnault, C. 147 125, 129 Barkaszi, B. 138 Arnes, J. B. 83 Azurdia, R. 105 Barlesi, F. 36, 142 188 ECP 2014 · London Index of Authors

Barlow, A. 157 Belhaj, M. 136 Bermudo, R. 101 Barmasheva, A. 134 Bel Haj Salah, M. 73, 108, 110, Bernardo, J. 156 Barnadas, A. 43 117, 135 Bernardo Lopes, D. 158 Baron, L. 116 Belharazem, D. 51 Bernet, L. 43 Barosa, R. 95, 141 Belharrat, F. Z. 110 Bernet, V. 121 Barreiro Morandeira, F. 110 Belien, J. A. M. 45 Berney, D. 33, 40, 97 Barresi, V. 59, 79, 116, Belizarte Pontes Pereira, L. 108 Bertheau, P. 53 120, 145 Belkralladi, H. 112 Bertz, S. 47 Barrett, J. 30 Bell, A. 157 Bespalova, E. 69 Barrios Mello, R. 134 Bellacchio, E. 49 Bessa, S. 96 Barroca, H. 109, 122 Bellamy, C. 55 Bessmertniy, D. 101 Barros, L. B. 75 Bellas, C. 123 Bethencourt, N. V. 54, 146 Barsan, D. 77 Bellevicine, C. 65, 122 Bettaieb, I. 73, 74, 78, Barsan, I. 77, 78, 148 Bellil, K. 74, 93, 100, 79, 82, 84 Barshack, I. 128 101, 118, 140 Bettaz, N. 70 Bartholo de Andrade, J. 102 Bello, I. 50 Beuscart, T. 34 Barthova, M. 63 Bellur, S. 65 Bhagwat, P. 83 Bartosch, C. 58, 109, 110, 154 Belovezhdov, V. 97, 153, 157 Bhattarai, S. 34 Bas, G. 30 Ben Abdallah, F. 70, 77, 113, Bhuvanai-Sitaraaman, H. 34 Basdemir, G. 135 121, 138 Bialas, M. 99, 105, Basheska, N. 149 Ben Abdallah, R. 110 112, 139 Bashuk, I. 109, 134 Ben Abdeljelil, N. 96, 154 Bianchi, P. 73 Baskin, E. 65, 127 Ben Ali, M. 100, 101 Bianco, A. 65 Bass, P. 57 Ben Brahim, E. 73, 108, 110, Bian, X.-w. 56 Bassorgun, C. I. 98, 119, 117, 118, Bichev, S. 157 136, 139 135, 140 Bick, T. 36 Bassullu, N. 72, 112, 156 Bence, C. 36, 37, 62, 142 Bidzinski, M. 151 Bastian, A. 103, 125, Ben Chaabane, A. 77, 114, 132 Biermann, K. 31 147, 153 Bendahl, P.-O. 87 Biernat, W. 63, 71, 84, 103, Bastimiyeva, B. 125 Bendavid, R. 53 105, 134, 145, 156 Basturk, O. 111 Bender, R. 143 Bilbao, R. 135 Basu, G. 108 Ben Dhieb, T. 82 Bilbie, J. 101 Bateira, P. 65 Bendib, M. 111, 115 Bilgic, B. 94 Batista da Silva Filho, V. 89, 90 Benerini, L. 106 Bina, M. 89 Battistella, M. 53 Ben Ghachem, D. 74, 93, 100, Binatli, A. O. 123 Baudin, E. 32 101, 118, 140 Bing, Y. 31 Baumert, T. 45 Ben-Ghashir, N. 69, 105 Bircan, H. Y. 111 Baur, C. 155 Benhadad, F. 104 Birceanu, A. 107 Bayazit, N. 93 Benhasouna, A. 42 Birceanu-Corobea, A. 102, 141 Baydar, D. 47, 97 Ben Hassouna, J. 84 Birceanu-Corobea, G. 102 Baykov, V. 94, 134 Benhayoune, K. 87, 103, 159 Birg, T. 45, 115 Baylan, E. 128 Ben-Izhak, O. 36, 156 Birner, P. 100 Bayol, U. 69, 72, 73, 80, 81, Ben Kahla, S. 95 Bishop, P. 112 92, 99, 100, 101, Benkhedda, G. 71, 98, 110, 148 Bisset, D. 111 102, 123, 124, 129, Ben Lakhdar, A. 50, 75 Bitu, C. 50 139, 147, 150 Bennett, M. 84 Bizzarri, C. 88 Beau-Faller, M. 142 Bennis, M. 150 Bizzarro, T. 65 Becheanu, G. 92, 93 Bennoui, R. 68 Bjasch, D. 106 Bechir, A. 131 Ben Rais, N. 97 Bjelovic, M. 138 Becker, K.-F. 61, 82 Benrezki, L. 133 Bjødstrup Jensen, M. 34 Beckingham, I. 138 Ben Sayed, N. 131, 132 Blackhall, F. 155 Beddar, L. 68, 104, 123, Ben Sidhom, R. 118 Blaise, A. 109 128, 148 Benthani, F. 116 Blal, K. 48 Bedekovics, J. 144 Benulek, S. 59 Blanchard, O. 36 Bedossa, P. 53, 54, 60, Ben Youssef, Y. 131, 132 Blanco, J. L. 122 132, 139 Beorlegui, C. 80 Blank, A. 46 Beeslaar, S. 72 Berber, U. 37, 75, 77, 103, Blanzquez, C. 144 Beggan, C. 147 131, 154 Blassnig, I. 143 Bégueret, H. 37 Bereciartua, A. 135 Blayney, A. J. 30 Beham-Schmid, C. 41 Berezikov, E. 46 Bleyen, I. 59 Behzatoglu, K. 77, 78 Berezowska, S. 59 Blokker, B. M. 34 Beiras Iglesias, A. 110 Berger, M. D. 119 Blokx, W. 44 Beke, L. 142, 144 Berger, N. 102 Blons, H. 37 Bektas, S. 102, 118, 128, Bergeron, C. 109 Bloom, E. 54, 95 140, 153 Berget, E. 48 Bloom, K. 170 Belar, O. 135 Berghuis, D. 38 Blotta, M. H. 108 Belaud-Rotureau, M.-A. 38 Bergman, J. 95 Blum, N. 56 Belbeye, I. 68 Berg, T. 150 Boa Sorte, N. C. 91 Belghiti, J. 139 Berjón García, A. 69, 89, Bobrov, M. 69 Bel Hadj Kacem, L. 106, 125 120, 147 Bocher, E. 43 189 Index of Authors ECP 2014 · London

Bodoky, G. 120 Bouziani, A. 70, 77, 91, 97, Bülbül, G. 72 Boehm, S. 58 113, 114, 121, Bulgaru-Iliescu, D. 139 Bofin, A. M. 81, 85 128, 132, 138 Bulimbasic, S. 98 Bogdanova, O. 157 Bouzouira, B. 112 Buluwela, L. 79, 82 Bogdanovic, R. 66 Bovin, N. 150 Bulvik, R. 50 Bogina, G. 113, 152 Bower, M. 48, 128, 129 Bumbasirevic, V. 146 Boldrini, R. 49, 88 Bowman, A. 116 Bunkov, K. 97 Boletis, J. 128 Boyaci, C. 77, 78, 85, 86, 87 Burdak-Rothkamm, S. 66 Bolfarini, F. B. 134 Boyko, V. 96 Burgués, O. 43 Bolijn, A. S. 46 Boyle, D. 145 Burke, G. A. 155 Bologna, S. 76 Bozkurt, E. R. 77, 78, 87 Burlea, A. 68 Bonde, J. 143 Bozkurtlar, E. 143 Burtin, F. 38 Bongiovanni, M. 52 Brabrand, A. 85 Bury, Y. 82 Bonin, S. 61 Brain, J. 45 Busca, M. 103 Bonomo, P. 76 Branca, G. 59, 79, 116 Bush, A. 49 Bonshek, R. 136 Branco, M. 125 Bussolati, G. 79 Bonventre, J. 33 Brandão, O. 109, 110 Busso, M. 144 Boos, L. 46 Brandner, S. 56 Butler, R. 51, 142 Booth, M. 51 Brankley, S. 143 Butori, C. 36, 37, 62, 142 Bor, S. 96 Brasanac, D. 38, 74 Butt, A. 95 Borchmann, P. 169 Bräsen, J. 50 Butt, M. A. 54, 93, 95 Borda, A. 99, 102 Bravou, V. 71, 81, 88, 99, 142 Buz, S. 88 Bordonne, O. 142 Brcic, I. 78 Byers, R. 31, 47, 48, 51, 53, Borges Soares, A. 71, 75, 76 Brcic, L. 133 128, 129, 155 Borghol, I. 112 Brcik, I. 133 Byun, J.-H. 138 Boricic, I. 74 Breijer, A. 59 Boricic, N. 38, 74 Brenn, T. 40, 104, 105 C Borka, K. 138 Brest, P. 142 Caamaño, V. 70, 97, 98, 124, 125, Borkenfeld, S. 42 Breur, M. 123 126, 139, 156 Borner, M. 119 Breuskin, I. 50 Caamaño Villaverde, V. 105, 106, Boros, M. 77, 78 Brew, F. 142 124, 127, Borovik, V. 141 Bria, E. 63 150 Borralho Nunes, P. 55 Bridge, J. 51, 70 Caballero, C. 147 Bortesi, L. 113, 152 Brites, G. 59 Caballero, R. 43 Bosch, L. 46, 144 Brito, M. J. 95, 141 Caballero Martínez, M. C. 125, 153 Bosch, R. 105 Britton, P. 83 Caba Molina, M. 127 Bosic, M. 34, 38 Brix, S. 65 Cabezas Agricola, J. M. 113 Bosman, F. 33, 44, 47, 48, Brochhausen, C. 54, 135, 146 Cabillic, F. 38 53, 63, 64, 132 Brochhausen, M. 135 Cabrera, A. 124, 127 Botelho, F. 59, 155 Brodsky, S. 134 Cabrera Cantoni, A. A. 98, 125 Botelho, M. F. 103 Broecker, V. 83 Cabrerizo, P. 124 Botelho, N. 109, 110 Brooks, N. 141 Çaglayan, K. 92 Bottura, G. 135, 156 Brotzakis, P. 104 Caie, P. 53 Boudabous, E. 154 Brouwer, R. 59 Caillol, F. 45 Boudaoud, K. 148 Brown, A. 75 Cakir, E. 73, 80, 92, 99, 102, Boudawara, T. 87, 93, 113 Brown, G. 114 123, 124, 150 Boudebous, E. 136 Brown, L. 149 Cakmak, O. 99, 102 Boudefeur, N. 68 Brown, S. 150 Calabrese, F. 32, 35, 62, 63 Boudjemaa, S. 109 Browne, T. J. 84 Caldas, C. 42 Boughattas, M. 136, 154 Browning, L. 33, 61 Caldas, M. 76 Bougherra, N. 123, 128 Bruder, E. 28 Caleo, A. 101 Boughey, J. 68 Brügmann, A. 43 Calik, M. 94 Bougrine, F. 70, 77, 91, 97, Brunelli, M. 63, 103, 124 Calin, G. 142 113, 114, 121, Bruneval, P. 34, 35, 41 Caliò, A. 63, 103 128, 132, 138 Bruni, F. 113 Caliskan, C. 94 Bouhajila, E. 91, 128 Brunner, P. 144 Callea, F. 49, 88 Bouhajja, L. 108 Brunt, E. M. 54, 63 Caló, F. 74 Bouhidel, F. 53 Brusnic, O. 93 Calonje, E. 37, 40 Bouhlel, L. 36, 62 Bryant, R. 99 Caltabiano, R. 145 Boujelbène, N. 113, 141, 154 Bryant, V. 108 Calu, A. 93, 105 Bouledjnib, F. 123 Brychtova, S. 106 Calvo, L. 43 Boulekzaz, Y. 104 Bubendorf, L. 57, 65, 120, 156 Calvo, P. 49 Boulma, R. 101 Budakov, P. 154 Camacho, F. I. 65 Boulytcheva, I. 108 Budde, K. 65 Camacho, J. 82, 102, 113 Bouslema, E. 131, 132 Budzilowska, A. 58 Cámara, M. 105, 133 Bouslema, S. 76, 123, 154 Budzynski, A. 112 Cambero Moratalla, O. 69 Bouthour, H. 108 Bugdayci, M. 141 Cambra, K. 79 Bouvier, C. 38 Bugyik, E. 138 Cameron, J. S. 30 Bouzaiene, H. 82 Bujas, T. 133 Cameselle Teijeiro, J. 36, 110, Bulbul Dogusoy, G. 46, 112, 156 111, 113 190 ECP 2014 · London Index of Authors

Camillo-Coutinho, C. 38, 74 Cash, B. 114 Chang, W.-C. 128 Campbell, F. 56 Casiraghi, O. 50, 75 Chanson, M. 62 Campbell, P. 40 Casnedi, S. 111 Chantot Bastaraud, S. 109 Campos de Orellana, A. M. 100, Cass, H. 49 Chantziara, M. 130, 157 111, 123 Cassis, J. 47 Chaplygina, M. 101 Campos de Orellana Castellano Megías, V. M. 151 Charfi, L. 113, 141, 154 Gomez, A. M. 151 Castelli, P. 113, 152 Charfi, S. 87, 93, 113 Campos, M. 85 Castell, J. 112 Charif, R. 128 Camps, J. 118 Castellví, J. 113 Chaturvedi, A. 134 Campuzano, S. 83 Castelvi, J. 102 Chatzaki, E. 151 Can, M. 140 Castera, L. 139 Chatziandreou, I. 144 Cancho, G. 147 Castiella Muruzabal, T. 109 Chatzinikolaou, F. 146 Cândido de Oliveira, D. 90 Castillo, L. 151 Chatzopoulos, K. 85, 106 Cândido-Soares, L. E. 76 Castillo, P. 61 Chaves, P. 91 Candusso, M. 49 Castillo Palomino, D. 96 Cha, Y.-J. 127 Canelhas, A. 130 Castro, C. 158 Chekalova, A. 97 Cañellas, J. 88 Castro Oliveira, M. C. 98 Chekinsky, L. 156 Cane, P. 62 Castro Poças, F. 65 Chekmareva, I. 137 Cangi, M. G. 103 Català, I. 85 Chelly, I. 72, 95, 105, 106, Canonica, K. 116 Catalina Fernández, I. 100, 111, 111, 117, 125, 129 Cansu, G. B. 113 123, 151 Chen, Y. 80 Can Trabulus, D. 77, 85, 86, 87 Catherine, M. 38 Cherif, A. 118, 140 Canu, L. 114 Cathomas, G. 37, 52, 53, 55, Cherif, H. 118 Caparrós, X. 145 63, 119, 144 Cherniaev, A. 159 Capatina, D. 109 Catón, B. 135 Cherstvoy, E. 103 Capella, C. 111 Cats, A. 46 Chetta, P. M. Luigi 103 Capelozzi, V. 158 Caubet, E. 112, 113 Chetty, R. 60, 63, 119 Capelozzi, V. L. 135, 156 Cauchy, F. 139 Cheung, C. 101 Capodimonti, S. 65 Cauni, V. 102, 103 Chiaravalli, A. M. 58, 94, 119 Cappia, S. 144 Cavalcante Brasil, A. 109 Chiattone, A. 130 Caracappa, D. 42 Cavalcanti de Araújo, V. 70, 71, 75 Chiattone, C. S. 130 Carbone, F. G. 59 Cavalcanti, V. 73 Chibbar, R. 137 Cardia, R. 120 Cazacu, E. 153 Chibelean, C. 102 Cardoso, M. 65, 122 Cazals-Hatem, D. 116 Chikandiwa, A. 149 Cardoso, S. 133 Cazejust, J. 138 Chikte, S. 157 Carey, F. 114 Cazes, A. 36 Chilosi, M. 63, 103 Carlos Souza, A. 134 Ceacaru, L. 129 Chin, C.-K. 127 Carlson, J. 149 Ceausu, A. R. 86 Chin, S.-F. 42 Carneiro, F. 84, 132, 171 Ceccaroni, M. 113, 152 Chirculescu, R. 102, 107, 141 Carneiro, M. 31 Cekodhima, G. 122 Chirieac, L. 28 Carnevali, I. 58 Celasun, B. 74 Chirita, D. 106 Caro Cuenca, T. 73, 88, 129, 133 Celestino, R. 114 Chitnis, M. 33 Carolan, D. 147 Celik, F. 98 Chitu, V. 131 Caroni, C. 78 Cemerikic, V. 68 Chiudinelli, M. 106 Carr, I. 119 Cemerlic Adjic, N. 89 Chlosta, P. 99 Carr, N. 115 Centeno Haro, M. 85, 127 Chmara, B. 53 Carrasco, E. 43 Centeno, M. 73, 88, 129, 133 Cho, C.-H. 139 Carreira, I. 62 Cerda Hernandez, N. 105, 150, Cho, K.-J. 69 Carrera, R. 144 156 Cho, N.-Y. 115, 117 Carter, J. 38, 68 Cerda, N. 70, 97, 98, 106, 124, Cho, Y.-S. 92 Cartwright, E. 34 125, 126, 127, 139 Choe, G.-Y. 116 Caruana Dingli, G. 46 Cereser, B. 119 Choi, C. 120 Caruntu, I.-D. 72, 82, 139, 141, Cerundolo, L. 99 Choi, J.-J. 110 146, 147, 151 Cetindag, O. 69 Choi, W. 143 Caruso, M. L. 71, 142 Cetin, Z. 76, 109, 110 Choi, W.-S. 120 Carvalho, B. 36, 46, 144 Ceylan, C. 153 Choi, W.-Y. 120 Carvalho, D. 144 Chabchoub, A. 84 Choi, Y.-D. 122 Carvalho, F. 132 Chadli, A. 118, 140 Chong, H. 117 Carvalho, K. C. 142 Chadli Debbiche, A. 73, 108, 110, Choreftaki, T. 87, 100, 101, 103, Carvalho, L. 31, 35, 49, 61, 62, 117, 135, 140 105, 107, 113, 89, 118, 155, 156, Chadwick, T. 42 124, 125, 152 157, 158, 159 Chae, H.-S. 92 Chott, A. 65 Carvalho, S. 58, 80, 99 Chakrabarty, B. 112 Chouchen, A. 135 Carvalho dos Santos, A. 98 Chaleplidis, N. 100, 101, 107, Chou, M. 38 Casanueva, F. 113 134, 152 Christidis, K. 76, 77 Casas, M. 43 Chalmers, J. 48, 131 Christie de Oliveira, E. 111, 117, Casautanu, B. 72 Chambers, D. 130 141 Cascone, A. 122 Chambers, P. 119 Christova, S. 128 Caseiro Silverio, P. 97 Chan, K.-E. 127 Chrysikos, D. 141 Casey, S. 58 Chan, S. 81 Chuah, K.-L. 145 191 Index of Authors ECP 2014 · London

Chua, K. 38 Comsa, A. S. 102 Crotty, T. 34 Chueca, E. 94 Condom, E. 82, 85, 88, 105, 112, Cruz, M. 68, 80, 99, 150 Chun, Y.-K. 108, 151 124, 139 Cruz, R. 132 Chung, D.-H. 156 Contolenco, A. 93 Csanadi, A. 155 Chung, J.-Y. 139 Contreras, J. A. 88 Cserni, G. 28, 31, 79, 81, 85 Chung, P. 101 Conzuelo, F. 83 Csörgö, E. 79 Chung, Y.-R. 120 Cook, A. 136 Cuatrecasas, M. 59, 117, 118 Cicek, A. F. 105 Cook, M. 44 Cuevas, D. 142 Ciesielska, K. 99 Cook, S. 34 Cuevas, J. 136 Ciftcioglu, M. A. 98 Cook, T. 52, 65 Cui, H. 97 Cil Gonulcu, S. 119 Coombes, C. 78 Cukurova, I. 72 Cima, L. 124 Coppo, R. 65 Cummings, R. 145 Cimetti, L. 58, 94, 119 Corbacho Cuevas, C. 104 Cumurcu, S. 69 Cimpean, A. M. 86, 92, 151 Cordoba, A. 79, 80, 115 Cunha, A. L. 141, 158 Ciniselli, C. M. 82 Cordova Ramon, J. C. 79 Cunha Pasqualin, D. 141 Cin, M. 153 Cornea, R. 99, 125, 155 Cunliffe, S. 48 Ciobanu Apostol, D. G. 72, 111, Cornford, E. 81 Cunningham, D. 31 146 Cornianu, M. 71, 91, 95, 99, Cuppen, E. 46 Cioplea, M. D. 102, 125, 131, 153 125, 155 Cuvelier, C. 47 Ciornenchi, O. C. 79, 92, 105, Corominas, A. 106, 124, Cvetkovic, Z. 68 129, 149 125, 127 Czapiewski, P. 103, 145 Cipriano, M. A. 139 Corominas Cishek, A. 70, 97, 98, Czernobilsky, B. 48 Ciric, D. 146 105, 124, 125, Czubek, U. 89 Cirovic, S. 34, 38, 66 126, 139, 150, Cirstoiu, M. 79, 149 156 D Ciuffo, L. 89 Correia, A. 80 da Fonseca Ferraz, M. L. 90, 107, Ciurdariu, D. 68 Correia, J. 109 147, 154 Clarke, B. 58 Corte Real, F. 53, 90 Daglis, F. 77, 104 Clarke, M. 30 Cortés, J. M. 97 dÁguiar, M. J. 31, 118, Classe, M. 75 Cortez, A. 150 157, 158 Classen, D. 68 Cosic Micev, M. 92, 138 Dahl, C. 37 Clavero, O. 149 Coskun, H. S. 119, 158 Dahlstrom, J. 61, 107 Clench, T. 48, 131 Costa, A. 69 Dainese, L. 109 Cleven, A. 63 Costa, E. 59 Dal Cin, P. 57, 61, 70 Climent Esteller, F. 131 Costa, F. 65, 70, 113 Dalmau, E. 144 Climent, F. 82, 85, 88, 105 Costa, J. 109, 130 Daly, L. 129 Clouston, H. 150 Costa, J. L. 170 D'Amati, G. 41 Coban, I. 46, 72, 112, 156 Costa, L. 109, 110 Damato, S. 75 Cobankent Aytekin, E. 109 Costa Braga, A. 69, 75, 113, Dana, E. 50 Coburn, N. 93 130, 136, 158 Danciu, M. 146 Cochand Priollet, B. 55 Costache, M. 79, 92, 105 Dandona, S. 106 Coelho, A. 42, 43, 65, 70, 113 Costa e Silva, A. 108 Dangalov, K. 153, 157 Coer, A. 39 Costes Martineau, V. 143, 149 Daniel, F. 138 Coetzee, A. 30 Costes, V. 51 Danila, R. 111, 146 Coffa, J. 31 Costigan, D. 156 Danilevskaya, O. 157 Coffin, B. 116 Cotea, E. 146 Danilewicz, M. 126 Coffin, C. 55 Cotter, M. 108 Danilova, N. 83 Cogo, P. 88 Coulomb, A. 57, 109 Danska-Bidzinska, A. 151 Cohen, M. 52, 116 Coulomb L´Hermine, A. 109 Dansonka-Mieszkowska, A. 58 Cohen, N. 60 Coumbe, A. 98 DÁntonio, A. 101 Cohen, P. 117 Coupe, V. M. H. 45 Dao, M. 49 Coimbra, N. 158 Coupland, S. 40, 41, 136 Darragh, T. 168 Coindre, J.-M. 63 Courtade-Saidi, M. 55 DÁrrigo, C. 103, 118 Colaço, B. 104 Coutinho-Camillo, C. 74, 76 Das, S. 73 Colak, M. A. 72 Couto, M. B. 75 da Silva, A. C. S. 107, 147 Colbeck, N. 125 Couvelard, A. 110 Daum, O. 91 Colecchia, M. 40 Coy, C. S. R. 116 Davidson, B. 48, 55 Cole, D. 33 Cozaru, G. C. 94, 109, 144, 153 Davidson, T. 128 Coleman, N. 49, 155 Cozzolino, I. 122 Davies, K. 32 Coletta, R. 50 Crawford, R. 58 Davies, S. 62, 155 Coletta, R. D. 71 Craze, M. 42 Davis, J. 81, 91 Collantes, E. 96, 115 Cree, I. 30, 87, 170 Dawsey, S. 95 Colling, R. 115, 119 Crespo Lora, V. 133 Dawson, H. 31, 116, 119 Collins, A. 107 Creytens, D. 63 de Alava, E. 131 Collins, N. 117 Cribe, A.-S. 45 de Almeida, O. P. 71 Colvin, B. 55 Crino, L. 171 Deans, S. 29, 143 Comanescu, M. 102 Crisan, D. 124 Deans, Z. 143 Comans, E. 155 Croitoru, A. 141 de Araújo, K. S. 75 Comba Miranda, J. 125, 147 Cross, D. 62 de Araújo, V. C. 75, 76 Compérat, E. 33 Cross, G. 36, 120 Debeljacki, D. 89 192 ECP 2014 · London Index of Authors

Debono, J. 46 Derban, M. 86 Doehla, M. 92 De Bono, J. 64 De Reina, L. 123 Doenz, F. 34 De Carvalho, L. 130, 134 Derin, A. T. 75 Doerner, E. 59 de Castro-Raucci, L. M. S. 74 de Rooi, J. 136 Dogan, A. 149 Decaussin-Petrucci, M. 93, 102 Deroulers, C. 53 Dogan, M. 58 Decker, T. 88 Dertsiz, L. 157 Dogan, S. 102, 154 De Falco, G. 61 Deryagin, O. 157 Doganavsargil, B. 94, 95, 96, de Freitas, N. S. 76 Desbiolles, A. 71 120, 135 Deftereou, T.-E. 151 de Seixas Alves, M. T. 122 Doghri, R. 113, 141, 154 De Gaetano, J. 46 deSouza, R. 59 Doglioni, C. 103 Degirmenci, M. 72 Despins, T. 82 Dojcinov, S. 44 Degnim, A. 78 Dessars, B. 36 Dokouhaki, P. 155 Dehaspe, L. 144 Detlefsen, S. 45 Dolcet, X. 142 Dei Tos, A. P. 60 De Torres, I. 102 Dolenc Strazar, Z. 94 de Jong, B. 135 Detsika, M. 66 Dolman, G. 45 Dekanic, D. 144 Dettmann, N. 143 Domanski, H. 121 de Klein, A. 59, 136 Deutsch, A. 144 Domínguez, J. J. 83 de Kock, L. 155 Devouassoux-Shisheboran, M. 37 Donauer, M. 155 de la Fouchardière, A. 51 Dezso, K. 138 Donnini, S. 104 Del Agua Camisón, C. 126 D'Haene, N. 36 Donovan, L. 78 de la Haba, J. 43 Dhaoui, A. 74, 93, 100, 101, Doran, H. 34, 62 Delahunt, B. 43 118, 140 Dória, S. 110 de la Oliva, J. 100 Dharmasena, A. 136 Dormer, J. 101 De la Oliva, J. 104 Diakatou, E. 87, 103, 154 Dorobantu, D. 105 De Leeuw, F. 50 Diamantopoulou, K. 76, 77, 104 Dorosevich, A. 88 Delektorskaya, V. 46 Diamond, J. 145 Dotsenko, O. 47, 64, 111 DeLellis, R. 113 Dias, C. 116 Douillard, J.-Y. 117 De Leo, A. 87 Dias, R. 74, 107, 131 Doukas, M. 135 de Leval, L. 58, 128, 169 Dias de Almeida, M. 141 Doukiantzakis, E. 136 Delev, D. 132 Díaz Delgado, M. 100, 111, Doulamis, I. 136 Delgado, M. 133 123, 151 Doutre, S. 149 Delgado Maroto, V. 133 Diaz Mercedes, S. 102 Dovedi, S. 133 Delgado, S. 117 Díaz Ramón, J. L. 105 Downes, M. 34, 101 Del Gerra, G. C. 134 Díaz, S. 82, 113 Downey, P. 147, 153 Deliligka, A. 146 Dickman, P. 57 Downing, A. 53, 86 De Lima, G. 80, 115 Diculescu, M. 92 Doyle, E. 108 Della Coletta, R. 74 Dietel, M. 42, 54, 61, 171 Drach, M. 58 Delladetsima, I. 46, 74, 91, 139 Di Gregorio, G. 62 Dragusin, A. 103, 153 Della-Guardia, B. 141 Dijkstra, C. 123 Drebber, U. 63, 137 De Luca, C. 65 Dikov, T. 128, 136 Drev, P. 88 De Luca, G. 145 Dima, A. 146 Driss, M. 113, 141, 154 Dema, A. 68, 71, 86, 91, 95, 99, Di Maggio, M. 142 Drummond, L. 78 102, 125, 155 Dimitriadi, A. 100, 101, 105, 107, Du, M.-Q. 41 Demasi, A. P. 75, 76,131, 132 125, 134, 152 Duarte, A. 95, 107, 113, Demczuk, S. 105 Dimitrios, K. 121 131, 132 de Mello, R. B. 122 Dimitriou, K. 76, 104 Dubbink, E. J. 36 De Melo Maia, B. 142 Dimitrova, L. 136 Dubbink, H. 59 De Menezes, R. 37, 135 Dina, R. 51, 151 Dubova, M. 91 Demetter, P. 36 Ding, C. S.-Lyn 145 Ducou Le Pointe, H. 109 de Meyer, T. 144 Dingemans, A.-M. 62 Dudala, J. 112 Demidov, L. 46 Dinic, J. 110, 156 Dugalic, V. 92 De Miguel, E. 135 Diniz, G. 152, 153 Dugay, F. 38 Demirag, A. 81 Dinjens, W. 31, 36, 141 Dumbrava, M. 92 Demiralay, E. 81, 93, 111, 150 Diosdado, B. 45, 46 Dumet Fernandes, J. 38 Demirel, D. 37, 75, 77, 103, Di Palma, S. 32, 50, 72, Dumitru, A. 79, 105, 125, 153 121, 131, 154 73, 130 Dumitru, A. V. 92, 129, 149 Demirhan, O. 156 Di Pietto, L. 122 Dummer, R. 106 Demiriz, M. 105 Dip, N. 99 Dundjerovic, D. 34 Deml, K.-F. 33 Dirschmid, K. 119 Dundr, P. 131, 145, 149 de Mora Féria, R. 75, 113, Disep, B. 94 Dunn, J. 95 130, 136 Dishop, M. 55 Duong Van Huyen, J.-P. 34 De Muda, S. 101 Diss, T. 116 DuParcq, P. 116 Demura, T. 144, 153 Divrik, R. T. 99 Duprez-Paumier, R. 84 den Bakker, M. 62 Djadja, I. 110, 148 Dursun, A. 95 De Nève, N. 36 Djikic Rom, A. 92, 138 Duskova, J. 122, 135 Deniz, E. 74, 89 Djordjevic, D. 34 Dutra, A. R. N. 135, 156 Denton, K. 168 Djuricic, S. 108 Dutulescu, S. 85, 131 Deodhar, K. 139, 148, 151 Dmitrovic, B. 80 Dvoracek, M. 106 de Oliveira, P. S. 140 Dobrzynska, O. 70 Dvorackova, J. 106 de Queker, E. 29 Dócs, O. 142 Dvorak, J. 53 193 Index of Authors ECP 2014 · London

Dvorak, M. 122 Enciu, M. 153 Fateen, W. 119 Dyduch, G. 99, 105, 112, 139 Engin, A. Y. 147 Faten, H. 76 Dyrnes, L. A. 85 Engledow, A. 116 Faulkner, C. 59 Dziadziuszko, R. 63 Engstrøm, M. J. 81, 85 Faur, A. 71 Dzodic, R. 110 Enguita Valls, A. B. 159 Faustino-Rocha, A. I. 98, 104 Dzombeta, T. 99 Eniu, A. 77 Fausto, S. 94 Enright, A. J. 49, 155 Favia, G. 71 E Ensari, A. 30, 95 Favia, M. 71 Earle, S. 94 Eraso, M. A. 82 Faye-Petersen, O. 52 Ebbers, L. 50 Erbarut Seven, I. 96 Fayzullina, N. 144, 152, 153 Ebran, N. 36, 142 Erber, R. 101 Fazakas, F. 142, 144 Eccher, A. 103, 124 Ercolino, T. 114 Feakins, R. 54 Ecim Zlojutro, V. 154 Erdamar, S. 95, 96 Fedorina, T. 97 Ede, B. 124 Erdem Huq, G. 78 Fedorova, N. 146 Eden, M. 120, 135 Erdogan Cakir, A. 46, 112 Feeley, L. 84 Edizer, B. I. 93 Erdogan, G. 154 Feichtinger, J. 39 Eduardo Arias, V. 134 Erdogan, N. 102, 118, 128, Fekete, K. 120 Edwards, J. 158 134, 140, 153 Felice, B. 112 Efstathiadou, P. 70, 86, 140 Ergin, M. 76 Felix, A. 58 Efstratiou, I.-P. 84 Eri, Z. 156 Felizardo, D. 158 Egal, E. 71, 108 Erickson, B. 143 Fend, F. 41, 48, 141 Egevad, L. 43 Erickson-Johnson, M. 38 Fenech, A. G. 46 Ehinger, A. 87 Erin, N. 136 Fennell, D. 158 Ehsan, N. 146 Erkul, E. 75 Ferchiou, M. 50 Ekinci, O. 95 Erol, O. 149 Fergie, B. 117 Ekin, R. G. 101, 102 Erol, V. 139 Ferhi, S. 68 Ektova, A. 108 Erramuzpe, A. 97 Feritsean, A. 94 Elafros, A. 134 Errett, L. 88, 147 Ferluga, D. 65 Elcoroaristizabal, X. 133 Ertoy Baydar, D. 100, 104 Fernandes, I. 69, 76 El-Daly, H. 53 Eryigit Kokkoz, S. 69 Fernandes, R. 109, 126 Eldeeb, N. 77 Eryigit, S. 150 Fernandes Silva Zacchi, F. 130 Eleftheriotis, V. 76 Escoda, M.-R. 144 Fernández de Mera, J. J. 100, 111, Eleutério Junior, J. 122, 154 Escudero, I. 125 123, 151 El-Fatemi, H. 87, 103, 159 Esmaili, A. 150 Fernández Fernández, L. 139 El-Habashi, A. 120, 121 Espíndula, A. P. 90, 154 Fernández, L. 150 El-Hachem, M. 88 Espinosa Hernández, M. 127 Fernandez, N. 136 Elhassan, M. E. 157 Espinosa, L. 31 Fernandez, P. L. 101, 145 El-Heliebi, A. 39 Esteve, R. 122 Fernández, S. 135 El-Hindawi, A. 121 Esteves, F. 132 Fernandez Seara, P. 75 El-Housni, H. 36 Evangelou, K. 139 Fernö, M. 87 Elizalde, J. M. 75 Evsei, A. 85, 94, 125 Ferrão, A. 109 Elkholy, S. 146 Ewen, J. 54 Ferrara, C. 100 Elkin, M. 50 Exposito Afonso, I. J. 154 Ferrazza Martín, L. 131 Elleithy, H. 49 Ezhova, L. 152 Ferreira, A. 110 Ellery, P. 62, 83 Ferreira Begnami, M. D. 30 Ellingsen, A. R. 127 F Ferreira, D. 132 Elliott, F. 30 Fabre, A. 36, 156, 159 Ferreira, M. 53, 68, 80, 99, 100, Ellis, D. 33, 53, 57 Fabregat, J. 112, 139 129, 140, 150 Ellis, I. 28, 42, 46, 66, 78, 79, Facchetti, F. 106 Ferreira, R. 98 80, 81, 82, 168, 170 Fadda, G. 29, 65, 121 Ferreira, T. 31, 49, 118, Elmansori, A. 78 Fadda, S. 126 157, 158 El-May, A. 71, 73, 74, 78, 79, Fadhil, W. 145 Ferreira Martinez, E. 70 82, 84, 120, 128 Faheem, N. 159 Ferreira Oliveira, L. 90, 107, Elmoursi, M. 49 Fairley, J. 143 147, 154 Elnaidany, N. 146 Faivre, S. 75 Ferrer, I. 124 Elochi, R. 78, 132 Fakhreddine, B. A. 68, 155 Festugatto Navarini, N. 70 Elod Erno, N. 132 Falkeis, C. 116 Fethi, B. 68, 155 Elouazzani, H. 78, 132 Fallowfield, J. 45 Ffolkes, L. 105 Eloy, C. 46, 110, 111, 114 Falo, C. 88 Figarella-Branger, D. 38 Elpek, G. Ö. 119, 136, 139 Falzon, M. 62, 83, 84, 85 Figueiredo, P. 83 El-Rebey, H. 120, 126 Falzon, S. 46 Figueroa, C. 86 El-Sabaawy, M. 146 Famulski, W. 152 Fijneman, R. J. A. 36, 45 Elsheikh, S. 30, 68, 111, 122 Farisoglio, C. 106 Filis, C. 152 El-Sheikh, S. 87 Farkasova, A. 63 Filleron, T. 84 Elston, C. W. 87 Farnedi, A. 73 Findlay, J.-L. 84 El-Tahmody, M. 78, 146 Farquhar, M. 45 Finetti, F. 104 Emoke, H. 132 Farquharson, N. 106 Finn, S. 156 Enache, A. 146 Faruqi, A. 58, 153 Fiocca, R. 56, 138 Enache, V. 92 Fassan, M. 106 Firat, O. 94 Encabo, B. 100 Fassina, A. 57, 65, 120 Firat, P. 122 194 ECP 2014 · London Index of Authors

Fischbach, A. 101 Fuentes Vaamonde, E. 73, 88, Gargouri, D. 118 Fischer, C. 144 129 Gargouri, F. 113 Fisher, C. 60 Fuentes Vaamonde, H. 85 Garmendia, M. 147 Fitsche, A. 106 Fuertes, I. 122 Garratt, J. 82 Fitzgerald, A. L. 75 Fukamizu, H. 132 Garred, Ø. 80 Fives, C. 84 Fukunaga, M. 148 Garrido, M. C. 105 Flanagan, A. 40, 57, 58, 66, 145 Fulawka, L. 70 Garrote, L. 146 Flannelly, G. 147, 153 Fulford, P. 112 Gartaganis, S. 136 Flavin, R. 129 Fumadó, L. 99 Gasljevic, G. 88 Fleischer, D. 95 Furlan, D. 58, 119 Gasmi, A. 132 Fleming, S. 43, 65, 126 Furness, P. 40 Gasparinho, G. 100, 129 Flesher, W. 82 Gaspar, V. 43 Fletcher, A. 106, 119 G Gatalica, Z. 86, 108, 143 Fletcher, C. 60, 66, 70 Gaafar, A. 125, 135 Gatius, S. 142 Flicker, K. 141 Gabrych, A. 145 Gatzidou, E. 140 Flodr, P. 130 Gabsi, A. 71, 120, 128 Gavalas, G. 151 Florea, C. 71 Gaganov, L. 94 Gavin, E. 100 Florêncio de Góis, A. L. 109 Gaifulina, R. 133 Gazic, B. 72, 88 Florez, H. A. 82 Gaisa, N. 101 Gazzo, S. 102 Floris, G. 31 Gaiser, T. 91 Gazzola, A. 129 Florquin, S. 57 Gajanin, R. 154 Gedik, M. L. 134 Flucke, U. 29 Gajanin, Ž. 154 Gedikoglu, G. 141 Focke, C. 88 Gajjar, K. 58 Geldof, A. A. 45 Folgueras, M. V. 150 Gakiopoulou, H. 66, 95, 128 Geller, S. 30 Follows, G. 83 Galaghar, A. 74, 76, 114, 141 Gelpi, E. 59 Fonseca, E. 131 Galanopoulos, G. 101, 121, Generalov, M. 90 Fonseca Ferraz, P. 90 147, 151 Genova, S. 157 Fonseca, I. 35, 70, 74 Galateau-Sallé, F. 28, 37 Georgakoulias, N. 125 Fonseca, R. 140 Galbarriatu, L. 125 Georgalis, A. 66 Font, A. 101 Gale, N. 32 George, D. 86, 87 Fontes-Ribeiro, C. 126 Gallagher, P. J. 45, 89 George, R. 37 Foreid, S. 80, 86, 109 Gallardo Rodriguez, K. M. 96 George, S. 89, 108 Foroni, L. 51 Galliford, J. 128 Georgescu, R. 77, 78 Forsyth, R. 38 Gallinger, S. 112 Georgiu, C. 124 Foschini, M. P. 31, 50, 73, 87 Galuscan, A. 71 Gerami, P. 37, 40, 47, 104 Foshat, M. 66, 128 Galván, J. A. 31, 38, 45 Geropoulou, E. 136 Foskett, P. 137 Galzerano, A. 93 Geropoulou, H. 85 Foster, J. 142 Gama, A. 104 Gessi, M. 59 Fouli, S. 136, 154 Gamboa Dominguez, A. 79 Geurts-Giele, I. 36 Foulkes, W. D. 155 Gammoudi, O. 78, 79 Ghazalpour, A. 86, 143 Fourtziala, E. 95 Gamoudi, A. 71, 73, 74, 82, Gheban, D. 129 Frackowiak, L. 152 84, 120, 128 Ghebrenegus, I. 98 Fraga Ianez, R. 74 Gamsizkan, M. 37 Gheorghe, C. 92, 93 Frampton, J. 37, 159 Gandhi, N. 118 Gheorghe Neacsu, C. 147 Francalanci, P. 49, 88 Gandon, F. 135 Gheorghita, S. S. 103, 107, Franceschi, S. 59 Gandy, M. 54, 62, 83, 147, 153 Franchi, A. 32, 64, 70, 84, 85, 95 Gherghiceanu, M. 92 76, 145 Ganeshan, B. 116 Ghimenton, C. 103, 124 Francisco, A. 89 Gao, L. 102 Ghorbel, J. 97 Francisco, R. A. 122 Garatt, J. 53 Ghosh, J. 148 Francis, N. 106 García, A. 100 Giagini, A. 140 Franco, M. I. 75 Garcia, C. 132 Giaginis, C. 46, 50, 74, Franco, S. 71 García, E. 139 140, 157 Frangia, K. 105, 107 Garcia, J. 82, 95, 113, 154 Giagkazoglou, P. 121 Frank, A. 144 Garcia, S. 37 Giandomenica, I. 31 Frank, G. 83 Garcia Bragado, F. 75 Giannopoulou, I. 46, 85, Frantz, E. 114 Garcia-Burillo, A. 112, 113 86, 144 Freire Sandes, A. 130 García-Caballero, T. 43 Giatzos, S. 102 Freitas, J. 95, 141 García Cosío, M. 130 Gibault, L. 35 Freitas, N. 75 García del Moral, R. 127 Gibbons, D. 153 Freschi, M. 103 García Fernández, M. E. 147 Gibson, E. 101 Fresno Forcelledo, M. 134, 139, García Fresnadillo, D. 123 Gil, M. 88 150 García González, M. A. 94 Gilg, M. 138 Fresno Forcelledo, M. F. 68 Garcia Machado, F. 96 Gilioli, E. 63 Fritchie, K. 68 Garcia Martin, R. M. 74, 159 Gilks, B. 53, 58 Froehlich, E.-V. 144 Garcia Pravia, C. 80, 139, 150 Gilks, C. B. 82 Frost, M. 78 Garcia Rojo, M. 42 Gill, M. S. 107, 113, 158 Fryer, E. 96, 115, 119 Gardovskis, J. 93, 124, 129, Gill, P. 33, 119 Fuentes Martínez, N. 123 140, 158 Gill, S. 96 Garev, T. 157 Gimeno Beltran, J. 127 195 Index of Authors ECP 2014 · London

Gimeno, J. 31 Gordienko, E. 137 Guimarães, M. 83 Ginty, M. 124 Gordon, K. 45 Guimarães, M. A. 122, 134 Giorcelli, J. 112 Gorelik, M. 83 Guimarães, V. 33 Giovannini, M. 45 Gorodetski, B. 34 Gülay, A. G. 111 Giovannoni, I. 49, 88 Goucha, A. 71, 73, 74, 79, Guldberg, P. 37 Giron, D. M. 145 82, 84, 120, 128 Gulluoglu, M. 94 Gissi, D. 50 Gouiaa, N. 93, 113 Gulubova, M. 116, 149 Giuffrè, G. 145 Goupou, E. 102 Guma, A. 85 Giusca, S.-E. 72, 82, 139, Gourvas, V. 85 Gunal, A. 116 141, 146, 147 Go, W. Y. 117 Gunasekara, T. 50, 70 Gkekas, N. 125 Goyault, G. 111 Gündisch, S. 82 Gkermpesi, M. 134 Grabau, D. 87 Gundogdu, G. 94 Gkialas, G. 101 Grabherr, S. 34 Gunduz, S. 119 Gkouleli, T. 151 Grabsch, H. I. 30, 31, 92, 93, 94 Guney, K. 76 Gladkov, S. 154 Gradhand, E. 49 Gunhan, O. 75 Glavac, D. 43, 94 Graham, T. 95, 116, 119 Gün, I. 154 Gleidiston Lima da Silva, C. 117 Grahovac, B. 144 Gunn, A. 69 Gloor, B. 38, 45 Grahovac, M. 144 Guo, M. 127 Gluszek, S. 68, 91, 115 Gramada, E. 85, 94, 107, 153 Gupta, A. 119 Go, H.-J. 156 Granados, E. 143 Gupta, L. 149 Gockel, I. 92 Granados, R. 65, 80, 83, 133 Gupta, S. 148 Goel, M. 139 Granov, D. 90, 141 Guran, R. 151 Gogas, H. 105 Graus-Nunes, F. 47, 114 Gurer, I. E. 113 Goggin, P. 64 Grech, G. 46 Gurevich, L. 69, 94 Gogos, C. A. 146 Green, A. 42, 46, 78, 79, Gurgel, C. 74 Goiburú Chenú, M. B. 89, 147 80, 81, 82, 108 Gurrea Vidal, N. 94 Going, J. 42, 77 Green, B. 115 Gursoy, F. 148 Goishvili, N. 80 Green, C. 86 Gursu, T. 150 Gokcu, M. 150, 152, 153 Grégoire, V. 37 Gursu, U. R. 77, 85, 87 Gököz, Ö. 37, 38 Grénman, R. 50 Gurung, B. 146 Goldinger, S. M. 106 Greten, F. 51 Gutiérrez Pecharromán, A. M. 130 Goldin, R. 47 Griffiths, C. 97 Gutnik, H. 149 Goldis, A. 95 Griffiths, D. 53, 146 Güven, B. 140 Goldman-Levy, G. 51 Griffiths, M. 142 Guzel Nur, B. 109 Golubovic, M. 155 Grigoras, A. 139, 141, 147 Guzzetti, S. 61 Gomes, A. 89 Grigoras, M. 71 Gyftopoulos, K. 99 Gomes Peixoto, S. 56 Grigorovici, A. 111 Gyongyosi, A. 142 Gomez Dorronsoro, M. L. 115 Grigor, T. 103, 125, 128 Gómez Mateo, M. D. Carmen 125, Grimm, J. 34 H 147, 153 Gritli, S. 71, 73, 74, 120, 128 Haan, J. C. 36, 144 Gómez Morales, M. 127 Grivas, A. 152, 156 Haase, D. 127 Gómez Sánchez, R. 133 Grobholz, R. 91 Habeos, I. G. 146 Gonçalves, A. 126 Groelz, D. 143 Haberal, A. N. 122 Gonçalves, D. 87 Grolman, W. 50 Haberal, M. 65, 106, 122, Gonçalves Silva Torquato, B. 154 Gromann, T. W. 146 126, 127 Goncharov, I. 134, 152 Grossin, M. 116 Haberal, N. 89 Gondak, R. d. Oliveira 71 Grossmann, P. 98 Habes, D. 49 Goñi, E. 80 Groves, A. 116 Hachicha, A. 74 Gonzales, E. 49 Growcott, S. 89, 128 Hachlef, H. 78, 132 Gonzales, M. 98 Grunkin, M. 43 Hacihasanoglu, E. 86 González Arnay, E. 154 Grygorenko, V. 97 Haddad, I. 76, 90, 154 Gonzalez, B. 117 Grzesiak, W. 43 Hadhri, R. 76, 90, 96, 112, Gonzalez-de-Casro, D. 51 Gu, M.-J. 91, 122 123, 154 Gonzalez del Rey, C. 150 Guarch, R. 97 Hädrich, M. 119 González, M. 70, 97, 98, 106, Guarch Troyas, R. 75 Hafezi-Bakhtiari, S. 112 124, 125, 126, 127, Guba, M. 116 Haffar, N. 121 131, 139, 156 Gubina-Vakulik, G. 96, 126 Haga, T. 139 Gonzalez, O. 112, 113 Guebsi, A. 78, 79 Hagen, A. I. 81 González Menchen, A. 88, 129 Guelcher, S. 53 Hager, H. 156 González Pessolani, T. 89 Guergue, O. 105 Hagström, J. 50 González Sanchez, J. F. 133 Guermi, M. 68, 72 Haholu, A. 37, 77, 154 Gonzalez Serrano, M. T. 85, 127 Guerra Fernández, M. 59 Haidry, R. J. 54, 93, 95 González Serrano, T. 73, 88, Guerra Merino, I. 133 Haitel, A. 100 129 Guerra, S. 103 Hajkova, N. 145 Gonzalez Vadillo, M. 105, 125, Guerrero, D. 115 Hakala, T. 112 150 Guettier, C. 49 Halas, R. 140 Goos, J. A. C.M. 45 Guha, N. 45 Halaszka, K. 70 Gopinath, P. 53, 86, 87, 89 Guibert, N. 36, 142 Halcu, G. 85, 125 Goranov, E. 156 Guilford, P. 79 Hale, M. 92, 135 Gorczynski, A. 103, 145 Guillemain, R. 34 Halfpenny, I. 142 196 ECP 2014 · London Index of Authors

Hall, G. 129 Helbling, M. 31 Holicki, M. 43 Hall, J. 48, 53 Helgeland, L. 48 Hollema, H. 48 Hall, L. 81 Helliwell, T. 35, 50, 70 Holton, J. 54 Hall, P. 44, 54, 63, 64 Helwé, O. 138 Holt, S. 87 Halling, K. 143 Hemmings, C. 38, 57 Holzer, G. 39 Halon, A. 70 Hemmings, G. 30, 142 Holzer, L. 39 Halsall, J. 103 Henchiri, H. 73, 108, 110, Homa, A.-B. 147 Halushka, M. 41 117, 140 Honda, T. 148 Hamaizia, F. 104 Henno, S. 38 Honeychurch, J. 133 Hamasaki, M. 155 Henricksen, L. A. 58 Hong, S.-M. 138, 139 Hamashima, Y. 93 Henrique, R. 76 Hong, S.-R. 108, 151 Hamdy, F. 99 Henriques de Gouveia, R. 30, 53, Hoogerbrugge, N. 46 Hamerschlak, N. 141 89, 90 Hoorens, A. 30 Hamilton-Dutoit, S. J. 37 Herbert, A. 57, 65, 120 Hopfer, H. 52, 57 Hamilton, P. 145 Herlea, V. 102, 141 Hopkins, K. 59 Hammedi, F. 76, 90, 96, 112, Herman, D. 99, 125 Hora, M. 98 123, 154 Herman, J. G. 144 Horecka-Lewitowicz, A. 68, 91, Hamoir, M. 47 Herman, P. 75 115, 152 Hamoudi, R. 51, 54, 84, Hernández Amate, A. 100, 111, Horiguchi, S. 30 95, 135 123, 151 Hørlyck, A. 34 Hanafy Mahmoud, M. 96 Hernández Carrillo, K. 111 Hörndler, C. 94, 131, 140 Hanby, A. 86 Hernández Cortés, P. 133 Horne, J. 115 Handra-Luca, A. 71, 73, Hernandez Gallego, A. 109 Hornick, J. 40, 47, 60 111, 115 Hernández Godoy, J. 69 Horst, D. 51 Han Lee, G. 119 Hernandez Losa, J. 143 Hortopan, M. 102 Hansell, D. M. 49 Hernández, S. 99, 101 Horvath, E. 148 Han-Seung, Y. 148 Hernberg, M. 142 Horvath, Z. 142 Hansford, S. 103 Herrero, L. 100, 104, 117 Hoscan, M. B. 102 Hanssen, K. 148 Herrington, S. 60, 63 Hoskin, T. 78 Haoues, N. 117, 118, 140 Herrmann, P. 31 Houla, N. 134 Haouet, S. 72, 93, 95, 105, Hershkovitz, D. 36, 156 Høyer, S. 34 106, 111, 117, Herzig, K.-H. 117 Hoyt, C. 135 125, 129 Hes, O. 40, 98, 108 Hrehoret, D. 141 Haramis, G. 103 Hetzer, R. 34, 56, 62, Hsieh, R. 38 Harkonen, P. 97 88, 89, 146 Hsieh, T.-C. 158 Harras, F. 96 Hewer, E. 59 Huang, C.-N. 103 Harrison, R. 96 Hewitt, L. 92 Huang, D. 70 Harris, P. 103 Hewitt, L. C. 30, 31, 94 Huang, S. 143 Harsányi, L. 120, 138 Heywood, W. 37, 135 Huang, W.-C. 97 Hartmann, A. 40, 101 Hickson, N. 155 Hübscher, S. 45, 63, 137 Hartmann, L. 78 Hidouri, S. 123 Hue, S. S.-Shan 127 Hasby, E. A. 31, 96, 136 Hiemstra, A. C. 45 Hughes, C. 96, 119 Hasby Saad, M. 31 Higaki, K. 110 Hughes, D. 68 Hasegawa, S. 92 Hindley, A. 119 Hughes, S. 88 Hassan, A. B. 57 Hirabayashi, K. 138 Hughes, T. 86 Haugen, O. A. 81, 85 Hirai, H. 139 Huh, K.-H. 126 Haugk, B. 138 Hirashima, Y. 151 Huhtala, H. 112 Hauke, S. 101 Hirokawa, M. 112 Humar, B. 79 Hauptmann, K. 88 Hiroshima, K. 155 Hunink, M. G. M. 34 Haus, O. 70 Hirsch, F. R. 63 Hunter, K. 29 Haußer-Siller, I. 64 Hirschowitz, L. 53 Huntsman, D. 44, 54 Hautaniemi, S. 115 Hirshorn, N. 50 Hurtarte Sandoval, A. 127 Hawkes, C. 45 Hitchcock, C. 134 Hussein, D. 121 Hayashi, K. 104, 110 Hmissa, S. 131, 132 Hutka, Z. 63 Haybaeck, J. 141, 148 Ho, S. 143 Hvingel, B. 148 Hayden, J. D. 31, 92 Hobot, J. 145 Hwang, M.-J. 84 Hayes, A. 51 Hocaoglu, J. 122 Hyrcza, M. 82 Hayes, M. 31 Hocevar, M. 72 Hytiroglou, P. 85 Haynes, H. 59, 124 Hodson, J. 86 Hyun, C. L. 117, 120 Hazmoune, Z. 68 Hoebers, F. 50 He, C. 127 Hoefler, G. 36, 61 I Heaton, N. 137 Hoeijmakers, J. 54 Iaccarino, A. 122 Hecht, J. R. 117 Hoekstra, O. S. 45 Iacob, R. 92 Heegaard, S. 40, 59 Hofman, P. 36, 37, 53, Iacob, S. 107, 153 Heidari, P. 136 62, 65, 142 Iakovidou, I. 99, 151 Heikkiä, P. 43 Hofman, V. 36, 37, Iakovleva, G. 97 Heimann, P. 36 62, 142 Iakovlev, E. 88, 147 Heim, S. 54 Hogendoorn, P. C. W. 38, 57, Iakovlev, V. 38, 53, 88, 97, Heise, K. 86 60, 68 147, 148 Helbert, M. 129 Holden, S. 57 Ianes, E. 129 197 Index of Authors ECP 2014 · London

Ianez, R. 74 Ivanov, I. 135 Johnson, K. 135 Ibrahim, H. 48, 128, 129 Ivanovskaya, M. 103 Johnson, P. W. M. 145 Ibrahim, M. 43, 86, 95 Ivantsov, A. 135 Johnston, P. 128 Ichihara, S. 80 Iványi, B. 101 Jojo, A. 138 Icke, S. 72 Iwamura, E. 122, 134 Jomaa, W. 71, 73, 74, 78, Idrovo Mora, F. 151 Iwasaki, A. 155 79, 82, 84, 128 Ieni, A. 79, 116, 120 Iwasaki, T. 104, 110 Jomni, T. 93 Ieronimaki, A.-I. 72, 83, 133, Iwaya, K. 30 Jones, C. 158 137, 147, Iyevleva, A. G. 144 Jones, M. 145 151, 156 Izadi, S. 148 Jones, P. 84, 116 Ievleva, A. G. 124 Izquierdo, L. 101 Jørgensen, K. A. 127 Igdem, A. 128 Jorgensen, M. 70, 144 Ighil Agha, Y. 72 J Joshi, K. 38 Iglesias, C. 113 Jabs, W. 65 Jotanovic, J. 92, 138 Iglesias Felip, C. 112 Jackson, D. 145 Jothy, S. 97 Iglesias, J. 125 Jackson, R. 131 Jouini, R. 73, 108, 110, Iglesias, M. 31 Jacob, D. 114 117, 118, 135, 140 Ignatova, M. M. 149 Jacobs, B. 30 Jouret-Mourin, A. 45 Ignatova, O. 121 Jácome, M. 74, 76 Jourjon, R. 109 Ihrler, S. 44 Jacquemin, E. 49 Jouven, X. 34 Ihvan, A. N. 58, 149 Jacques, T. S. 126 Jover, J. M. 83 Ikonomi, M. 94, 122 Jader, S. 53, 86, 87 Jovino Silva, M. I. 117 Ilc, K. 142 Jahkola, T. 142 Juanpere, N. 99, 101, 146 Ilhan, H. D. 136 Jakic-Razumovic, J. 78 Juaristi, A. 147 Ilhan, H. R. 153 Jakovlevs, A. 124 Judge, M. 53 Iliadis, A. 106 Jaksa, R. 131 Juini, R. 110 Ilie, M. 36, 37, 62, 65, 142 Jakub, J. 68 Jukna, A. 158 Iliesiu, A. 79, 92, 129 Jalali Nadoushan, M. 110 Juliano, G. R. 90 Illarramendi, J. J. 79 James, M. 142 Julião, M. J. 132 Illidge, T. 133 Janakova, L. 63 Jun, S.-Y. 121, 139 Ilyas, M. 36, 43, 96, 116, Janeiro, J. 69 Jung, A. S. 117 120, 141, 143, Jang, H.-J. 138 Jung, H.-Y. 137 144, 145 Jang, J.-J. 120, 137 Juniku-Shkololli, A. 91 Ilyes, A. 71, 72, 77, Janin, A. 53 105, 120 Jansen, M. 95, 119 K Imanbayeva, G. 126 Japon Rodriguez, M. 96 Kaba, E. 156 Imyanitov, E. N. 124, 144 Jarosova, M. 130 Kachanov, D. 49 Incesu, M. 69 Järvinen, H. 115 Kaczmarczyk, K. 99 Ince, Ü. 170 Järvinen, P. 115 Kadambi, P. 66 Inderbitzin, D. 119 Jasani, B. 142 Kadare, S. 94, 122 Ines, H. 76 Jasek, E. 89 Kage, M. 30 Invernizzi, F. 103 Jaskowiec, A. 70 Kähler, G. 91 Ioannis, V. 136 Jassem, J. 63 Kain, R. 57 Ionescu, L. 111, 146 Jelen, M. 108, 149 Kaisas, C. 73 Ionescu, R. Z. 79, 92, 129 Jelicic, B. 156 Kajander, H. 89 Ipekci, O. 98, 102 Jelicic, I. 156 Kakiopoulos, G. 107, 152 Ipekci, T. 102 Jenei, A. 101 Kaklamanis, L. 88 Iqbal, J. 127 Jenei, V. 37 Kakolyris, S. 151 Iringo, K. 132 Jenkins, J. T. 119 Kakturskiy, L. 79 Irion, L. 136 Jenkins, M. 50 Kalfert, D. 142 Ironside, A. 153 Jennings, L. 51 Kalimuthu, S. 145 Ironside, J. 54 Jensen, V. 43 Kalinski, T. 134 Irsai, G. 144 Jeon, W.-Y. 117 Kalipciyan, M. 143 Irving, W. 45 Jeon, Y.-K. 156 Kaliyeva, D. 155 Isajeva, D. 157 Jeong, H.-J. 126, 127 Kallel, R. 87, 93, 113 Isajevs, S. 88, 157 Jeong, H.-S. 108, 151 Kalman, M. 87, 118 Iscaife, A. 99 Jeong, J.-Y. 112, 116, 130, 139 Kalodimos, G. 94 Iselin, C. 97 Jerjees, D. 46, 78, 79, Kalogerakos, K. 83 Ishchenko, R. 115 80, 81, 82 Kalogirou, I. 154 Ishida, K. 79, 83 Jerónimo, C. 154 Kamalathevan, P. 116 Isik Gonul, I. 100 Jeruc, J. 33 Kamei, T. 155 Ismail, A. 104 Jia, Y. 38 Kamenova, M. 70, 147, 157 Isoglu, S. 99, 100 Jimenez-Linan, M. 58, 83 Kaminski, M. 117, 118 Issam, M. 68, 155 Jimenez, R. 82 Kammerer-Jacquet, S.-F. 39 Itaya Yamaga, L. Y. 111 Jimeno, M. 118 Kamoun Azouz, H. 93, 111, Ito, I. 151 Jin, J. 137 117 Ivancheva, H. 153 Jitariu, A. 86 Kanakis, D. 124 Ivanov, A. 90 Joamaa, W. 71 Kanczuga-Koda, L. 148, 152 Ivanova, K. 149 Johansson, U. 48, 131 Kandil, M. 59, 74, 78, Ivanov, G. 69, 97 Johnson, J. 33 120, 134 198 ECP 2014 · London Index of Authors

Kandiloros, D. 73 Kchir, N. 72, 93, 95, 105, 106, Kim, S.-H. 125 Kang, C.-H. 156 111, 117, 125, 129 Kim, S.-I. 121, 126 Kang, G.-H. 115, 117 Kdous, J. 72 Kim, S. S. 92 Kang, H.-C. 120 Keating, K. 142 Kim, S.-S. 120, 122 Kang, J. 121 Kececi, B. 135 Kimura, H. 110 Kang, S. J. 110 Kedous, S. 71, 73 Kim, W.-H. 116 Kankate, L. 82 Keeling, C. 155 Kim, Y.-H. 99, 117, 127 Kankaya, D. 100 Keen, C. 69 Kim, Y.-S. 126 Kan, N. 150 Kelemen, G. 79 King, E. 50 Kanthan, R. 68, 80, 137, 155 Kellokumpu-Lehtinen, P. 112 Kinoshita, M. 93 Kanthan, S. 137 Kelly, H. 149 Kipp, B. 143 Kaplan, C. 52 Kelten, E. C. 77, 78, 85, 86, 87 Kir, G. 30, 58, 98, 99, Kap, M. 82, 135 Kemp, K. 124 121, 148, 149 Kapp, J. 51 Kemper, D. 56, 62, 88, 146 Kirby, J. 45 Kapran, Y. 46 Kendall, C. 133 Kirchmair, M. 103 Kaptanis, S. 78 Kepil, N. 95 Kirchner, T. 51, 56, 116 Karabogias, C. 100, 101, 102, Kepka, A. 125 Kirk, B. 89 124, 125, 152 Keramidas, I. 121 Kirkham, N. 51, 104 Karaca, M. 149 Keramopoulos, A. 85, 86 Kirkpatrick, C. J. 54, 135, 146 Karacetin, D. 77, 85, 87 Kerasioti, A. 94 Kiss, C. 144 Karadeniz, T. 72, 73, 99, 149, Kerkar, R. 148, 151 Kiss, O. 86, 143 150, 151, 152, 153 Kerliu, I. 91 Kitamura, Y. 104 Karagiannopoulou, G. 85 Kerliu, L. 91 Kiziridou, A. 151 Karagoz, B. 77 Kermas, F. 112 Kjærgaard Nielsen, T. 34 Karakaya, K. 140 Kern, I. 65 Klanova, M. 131 Karakilic, E. 46, 112 Kerr, K. 171 Klapper, W. 169 Karakitsos, P. 78 Kerr, K. M. 156 Klatte, T. 100 Karakurt Eryilmaz, M. 157 Keshav, S. 119 Klener, P. 131 Karamitopoulou-Diamantis, E. 45 Keskin, E. U. 72, 80 Kleshchov, M. 135 Karamitopoulou, E. 31, 38, Keskin, M. 94 Klijanienko, J. 50, 52 116 Ketcheson, S. 38 Klimstra, D. S. 111 Kara, O. 76 Ketenci, S. S. 153 Klingen, T. A. 80 Karaveli, S. 154 Ketit, S. 68 Klintrup, K. 117, 119 Karavokyros, I. 140 Khadhar, A. 93, 105, 111, 117 Klis, D. 121 Karev, V. 146 Khakhutaishvili, I. 80 Klöppel, G. 32 Karim, H. 36, 120 Khamidullina, G. 78 Kneževic Ušaj, S. 156 Karinoglu, U. 102 Khan, M. 107, 111, Knieling, L. 89, 139, 147 Kariuki, I. 85 113, 122 Knight, S. C. 119 Karkavelas, G. 124 Khan, S. 54, 93, 95 Knoblich, A. 88 Karnaukhov, N. 110 Khatri, B. 58 Knuechel, R. 101 Karst, W. 136 Khayat, O. 73, 108, 110, 117, Knuutila, S. 63, 103 Karthaus, M. 117, 171 118, 135, 140 Ko, K.-T. 33 Karttunen, T. 117 Khedaoui, R. 100, 125, 133 Ko, Y.-H. 130 Karydis, A. 136 Khedr, G. 49 Koc, A. 72 Karydis, I. 119 Khelif, A. 131, 132 Koc, B. 93 Kashofer, K. 29, 61 Khetrapal, P. 34 Kocsis, L. 81 Kasselaki, I. 99 Khiari, R. 97 Koda, M. 148, 152 Kassif, Y. 128 Khodr, F. F. H. 134 Koelzer, V. H. 31, 38, 116, 119 Kastrati, M. 91 Kholová, I. 45, 89, 112 Koepsell, S. 70 Katafygiotis, P. 130, 152, 157 Khoo, J.-J. 69, 127 Koffa, M. 151 Kathir Kamarajah, S. 133 Khouni, H. 100, 101 Kofoed, L. 133 Kato, M. 104, 110 Kiedrowski, M. 117 Kogan, E. 144, 152, 153 Katoh, R. 79, 83 Kiho, L. 49 Koh, J.-M. 156 Katsaragakis, S. 73 Kijima, H. 139 Koivunen, P. 50 Katsianis, D. 125 Kilicaslan, I. 100, 102 Kojima, M. 30 Katsos, K. 130, 152, 157 Kilic, E. 59, 136 Kokai, G. 49 Katunaric, M. 144 Kim, B.-C. 119 Kokenek Unal, T. D. 46, 112 Katz, B. 99 Kim, B.-S. 126 Kokoskova, B. 91, 98 Katz, R. L. 52, 57 Kim, C.-S. 33 Koksal, G. 72 Kavalar, R. 133 Kim, H.-K. 92 Koksal, N. 93 Kavantzas, N. 74, 96, 136, 157 Kim, H.-S. 108, 151 Köksoy, F. N. 134 Kawahara, K. 155 Kim, J.-W. 119 Kolarova, L. 146 Kawasaki, T. 79, 83 Kim, J.-Y. 81, 121, 138 Kolb, D. 39 Kay, E. 85 Kim, K.-H. 92 Kolesnikov, D. 134, 152 Kaya, H. 143 Kim, K.-P. 138 Koletsa, T. 85, 106, 116, 129 Kaye, P. 94, 96, 111, 141 Kim, K.-S. 138 Kolos, M. 82, 105 Kayser, G. 42, 155 Kim, M.-S. 126 Kolousova, N. 96, 126 Kayser, K. 42 Kim, M.-Y. 156 Kolyva, A. S. 146 Kazantseva, I. 69, 94 Kim, S. 156 Kombak, E. 143 Kim, S.-C. 138 Komminoth, P. 36, 110 199 Index of Authors ECP 2014 · London

Konopka, B. 58 Kremer, M. 41 Lacroix-Triki, M. 84 Konovalov, D. 49, 108 Krepisc, A. C. V. 71 Ladeirinha, A. 49, 62, 118, 157 Konstantinidou, A. 110 Krijgsman, O. 36 Lade Keller, J. 37 Konstantinou, D. 123 Krist, B. 59 Ladra, M. J. 110 Konstantinova, A. 104 Kritharis, A. 107 Lae, M. 73 Kontzoglou, K. 87 Krivopuskov, V. 123 La Ferla, M. 59 Koo, S. 49 Kroneis, T. 39 Lai, C.-L. 158 Koobaa, W. 110 Kruczak, A. 70 Lakiotaki, E. 46, 102, 133, 139 Koole, K. 50 Krüger, K. 81 Lakomy, J. 105 Koole, R. 50 Kruslin, B. 99 Lalvée, S. 36, 37, 62, 142 Koopman, M. 144 Kubat, B. 136 Lamba Saini, M. 47 Koopmans, A. 59, 136 Kubova, Z. 130 Lambropoulou, M. 151 Kopaka, M. E. 103 Kucukodaci, Z. 37, 75, 77, 103, Lamine, O. 71, 78, 79, Koppert, L. 31 131, 154 120, 128 Kordek, R. 80 Kucuk, U. 69, 72, 73, 80, Lamouti, Y. 68, 71, 98, Korendovych, I. 91, 115 92, 99, 102, 110, 148 Korkmaz, M. 96 123, 124, 150 Lamovec, J. 72 Korkolopoulou, P. 66, 95, 144 Kudaybergenova, A. 90, 141, Lam-Ubol, A. 75 Korneva, Y. 88 154, 170 Lanas, Á. 94 Kornev, N. 103 Kukal, J. 62 Lanaspre, E. 117 Korneyko, I. 108 Kulda, V. 142 Landolfi, S. 102, 143 Koromilas, A. 85 Kulikova, G. 150 Lang, J. 114 Korou, L.-M. 136 Kulka, J. 31, 85, 86, 120, 143 Langley, R. 31 Kos, M. 108 Kulkarni, K. 107 Langner, C. 37, 56, 60, Kosaka, T. 79, 83 Kunc, M. 145 114, 138 Kosemehmetoglu, K. 104 Kupryjanczyk, J. 58 Lankosz, M. 112 Koshyk, E. 115 Kurbel, S. 80 Lantuejoul, S. 37 Kosjerina Ostric, V. 156 Kurian, K. 59, 124 Lanzafame, S. 145 Kostakis, I. 96 Kurian, R. 130 Laplace-Builhé, C. 50 Kostopoulos, I. 85, 106, 129 Kuroda, N. 97 Laquente, B. 139 Kostopoulou, A. 73, 87, 100, Kurokawa, S. 138 Laranjo, M. 59, 155 103, 105, 107, Kurt, O. A. 75 Larocca, L. 65 113, 124, 125, 154 Kurt, Y. 77 La Rosa, S. 36, 46, 111 Kotiloglu Karaa, E. 49 Kuryk, O. 91, 115 Larque, A. B. 117 Kotorri, V. 91 Kus, S. 95 Larrinaga, B. 115 Kotsopoulou, M. 129 Kusafuka, K. 72 Larroquet, M. 109 Kotta-Loizou, I. 50 Kuscu, E. 122 Larsen, M. 133 Koubaa Mahjoub, W. 73, 108, Kushima, R. 30, 95 Lascane, N. 75 110, 117, 135 Kushlinskiy, N. 108 Lassalle, S. 37, 62, 142 Koubâa, W. 118, 140 Kusinska, R. 80 Last, A. 59 Kouchkar, A. 85 Kusku Cabuk, F. 72, 112, 156 Latalova, P. 130, 143 Koulia, K. 72, 83 Kuthi, L. 101 Lateckova, L. 131 Koulis, A. 128 Kuwamoto, S. 104, 110 Latona, A. M. 69 Koumoundourou, D. 85, 134, 153 Kuznetsova, I. 89, 134 Lau, K. 133 Koumpanaki, M.-M. 146 Kuznetsov, S. 86, 93 Laudanski, P. 152 Kounelis, S. 81 Kvasnicka, H. 41 Laurinavicius, A. 42 Kouraklis, G. 96, 137, 140 Kviatkovska, Z. 63 Laurino, L. 87 Kourea, H. 106 Kwak, C. 33 Lavergne Slove, A. 116 Koutsilieris, M. 96 Kwak, Y.-J. 116 Lavorato-Rocha, A. M. 142 Koutsonikas, G. 73, 101, Kwiatkowski, A. 53 Lax, S. 60 105, 113 Kwon, H.-J. 126 Lazar, A. 47 Koutsounas, I. 140 Kyrodimou, E. 70, 73, 75, Lazar, D. 91, 95, 129 Kövári, B. 79 100, 105, 107, Lazar, E. 71, 95 Kõvári, B. 81 113, 124, 125 Lazaris, A. C. 133 Kowalewska, M. 151 Kytölä, S. 142 Lázár, P. 79 Kowalski, L. P. 71 Kzhyshkowska, J. 88, 89 Lazureanu, C. 68, 71, 91 Kozachenko, A. 144 Lazureanu, D. 86, 125 Koziel, D. 68, 91, 115 L Le, N. 58 Kozlov, D. 97, 126 Laabidi, B. 68, 70, 77, 91, Leach, I. 107 Krabatsch, T. 34 97, 113, 114, 121, Leach, M. 131 Kraby, M. R. 81 128, 132, 138, 155 Leal Filho, W. B. 75 Krajsova, I. 149 Laamouri, B. 84 Leal, R. F. 116 Kral, R. 150 Labanca, M. J. 98, 105, 125, Leblebici, C. 77, 78 Kram, A. 43 126, 156 Le Bouc, Y. 109 Krasnokutskaya, T. 86 Labbene, M. N. 135 Le Calve, M. 38 Kraszewska, E. 117 Lachkova, A. 93 Lee, B. 127 Kravic Stevovic, T. 146 Lachmann, N. 62 Lee, C.-L. 128 Krechler, T. 122 Lacko, M. 50 Lee, F.-Y. 153 Kreipe, H. 41 Laco, J. 28, 142 Lee, G. H. 119 Kremer, B. 50 Lacour, J.-P. 37 Lee, H.-C. 79, 80 200 ECP 2014 · London Index of Authors

Lee, H.-S. 116 Limongelli, L. 71 Loucif, A. 148 Lee, H.-Y. 145 Limon, J. 105 Loughrey, M. 145 Lee, J. 48 Lin, T. 38 Louis, B. 111 Lee, J.-J. 121 Linardou, A. 70, 86, 140 Loundou, A. 38 Lee, J.-S. 69, 120 Linardoutsos, D. 95 Loupy, A. 34, 55 Lee, K.-B. 137 Linares, J. 84 Loureiro dos Santos, S. 75, 113, Lee, O.-J. 79, 80 Lindberg, M. 133 130, 136 Lee, S.-J. 116, 122, 139 Lindenmann, J. 155 Loureiro, R. 95 Lee, V. 38 Lind-Landström, T. 124 Lourencini Cavellani, C. 90, 107, Lee, Y.-M. 79, 80, 110 Ling, H. 142 147, 154 Lee, Y.-Y. 103, 119 Linton, K. 48, 53, 129 Lourencini Cavellani, M. L. 90 Leftheriotis, V. 77 Lionaki, S. 128 Lourenço, J. 132 Legrès, L. 53 Lis, G. 89 Lourenço, S. 74 Le Guellec, S. 63 Lishman, S. 32, 33 Lourenco, S. V. 38, 55, 74, 76 Lehtonen, R. 115 Lisova, S. 145 Louwagie, J. 144 Leibl, S. 81 Litwin, J. A. 89 Lovat, L. 54, 93, 95 Leinonen, R. 112 Liu, B. 42 Lovrenski, A. 89, 156 Leitão, Á. 74 Livolsi, V. A. 29, 36 Lowe, J. 54 Leite, K. 33 Llach, J. 118 Lowes, H. 89 Leite, K. R. Moreira 99 Llanos, C. 80 Lowis, S. 59 Leithner, A. 39, 70, 144 Llanos, M. C. 115 Loy, M. 62, 63 Leivo, I. 35, 50 Lloret, A. 146 Lozano, J. J. 94, 145 Lekarakou, M. 103 Lloreta, J. 99, 101, 146 Lozneanu, L. 72, 82, 111, Lekic, B. 38 Lloreta-Trull, J. 61, 145 146, 151 Lekka, I. 152 Lloveras, B. 146 L.S. Ayrizono, M. 116 Lelytsia, A. 96, 126 Lloyd, R. 129 Lucas, S. 52, 55, 146 Lemaistre, A. I. 45 Lluch, A. 43 Lucianò, R. 103 Le Mercier, M. 36 Loayza, C. 88 Ludvikova, M. 142 Lemos, M. 69 Lobo, C. 147 Lugli, A. 31, 38, 45, Lentini, M. 145 Lobo, D. 137 116, 119 Leodara, V. 101, 102, 152 Locker, D. 135 Luís, A. 58, 74, 109 Leonardi, E. 73 Locker, G. 100 Luis, P. 53, 65, 109, 122 Leone, O. 41 Loeschke, S. 50 Luis, R. 140 Leonidou, A. 46 Loghin, A. 99, 102 Luís, R. 65, 122 Leontara, V. 137 Loh, A. H.-Liang 127 Luiz de Vasconcellos Lepistö, A. 115 Lohberger, B. 144 Macedo, A. 111 Le Quesne, J. 40, 158 Löhrs, L. 116 Luiz Rosa, A. 74 Lequoy, M. 138 Loibl, S. 64 Lunardi, F. 62, 63 Leroy, X. 75 Lolli, I. R. 142 Lundell, L. 92 Lessi, F. 59 Lombardi, C. 65 Lungu, G. 124 Le Stang, N. 37 Lømo, J. 80 Luong, T. V. 110 Levidou, G. 144 Lompo Goumbi, O. 149 Luz Menendez, C. 33 Lewis, J. 32 Long, G. 107 Lynch, V. 131 Lewitowicz, P. 68, 91, 115, Longerich, T. 60 Lyså, L. M. 148, 149 148, 152 Long-Mira, E. 36, 37, 62, 142 Lysov, A. 109 Leynis Isabel, M. B. 154 Lopes, J. 122 Lytras, D. 94 Lezureanu, C. 99 Lopes, J. M. 154 Li, C.-C. 103 Lopes, P. 58 M Li, C.-F. 103, 119 Lopez Arribillaga, E. 31 Macagno, N. 38 Li, H. 117 López Barea, F. 69, 120 MacDonald, D. 48 Li, H.-N. 153 Lopez-Beltran, A. 29, 43, 47 Machado, B. 76 Li, M. 51 López, C. 100 Macías, L. 98 Li, R. 127 López Cerón, M. 118 Mackie, S. 62 Liadakis, G. 102 López, D. 69 Mac Mahon, J. 131 Lianos, E. A. 66 Lopez Fernandez De Macmillan, D. 42 Liapi, G. 70, 86, 140 Villaverde, J. I. 126 MacPherson, S. 43 Liapis, G. 102, 139 López Ferrer, P. 120 Macut, D. 138 Liatkouskaya, T. 103 López Hernández, E. 83 Madaras, L. 85 Libera, L. 58 Lopez, J. C. 136 Madentzoglou, M. 94 Liebmann, R. 78 López, J. I. 97, 98, 127 Mader, R. M. 143 Liegl, B. 70, 144 López, M. 85 Madhusudan, S. 42, 81, Liegl-Atzwanger, B. 39 López Macías, M. 100, 111, 82, 137 Liepniece-Karele, I. 88 123, 151 Madsent, M. 127 Liestøl, K. 80 López Ojeda, A. 82 Madureira, R. 158 Ligory, C. 117 López-Presa, D. 65, 122 Maeda, N. 150 Ligtenberg, M. 46, 170 Lopez-Rios, F. 169 Mæhlen, J. 80 Liliana, C. 132 López Ruiz, E. 69 Maeng, L.-S. 121 Lilis, I. 81, 88, 99, 142 López Zambrano, M. 131 Maeng, Y.-I. 139 Lilledahl, M. B. 85 Lorente, J. A. 99 Magee, D. 135 Lim, B.-J. 126, 127 Lorenzo, M. 99, 101 Mageriu, V. 107, 118 201 Index of Authors ECP 2014 · London

Magi-Galluzzi, C. 43 Marchand, J. 143 Mathew, B. 114 Magkou, C. 73 Marchetti, A. 156 Mathew, J. 103 Magliacane, G. 103 Marchetti, C. 50, 73 Matias-Guiu, X. 60, 142 Magliano, D. 114 Marchiò, C. 46, 61 Matisic, J. P. 149 Magno Cavalcante, D. I. 56, 117, March, P. 170 Matoba, H. 148 122, 154 Marcinek, J. 87, 118 Matos, C. 100 Magopoulos, C. 77 Marcos, F. 80 Matsionis, A. 83 Maguire, S. 46 Marcussen, N. 127 Matsko, D. 124, 144 Maheshwari, A. 148, 151 Maresi, E. 93 Matsko, M. V. 124, 144 Mahler-Araujo, B. 42, 83 Mares, R. 143 Matsubayashi, J. 123 Mahmudzadeh, L. 92 Margaris, I. 137 Matsuda, K. 112 Mahrous, A. 120 Margaritescu, I. 106 Matsuda, Y. 93 Maia, B. M. 142 Maria Grazia, T. 94 Matsumoto, S. 155 Maia, T. 110 Mariani, R. 49 Matsushita, M. 104, 110 Mailly, L. 45 Mariano, F. V. 71, 108 Matthiesen, S. H. 133 Maiorano, E. 28, 71 Marinescu, I. 107 Mattos, A. 91 Maiques, O. 142 Marinoni, I. 46 Matykiewicz, J. 91, 115 Majewska, H. 71 Marinova, D. 147, 156 Matyskiel, A. 105 Mäkelä, J. 117, 119 Marion, C. 147 Maughan, T. 142 Mäkinen, M. 117, 119 Marjanovic, K. 80 Maulid, P. 102 Makni, S. 113 Markovic-Lipkovski, J. 34, 57, 66 Maurice, Y. 84 Makretsov, N. 35, 53, 77, 82 Markovic, O. 146 Mauri, F. 147 Mak, W.-B. 143 Markovskaya, V. 101, 134 Mautoni, C. 122 Malagoli Rocha, R. 142 Markovsky, V. 108 Mayaud, P. 149 Malamouli, I. 94 Markusevich, E. 89 Maystrenko, A. 90 Malapelle, U. 65 Marnerides, A. 108 Maystrenko, D. 90, 141 Malheiros Coutinho Marques, C. 126 Mazurec, M. 108, 149 Camillo, C. 30 Marques, S. 132 Mazzanti, C. M. 59 Malietzis, G. 119 Marquette, C. H. 36, 62, 142 McCarthy, A. 34, 108 Malkov, P. 83 Marquez Maggio, E. 106 McCleary, D. 145 Mallaev, M. 119 Marquina Ibañez, I. 126 McClelland, D. 114 Mallett, S. 35, 53, 82 Marshall, N. 84 McClements, P. 114 Mallofré, C. 100, 104 Marta, C. B. 75, 109 McCluggage, G. 33, 58, 60, 147 Mallon, E. 168 Martignoni, G. 43, 103 McCulloch, T. 68 Malmström, P. 87 Martín, A. M. 125 McDermott, J. 51 Malpica, A. 48 Martinek, P. 98 McDermott, U. 44 Maltezos, N. 106 Martinez de Pancorbo, M. 133 McDonald, S. 95, 119 Mamede, A. C. 103 Martinez, E. 76, 131, Mchedlishvili, M. 80 Manakova, T. 135 132 McKeating, J. 45 Mancebo, E. 85 Martinez, E. F. 75, 76 McKee, C. 99 Manchini, M. 59 Martín, F. 133 McKenzie, J. 87 Mandarim de Lacerda, C. 47, 114 Martín Fragueiro, L. 104 McKinney, O. 73, 130 Manders, P. 46 Martini, M. 65 McLean, A. 128 Manel, N. 76 Martin, J. 59, 123, 125 McLeer-Florin, A. 37 Manel, Y. 68, 121, 155 Martin, J. E. 124 McMahon, R. 61 Manganoni, A. 106 Martin Lopez, J. 104 McMullan, D. 142 Manger, K. 36, 120 Martín, M. 43, 100, 131 McNally, J. 49 Mangin, P. 34 Martín, N. 43 Medhi, S. 139 Mangray, S. 113, 119, 134 Martino, R. 137 Medina Pérez, M. 73, 85, 88, Manikis, P. 152 Martinovic, T. 146 127, 129, 133 Mannelli, M. 114 Martin, S. 81, 144 Medini, B. 140 Mannu, C. 129 Martín Sánchez, M. 74 Medrado Ribeiro, T. C. 91 Manojlovic, S. 29 Martins, A. S. 71 Mega, C. 126 Manoloudaki, K. 72, 83 Martins, M. 80 Mehes, G. 142, 144 Mansel, R. 87 Martins Menezes, N. 109 Meiers, P. 80 Manseur, Z. 71 Martins Menezse, L. 109 Meijer, G. A. 36, 45, 46, 144 Mansfield, J. 48, 53, 129, 135 Martins, V. 135, 156, 158 Meijer-Jorna, L. 45 Mansouri, N. 70, 113, 121, Maruno, A. 138 Meijer, S. 95 132, 138 Maruszak, K. 152 Meireles, C. 58, 74, 76, 158 Mansuet-Lupo, A. 37 Marx, A. 51, 91, 147 Meirelles, L. R. 116 Mansy, M. 79 Masansky, I. 103 Meirovitz, A. 50 Mantzourani, M. 140 Massi, D. 44 Mejia, E. 107, 115, 131, 140 Manxhuka-Kerliu, S. 91 Mat, E. 153 Mejía Urbáez, E. 75, 109, 126 Mao, X. 127 Matcionis, A. 83 Mekjanov, M. 128 Mapstone, N. 94 Mate, J. L. 131 Mele, V. 31 Marafioti, T. 128 Mateescu, B. R. 118 Melian, G. 72 Maragliano, R. 111 Matej, R. 62, 123 Mellouli, M. 87, 93, 113 Maran-Gonzalez, A. 84 Matejková, A. 88 Melnikova, M. 108 Marbaix, E. 47 Mateoiu, C. 154 Melo, A. 108 Marçal Gomes, J. 31 Mateos, B. 125 Melo, J. 108, 109, 117 202 ECP 2014 · London Index of Authors

Melo, L. 74 Miller, K. 43, 84, 86, 95, 103, 118 Moon, K.-C. 33, 98, 99 Melocchi, L. 106 Miller, P. 135 Mooney, E. 153 Melton, S. 119 Mills, K. 37, 135 Moore, A. 73 Memoli, D. 101 Milner, D. 61 Moore, D. 106, 158 Menasce, L. 106, 111, Milosevic, Z. 110 Moore, L. 58, 83, 95 129, 130 Milovanovic, Z. 110, 156 Moorehead, J. 83 Menassa-Moussa, L. 138 Milutin, D. 71, 105 Moorghen, M. 119 Mendes, L. 62 Minaidou, E. 70, 75, 100, 107, Mora de Féria, R. 158 Mendes, R. 74 113, 124, 125, Morais, D. R. 99 Mendes de Almeida, M. 112 137, 154 Morales Bastos, C. 147 Mendes Porto Azevedo, M. 154 Minarik, J. 143 Morán, C. 61 Méndez Medina, R. 154 Minciu, R. 99 Morandi, L. 50, 73 Mendilcioglu, I. 109 Minotakis, D. 102 Moray, G. 65, 126 Mendo, S. 132 Miquel, R. 63 Moreno, F. 42, 43, 95, 107, Mendoza, G. 134, 139, Mir, Y. 43 113, 131 150, 158 Mirabile, I. 145 Morgan, F. 62 Mendoza Pacas, G. 68, 80, 123 Miralles, O. 31 Morgan, J. 53 Menéndez Rodríguez, P. 80 Mirwa-Tomczak, I. 43 Mori, K. 80, 128 Menezes, F. 76, 158 Mirza, S. 46, 80, 82 Morohashi, S. 139 Mengual, L. 101 Mistiri, S. 136 Moroz, E. 137 Menke-van der Houven Mitchison, M. 115 Morozov, S. 72, 74 van Oordt, C. W. 45 Mitildzans, A. 88 Morrill, P. 37, 159 Mennander, A. 89 Mitkov, D. 128 Morris, J. 107 Menon, S. 96, 148, 151 Mitrache, L. 79, 92, 149 Mortensen, M. B. 45 Menon, V. 31 Mitrofanova, A. 49, 108 Mortuaire, G. 75 Mensenkamp, A. 46 Mitroi, A. 94, 109, Moscoso, J. 143 Menta S. Nico, M. 38 144, 153 Moshammer, M. 143 Mera, M. 124 Mitropoulou, G. 72, 83, 99, 121, Moso, T. 102 Mercado, M. R. 115 129, 133, 137, Mosteiro, L. 124, 125 Mergen, B. 96 147, 152 Mota, A. 103 Merghem, K. 104 Mitsopoulos, G. 78 Moulai, N. 68, 70, 107 Merino, J. A. 99 Miura, K. 132 Mounié, E. 84 Merino, M. 35 Miura, S. 112 Moura, C. 99 Meristoudis, C. 84 Miyagi, Y. 94 Mourad, M. 47 Merlio, J.-P. 37 Miyauchi, A. 112 Mouroux, J. 62, 142 Mestiri, S. 154 Miyauchi, H. 110 Mourra, N. 150 Métellus, P. 36, 38, 142 Mnikhovich, M. 79 Moussa, A. 76, 90, 96, 112, Mete, O. 112 Mocan, S. 71, 72, 93, 123, 154 Metodiev, D. 155 105, 120 Moustakas, G. 102 Metze, K. 42, 135 Moch, H. 33, 58, 106 Moustakas, K. 121 Mhiri, N. 113 Moe, B. T. G. 148, 150 Moutasim, K. 37, 40, 50, 64 Mialhe Morellon, B. 45 Moes-Sosnowska, J. 58 Mozaffari Kermani, R. 148 Miccoli, S. 71 Mogos, V. 111 Moza, M. 142 Micev, M. 92, 138 Mohamed, A. 95 Mpatsoulis, D. 146 Michail, G. 153 Mohamed, M. 98, 121 Mpolanos, N. 156 Michal, M. 91, 98 Mohammed, S. 141 Mposgana, P. 134 Michaud, K. 34 Mohsenifar, Z. 148 Mpota, E. 85 Michel, W. 147 Moinfar, F. 48, 70, 81, 141 Mrad, K. 113, 141, 154 Micklem, D. R. 83 Mokhtari, K. 38 Mrcela, M. 149 Micsik, T. 120 Mokni, M. 136, 154 Mroz, A. 117 Micu, G. 94, 107, 118 Moldovan, C. 77, 78 Msakni, I. 70, 77, 91, 97, Middleton, M. 119 Møldrup, U. 34 113, 114, 121, Mihai, A. 79, 92 Molnar, C. 148 128, 132, 138 Mihai, T. 132 Molven, A. 48 Mu, K. 79 Mihci, E. 109 Momblan, D. 117 Müderrisoglu, H. 89 Mihic-Probst, D. 106 Momtahan, N. 84 Mudhar, H. 41 Mijatovic, D. 78 Monaco, R. 62 Mue, Y. 79, 83 Mijovic, G. 155 Moncea, D. G. 77, 78, 148 Mufaddal, M. 52 Mikel, J. 103, 118 Mondello, S. 59, 116 Muftah, A. 46, 78, 82 Miladi, S. 71, 73, 74, 78, Monroig, P. 142 Muftah, A. A. A. 81 79, 82, 84, 128 Montalli, V. A. 70, 75, 108 Muhlfay, G. 71, 72 Milano, G. 36, 142 Montebugnoli, L. 50 Mukherjee, A. 42, 47, 64, 116 Milanski, M. 116 Monteiro, G. G. R. 134 Mukhtar, S. 114 Milenkovic, S. 68 Monteiro, P. 76 Mulder, C. J. J. 46 Milias, S. 77 Montero, A. 49 Muller, S. 158 Milic, M. 89 Montero-Fernandez, M. A. 88 Müller, S. 142 Miligy, I. 69 Montero, M. A. 157 Mulligan, A. 37 Milinkovic, V. 156 Montgomery, N. 145 Muniesa, C. 105 Milione, M. 111 Monti, V. 50 Muñoz, A. 131 Miller, B. 134 Montironi, C. 100, 117 Muñoz, E. 135 203 Index of Authors ECP 2014 · London

Muñoz, G. 75 Nauth, A. 38 Njim, L. 76, 90, 96, Muñoz Gonzalez, G. 109 Navarro Otano, J. 59 112, 123, 154 Muñoz, M. 145 Navas, C. 112 Noel-Storr, G. 62 Muntean, A. 93 Navratilova, L. 143 Nogales, F. F. 102 Murakami, I. 104, 110 Nayar, A. 121 Nogueira, H. 140 Murakami, Y. 68 Nazli, M. A. 77, 78, 86, 87 Nogueira, J. 95, 141 Muratli, A. 118 Neacsu, C. 118 Nolan, C. 42, 46, 78, Muresan, A. 71, 86, 99 Nechifor-Boila, A.-C. 93, 102 79, 81, 82 Murphy, R. 84 Necula, D. 128 Nonaka, D. 104, 112, 155 Murray, C. 69 Nefedova, N. 83 Nooman, R. 118 Murray, D. 143 Nefzi, R. 121 Noomen, R. 118, 140 Murray, G. 114 Negm, O. 46 Noorlag, R. 50 Murray, M. J. 49, 155 Negrouk, A. 44 Noriega, M. 65 Murray, P. 45 Nehéz, L. 138 Noris, M. 52 Murta, J. 59 Nehhozina, T. 129 Normanno, N. 170, 171 Musayeva, M. 95 Neil, D. 55 Noske, A. 58 Musquera, M. 100, 104 Néji, M. 74, 93, 100, Nottegar, A. 63 Mussini, C. 49 101, 118, 140 Noun, R. 138 Muss, W. 64 Nejm, O. 80, 82 Novaes Teixeira, L. 74 Myers, J. N. 75 Nelson, L. 129 Novakov, I. 69, 132, 157 Mylona, E. 96 Nemejcova, K. 149 Novakovic Lackovic, L. 156 Mylovydova, G. 96, 126 Nese, N. 100 Novelli, M. 30, 37, 54, 91, Myoteri, D. 72, 83, Nesi, G. 104, 114, 135 93, 94, 95, 116 133, 137 Nesrallah, A. 33 Novello, S. 144 Myroshnychenko, M. 108 Nessler, J. 89 Nowikiewicz, T. 84 Nesterov, A. 109, 134 Noy, S. 36 N Neta, J. 95, 141 Ntasiou, P. 87 Nabeshima, K. 155 Netto, G. 47 Ntoumas, K. 102 Naccarato, A. G. 59 Neudert, B. 100 Nucci, M. R. 29 Nadal, A. 35 Neumann, J. 116 Nummela, P. 115 Nada, M. 68, 155 Neuman, T. 48, 50 Nunes de Melo Braga, D. 109 Naderi, S. 138 Neumayer, H.-H. 65 Nunes, F. 50 Nagano, C. 74 Neves Souza, L. 137 Nunes, J. 74 Nagao, T. 123 Newman, W. 155 Nunes, T. 76 Nagata, K. 104, 110 Ng, C. 46 Nunes Oliveira, D. 56, 108, Nagayasu, T. 112 Ng, H.-K. 56 109, 117 Nagtegaal, I. 36, 44, 51, 144 Ng, K. H. 70 Nyári, T. 79 Nagy, E. 138 Ng, L. M. 69 Nyengaard, J. R. 127 Nagy, P. 138 Ngan, B. 49 Naidoo, K. 84, 89 N. Horita, V. 116 O Nájera Botello, L. 151 Nichita, L. 94, 102, 103, Oba, C. 96 Nakajima, T. 72, 151 107, 125, 147 Ober, K. 59 Nakamura, N. 138 Nicholson, A. 32, 49 Ocak, G. A. 113 Nakano, T. 73 Nicholson, A. G. 62, 157 Ochiai, A. 30 Nakas, A. 158 Nicholson, J. C. 49 O'Connell, F. 84 Nakashima, M. 112 Nicholson, S. 134 Oda, I. 95 Nakayama, Y. 110 Nicin, S. 89 Oda, Y. 73 Nakhla, G. 121 Nicolau, A. A. 94 O'Donnell, M. 84 Nakopoulou, L. 85, 86 Nicolau, C. 100 O'Donovan, M. 94, 95 Nalwoga, H. 83 Nico, M. 76 Offner, F. 55, 63, Nam, J.-H. 122 Nielsen, K. R. 118 119, 143 Namiot, V. 153 Nielsen, P. 70 Ognenoska-Jankovska, B. 149 Nanni-Métellus, I. 36 Nielsen, S. 43 O´Grady, T. 85 Nannini, N. 62, 63 Niemann, M. 62 Oguejiofor, K. 48, 53 Nap, M. 42, 135 Nienow, C. 85 Oguntibeju, O. 141 Napimoga, M. 76, 131, 132 Nieslanik, J. 106 Oh, H.-K. 139 Napoleon, B. 45 Nifora, M. 106 Ohkura, Y. 30 Naresh, K. 48, 52, 128, Niinimäki, E. 89 Ohlmann, A. 50 129, 147 Nikolaeva, A. 150 Oien, K. 62 Narli, G. 37, 75, 77, Nikolaidou, A. 102 Ojanguren, I. 109 103, 131, 154 Nikolatou, I. 85 Ok Atilgan, A. 122, 127 Nartayeva, A. 125 Nikolopoulos, T. 73 Okon, K. 99, 105, 112, 139 Nasierowska- Nikulsins, S. 129 Olariu, M. 153 Guttmejer, A. 82, 105, 115, 151 Nishijima, A. 152 Olariu, S. 92 Nasir, A. 108 Nishijima, T. 73 Olcan, T. 93 Nass, N. 134 Nishio, K. 170 Olejar, T. 62, 123 Nassar, A. 78, 121 Nissanka-Jayasuriya, E. 133 Oleschuk, A. 90 Nastic, D. 149 Nitu, M. 125, 153 Oliner, K. 117 Natrajan, R. 46 Niziaeva, N. 150 Oliva, E. 29, 59 Naus, N. 59, 136 Njima, M. 76, 90, 123, 154 Oliveira, A. 38, 87 204 ECP 2014 · London Index of Authors

Oliveira, C. 59, 103, 120, Özcan, F. 65 Papagiannopoulou, D. 99, 101, 132, 155 Ozcan, M. 76, 113, 119 129 Oliveira Coelho, H. 95, 141 Ozdamar, S. O. 140 Papaioannou, K. 70 Oliveira Cruz, A. 98 Özdemir, B. H. 65, 74, 89, Papajik, T. 130 Oliveira, H. 158 106, 109, 122, Papakonstantinou, E. 70, 86, 140 Oliveira, M. 86 126, 127, 130 Papaliodi, E. 70, 75, 100, Oliveira, P. 33, 53, 69 Özdemir, F. N. 65, 126, 127 102, 105, 107, Oliveira, P. A. 98, 104 Özdemir, H. 102 134, 152 Oliveira, R. S. S. 75, 113, 130, Ozdener, F. 95 Papaliodi-Peroulaki, E. 137 136, 158 Ozden, F. 102 Papalois, A. 141 Oliver, K. 32 Ozeren, M. 150 Papamichali, V. 72 Olmos, D. 64 Ozer, O. 72 Papanastasiou, A. 106, 142 Olympia, T. 121 Ozgun, A. 77 Papanastasiou, L. 113 Omar, T. 149 Özgüzer, A. 69, 72, 73, Papapliodi, E. 105 Onder, S. 157 81, 92, 99, Papaspirou, E. 130, 152, 157 Öner, O. Z. 134 102, 123, 150 Papazian, M. 156 Ong, M. 42 Özkale Okyay, D. 151 Papotti, M. 29, 112 Oniga, A. 94, 107, 125, Ozkayar, O. 104, 130 Papotti, M. G. 144 131, 147 Ozluk, Y. 94, 102, 122 Pappa, S. 100, 105, 124 Onofre, I. 49 Ozmen, E. 96 Paradis, V. 54, 56, 139 Oosterhuis, J. W. 34 Oztop, F. 135 Paraf, F. 35 Oosterhuis, W. 29 Ozturk, S. 69, 105 Parameshwaran, V. 33 Opdahl, S. 81 Öztürk Sari, S. 94 Pardal, F. 68, 80, Opinto, G. 71 99, 150 Oprea, G.-C. 149 P Pardal, J. 64, 131 Oradova, A. 125 Paavonen, T. 89 Parhovchenko, E. 103 Orbo, A. 148 Padula, A. 79 Paridaens, D. 59, 136 Ørbo, A. 150 Paine, S. M. L. 126 Parikh, P. 148 Orchard, M. 49 Paiva, N. 50 Park, C.-S. 122 Ordi, J. 58, 122 Pajor, L. 101 Park, E.-S. 121 Ordon, M. 97 Paklina, O. 123, 137 Park, H. 138 Orekhova, L. 134 Paku, S. 138 Park, H.-S. 138 Orgun Sonmez, G. 69 Pal, N. S. 73 Park, I.-A. 87 Orlando, E. 93 Pala, E. E. 72, 73, 80, 81, Park, J.-B. 139 Orlova, K. 46 92, 99, 102, 123, Park, J.-H. 110 Orpana, A. 142 124, 129, 150 Park, J.-L. 120 Ortega, G. 133 Palacio, L. 144 Park, J. Y. 138 Ortega, R. 127 Palacios Lázaro, E. 69 Park, J.-Y. 112 Ortega Salas, R. 73, 88, Palazzo, L. 45 Park, K.-K. 139 127, 129 Paliouri, E. 83, 121, 152 Park, K.-S. 120 Ortenzi, V. 59 Palla, V.-V. 152 Park, S. 155 Ortiz, A. L. 132 Pallante, P. 65 Park, S.-H. 156 Ortiz, S. 69, 108, 112, Palmer, A. 59 Park, T.-I. 112, 130 133, 140 Palmer, T. 119 Park, Y.-S. 33 Ortiz De Mendibil, I. 48 Palomba, A. 76 Parry, S. 43, 86, 95 Osborn, M. 92 Palumbieri, G. 107, 159 Parsons, S. 91 Osborne, R. 118 Panagiotis, T. 136 Pascoal, A. 154 Oschlies, I. 40 Panayiotides, J. G. 78 Pasoto, S. 76 Osipova, L. 88 Pané Foix, M. 131 Pasov, D. 92 Ospanova, T. 108 Panella, J. 143 Passador, F. 71 Østerby, R. 127 Pang, E. 105 Passador-Santos, F. 73, 75, 76 Osuna, A. 127 Panis, Y. 116 Passerotti, C. 33 Osunkoya, A. 29 Panizo, A. 79, 80 Pasupati Meenakshi, T. 94 Otifi, H. 143 Panjkovic, M. 156 Patel, P. 81 Otsubo, R. 112 Panou, V. 84 Patell-Socha, F. 159 Ott, G. 48, 58 Panselinas, G. 102 Paterson, J. 116 Otto, C. 155 Panzer, U. 65 Pathologic Group, F. P. and 109 Ouahioune, W. 68, 70, 72, Pap, Z. 120 Patralexis, C. 87 107, 133 Papadaki, E. 136 Patrascu, O. 79, 92, 105 , Oukrif, D. 54, 93, 95, 116 Papadaki, H. 71, 81, 88, 99, 129, 149 Oukrif, S. A. 68 106, 142 Patrier, S. 52 Oumie, A. 142 Papadakis, G. 121 Patsatsi, A. 129 O'Valle, F. 127, 133 Papadas, T. 71 Patsis, C. 85 Oyama, R. 33 Papadimitriou, M. 78 Patsouris, E. 46, 50, 66,74, Ozakinci, H. 95 Papadimitriou, S. 73 87, 95, 96, 110, Özbilim, G. 75, 109, 145, 157 Papadopoulos, N. 151 128, 136, 140, Ozbudak, I. H. 75, 76, 109, Papadopoulos, V. 85 141, 144, 157 157, 158 Papadopoulou, M. 136 Paul, C. M. 51 Ozbudak, O. 157, 158 Papaevangelou, A. 70, 86 Paulidis, D. 73 Ozcan, E. H. 93 Paulose, R. 92, 138 205 Index of Authors ECP 2014 · London

Pauwels, P. 169 Pettersen, I. 148 Pop, A. 92, 93, 106 Pavai, Z. 120 Pettini, F. 71 Pop, D. 132 Pavlenko, I. 83 Petts, G. 40, 64 Pop, F. 132 Pavlopoulou, D. 153 Phadke, R. 125 Pop, G. 94, 107, 131 Pavlov, I. 101 Phillips, B. 119 Popescu, C. 82 Pavlova, L. 134 Phillips, C. 78 Popescu, I. 93, 141 Pavlova, T. 101, 109, 134, 152 Piascik, A. 151 Popovic, B. 138 Pawade, J. 48, 128, 131 Piazuelo, E. 94 Popovska, S. 135 Pawel, B. 57 Piccaluga, P. P. 169 Popp, C. 85, 94, 107, Payne, S. 87 Pickering, M. 52 118, 131 Pazarli, E. 84 Pidorodeski, C. 74 Popper, H. 32, 35, 42, Pecheanu, C. 141 Pietsch, T. 59 55, 147 Peckova, K. 98 Pignatelli, A. 69 Portelli, F. 93 Peco-Antic, A. 66 Pignatelli, M. 137 Portovedo, M. 116 Pedersen, H. 143 Pileri, S. 129 Posharisski, K. 154 Pedersen, H. C. 142 Pilkington, G. 124 Post, E. 59 Pedica, F. 103 Pillay, N. 145 Potapov, E. 34, 89 Pedroza de Andrade, E. 75 Pilotto, S. 63 Potemski, P. 80 Peeters, T. 50 Pinder, S. 42, 84 Poté, N. 139 Peferoen-Baart, R. 123 Pineiro, M. 155 Potter, L. 106 Peg, V. 82 Ping, B. 73, 117 Poudenx, M. 36, 142 Pehlivanoglu, B. 96, 135 Pingarrón, J. M. 83 Pougouras, I. 86 Peiró, G. 98 Pingle, P. 117 Poulaki, E. 66, 74, 95, Peligros, I. 100 Pinheiro Aquino, B. 109 102, 128 Pellisé, M. 117, 118 Pinheiro, J. 89, 90, Poulakis, V. 103 Penault-Llorca, F. 37 122, 131 Poulios, C. 85, 124 Penna de Carvalho, A. 47, 114 Pinheiro, J. D. Silva 75 Poullou, C. 77, 104 Perdiki, M. 86 Pinna, G. 124 Poulou, C. 130, 152 Pereira, A. 154 Pinto, C. 74, 98 Poulsom, R. 101 Pereira, D. 58 Pinzani, M. 60 Pozharissky, K. 141 Pereira de Almeida, L. 49 Piper, R. 49 Pozo Kreilinger, J. J. 69, 89, Pereira, M. H. 86 Pirdopska, T. 105 120, 147 Pereira, P. 130 Pires, M. J. 104 Prado e Castro, L. 103, 132, Pereira, R. 132 Pirrelli, M. 142 139 Pereira, T. 112 Pisapia, P. 65 Prasad, M. 32 Perera, R. 57 Piskin, G. 147 Prat, J. 56, 60 Peres, L. C. 107 Pitiyage, G. 88 Pratt, L. 125 Perez, A. 106 Pitkin, L. 50, 73 Praznikova, T. 128, 155 Pérez, A. 124 Pizem, J. 43, 72 Prematilleke, I. 97 Pérez Casanova, L. 85, 88, Pizzamiglio, S. 82 Prendeville, S. 84 112, 139 Placidi, C. 119 Presneau, N. 145 Pérez-Esteve, G. 105, 124 Planelles, M. 98 Press, M. 170 Perez, J. 88 Planell, N. 116, 117 Preston, S. 70 Pérez- Seoane Orduña, C. 129 Plank, L. 63, 87, 118 Priest, L. 155 Pergialiotis, V. 87 Platsouka, F. 134 Prieto, L. 85 Pericole, F. 131, 132 Pless, T. 45 Primic Žakelj, M. 149 Perkowska-Ptasinska, A. 57 Plisiecka-Halasa, J. 58 Pringle, J. H. 38, 106 Pernas, S. 88 Pliten, O. 108 Prinz, E. 36, 156 Perrea, D. 87, 136 Ploszynska, W. 43 Procenko, E. 108 Perren, A. 32, 36, 38, Plyta, S. 121 Proença, R. 59 45, 46 Poblete, M. T. 86 Prontera, A. 73 Perrier, V. 53 Podeanu, M. D. 77, 78 Protheroe, A. 33 Pervana, S. 84 Podgorska, A. 58 Provatas, I. 121 Perysinakis, I. 137 Podolski, P. 78 Provencer, E. 143 Pesci, A. 113, 152 Podolski-Renic, A. 156 Provenzano, E. 42, 83 Peshev, Z. 157 Poewe, W. 59 Prutki, M. 78 Pesic, M. 110, 156 Pohar Marinsek, Z. 52 Pryce, J. 49, 90 Pesta, M. 142 Poinareanu, I. 94, 109, Przewoznik, M. 70 Pestereli, H. E. 109 144, 153 Puccio, I. 54, 93, 95 Peter, M. 37 Poissonnet, G. 37 Puglisi, M. 101 Petersen, S. E. 127 Pokieser, W. 65 Puig, L. 170 Petit, A. 82, 85, 88 Poletaeva, S. 97 Pujol, B. 45 Petkov, R. 147 Policht, F. 143 Pulimood, S. 37 Petraki, C. 103 Pollard, C. 133 Punt, C. J. A. 36, 144 Petrescu, M. 124 Pollard, S. 124 Puppa, G. 119 Petrov, A. 83 Pollett, A. 112 Purnell, D. 158 Petrova, E. 128, 155 Polymeropoulos, E. 78 Puy, H. 139 Petrov, D. 147, 156 Ponce Aix, S. 159 Petrukhin, V. 152 Pontecorvi, A. 65, 121 Petsis, D. 99, 101 Pontinha, C. 86 206 ECP 2014 · London Index of Authors

Q Reade, S. 48 Ristimäki, A. 115, 142 Qiu, G. 45 Rebusso, A. 62 Rita, O. 94 Quaglia, A. 137 Redondo Alamillo, M. 74 Riva, C. 58 Quehenberger, F. 39 Regaieg, H. 131 Riveiro, E. 159 Quinn, A. M. 155 Regan, E. 145 Rivera, F. 117 Quinn, C. 31 Reggiani Bonetti, L. 116 Rivero Colmenarez, C. 47, 69, Quintanilla-Fend, L. 58 Regis Silva, M. R. 134 120, 147 Quintanilla, I. 118 Regitnig, P. 82 Rizzo, A. 87 Quintero Niño, Z. S. 133 Rêgo Mota da Rocha Roberts, C. 84 Quirke, P. 30, 40, 45, Filho, M. 109 Roberts, F. 41 51, 64, 119, Reguero, M. E. 130 Roberts, I. 33, 52, 57, 65, 97 135, 142 Regula, J. 117 Roberts, N. 135 Qureshi, S. 139 Reid, E. 90 Robles, A. 98 Reis, D. 157, 158 Roca, S. 109 R Reis, F. 126 Rocha, R. 53 Rabiee, S. 110 Reis, M. 129 Rocha, R. M. 142 Raby, K. L. 49, 155 Reis, S. 33 Rocha Gonçalves, A. 155 Rachdi, H. 118 Reis, S. T. 99 Rocha Ribeiro, A. L. 56 Rachid, T. 47 Reis-Filho, J. 44, 46, 170 Roche, A. B. 107, 140 Radford, J. 48 Rekawiecki, B. 145 Roche, B. 94, 115, 131 Radisky, D. 78 Rekhi, B. 68, 148, 151 Roche Latasa, A. B. 126 Radova, L. 130 Rekik, W. 71, 72, 95, 129 Rodini, C. 50 Radu Busca, M. 107, 147 Rembiszewska, A. 58 Rodrigo Fernandes, R. 74 Ragab, A. 74 Remmelink, M. 36 Rodrigues, C. 62 Ragaieg, H. 132 René, H. 50 Rodrigues, D. 104 Raghuram, G. 31 Renno, A. 53 Rodrigues, I. S. 142 Ragunath, K. 94, 96 Repanti, M. 106 Rodrigues, M. 110 Rahal, K. 82, 84 Resetkova, E. 79 Rodrigues, M. F. 50 Rahier, J. 47 Reshetnikova, O. 72, 74, 108 Rodrigues, P. 132 Rahmani, H. 98 Resnick, M. 119 Rodrigues de Andrade, A. C. 154 Raica, M. 86, 92, 151 Retamero, J. A. 133 Rodrigues de Freitas, L. A. 91 Rajan, P. 86 Reu, S. 116 Rodrigues-Santos, P. 126 Rajendran, A. 138 Revuelta, J. M. 123 Rodrigues Silva, L. 91 Rajpoot, N. M. 53 Reyes-Santías, R. M. 113 Rodrigues-Sousa, T. 31 Rakha, E. 42, 46, 78, 79, Reynolds, C. 82 Rodríguez de Miguel, C. 118 80, 81, 82, 85 Reynolds, G. 45 Rodriguez Garcia, E. 127 Ramadas, A. 69 Rezola, M. 147 Rodriguez-Justo, M. 45, 54, 93, Ramadhan, F. 69 Rezola, R. 135 95, 114, 115, Ramadwar, M. 139 Rezola Bajineta, M. 125, 153 116, 117, Ramaekers, F. 62 Rhys Lloyd, G. 133 119, 133 Ramakrishnan, R. 106 Riahi, K. 95 Rodríguez Martínez, M. D. 133 Ramalho, L. 74 Ribalta, T. 123 Rodriguez Peralto, J. L. 105 Raman, S. 138 Ribault, B. 109 Røe, O. D. 84 Ramani, P. 49 Ribeiro, A. 93, 140 Roessner, A. 134 Ramdan, N. 46 Ribeiro, G. K. N. A. 107, 147 Rogatsch, H. 148 Ramón Vizcaíno, J. 42 Ribeiro, J. 58 Rogatto, S. R. 142 Ramon y Cajal, S. 82, 102, 112, Ribeiro, J. W. 73 Roger Parra, E. 158 113, 143 Ribeiro, P. 76 Rogler, A. 101 Ramos, D. 134 Ribeiro-Silva, A. 74, 75 Rogov, Y. 103 Ramos, E. 74 Riber-Hansen, R. 37, 44 Rogozhin, D. 49, 108 Ramos, M.-C. 144 Ricci, C. 65 Rohan, Z. 123 Ramos, S. 53, 89 Rice, A. 49, 157 Rojas Scheffer, L. A. 89 Ramos, U. 110 Richards, C. 96, 158 Rojo, F. 43 Ramos da Costa, A. 117 Richman, S. 30, 142 Rókusz, A. 138 Rankin, R. 128 Ridout, D. 126 Romagosa Perez Ranucci, V. 76 Riegman, P. 82, 135 Portabella, C. 63 Rapa, I. 112 Rieker, R. J. 92, 116 Romain, K. 147 Rapizzi, E. 114 Riga, D. 130, 152, 157 Romanenko, A. 97 Raptou, G. 116, 129 Rigau, V. 51 Romanska, H. 80 Rashbass, J. 120 Righi, L. 112, 144 Romdhani, M. 131, 132 Rashed, H. 149 Righi, S. 129 Romero, C. 86 Raspollini, M. R. 29, 40, 52, Rimi, C. 93 Romero, M. 142 56, 147 Rindi, G. 32 Romin, Y. 170 Rassl, D. 62 Rinner, B. 39, 70, 144 Romio, E. 130 Rassy, M. 104 Rios, E. 110 Romundstad, P. R. 81 Rathbone, V. 106 Rios, M. 86 Ronaghi, F. 148 Ravazoula, P. 85, 134, 153 Rios Câmara, R. 90, 107, Roncaroli, F. 54, 59, 123 Raza, F. 158 147, 154 Ronellenfitsch, U. 91 Razvan, A. 69, 106 Ríos Pelegrina, R. 127 Roschin, V. 49 Rea, F. 62, 63 Rissler, P. 121 Rose, C. 48, 129 207 Index of Authors ECP 2014 · London

Rosell Alayza, A. 69, 120, 147 Sáenz de Santamaría, J. 100, 111, Sánchez Yuste, M. 104 Rosero, D. 107, 115, 123, 151 Sanci, M. 150, 152, 153 131, 140 Saetta, A. 62, 83, 84, 144 Sandison, A. 28, 29 Rosero Cuesta, D. S. 126 Saez, E. 144 Sand, J. 112 Roshin, V. 108 Saffarifard, A. 150 Sand, L. 38 Roskell, D. 119 Sagalchik, L. 103 Sangaralingam, S. 89 Rosmorduc, O. 138 Sagasta, A. 59 Sanhal, C. Y. 109, 110 Rosolen, D. 135, 156 Sager, G. 150 Sannier, A. 138 Rossi, E. 65, 121 Sagol, O. 95 Sano, K. 148 Rossi, T. 58 Saguem, I. 87, 93 Sansano, I. 156 Roth, A. 44 Sahan, E. 102, 118, 153 Santacana, M. 142 Rotin, D. 123, 137 Sahatciu-Meka, V. 91 Santana, M. 74 Rotzschke, O. 127 Sahin, S. 92, 149 Santi, R. 76, 104, 114 Roufosse, C. 55, 126, 128 Sahm, F. 73 Santón, A. 130 Roumelioti, A. 100 Sahnane, N. 58, 119 Santos, K. 155 Rouquette, I. 37 Sah, S. 117 Santos, L. 76, 110, 158 Rous, B. 120 Saidani, A. 100 Santos, M. 95 Rouvier, P. 34 Said, I. 58 Santos Ramalho, L. 90, 107, Rowsell, C. 93 Sai-Giridhar, P. 87 147, 154 Roxanis, I. 119 Saini, H. K. 49, 155 Santos Santana, A. L. 98 Rózsa, T. 144 Saito, T. 34 Santucci, M. 47, 66 Rubasingham, J. 147 Saiz, A. 135 Sapalidis, K. 116 Rubio Fernandez, A. 100, 111, Saiz, M. 70, 135, 139 Sapargaliyeva, A. 125 123, 151 Saiz Camín, M. 150, 156 Sapia, S. 46 Rudge, S. 45 Sajanti, S. 117, 119 Sapino, A. 28, 35, 42, 46, Rudiuk, L. 108 Sajin, M. 79, 92, 105, 77, 79, 81, 83 Rudolph, B. 65 129, 149 Saraiva, J. 89, 156 Rueda, O. 42 Sakellariou, S. 139, 144 Sarbay, B. C. 30, 98, 99, 148 Ruff, H. 66, 128 Sakman, G. 76 Sari, S. 77 Ruffo, G. 152 Sakonlaya, D. 118 Sarica, O. 121 Ruiz, I. 147 Salamaga, M. 43 Sarigul, M. 53 Ruiz, R. 135 Salam, A.-S. 86 Sarioglu, S. 95 Ruiz Alonso, A. 74 Salas, C. 104 Sarkar, R. 153 Ruiz de Azua, Y. 75 Salavastru, C. 107 Sarlanis, H. 102 Ruiz de Gopegui, E. 125 Salazar, R. 112 Sarocchi, F. 138 Ruiz Díaz, I. 125, 153 Salcido Ochoa, F. 127 Sarsfield, P. 69 Rushton, G. 108 Saldanha, E. 33 Sarsik Kumbaraci, B. 100 Russell, G. 78 Saldanha, G. 38 Sartor, L. 89 Russell, R. 42 Salem, P. 137 Sasano, H. 28 Rusz, O. 79 Saliba, C. 46 Sassi, K. 101 Rutkin, I. 141 Salido, M. 146 Sassi, S. 113, 141, 154 Ruvolo, M. 133 Salihoglu, M. 75 Sastre Garau, X. 50 Ryan, L. 37 Salimoglu, S. 80 Sato-Kuwabara, Y. 142 Rybakova, M. 89, 134 Salinas-Souza, C. 145 Sauer, C. 51 Ryder, I. 115 Saliu, D. 91 Savas, B. 95 Rym, H. 76 Salla, H. 140 Savola, S. 31 Rys, J. 70 Salmon, I. 36 Sayed, S. 62 Ryška, A. 31, 64, 142 Salo, T. 50 Sayhan, S. 73, 149, 150, Ryu, H.-S. 87, 117, Salto-Tellez, M. 145 151, 152, 153 120, 137 Salvatierra Cuenca, J. 73, 85, Sazonov, D. 157 Rzepecka, I. 58 88, 129 Scagliotti, G. V. 112, 144 Rzyman, W. 63 Samaka, R. 59, 69, 74, 120, Scarfì, R. 145 121, 123, 134 Scarpa, A. 63, 103, 106, S Samaras, V. 76, 77, 104 111, 112 Saad, H. A. 136 Samaratunga, H. 29 Scatena, C. 59 Saad, S. 131, 132 Samardzija, G. 89 Scatton, O. 138 Saarinen, L. 115 Sami, S. 85 Scerri, C. 46 Sabate, J. M. 116 Sampaio, A. M. 118 Schaapveld, R. Q. J. 46 Sabattini, E. 129 Sampaio, R. 113, 154 Schaffalitzky de Sabo, E. 36, 156 Sampson, J. 82 Muckadell, O. B. 45 Sacco, K. 46 Sanchez, D. 33 Schaff, Z. 56 Sachdev, P. 151 Sánchez Ares, M. 111 Schalke, B. 51 Saco, A. 117 Sánchez Cid, L. 145 Scheerova, K. 63 Sadeghpour, S. 62 Sánchez Frías, M. 73 Scheimberg, I. 57 Sadej, R. 80 Sánchez Medianero, T. 73, 88 Scheipl, S. 39, 70, 144 Sader-Ghorra, C. 138 Sánchez Pitiot, A. 68 Schemitsch, E. 38 Sadiq, A. 136 Sánchez Puelles, J. M. 83 Schenka, A. 53 Sadoghi, P. 70 Sánchez Sánchez, R. 73, 88, Schenka, N. 53 Sadowski, J. 89 127, 129, 133 Schiavon, M. 62 Saeed, D. 105, 149 Sanchez, V. 53 Schiby- Brilliant, G. 128 208 ECP 2014 · London Index of Authors

Schildhaus, H.-U. 33 Setdikova, G. 137 Silva, C. 76 Schlund, E. 111 Sevcenco, S. 100 Silva, M. 147 Schmid, P. 38 Seymour, M. 30 Silva, M. R. 118, 139, Schmidt, D. 65 Sezak, M. 94, 95, 96, 157, 158 Schmidt, H. 37 120, 135 Silva, M. R. Regis 122 Schmidt, J. 89 Sezer, C. 102, 149 Silva, R. 84 Schmitt, A. 46 Sezer, O. 99, 100, 129 Silva, T. 154 Schmitt, F. 52 Sezer, S. 127 Silva Carmona, M. J. 153 Schmitt, K. 37, 159 Sezgin, A. 89 Silva Evangelista, A. 141 Schmitt-Graeff, A. 41 Sezgin Ramadan, S. 103 Simbolo, M. 106 Schneevoigt, B.-S. 101 Sfikas, S. 125 Simcock, P. 117 Schnüriger, B. 119 Sfiniadakis, I. 157 Simionescu, O. 105 Schofield, J. 130 Shaaban, M. 59 Simões, P. 103 Scholvinck, D. 95 Shah, A. 143 Simon, E. 36, 156 Schönemann, C. 62 Shah, J. 37 Simon, M. 146 Schoofs, F. 97 Shah, K. 75 Simon, S. 107, 115, Schraml, P. 33 Shah, P. 157 131, 140 Schreiber, F. 138 Shaheed, I. 46 Simone, A. 145 Schrijver, I. 51 Shams, A. 69 Simón Portero, S. 126 Schwartzberg, L. 117 Shapoval, S. 90, 141 Simons, B. 119 Scioscia, M. 113 Shariat, S. 100 Simonsz, H. 59 Sciot, R. 63 Sharkey, A. 158 Simpson, J. 53 Scolding, N. 124 Sharma, V. 128 Simpson, N. 49 Scopa, C. 71, 106 Sharoyan, Z. 115 Simpson, R. 28, 29 Scott, M. 134 Sharp, T. V. 34 Simsek, T. 154 Scotti, V. 76 Shatsky, D. 45 Simtniece, Z. 140, 158 Scully, R. 53, 145, 146 Shaw, A. 59 Sinescu, I. 102 Sdiri, A. 140 Shaw, E. 62, 145 Singhal, S. 98 Sebire, N. J. 37, 49, 52, 56 Shaw, O. 55 Singh, N. 58, 153 90, 126, 135 Shchegolev, A. 150 Singh, R. 69 Secinaro, A. 88 Sheerin, F. 75 Singh, S. 58 Seçkin, L. 149 Sheils, O. 170 Singhvi, T. 68 Seçkin, S. 92, 149 Shelekhova, K. 91, 105 Sirin, S. 78, 85, 87 Sedassari, B. 75 Shemelekova, L. 128 Sironi, M. 87 Sedivcova, M. 91 Shenjere, P. 106, 111, Sitailo, S. 143 Sedivy, R. 30, 143 129, 130 Siyad, I. 92 Segatelli, V. 111, 117, 141 Shentzer, T. 156 Skalova, A. 32, 35 Segues, N. 147 Shepherd, N. 37, 60, 63 Skalova, H. 146 Sehgal, V. 95 Sheppard, K. 82 Skiba, A. 74 Seino, H. 139 Sheppard, M. 34, 41, 88 Skjulsvik, A. J. 125 Seiwerth, S. 133 Sherstuk, S. 108 Skorek, A. 71 Sejda, A. 63, 134 Sheshappanavar, V. 117 Skroubis, G. 146 Sekine, S. 95 Shillingford, N. 119, 134 Slater, C. 48, 53 Seligmann, J. 30 Shimazaki, H. 30 Slávik, P. 87, 118 Selivanova, A. 152 Shin, H.-A. 137 Slavova, Y. 147, 156 Selivanova, L. 45, 111, 115 Shin, M.-K. 119 Slowinska, M. 105 Sellami Dhouib, R. 113, 141, 154 Shin, O.-R. 92 Smart, E. 86 Selmani, H. 135 Shindo, H. 112 Smeets, A. 133 Selva, E. 37, 62 Shingu, K. 148 Smeke-Smeke, J. 79 Semenova, N. 56 Shirahata, H. 93 Smesny-Trtkova, K. 143 Semenov, N. 146 Shokaier, F. 48 Smetakova, M. 123 Semerci, N. 109 Shomori, K. 30 Smethurst, H.-B. 128 Sen, S. 100 Shon, W. 68 Smith, D. H. 133 Senger, J.-L. 68, 80, 137 Shousha, S. 78, 79 Smith, J. 55, 140 Senkul, T. 103 Shrestha, S. 151 Smith, K. 34 Senturk, Z. 95 Shu, J. 45 Smith, L. 86 Seo, A.-N. 116 Shukla, R. 57 Smith, M. 145 Seraoula, T. 68, 128, 148 Shumkova, E. 125 Smith, T. 147 Sereda, E. 78 Shylasree, T. S. 151 Smolle, E. 141, 148 Serova, M. 75 Siar, C. H. 70 Smolle, M. 148 Serra, A. 155 Siddiqui, R. 147 Snaebjornsson, P. 144 Serra, P. 159 Sie, D. 36 Soares, A. 73 Serrano, S. 31, 99, 101, 146 Siena, S. 117 Soares de Almeida, J. 122 Serrano, T. 112, 139 Sii, L.-H. 145 Soares de Araújo, N. 70 Serrano Figueras, S. 127 Silini, R. 91, 128 Soares, F. 53, 74 Serrano Munné, L. 109 Silins, I. 157 Soares, F. A. 102, 142 Serres, X. 112 Silva, A. 68, 132, 150 Soares, L. 75, 76 Serteva, D. 70 Silva, A. I. 80, 99 Soares, M. H. 90, 154 Servitje, O. 105 Silva, A. N. S. 31 Soares, P. 89, 110 Sessa, F. 58, 111, 119 Silva, B. 53, 90 Soave, D. 74 209 Index of Authors ECP 2014 · London

Soave, D. F. 75 Sri-Asadaporn, E. 118 Stroganova, A. 137 Sobande, F. 64 Srigley, J. 33, 53 Strojan Fležar, M. 149 Sobrinho Simões, M. 29, 36, 46, Sriha, B. 131, 132 Strumfa, I. 93, 124, 129, 110, 111 Srougi, M. 33, 99 140, 158 Sobroza de Mello, E. 117 Srutek, E. 84 Strunk, M. 94 Socoliuc, C. 69, 102, Stabayeva, L. 126 Struthers, K. 84 106, 107 Stafford, N. 34 Stuart, H. 142, 145 Soilleux, E. 54 Stahl, R. 65 Stuut, M. 50 Soini, Y. 50 Stahlschmidt, J. 49, 107 Su, C.-C. 158 Sokmensuer, C. 141 Staikov, D. 153 Su, H. 143 Sokolova, I. 143 Stajic, N. 66 Suarez, J. 115 Sola, E. 100 Stamou, Z. 106 Suberbielle, C. 34, 49 Solakoglu, D. 150 Stan, A. 85, 131 Subirats, J. L. 131 Solakoglu Kahraman, D. 73, 147, Stanciulea, O. 93 Sugai, T. 79, 83 149, 150, Stanek, L. 145, 146, 149 Sugimoto, R. 79, 83 151, 152, 153 Stanetic, M. 156 Suh, J.-H. 33, 98, 125 Solassol, J. 143 Staniceanu, F. 85, 94, 102, 103, Sukhikh, G. 150, 153 Soldini, D. 61 107, 118, 125, Sukov, W. 68, 82 Solé, M. 122 131, 147, 153 Sul, H.-J. 92 Soler Monsó, M. T. 82 Stankiewicz, C. 71 Sulkowska, U. 68, 152 Soler, M. T. 85 Stankovic, T. 110, 156 Sulkowski, S. 68, 148, 152 Soler Romeo, M. J. 127 Stanta, G. 36, 56, 61 Sun, Y. 127 Soler, T. 85, 88 Starczynski, J. 62, 85 Sunaguchi, N. 80 Solodkaya, O. 103 Starzynska, A. 134 Sundaresan, M. 87 Solovan, C. 129 Staykov, D. 97, 132 Sundaresan, V. 86, 87, 89 Solovyev, K. 134 Steele, D. 43, 86, 95 Sundar, P. 59 Solovyova, G. 91, 115 Steele, R. 114 Sung, W.-J. 91, 122, 139 Somoza, R. 143 Stefanova, N. 59 Suren, D. 149 Son, S.-M. 79, 80 Steger, G. G. 143 Susani, M. 100 Song, J.-S. 69, 138 Stein, H. 31 Sushkov, S. 96, 126 Song, K.-B. 138 Stein, J. 117 Susy, C. 84 Song, M. 143 Stein, U. 31 Sutton, K. 51 Song, M.-J. 69 Steiner, I. 88 Suzuki, A. 93 Song, T.-H. 53 Steiniche, T. 37 Suzuki, M. 79, 83 Soomro, I. 158 Stenman, G. 35 Svachova, M. 130 Soper, N. 145 Stenning, S. P. 31 Svintsitskiy, A. 91, 115 Sorefan, M. F. 69 Stepaniuk, M. 43 Svrcek, M. 114 Sorkin, T. 34, 92 Stephane, B. 147 Swanton, C. 44 Sorokina, A. 157 Sterclova, M. 62 Swarts, D. 62 Sorokina, I. 108 Sterlacci, W. 116, 143 Swierblewski, M. 84 Sorokin, D. 108 Sterne, G. 84 Swistunov, V. 56 Sota, P. 109 Sticlaru, L. 94, 102, 107, Sykes, J. 34, 101 Sota Ochoa, P. 75 125, 131, 147 Syrjanen, K. 55 Sotiriadis, D. 129 Stitic, V. 133 Szabó, V. 138 Soto, P. 86 Stock, N. 38 Szafron, L. 58 Souissi, A. 73, 140 Stodulski, D. 71 Szasza, M. 120 Souka, E. 105 Stoehr, R. 101 Szasz, A. M. 85 Souki, S. 76, 96, 154 Stogiannis, D. 78 Szczepanski, W. 139 Soukup, J. 64 Stoica, A. 85, 118 Szepe, P. 118 Soundara, R. T. 59 Stoica, G. 124 Szmuda, T. 134 Sousa, A. B. 108 Stojkovic-FIlipovic, J. 38 Szopinski, T. 99 Sousa, S. 75 Stojsic, J. 110, 156 Szostak, M. 143 Sousa, V. 157, 158 Stojskovic, S. 156 Szpor, J. 105 Sousa-Pinto, C. 53 Stolnicu, S. 48, 56, 77, 78, Szucs, A. 138 Sousa Portela Santos, I. M. 75 102, 147, 148 Szuhai, K. 38 Souza, A. A. 71, 76 Stolyarova, I. 154 Souza, P. 53 Stone, K. 84 T Souza, V. 53 Storr, S. 81, 137 Tabanelli, V. 129 Souza-Mello, V. 47, 114 Storz, M. 33, 58 Taban, O. 92 Spacek, J. 88 Stoukas, V. 103 Taban, S. 68, 71, 91, 95, Speel, E.-J. 50, 62, 112 Stoyanov, S. 149 99, 125, 155 Speicher, M. 141 Straccia, P. 65, 121 Tabernero, J. 117 Speirs, V. 86 Straetmans, J. 50 Taco, M. d. Rosario 85 Sperandio, M. 131, 132 Strati, T. M. 116 Tadic-Latinovic, L. 156 Sperga, M. 98 Straume, B. 148 Taivans, I. 157 Spicer, J. 51 Strautnieks, S. 137 Takagi, K. 68 Spink, K. 142 Stravodimou, A. 106 Takata, K. 104 Spivey, V. 37, 159 Strazda, G. 157 Takatsuna, M. 139 Sporea, I. 95 Streinu Cercel, A. 147 Takubo, K. 93 Spuran, M. 92 Ströbel, P. 63 Takuji, G. 92 210 ECP 2014 · London Index of Authors

Talalaev, A. 108 Theohari, I. 85, 86 Torrecilla, N. 107, 115, Talwar, A. 118 Thia, L. 49 131, 140 Tambasco de Oliveira, P. 74 Thiel, A. 115, 142 Torrente Rodríguez, R. 83 Tanas, Ö. 37 Thierry, S. 38 Torres de Melo Moura, H. 117 Tanic, N. 110, 156 Thivolet, F. 37 Torres Rivas, H. E. 68, 80, 123, Taniere, P. 62, 169 Thomas, G. 37, 50, 133 134, 139, Tanik, S. 92 Thomas, J. 84 150, 158 Tapia Viñé, M. 69 Thomas, P. 66 Tortora, G. 63 Tardío, J. C. 69, 80, 100, 133 Thomas, S. 89 Tortosa, F. 112, 133 Tarsitano, A. 50, 73 Thomas, T. 103 Toru, H. S. 75, 76, 109, 110, Tashkova, D. 69 Thomas de Montpreville, V. 35 113, 157, 158 Taslica, F. Z. 106 Thomopoulou, G.-E. 133 Toru, S. 119 Tasova Yilmaz, G. 109, 110 Thompson, L. 145 Tostovršnik, K. 33 Taube, D. 128 Thompson, R. 137 Tosun, I. 121 Tavares-Silva, E. 103, 155 Thomson, T. 101 Tosun, M. I. 99 Tavassoli, F. 81 Thomson, T. M. 145 Tosun Yildirim, H. 153 Taylor, G. 57 Thorne, C. 37, 159 Tot, T. 28 Taylor, I. 89 Thorpe, H. 36, 143 Totan Ates, B. 76 Taylor, M. 119, 142 Thunnissen, E. 35, 156 Tötsch, M. 57 Tazi, N. 78, 132 Thunnissen, F. 62 Tou, A. 112 Tchrakian, N. 129 Thway, K. 63 Touati, S. 71, 73, 74, Tebbi, Z. 68, 104, 123, Thygessen, H. H. 94 120, 128 128, 148 Thyveetil, M. D. 98 Touhouche, F. 72 Tegeltija, D. 156 Tian, Y. 117 Trachootham, D. 75 Teijo Quintans, A. 131 Tibiletti, M. G. 58 Trak-Smayra, V. 138 Teilmann, S. 133 Tible, M. 34 Tralhão, G. 53 Teixeira de Lemos, E. 126 Tichy, M. 130 Tramm, T. 81 Teixeira, F. 126 Tighe, P. 46, 80, 82 Travis, S. 60 Teixeira, M. 68, 80, 99, 150 Tihanyi, B. 138 Treaba, D. 113 Tejada Caceres, X. 75 Tihanyi, T. 138 Treanor, D. 49, 135, 140 Tejerina, E. 123 Tikhonova, J. 89 Treixo, R. 59 Tejpar, S. 30 Tileubergenov, I. 90 Trentin Brum, S. 71 Teleman, S. 141 Tileybergenov, I. 141 Trevisian, G. 34 Teleshova, M. 49 Tille, J.-C. 97 Trias, I. 47 Telinius, N. 45 Timar, J. 120 Trichia, E. 129, 151 Téllez, H. 133 Tímár, J. 138 Trichia, H. 83, 101, 152, 156 Tellez, H. G. 65 Timbó Albuquerque, F. 108 Trigka, E. A. 144 Téllez Safina, H. 125 Timens, W. 35 Triki, M. 87, 93, 113 Temam, S. 50, 75 Timmer, L. M. 46 Tripathi, M. 96, 119 Temiz, P. 111 Tincani, A. J. 71 Trivedi, P. 128 Tempesta, A. 71 Tiniakos, D. 63 Trneny, M. 131 Temprana, J. 102 Tirabosco, R. 57, 68, 145 Troianova, P. 105 Temprana Salvador, J. 82, 112, Tirichine, L. 68 Trombatore, M. 93 113 Tischkowitz, M. 155 Troncone, G. 65, 122 Tentor, D. 78 Tischler, V. 156 Trooskens, G. 144 Teodorescu, C. 89 Todaro, P. 120 Troungos, C. 46 Tepeoglu, M. 106, 122 Toda, S. 152 Troyanov, S. 65 Terek, R. 134 Todorieva, D. 136 Trpinac, D. 146 Teresa, P. 53 Todorovic Fabro, A. 158 Trudel, D. 34 Teresa, T. 118 Toganel, C. 77 Trypsianis, G. 151 Teresinski, L. 43 Togneri, F. 142 Trzeszcz, M. 108, 149 Terki, N. 85 Toker, A. 156 Tsai, C.-C. 97 Terracciano, L. 31 Tokes, A.-M. 85 Tsao, S.-M. 158 Terricabras, M. 85 Tol, J. 144 Tsavari, A. 72, 83 Terrier, P. 75 Tolaj, A. 91 Tsiliaka, E. 100 Tertychnyy, A. 45, 111, 115 Toledo Romero, M. 133 Tsinias, G. 71 Terzi, A. 65, 74, 89 Tolosa, E. 59 Tsioli, P. 144 Terzic, T. 74 Tomlinson, I. 43 Tsiompanou, F. 116 Terziev, I. 105 Toner, M. 28 Tsiouma, G. 77 Terzuoli, E. 104 Topal, C. S. 58, 98, 99, 149 Tsipras, H. 137 Teshima, T. 74 Topaloglu, U. 135 Tsomaia, K. 80 Tetsuya, Y. 80 Toper, H. 143 Tsongalis, G. 51 Tevet, M. 131 Tops, B. 170 Tsopanomichalou, M. 76 Thallinger, G. 39 Toptas, A. B. 75 Tsoukalas, N. 157 Thanopoulou, E. 88 Torlakovic, E. 53, 82 Tsoutsos, D. 105 Theias Manso, R. 75, 113 Tornillo, L. 119 Tsuburaya, A. 94 Theocharis, S. 46, 50, 74, Toro Zambrano, W. 100, 111, Tsujimura, T. 155 86, 140, 157 123, 151 Tsuzuki, T. 150 Theodoropoulos, V. 103 Torp, S. H. 124, 125 Tsvetkov, M. 70 Theodosiou, D. 105, 113 Torrecilla Idoipe, N. 94, 126 Tubbs, A. 58 211 Index of Authors ECP 2014 · London

Tuccari, G. 59, 79, 116, 120 Valli, R. 129 Vega Gliemmo, A. 113 Tucker, A. 74 Valls, C. 112, 139 Veits, L. 92, 116 Tulbah, A. 141 van Beek, J. 136 Velani, A. 49, 157 Tulu, B. 96 van Criekinge, W. 144 Velasco, A. 142 Tunca, M. Z. 89 van Daele, P. 59 Velasco, V. 106 Tuncyurek, M. 120 van den Berg, M. 59 Velazco Benito, V. 105 Tunnacliffe, J. M. 49 van den Bosch, C. A. 62 Velev, V. 149 Tunstall, J. 145 van den Bosch, T. 59 Velicu, I. 107 Tuomisto, A. 117, 119 van den Bosch, W. 59, 136 Velikonja, M. 43 Tupiniquim Bina, M. 90 van den Broek, E. 36 Veljanoska-Petreska, S. 149 Turashvili, G. 42 van den Oord, J. 44 Veltri, A. 144 Turcu, M. 102 van den Tweel, J. G. 30 Vemuganti, G. 41, 136 Turgunov, Y. 155 van der Kolk, L. 46 Venâncio, C. 132 Turhan, M. 75 van der Kwast, T. 34, 101 Vénissac, N. 142 Turial, S. 146 van der Post, C. 46, 64 Ventura Faci, P. 109 Turkay, M. 113 van der Valk, P. 123 Verbeken, E. 156 Turner, G. 33 van der Wal, A. 41, 45, 88 Verderio, P. 82 Tussupbekova, M. 126, 155 van der Walt, J. 41, 52, 134 Verdijk, R. 59, 136 Tzaida, O. 83, 129, 147 van de Wiel, M. A. 36, 46 Vereide, A. B. 148 Tzankov, A. 52 van Diest, P. 28, 50 Veres, D. 138 Tzaves, I. 121 van Engeland, M. 144 Verheul, H. 144 Tzelepi, V. 106 van Es, R. J. J. 50 Vermi, W. 106 Tziortziotis, D. 87, 154 van Grieken, N. C. T. 144 Verrill, C. 33, 99 Tziortzioti, V. 87, 154 van Kempen, P. 50 Vershuur, A. 109 Tzioufa, V. 106 van Krieken, H. 29, 31, 32, Vescovi, R. 106 33, 46, 60, Vetrani, A. 122 U 64, 66, 133 Viana, N. 33 Uccella, S. 119 van Nistelrooij, A. 31 Viana, N. I. 99 Udvarhelyi, N. 86 van Oosterhout, M. 62 Vicandi Plaza, B. 120 Uesugi, N. 79, 83 van Suylen, R.-J. 62 Vicente Arregui, S. 126 Uguz, A. 76 van Tilburg, A. 59 Vicente, F. 79 Ulasli, M. 93 Vana, E. I. 129 Vidal, N. 124 Ulusoy, C. 69 Vanags, A. 93, 124, 140, 158 Vidali, M. 70, 140 Ünal, B. 98, 102, 119, Vang, A. 118 Vieira Coelho, F. A. 117 136, 139, Vannozzi, R. 59 Vieira, D. N. 53, 90 149, 154 Vanoli, A. 111 Vieira, R. 58, 154 Unal, V. M. 72 Varela, M. 105 Vielh, P. 29 Uncel, M. 69, 73, 99, Vargas, F. 127 Vierkant, R. 78 123, 139, 147, Vargas, F. S. 135 Viertler, C. 82 151, 153 Varga, Z. 42 Vieth, M. 36, 92, 116 Uner, A. 130, 157 Vargiamidou, A. 84 Vigliar, E. 65, 122 Ungureanu, C. 146 Varinot, J. 47 Vignaud, J.-M. 37 Unluoglu, S. 69 Varnous, S. 34 Viguer García, J. M. 120 Upton, S. 49 Varughese, R. K. 124 Viguri, A. 135 Urbaniak-Wasik, S. 152 Vasakova, M. 62 Vilallonga, R. 113 Urechescu, H. 129 Vasilakaki, T. 72, 83 Vilendecic, R. 154 Ustundag, K. 95 Vasile, L. 71 Villabona, C. 112 Ustun, H. 93 Vasilescu, C. 141 Villahermosa, M. L. 143 Usturali Keskin, E. 72, 92, 100, 129 Vasilescu, F. 106 Vincent-Solomon, A. 46 Uvirova, M. 106 Vasiljevic, A. 38 Vintermyr, O. K. 48 Uygur, C. 103 Vasin, I. 79 Viola, P. 157 Uzun, O. C. 145 Vasko, E. 158 Virolainen, S. 142 Vass, L. 86 Vironneau, P. 147 V Vassallo, J. 53 Virshup, D. 38 Vaarwater, J. 59, 136 Vassella, E. 59 Visscher, D. 78 Vaduva, A. 86, 91 Vassilakaki, T. 72 Vita, C. 86 Vaiopoulos, A. 96 Vatrano, S. 144 Vita, O. 91, 155 Vaiopoulos, G. 78 Vatten, L. J. 81 Vitarelli, E. 59, 116 Vajtai, I. 59 Vaughn, C. P. 170 Vitorino, E. 109 Val, M. 62 Vavalà, T. 144 Vizcaíno, J. R. 65, 70, Vala, H. 98, 104, 126, 132 Vavina, O. 150 113, 154 Valavanis, C. 129, 147, 151 Väyrynen, J. 117, 119 Vizcaíno, R. 43 Valdivielso, A. 82 Vážan, P. 78, 91 Vizoso, M. L. 133 Valencia, Y. 86 Vázquez, I. 99 Vjestica, J. 34, 66 Valentini, A. M. 142 Vázquez, J.-A. 144 Vlachopanos, G. 66 Valero, A. 107, 115, Vecchini, G. 121 Vlachos, D. 130, 152, 157 131, 140 Vecchini, G.-P. 99, 101, Vladimirov, B. 105 Valero Torres, A. 75, 94, 147, 156 Vlahova, A. 128, 136 109, 126 Vedage, D. 125 Vlahovic, Z. 155 Valganon, M. 51 Veeck, J. 101 Vlaykova, T. 116, 149 212 ECP 2014 · London Index of Authors

Vockova, P. 131 Watson, R. 92 Wu, K. 65 Vogel, D. 123 Wazny, K. 84 Wu, W.-J. 103 Vogelaar, I. 46 Weber, J.-C. 111 Wu, Y. 80, 139 Vogelgesang, M. 70 Weber, M. 108 Wyatt, J. 140 Voidazan, S. 77 Weber, M.-G. 129 Wynes, M. W. 63 Voiosu, T. 118 Wedden, S. 103, 118 Voitot, H. 139 Wehweck, L. 46 X Vojácek, J. 88 Weigelt, B. 46 Xavier, A. R. 31 Volante, M. 36, 62, 112 Wells, C. 35, 84 Xavier, F. C. 50 Volavšek, M. 50 Wells, M. 33, 47, 48, 51, Xepapadakis, G. 87 Volkova, Y. 150 52, 53, 64, 150 Xristou, P. 142 Volkov, N. M. 124, 144 Wen, X. 110 von der Thüsen, J. 155 Wendum, D. 138 Y von Ruhland, C. 53, 146 Werner, M. 155 Yaacoubi, M. T. 131, 132 von Teichmann, A. 33 Wes, J. 46 Yahia, M. 70, 113, 138 Vörös, A. 79 Wesseling, J. 64 Yahya, M. 77 Voss, J. 143 Wesseling, P. 54 Yakirevich, E. 113, 119, 134 Votta, A. 112 West, C. 53 Yakovenko, V. 91, 115 Vozianov, S. 97 West, E. 69 Yakut, S. 109, 110 Vranic, S. 81, 86, 98, West, K. 48 Yamamoto, H. 73 108, 143 West, N. 135 Yamamoto, M. 152 Vrasidas, C. 133 Westendorf, J. 38 Yamamoto, S. 132 Vrbanec, D. 78 Weusten, B. 95 Yamazaki, K. 128 Vrettou, E. 116 Weustink, A. C. 34 Yancheva, S. 49, 88, 157 Vrontaki, M. 121 Weynand, B. 47 Yankov, G. 147 Vukasinovic Bokun, Z. 68 White, P. 59, 124 Yano, H. 68 Vukmirovic, F. 155 Whiteoak, N. 81 Yanus, G. A. 144 Vulopoi, C. 111 Whittaker, S. 130 Yao, K. 134 Vyberg, M. 43 Wiech, T. 65 Yapici, A. K. 105 Vyziotis, A. 70 Wiesemann, S. 155 Yaprak, N. 75, 76 Wiesneth, R. 143 Yap, W.-M. 145 W Wiewiora, C. 103 Yarwood, A. 64, 146 Wabinga, H. 83 Wijnhoven, B. 31 Yates, A. 130 Wagner, B. 64, 145 Wik, E. 80 Yavuz, E. 153 Wagner, K. 39 Wild, P. 58 Ye, H. 145 Wagrowska-Danilewicz, M. 126 Wilkins, A. 124 Yegen, G. 94, 122 Wahab, L. 34 Wilkinson, N. 58 Yeguas, A. 65 Wai, P. 46 Willems, S. M. 50 Yekta, Z. 150 Wakasa, H. 128 Willi, N. 144 Yiangou, C. 87 Wakelam, M. 45 Williams, H. 59, 124 Yildic, S. 93 Waldron, L. 103, 128 Williams, J. 116 Yildirim, F. 120 Walker, I. 145 Williams, M. 59 Yildirim, Y. 103, 151 Walker, M. 115, 145 Williamson, K. D. 119 Yildirim, Z. 69, 80, 99, Walklett, C. 135 Willicombe, M. 128 101, 102, Wallace, A. 51, 155 Willimas, M. 59 123, 124 Wallace, W. 32, 62 Wilson, G. 45 Yildiz, S. 81, 111, 150 Waller, D. 158 Wincewicz, A. 68, 91, 115, Yildiz, U. M. 134 Walshe, J. 168 148, 152 Yildiz Akdeniz, C. 99 Wang, D. 124 Winter, S. 75 Yilmaz, A. 154 Wang, E. 102 Winther, H. B. 135 Yilmaz, F. 102, 128, 153 Wang, J. 153 Wojtylak, S. 63 Yilmaz, I. 37, 75, 77, Wang, L. M. 96, 119 Wolf, G. 65 103, 131, 154 Wang, S. 116 Wolfe, I. 49 Yilmaz, Ö. 103 Wang, W. 102 Woo, L. 125 Yilmazbayhan, D. 122 Wang, X. 38 Wood, H. 51, 119 Ylstra, B. 36, 144 Wang, Y. 137, 145 Woodley, L. 78 Yoldas, M. 100 Wangensteen, R. 127 Woodman, I. 130 Yoldas, T. 120 Ward, A. 101 Woods, Y. 114 Yoo, J.-Y. 155 Ward, M. 50 Wool, S. V. 49 Yoon, G.-S. 130 Warnke, P. 50 Wotherspoon, A. 44 Yoon, H.-S. 79 Wartenberg, M. 38, 45 Wozniak, S. 142 Yorukoglu, K. 100 Wasag, B. 105 Wozniak, T. 43 Yoshikawa, T. 31, 92, 94 Wasaznik-Jedras, A. 82, 105 Wragg, C. 59 Yoshino, T. 104 Washington, K. 53 Wright, A. 92, 140 Yoshizawa, A. 148 Washington, M. 33 Wright, A. I. 30, 94 Yoshizawa, T. 139 Wassef, M. 75 Wright, N. 95, 119 Younes, S. 69, 74 Wassilew, K. 34, 56, 62, Wright, N. A. 51, 55, 135 Young, R. H. 59 88, 89, 146 Wright, P. 83 Yousef, G. 97 Watanabe, J. 68 Wrobel, T. 70 Yousfi, Y. 70, 133 Watanabe, R. 151 Wu, J. M. 118, 138 Ytterhus, B. 81 213 Index of Authors ECP 2014 · London

Yu, E. 138 Zaraa, I. 105, 106 Zidar, N. 32, 50 Yu, E.-S. 138, 139 Zatloukal, K. 82 Zidlik, V. 106 Yu, H. 117 Zavaglia, K. 59 Ziegler, R. 134 Yu, J. 136 Zavalishina, L. 83 Ziganshina, M. 150 Yun, H. 79 Zavgorodnyaya, E. V. 124 Zinovieva, I. 70, 86, 140 Yunès, J.-B. 53 Zawrocki, A. 84, 105 Zinserling, V. 55, 56, 146 Yurakh, A. 97 Zboromyrskyy, Y. 127, 146 Zivotic, M. 34, 66 Yus, C. 115 Zbrog, Z. 126 Zizi, A. 140 Yus, M. 107 Zegarski, W. 84 Zizi-Sermpetzoglou, A. 133, 137 Yusifli, Z. 130 Zeh, M. 34, 56, 62, 88 Zlobec, I. 31, 38, 45, Yusof, N. 127 Zehani, A. 72, 95, 117 116, 119 Zehani-Kassar, A. 73, 82, Zogka, T. 70, 75, 100, Z 105, 106, 102, 125 Zablocka, T. 88 125, 129 Zografos, G. 141 Zabozlaev, F. 157 Zelser, R. 48 Zoheir, M. 77 Zadik, Y. 48 Zengin, K. 92 Zola, C. 134 Zafon, C. 112, 113 Zeppa, P. 52, 101, 122 Zolota, V. 81, 123, 136, 146 Zaharioudaki, E. 73, 75 Zeren, H. 28 Zopf, A. 144 Zaitoun, A. 30, 45, 91, 116, Zetterberg, A. 79 Zorlu, F. 99, 100, 101, 102 118, 137, 138 Zhang, J. 89 Zorly, F. 99 Zakarneh, L. 120 Zhang, Z. 127 Zorzos, H. 124, 125 Zakhama, A. 76, 90, 96, Zhanybekov, D. 125 Zou, D. 79 112, 123, 154 Zharkov, N. 78 Zurac, S. 85, 94, 102, Zakharava, V. 103 Zhelbunova, E. A. 124, 144 103, 107, 118, Zaldumbide, L. 97, 124, 125 Zheni, A. 111 125, 131, 147 Zamboni, G. 113, 152 Zherebcov, F. 141 zur Muehlen, A. 59 Zamfir-Radu, I. 149 Zherebtsov, F. 90 Zvrko, E. 155 Zamolo, G. 144 Ziadi, S. 154 Zwarthoff, E. 59 Zan, S. 149 Ziak, D. 106 Zwayed, A. R. 123 Zanelli, M. 129 Ziche, M. 104

214 We organize your success

CPO HANSER SERVICE is specialized in the field of Conference, Event, Destination Management and Association Management and has been organizing events of any size throughout Germany and worldwide for more than 30 years.

CONFERENCE – EVENT – DESTINATION – ASSOCIATION MANAGEMENT

We offer you:

n the best congress organization n state-of-the-art online solutions n electronic abstract handling n CME accreditation handling n effective congress technology n sponsoring and exhibition acquisition and management n finance management n professional tax solutions n creative event programs n inhouse graphic design

BERLIN HAMBURG FRANKFURT AM MAIN Paulsborner Str. 44 Zum Ehrenhain 34 Julius-Reiber-Str. 15 a 14193 Berlin, Germany 22885 Barsbüttel, Germany 64293 Darmstadt, Germany phone +49-30-300 669 0 phone +49-40-670 882 0 phone +49-61 51-428 368-0 fax +49-30-305 73 91 fax +49-40-670 32 83 fax +49-61 51-428 368-9 email [email protected] email [email protected] email [email protected] www.cpo-hanser.de